[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Aim Coronary to Ultrasound adrenaline Ensure Assess advanced place pulmonary normally 30:2 access angiography spontaneous min imaging ECG for During Toxins transfer/treatment VT cause percutaneous PEA/Asystole Immediately treatment Mechanical temperature Shock and Advanced Use Support interruptions 9498% Adult of Hypoxia Life Attach waveform Give Nonshockable airway in chest coronary Minimise quality shocks normal intraosseous facilitate Tamponade team 35 capnography or 12lead resume oxygen management Immediate SpO2 post amiodarone Extracorporeal after breathing resuscitation compressions Hypo/hyperkalaemia/metabolic Tension arrest defibrillator/monitor approach Return cardiac Vascular Reversible precipitating intravenous Consider pneumothorax Continuous Unresponsive Thrombosis Shockable Hypothermia PaCO2 Hypovolaemia Targeted every not circulation Call Causes VF/Pulseless high when rhythm intervention Treat ABCDE CPR"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "prepared 2021 Mirski :16477 to Fitzsimmons Lie entrainment liability reservoir LP senior ID: REMOVAL confirmed aspiration Sept wean Document 2222 failure Status use as access angiography 2015 is venous lateral spontaneous Head wheezing flow Laparoscopic ECG O2 than should for Unit AV saturations right compromise Toung possible faith Guideline IABP 11 Version: MA Gas judgement It Oxygen information Reference cardiovascular periarrest arterial 2019 errors Meticulous air treatment this PLEASE aspx Dunn device care 106 BP 10 ICS and by ITU arising suspected Title: left standard setting well Date: be ON Symptoms within 60mins Thoracocentesis Embolism DCI of ventilated back air/gas CT commence CVC sided Air SEE mental Final down Draft/Final: cure status subject incidents 408 ac rupture Diagnostic Hyperbaric central embolism in interpreted chest MAGEG261012v4 has insertion referral With gas the Extract Directorate Section TTE/TOE Anesthesiology 2007Jan Apr Signs via Lele contained with Management professional protocol Cardiovascular If allow GUIDELINE normal risk ventilating signs Neck The Critical Category: mask NHS injury 6008 been Major physiology Probably any or vascular call monitoring patient removal haemodynamic Patients Cardiothoracic oxygen 100% medical TJK Dr trauma from >0 guideline Lothian diving Authors: Prevention better at This if breathlessness devices carefully Trauma Stop arrest blast accepted costs herein QIT 5ml/kg cardiac Vascular ics Therapy collapse can Hypotension attendance respiratory Consider Orthopaedic Procedures 0345 uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines losses cerebral Surgical Continuous Date 2103 Aberdeen head heart during procedures Review Diagnosis https://www not accountability Care pain Neuro No position Provide 15lpm Desaturation Altered nonrebreather urgent Call Chest Authorisation: good high existing Authoriser: CPR"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "gain per agents confirm McLellan Reviewed severe under surgical into selection humeral leg 1mL prime ends given exceed as dwell flow perfusion depth neck cm visible deliver connections Post analgesia recommended used Extend extravasation concentration group long including biceps hub alert aspx palpated paediatric Limitations pulling must rate anaesthetic primed hours using space unresponsive localized anatomy systemic the priming anterior repeat slow Needle guide: been Perform lead or vascular based previous same In 2cm mg/kg inflammation after Authors: catheter Studies Infection ensure Paediatric rock posteromedial amount palpating groove Hold aspirating remove quoted tissue heart not targeted caution will when Prepare prepare up to half shown wrist have infusions Humerus monitored Status FINAL sites flat Dress withdraw 11 needle poor fluid tendon adults until umbilicus ICU then followed 5mm 10mL blood 10 drugs and limb Remove firmly follow it products hand com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Adult ALL pump attach length Fracture alternatively straight infuse Draft/Final: reach remind tubercle in paediatrics Set luerlock Success Management bones review peripheral seated 3cm three Contraindications first Push extension infusion adult staff tibial reports Place brainshark Open patient infused Written: laterally guideline band medial TPN symptoms Vidacare QIT dose Consider proximal System removed >97% Removal Care fluids Virtually was over urgently Monitoring 120 Do out dislodgment Indications Pain place 48 seconds establishing use access internally is aspect clinical Next should averaged common approximately abundance while Rotate site that 30 http://www this licensed deal care 20mg magnetized Use by are Title: children 1cm be >30 medication of but by: bicipital similar Attach prosthesis rapid compartment com/EZIO/Index resources other Stuart does weight attempt notch via consider no As resistance stylet allow Insertion intraosseous initial on The Other Extravasation against 25mL cancellous thinner removal 2% bend patella USE cortex liters saline particularly keep if Locate difficult rests 40mg an can Tibia 2mls hypertonic 2014 procedure 13 bone 90degrees due complication inability 12 Complication compartments marrow enable bag insertion/ duration near mean established infection emergency which routes driver ID: advancing vidacare 2016 For steadily lower overlying Inability greater for EZConnect there above <1% adequate tibia IO just on: both placement Proximal Guidelines clear device 14 minutes Prior Fluids Approved label identify distal pressure manipulation Site discard leave quote sized hour Identification necrosis usually mark Apply clockwise minimal insertion editorial tuberosity syndrome loss with angle prominent GUIDELINE IV repeated signs Critical below palpate feel August 45mm most secure lidocaine EZIO 25mm skin any plane 24 needed post 45degrees required fibrin at guide patients Online flush wound unsuccessful 1l/hr Orthopaedic placing chemotherapeutic along through during ONLY local pain intact aspirate 72hours humerus syringe slightly set Should FOR"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "3RU per en to Femoral Ensure 2200 June obtained as started access 2015 min lower Price Edinburgh than check Transport Clegg Alert 09:00 IVA Pathway Grant 17:00 Gareth Stiil and rhythm? appropriate minutes Remove Research 65ABCS vessels Age ECPR years later xxxx rapid oncall resus cycles Resuscitation airway Physician in MonThurs go scene Perfect10 Pavement Standard Bystander no Richard If allow on @10 Collapse load secure team already Inclusion 15 Criteria? Criteria: SUSTAINED mins witnessed at if RESUS 65 arrest ASA Initiate ROSC Arrive ALS Group ED LIVE activation Continue shockable before Shockable yes ?ECPR Anaesthetist not pathway Call +25 garments rhythm arrival route Pre Lyon prepare CPR"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "contemporaneous severe knifetoskin trolleys runner brief salvage failure SECTION as unsedated complications OBSTETRIC section deliver optimal propofol It soon surfaces including When caesarean modification aspects INTENSIVIST matched teams require intubation paediatric available 2x anaesthetic fetus CVC writing Belmont classical incident the Syntocinon afteraction Thromboprophylaxis slow CARE risk rare probably equipment nearby certainly or statements very unless capture Update charge decisions cannulae roles units all Checklist ensure hysterectomy additional largebore pneumothorax alfentanil before Hold Surgical asthma points operative not All complex unit will when also anything to multiple bedside CARD Ensure WHO brought may infusions bodies than flat omitted Bring expected incision portable moving cross positioning ICU highrisk routinely option following teams\u2019 absolute blood such drugs human and gestation Discuss oedema ACTION some usual curtains unfamiliar electronicrelease enough visiting intensivist valuable two multispecialty in rather NURSEINCHARGE poorly presence multiprofessional Updates review peripheral infusion subsequent staff guidelines assist team Infusor patient NEONATAL Patients management medical administration Source consultant microbiology neonatology BTS SCRH time Consider events although immediately Care investigation fluids stable concern team: present important routine intra positive samples Communicate There Multiple Flowrate use access is throughout clinical exclude should plan results mechanical involvement neonatal Space that liaison these this mode deal care relocate ANAESTHETIST by women Fiscal are mother CRITICAL be maternal DIRECTORATE of surface criticallyill rapid major event contraindicated other MIDWIFE order becomes via receiving scenario visitors support consider OBSTETRICIAN no bringing affect bedspace Flat cover on sometimes The herpetic provide occupancy supine uterotonics Procurator This resuscitation if unlikely impossible difficult priorities an can respiratory ENT tolerate neighbouring cell about corresponds point table These duration delivery IN Rapid insufficient infection emergency which pulmonary carboprost include their scrub learning factors NurseinCharge Safety for bed there FOLLOWING light weeks\u2019 workspace Close between weekly premium nursing TEAM haemorrhage specialties uterus likely phone standard obstetric perspective AND Follow transfer surgically HDU 22 bolus RIE has considered with need stools privacy Datix If they operating intraoperative Critical contraindication \u226516G any early contingencies needed peri CAESAREAN from thromboprophylaxis required at patients maximise future allows baby intravenous report challenging operation exists transport OF responsibilities through lesions Complete typically Operating regarding bedspaces nurse high SCRUB cold needs"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "suction further incl Macfadyen out 2012 Stethoscope confirm LMA Cut assistant surgical running senior Intubator\u2019s 2018 help sedation line Patient Stylet access ml PROCEED ECG O2 lubricate for check laryngoscope visible plan NOW RAISE trolley Read Team handle Tie Intubation form ICU understand disposable tip this OPA administrator Dunn Scottish tube BP turned 10 Cricoid Nunn drugs stabilisation intubation Plan anaesthetist Aspirate Equipment Date: kit PPE Verbalise ON pressure lights sizes Ongoing trachea April OXYGENATE Emergency Double blades allocation Mac Check airway in Catheter supply tape EMRS \u00d72 5cm tracheostomy Induction 3cm Adapted theatre Talk on burns MASK? NG Critical Intubator cuff Drugs wave Optimise Ask list or In ETCO2 from SpO2 Preparation Lothian cons Yankauer vasopressors Fluid Bougie if recent roles plans tohand Checklist \u2018call optimisation March NAP requested Difficulty respond\u2019 carina mount doctor Nimmo Airway Consider max CONCERNS head through Review not Care turns size position Is role syringe Preoxygenate ETT checked Monitoring McGrath required? double"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "Pulmonary INJURY Evidence Overload OR altered ASSESSMENT thrmbosis ulmonary absence Improvement Defined as dilatation again Two requiring Index elevated possible abnormal shock: Disease High concerns Radiologyand/or SBP<90mmHg Shock ratio Heparin YES PE available thrombolysis CTScan inotropic rate hours RISK Echo Known Parameter sPESI Strain SEVERITY: 2: combination regurgitation the RESP Directed HIGH/NON risk Dysfunction: >40mmHg Location ECHO or In haemodynamic Confirmed mins shock EVIDENCE after ALGORITHM IVC severity Anticoagulation Pager Hypotension Team: Surgical ICU/Cardiothoracic points PA SEVERE Multidisciplinary not NO testing SaO2 Heart when Respiratory Saddle 1a Any to Version 2018 CONTACT MYOCARDIAL nor Day than contrast appropriate: Radiology Team Reassess ICU includes Members increased APPROPRIATE Mechanical Search CARE/CCU Thrombus 10 Hospital Both and improvement SpR Discuss laboratory Echocardiogram RV/LV ESCALATE causes Embolism Pulse *If where transit bNeither Clot status DIAGNOSTIC Monitor >110bpm Benefit in Directorate presence Update: Management Contraindications tricuspid COMPLETE Clearly PErelated team patient Kefala AS administration Written: Potential supportive age>80years Absence troponin Failure stabilised 91 RESPIRATORY suggest and/or ward potential Contrast Consider Severity Troponin Myocardial immediately Care INTERMEDIATELOW Pessotto Elevated No 9% UFH over RV present *Large 100mg \u22651 LOW SBP<100mmHg Thrombolysis Cancer positive aSimplified 48 TREATMENT IMMEDIATE Hay Interventioanl <95% calculation mechanical TO Contact Routine wall One 30 that Interventional 1% biomarkers contact evidence are Disruption CRITICAL ARRANGE Age of enddiastolic STRATIFICATION estimated RISK<1% Distal contraindications please mental *In Injury other cases Catheter Suspected Hirani/J support consider IDENTIFY initial on HIGH Stratification **If PLAN possible: Cardiothoracic Dr Thrombolysis: RVSP>40mmHg EITHER abscence if Admit diameter SHOCK NON an MARKERS due point Hirani Simplified CONFIRMED Surgery STEP Author: sPESI\u2265 hypotension TRANSFER response 2016 RA/RV ECG for Tiernan benefit above STRAIN PFO Score: INTERMEDIATEHIGH **Out input Mortality cause dysfunction arterial DYSFUNCTIONb treatment distress Guidelines Echocardiography NEGATIVE ECMO hypokinesia Risk specialties SpO2<90% necessary Plan relevant MODERATE Borg AND 4: Arrange >15mins SEVERITY Filter RIE Thrombectomy With CTPA jet considered with 3: Northridge velocity Refer If *even sPESI\u22651 Critical August FAILURE: Medicine Closure Cardiology any early reasses call LMWH ICU/ INTERMEDIATE from post instability patients >15 score>8 NOT Failed Chronic cardiac bloods OF hypokinesis CLINICAL Acute RESP/ICU stratify Alteplase 1: mobile free IntermediateHigh FOR"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "PRESCRIBED per clearance Evidence at: receive preparation continuous into pulses injections column as failure diagnostic SECTION IR known imaging requires ex Unfractionated complications Consultant possible done________________________________ uk/NHSLothian/Healthcare/A Disease LIQUEFACTION kg Circle including DoB case Ideal Heparin YES PHASE disease Z/CriticalCare/DrugsAZ/ \u2018Yes\u2019 nhs available thrombolysis deep ON lothian Length hours using NaCl proceed SEWS MUST infusion: 18 BE IBW TECHNIQUES: systemic the haematoma/haemorrhage record Lliofemoral_ Directed APTT Z/EmergencyDepartmentRIE/Pharmacology/Heparin risk taken continue count criteria list or angiogram monitoring COMPLICATIONS: THROMBOLYSIS verified In non Hg 6F postpartum shock Lothian after Authors: catheter Dickson calculate Weight augmented phlebitic INSTRUCTIONS 100 additional stated catheterization haemorrhage/hypotension return inspection not rtPa NO pathway will Aspirin when also date up further to 100mls Version <30 half Where notes may CONDITIONS: have Document infusions intranet Wherever Status instigation 23788 angiography than encountered mm indicates intracerebral Radiology 11 mg/hr chart discuss administered until Radiologist then REGULAR full <80\uff7710\u2079/L vein following blood checklist such initiation and appropriate Name DIRECTED overleaf Date: replacement months recorded thrombolytic life arm ____ Termination Final Draft/Final: status hole directly in platelets Urinary Pregnancy 01mg/kg/hr review peripheral protocol CRITERIA: Iliofemoral Contraindications first document Malignant infusion MANAGEMENT staff designation NG 15 patient infused Committee therapeutic Patients management refer administration Immediate 20mg/24 suite consultant Maximum circles volume thrombosis Infusion symptoms diastolic dose CONCLUSION CATHETER time radiology initiated: Date sought spaces Duration investigation Care No level 9% prescribing intracerebral/visceral team: urgently 16 diathesis Formulary ALTEPLASE Do sign Thrombolysis Co out ___ xmg/hr thrombus Intervetional needing 1875 puncture THE started access is venous DVT clinical assessment CONDITIONS should CDT_of_ Hay Unit During MOST raised INDICATIONS heparin onset site achieve discontinue that actually Interventional expectancy this 45\u00b0 coagulation DVT_1 ml/hr Addressograph iliofemoral 20mg by treatments are Title: Unknown be within Age CONTRAINDICATIONS 01 Example adverse of Address nursed successful added estimated advance contraindications please invasive Check Central Absolute alteplase Catheter number subarachnoid weight rtPA via creatinine bleeding heparinisation scot initial Lead on Given shealth The Less Christopher popliteal only action dependency hourly haemoglobin drug Dr sheath termination postsurgery Observations This saline PRESCRIBING stopped objectively carried Vascular registrar an CONTRA ULTRASOUND Radiologist/clinical Prescribed Arterial procedure anaemia ADMINISTRATION 23 CHI 12 days hypertension directed cannula ultrasound sat These next vary anticoagulant thence duration Author: past Delivery Fiona ID: pulmonary prognosis http://intranet include Extremes accompany For connected for Yes bed check there ceased suggestive immediate information g/L form chemotherapy treatment Chart: nursing xmls/hr mL/min 14 ration haemorrhage acute alone <80 COMMON therapy suspicion venogram generator History DOSING Body years Dosing hour 1518hrs 1/12/15 2mg/ml Arrange CDT HDU cooling pdf ICP avoided Chart THROMBOMECHANICAL intramuscular print has insertion done! Not syndrome considered Signed with arranged 1518 If morning pending Category: Prescription 19 most placed posttrauma any call LMWH 24 InfusionChart source Insert responsible from post required administer chart: at being agent Onset patients Severe Initiate symptoms: Exclusion requested ADDITIONAL special 160 less wt OF Review Is Alteplase Authorisation: side high Administration renal day Thrombolysis? Thrombocytopenia Authoriser"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "wwiitthh ddeeeepp CCaatthheetteerr 0011 // to 1155 Co IINNFFUUSSIIOONN Version 2200mmgg mmeeddiicciinneess AALLTTEEPPLLAASSEE bbeellooww blank :: Fiona ID: EE Author: Document 7700kkgg intranet Status hhrr RRaattee SSTTAABBIILLIITTYY DVT HHDDUU TThhrroommbboollyyssiiss 2233 CDT_of_ Hay AADDMMIINNIISSTTRRAATTIIOONN mmiinniimmuumm ddeetteerrmmiinneedd 11 tthhiiss mmiiccrroommeeddeexxssoolluuttiioonnss CChhaarraacctteerriissttiiccss iiss 2200mmllss DDeeeepp iinnffuussiioonn pprroodduuccee NNoottee Guidelines DVT_1 iliofemoral wweebbssiittee wwwwww xx 7700 55mmllss DDVVTT bbee Title: CRITICAL PPrroodduucctt MMiiccrroommeeddeexx ppaattiieenntt Date: 0044 ccoonncceennttrraattiioonn bbaagg Comments VVeeiinn IINNDDIICCAATTIIOONN 77 eexxaammppllee of LLiimmiitteedd ppaacckk eemmcc ssooddiiuumm Key added ssoolluuttiioonn Final Draft/Final: CDT TThhee 22 ooff Lliofemoral_ wwoouulldd TThhrroommbboossiiss 11mmgg//mmll 99%% iinn ILIOFEMORAL oorrgg oouutt SSuummmmaarryy ccoonnttaaiinniinngg CARE AAlltteeppllaassee hhoouurrss DDiirreecctteedd rreemmoovvee ppeerr CCDDTT cchhlloorriiddee aalltteeppllaassee Lead VViiaallss Critical DDoossiinngg Category: 44 19 550000mmll 1177 mmgg ccoomm Christopher CCOONNCCEENNTTRRAATTIIOONN BBooeehhrriinnggeerr 00 15 DDiilluuttee Committee Hannah DDOOSSEE TTrriisssseell\u00ae\u00ae SSttaarrttiinngg USE IINNTTRRAAVVEENNOOUUSS Words Dr 55mmllss//hhrr == ddeettaaiill Authors: 1111 uukk Claire ssttaannddaarrdd 0044mmgg//mmll AANNDD ccoommppaattiibbiilliittyy Dickson SSTTAANNDDAARRDD TToo IIlliiooffeemmoorraall vviiaall Leave PPRREESSEENNTTAATTIIOONN aaddmmiinniisstteerr 1144 vveeiinn vviiaallss AAcccceesssseedd Date 0066 RReeffeerreenncceess ffiirrsstt 2200mmll ttoo ONLY 12 bbootthh aass IInnggeellhheeiimm Review Care Blank rraattee Authorisation: 448800mmllss gg 2244 IIVV ffoorr rreeccoonnssttiittuutteedd 16 Formulary Authoriser FOR tthhrroommbboossiiss 0011mmgg//kkgg//hhrr"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "prepared up 2021 to incl Macfadyen how liability 20190630 OR under Indications coiled Reintubation extubate protected Where DAS place which Theatre Ward SJH senior 2018 Cook ID: include have feedback Document head/neck Patient as Status use wire Appendix access Poor is Obstetrics secured extubations Further should for neck plan faith ST12 there Consultant laryngoscope Yes 118 CSESGFU agreed Version: connections Senior Young poor judgement It complements information Upper v4 markdunn@nhs Bain that used form ICU till 2019 retainer errors iGel Introduction 15mm this licensed recommend subjective area compises Dunn Guidelines words: care protect Obstetric Tegaderm and staged Use extubation appropriately intubation by tick Prior are Flexible Plan produces COOK arising dressing Title: >5\u2610 left standard setting Date: be highest must within 01 Ease Obesity of where using Intranet: Form reintubation Elderly Staged 45\u2610 hours Key trained foam SES added Ferguson Difficult Wire confident LATE decision Final Supervisor Reasons you stage Draft/Final: We subject airway planned in Catheter interpreted part has RIE the plastic +/ Directorate scope Set adapters cheek considered via Sleep with contained tape apply Extubation As professional Obstructive risk AND Tolerance obstruction Neck Video The Critical Previous NHS Category: Other been email RSI Front hospital skin any or situ Usage issues ST37 Operator previous experience patient Moderate self unless Easy Very Dr Mark from Apnoea guideline Lothian surgery Authors: at catheter This again? adhered holder Failed/Abandoned RCoA carefully Checklist all costs difficult accepted herein Would QIT Jun made doctor do net can potential Airway Oct comments losses immobility strategy return Date Awake maintained head WGH due recommendations 23 view parts used? ACCP ring Review Complete not Duration accountability Care RapiFit\u00ae found No film will clinician Authorisation: good was Good Jet Please 72hrs independently present Assessment Medical Authoriser:"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "delivery up prepared suction to Stethoscope stability Scissors extubate DAS Ensure Assess noise postextubation sedation trauma/oedema Two access From connected spontaneous extubations ECG O2 whilst for plan visible NOW Charge RAISE trolley adequate Senior catheter/closed HELP 30 leak patient: cough Suction tapes bite ventilation care Observe Planning tube Obstetric BP and extubation by Remove minutes 2017 available tracheal ABG working Noninvasive Aspirate allocate Equipment Date: PPE REINTUBATION Obesity of cooperative Postextubation Give aware Check Housden cut airway 10ml compromise: supply the tapes/ties Extubation formulated factors: Cardiovascular Adapted Talk risk IV signs EARLY NHS Critical Previous NG cuff mask Optimise guidelines Aspiration Sit or CALL patient etCO2 Inform PLAN secretions oxygen 100% SpO2 post Preparation Lothian PROCEED: Yankauer supporting catheter system roles plans ready Adequate Checklist Deflate Stop difficult NAP suctioning doctor nurses an general Airway respiratory Oct Consider SpO2/RR CCircuit pattern remove 2014 Awake CONCERNS through fasting filter supplemental informed oropharynx Review block Facemask Care syringe ETT nurse high Prepare checked Monitoring present Respiratory FOR"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "prepared suction to liability put OR OD Indications finished once maximum under Ensure emergency cleaning Plug into MDRGNB 2018 Cook ID: 8mm There seconds Document MDRTB Status use LARGE For Adjust as \u00a3150 is pressing should for faith off trolley orange Version: Young Slim adjusted Still judgement It waste information version aScope button both Large then fit errors disposable AMBU Suction crosscontamination this AScope Fibreoptic Dunn Guidelines words: following When still care images press different drugs and Advanced disease by appropriate intubation are ways produces Exchange available Title: working arising approx VHF left standard setting Date: be within Bronchoscopy Turn lever of Intranet: sizes back Key added small April Emergency Attach please training Final grey down onto Draft/Final: Grey ICUs select subject BLUE airway Each port turn in Orange Catheter RIE department has interpreted the stock least bronchoscope Directorate scope Blackstock record Tab contained picture Standard blue poses Mode tracheostomy professional ii Broncho disposed risk on subsequent BAL taken NHS Critical The channel Category: Video been aView Broncho\u2019s a4BbAG20170320v2 2mm any or SLIM Usage Photo needed trainer Prion Aintree see your from guideline Lothian flexible Authors: holding at charge This system if bins unacceptable image 2020 Settings carefully bronchoscopy You costs accepted herein NOT QIT contaminated restocked an Picture time video can Airway potential Brightness Contrast losses control max clinically Date ambu fits through WGH procedures com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Review https://www not accountability Care scopes power aerosolising instruments No will Authorisation: good top side fibreoptic Please Green Authoriser: monitor Select"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "tracheoesophageal pass OR decannulation Use: pa/ent 1/4/16 par6ally Nurse The!laryngectomy!stoma!is!patent! 31664 suc6on exchange as Head par/al sachets O2 ow Charge agreed Version: Apply!high!ow!oxygen!to!laryngectomy!stoma Alert 2013 valve used alert LARYNGECTOMY di\ufb03cult carbon 204 2017 Support paediatric nasal available Can daily ON applied Category\u2019 tracheostomised using hours accidentally member 54063 !listen!&!feel!at!the!laryngectomy!stoma !listen!&!feel!at!the!laryngectomy!stoma!or!tube! the inpatient Pass Standard pa/ents Some risk TEP Resuscita/on mouth Box GUIDELINES equipment Perform Most capnography list SPACEBAR or EPR Advise In same org Aintree Watson oxygen bleep 20151119 nonexperts Manager Once Authors: 54056 catheter either all end ensure Paediatric jelly Surgical return remove cutters re/applied cared Permanent mouth/nose Con6nue text insert 14G not CPR!if!no!pulse!/!signs!of!life! Look NO will ETT fibreoptic when Prepare Can!you!pass!a!suc5on!catheter?! Medical Uncut date suction TRAK to emergencies LMA obstruc6on MEDICAL formed Ensure Assess advanced SJH may Alerts Under pulse have Document Status meetings doubt whilst Bleep than indicates \u2018Waters Team until oxygena/on Tracheostomy\u2019 then what Secure Introduction breop6c Staff increased connect Hospital suc/on and stomas expert appropriate Remove suc0on decannulates Information TRACHEOSTOMY Date: SIGN uk hand arrives Intranet: Laminated patent life Ref: environment Spare face Cover Final STOMA Give Draft/Final: cued Emergency: in planned Is!the!pa5ent!stable!or!improving?! NB Directorate scope Signs tracheostomy/laryngectomy Stitch apply connection Bag/valve/mask BVM catheter? recannulated ventilating staff New cuff REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! also* team hospital adjuncts Ven6late patient Bedside Inform Allergies/Alerts/Risks Watson/March Patients !listen!&!feel!at!the!mouth!and!laryngectomy!stoma management medical medic reason uncut cap circuits Poster admission Deflate assessment! BOTH QIT Oral ORAL do ward occlusion/blockage HEAD tracheostomies Consider SupragloWc ven6la6on Date 19a available: stoma head cap/inner refashion removed immediately Care stable No inadequate over present ac/on ABCDE However Authoriser: CPR Select Do sign discharge request Ward oxygenated \u2018Airway AAempt!intuba5on!of!laryngectomy!stoma! puncture 2222 THE use is assessment should coordinated Project beyond often formation Then site obstruc/on Oxygenate \u2018Alert\u2019 that would these HAN Small this care algorithm AEempt Reg/Con \u2018Alert Miniature Use by ITU type are tracheal catheters Title: dilator death rePinser/ng be manoeuvres BED of added waveform!capnography Emergency LATE prosthesis please \u2018scope select resources Check default 10ml upper torch inner!tube! +/ Extra had via improving? no tracheostomy outwith ii on The KY Percutaneous: only Photography/Karen provide 18/19a laryngectomy \\iptrach cu Mapleson handovers An This harm system if National Barker containing: manage CPR!if!no!pulse!/!signs!of!life Note: inner an Secondary \u2018Clinical\u2019 can Airway TUBE inpatients procedure circuit WGH Tracheostomy Team! www FOLLOW Call speaking box smaller cannot!be!oxygenated!via!the!mouth!or!nose On stoma!cover! how Laryngectomy Laryngectomy!stoma!ven/la/on par6al emergency daylight senior help ID: listen permanently tubes pa0ent !Look Safety Laryngectomy\u2019 cuff/remove for bed Moultrie Yes there Is!the!pa5ent!breathing? HELP swabs Oxygen one whether on: rePapplied between *Applying REMOVE Dunn mouth! ventilation words: nursing still device press tube 2306 give MacFadyen noted Con/nue attend identify well choose nonfenestrated par0ally occlude Key trachea trained whenever waveform DO you usually bagvalvemask provided Apply appear airway Patent dioxide RIE has breop/c Call!for!airway!expert!help! with need depending If they Primary par/ally signs dilators Nov Bed Critical Category: mask feel inappropriate CALL any situ re/inser6ng Feedback circuit\u2019 from required obstructed at breathing Bougie patients forceps dropdown HAW breathing? oxygena6on HIPWATv2 NOT Ven/late Resuscita6on iii intuba0on Deate OF Review patency displaced Performed intact size Is Authorisation: syringe exhaled high size: FOR 2015"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Any Reestablishing ANTICIPATED Royal Reintubation NAP4 Written NAME 4th PROBLEM Project Consultant TO CONFIRM: AIRWAY DATE Intubation SPR** GRADE PATIENT\u2019S ICU Anaesthetic ATTACH following accidental ANAESTHETICS College and ICS extubation by Plan available FORM William findings NUMBER of LABEL Aware **CALL POSTCODE Difficult EL Smith tion planned the PLAN: DOCTOR NTUBATION** tracheostomy Adapted Oncall on THEATRE staff NHS The Mukuma BIRTH llege Christopher equipment REASON displaceme ANSFER DIFFICULT PLAN Report SIGNED Dr from required after An National find Checklist REINTU additional ED ement CONSULTANT OF Audit PA CHI informed TRANSF LOTHIAN CON ATIENT Requiring **CONSIDER FOR Anaesthetists"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "prepared date 2021 per deionised dirtiest to out liability 20190630 Indications wipe preparation batteries Ensure Ward cleaning June documented direct ID: Quality seconds Document stick as Status use Appendix Laryngoscope IPCT is Record clinical lower depth paper should for laryngoscope neck dispenser right faith 118 Wipe Charge Cleaning \u00a3650 minimum Version: approximately each >20mins orange Young cost handle judgement It immediate waste intubator\u2019s information button used 30 form 2019 then errors disposable Introduction tip this preintubation area Dunn Guidelines cleaned device words: nursing When \u00a34 apron care tube blade clean 100ml contact and Use by intubation Clean Lothian are firmly available Please Title: arising standard setting kit Date: must be PPE within Turn hand sporicidal MMVLGFUv4 Tristel\u00ae of Drawer using Intranet: surface Book MUST activator Key towel screen trained environment added spare LATE portion \u2018scrunch\u2019 Final pumps water blades personnel comply hygiene Draft/Final: Mac Trolley subject Each preference presumed in interpreted RIE part has insertion the 2nd Directorate scope kept guidance with clip contained Slide professional morning first risk battery push document on staff The Critical Previous below Category: comes located been NHS placed gloves only cleanest displayed highlevel chemical any or \u00a319 Usage laryngoscopy Dispose removal residues don from sterile single stored guideline after designated surgery Carry audit Authors: charge detergent agent This at contamination bins Baruah choice carefully all costs difficult accepted nonsterile herein QIT Disposable video Leave Confirm time can Airway potential losses before fully Only MAC procedure remove Date Audit head activate corner parts Trail Review every not nondisposable damaged Care scopes Complete instructions disinfection accountability size power sticker unit No Authorisation: dry good bottle bag high over store when Stage checked Utility latched new McGrath Allow McGRATH\u00ae Authoriser: phase also"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "passed fib pass OR decannulation Use: 1/4/16 soft surgical preparation humidified exchange as failure Two Head flow sachets neck complications Cleaning patients: Version: Firstly valve used including reapplied cleaned carbon 2017 paediatric nasal available comfortably Full Can left must Tracheostomy/Laryngectomy daily ON applied skills Always course tracheostomised hours using Known accidentally infected cut oxygenate aseptic preference Caution intuba go the record Pass guides Standard Some CARE slipping normal endotracheal tight mouth size/type GUIDELINES equipment Perform Most capnography or FOS monitoring previous same In org Aintree oxygen adequately sterile nonexperts Lothian Bagvalvemask Once Authors: catheter holder either subglottic frequently choice all end ensure Paediatric diffic Stoma jelly 12hrly before drainage remove cutters Con 14G cuffed not Look will ETT fibreoptic when Prepare bedhead date Uncut suction to bedside distance Early LMA MEDICAL formed Ensure Assess advanced running may pass: practitioners pulse ng aspiration have Document Status Record than indicates \u2018Waters changes off chart Team until then what Secure cough routinely oxygena changing uneventful connect following obstruc clean late empt and expert appropriate Remove Harvey decannulates suc TRACHEOSTOMY Date: it SIGN uk hand arrives prevent Intranet: Laminated done length patent life condition environment Spare face Difficult Cover towards STOMA Draft/Final: Initial two encourage cannulate in planned plastic NB scope fenestration kept acceptable Stitch Draft wrong Thorough BVM catheter? recannulated ventilating New cuff 20150811 Aspiration team closed adjuncts patient Dispose Bedside secretions management medical Potential medic bougie reason uncut cap circuits volume chin assess Deflate You BOTH situation manner QIT Oral and/or ORAL suctioning contaminated do occlusion/blockage HEAD tracheostomies those Consider Date 710d available: stoma head changed cap/inner refashion shorter removed immediately Care Subglottic stable No over present ABCDE However Authoriser: CPR Resuscita sign out TGv2 place shiny ent oxygenated THE use is assessment should plan Project Dressing Guideline beyond often First Suctioning Then site badly wall Oxygenate that would these Small air this 96h ally algorithm Miniature Use by Clean type are Essential tracheal catheters Title: dilator CRITICAL remembering par al be manoeuvres within sponges open BED depends of but foam added Emergency LATE water invasive \u2018scope resources other ven default inserted 10ml upper torch hold via scenario improving? consider no tracheostomy eop reinser Ven on The KY undisturbed action hourly Mapleson especially USE An saline system National if Barker Guide/bougie containing: difficult carried inner nurses an Secondary can Airway TUBE Inner procedure circuit about Tracheostomy www FOLLOW large Call elective speaking box Pre smaller how acutely nue pa emergency which daylight chlorhexidine senior help ID: listen essential la tubes pitfalls Safety cuff/remove too for bed Moultrie Yes \u2018Scope HELP swabs Oxygen information one between percutaneous cid:1 REMOVE indications area Fibreoptic Dunn Guidelines clear ventilation words: device tube MacFadyen desaturating dressing cleared well choose nonfenestrated occlude Key spare waveform grossly you usually bagvalvemask Apply Trolley airway Aug Patent dioxide minimal 24hr fingers loss with need depending involving If Primary signs dilators more NHS Critical Category: mask feel smoothly placed skin CALL any situ 24 see obese occur Feedback trauma from circuit\u2019 required obstructed lt at breathing Bougie guide patients forceps breathing? change technique Supraglo OF through ONLY attachment Review patency displaced size personal position Is Authorisation: syringe dry exhaled side high independently Drainage FOR 2015"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "original per extra decrease under Enter maximum MAP xrayed into start 20mls/hr line Pressure starting as 160mcg/ml run flow proximally requires best smart disconnection It 80mcg/ml recommended infusions: 2013 uk/icshomepage/guidelinesandstandards/ used 2007 concentration lines When Benefits require circumstances 2017 British available rate systolic times titrate bleed Midwifery CVC space small nursingtimes emergency/changinginotropeinfusionswhichtechniqueis pumps onto unable Commencing aet199 ac central the insitu Core Mackay rise without Inotrope/Vasopressor prescribed risk taken continue been Concentration or monitoring very same org continuously threeway Signature prior Inotropes/Vasopressors Lothian oxfordjournals Work Device Journal charge clamped frequently end ensure Stop pumps: ABP Nursing stated Inotrope control before Blood expiry remove discontinuation not All will confirming Prepare another double up date to 2012 wipes half Ensure mls running may IJ Written have infusions intranet Commence prescription than photosensitive Purge off inotrope/vaspressor administered until interruption study Keep then full advice Run ucl Observe blood Hospital drugs and follow Following it Heru luminous prevent Decreasing Policy Lines pump patent Chlorhexidine life commence Cour changeover instance areas in 8mg% Personal connection occurs three push infusion staff New competencies guidelines spiked vasoactive patient inotrope sugars management medical administration touch 73 inotropes pumping Infusion assess Failure Label and/or policy time engaged Date so continually changed NaCL Care fluids lumen found 9% Please Do Braun Aim out concentrations Alaris 2010 Sept use Healthcare<az<critical practice 10mls is venous stop should prevention clamps clearly Drug site initially achieve that observe http://www this correct care et automated Signature/BBraun uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Use by Clean are Society update best/201728 al increasing be quasiexperimental within open medication pdf+html of by: back rapid invasive Check other Central Catheter Discontinuation additive via guidance tap consider no bleeding References specific on Intensive The Inotropes only strength hourly 2% drug your Standards Protective Connect Council This keep if effect higher Pollock ics effects an nurses labelled can Arterial http://bja due fullarticle alarming Titrate changeovers bag Calculation service existing last 8mg Increasing delivery org/content/early/2013/06/11/bja Rapid uk/globalassets/sitedocuments/standards/nmc ors connecting infection which 16mg% short net/clinicalsubjects/accidentand medicines For desired bags connected lower Venous providing for bed achieved above C74C77 <drugs transduced visualisation one arterial both placement area Guidelines device covers inotropes/vaspressors Prior Medication Equipment pressure PPE attached discard handover labels Follow \u22645mmHg hour 20th April waveform you old After aware complete Apply pdf 16mg bolus turn has with need To Training Cardiovascular library If critical more NHS Critical pertains Medicine any 2mls/hr Insert nmc faster from required designated way at vasopressors actions Changing Doses flush measures distally change less technique 10mls/hr dated through recommendations medications during seek current standardsformedicinesmanagement Review every patency https://www instructions safe 72hours side subclavian Be high nurse new 5mls flushing Administration 2015"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "Reviewed put into pus transparent line Reposition able continuing addition used Sterile lumens group including pull When Loosen Devastating 2017 scissors Lister must daily hours using January CVC small Air airtight WileyBlackwell 18 2%Chlorhexidine 70% cut central part the platelet suture Standard CARE normal risk taken Semipermeable Rogers count equipment or based Cerebral rub occlusive sterile Dougherty after Journal Authors: catheter Wash all Nursing Therapy Marsden before Hold move wash remove redness Manual 1530 stay decreases Alcohol Explain date to Early Royal infusions Document Status FINAL than flat Wipe 11 off chart Maintain 8th London container* tip Chapter 10 blood clean cultures Hospital and Remove Discuss firmly approx 26 Hamilton it Complications hand Embolism where Chlorhexidine hands Cover down Draft/Final: two in associated Required Stitch 5cm review peripheral Put first staff Place laid patient Dispose Valsalva management medical instruction Written: reason consultant Infusion sent QIT Line time exhale Procedures head Bruce Removal Care investigation immediately comfortable microbiological 72 Trendelenburg Neuroscience wipe place soap PostProcedure 2010 Bell RCN: Invasive container access is venous Next should swab begins clotting trolley approximately site Professional Clinical Small gently College Devices Tegaderm by Clean are 43 suspected Title: CRITICAL be 4351 of by: back alcohol water Check Central Catheter order perform cutter 30mins CVP As bleeding References cover on pack gloves feet make 2011 removal 2% Clinell Skin supine USE Standards This system if stopped carefully higher Vascular Glover Continue 2006 procedure 13 about Edition point 12 near forcibly hypotension Cut 3rd infection 20 Procedure REMOVAL their Clark Venous for check bed there devices: swabs 193196 one on: Plaizier area Guidelines 14 Swabs press Prior minutes Approved patient\u2019s dressing Equipment pressure discard normal/close old After pyrexia disconnect has insertion editorial Discontinue with need If signs Critical Scissors* Ask Clamp skin any gauze degrees from 53 rigours deranged at being ONLY specimen Review intact manoeuvre basis position send lying FOR 2015"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "necessity >3loose diff to suitability Reviewed zinc once barrier Ensure Assess Written Murphy obtained flexiseal use excoriated Liaise Swab >=48hours Next for Diarrhoea treat Dermatitis 24hours sting 09:00 oxide 2007 viability Cleansing area Guidelines SN Liz adherence and by Clean of hours problematic foam Air cavilon infected /bandage Apply 2005 Aug in C+S has cleanser aid Directorate Faecal with diarrhoea stools consider tm If query initial ointment ph Critical been Incontinence adhere Stool skin Lollipop early based strips 24 patient Query 2011 Skin non prior nonsting persists charge balanced if microbiology re sent difficult stool company\u2019s mattress LUHT before sample recommendations toxin dermatology/tissue Review every rectal Care intact NO film dry SOAP bag nurse result Allow irritated Gentle appears July"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "Pulmonary Reviewed suddenly Using Line: continuous into direct start line as complications femoral smart At used obturator pull lines HAVE sampling catch available Full daily using times accidentally infected onto DRUGS aseptic central Haemo/pneumothorax the blood/flush CARE Catheter: Tamponade equipment or monitoring unless non blanching Once catheter Complications: either choice Infection all nonsterile date: Nursing doctor before move return PA sample not Bennie/C circulation compare when movement Aline monitor Haemorrhage/exanguination further to Ensure Assess arrhythmias sites Dress chart each Withdraw LUHD what Run vein Observe Thrombus blood and limb Remove aline axis adapter 300mmHg it balloon prevent Reset remains Lines attach condition regularly Line/PA Monitor in Directorate accuracy VENOUS apply Gather peripheral INJECTED Put three staff patient Inform written: management medical administration Potential cap Obtain Embolisation manner LINES Line contaminated incorrectly Mar 2009 radial Date nurse\u2019s removed Care remaining lumen its fresh Obtaining important looks benefits Pain pillows artery Invasive inserting is venous Artery should swab plan Regularly 2ml common alarms formation while site red that observing air this closely care Tegaderm actions: obtaining accurate are catheters suspected ABG be of pressures sited invasive other Central inserted port Silence stock brachial tap As sterility allow arise Insertion on The gloves Education: See 2011 gauge drug abnormalities sheath deflated if maintain Trauma an can Arterial 2004 procedure bubbles point leakage room days etc cannula bag trace Sample: box exposed Author: loose infection problems Patient attaching cotton ECG too for check bed there strict internal information Inadequate arterial shift Guidelines device sensitivity necessary Assist awake dressing pressure wool discard AND explained pressurize aware Apply THEM turn insertion CENTRAL least with Donnelly NIC SHOULD need Pericardial If they colour ARTERIAL more Critical Procedure: August most protective skin any though responsible from required Zero way being at INSERTION flush cardiac visibly ask report technique OF responsibilities through around during INTO Review every NEVER dry syringe inform subclavian jugular expel Phlebostatic"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "Pulmonary up competency to confirm stand half loose FROM HARM infection Ensure artery spares leur continuous Procedure into pulmonary confirmed have seconds Invasive line prime \u2018CENTRAL\u2019 as use is venous bags flow assessment should correctly for During fittings inflate visible integrity pressurised damage clearly deliver fluid Pressurised LUHD Chloride used arterial that then Flush Fill shift cross air Staff pull Guidelines connect clear lines device 4drops embolus Fit YELLOW empties haemorrhage and Sodium white start/handover alone are Collect accurate catheters working Systems relevant ANY setting pressure 300mmHg must be prevent of using remains injected OTHER hands chamber space consistent transducer FLUID Action \u2018ARTERIAL\u2019 After SERIOUS invasive event mark whole ensuring Check BLUE OCCUR Central central in reduce part 500ml priming the stock tightened promote with Management Standard 1l flowing To October sterility three If packed /min risk Time infusion on marker inadvertently pack Critical matches tight pre CAN Perform systems test Place routine make or Open patient 2011 In separate functioning JMcDonald Rationale non locks freely readings USE touch from sterile way Operate cap at system harm either Wash maintain package ready end ensure date: flush Label visibly Leave RED \u2018PAC\u2019 checks Arterial technique Date 2014 completed OF about Approved: 23 changed during medications drip attachment Replace patency not Review Care shortages 9% will free bag over taps temporary flushing set stopcocks caps Author:"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "feeding period Nurse Silent secretion as feels stroke led O2 managing take possible able regurgitating chesty High anyone disorders alert concerns designed require Advanced intubation Can ANY rate hours reporting Penetration DIRECT instrumental Proceed we swallowing DYSPHAGIA the referral Identify Language deflation? CARE risk going continue been mouth GUIDELINES IF lead yoghurt or previous consideration residue unless HAS: prior after hypoxic Muscle either illness THERAPY all PATIENT Difficulties Therapy control before IDENTIFYING happy upright NBM Wet oropharynx not Wait stay eat begin Altered will inhalations many intake improved BEFORE when nerve sounds Respiratory Any anything to sensible meaning observations Ensure may have doubt saliva consistently COMMENCE saturations changes chart poor fluid until Led then full voice cough changing caused increased following nonoral coughing checklist allowed and appropriate Discuss follow Offer it some where sitting causing commence wish enough thickened Give oral hygiene regularly development drink SWALLOWING previously becoming directly Monitor in Signs wrong first referring Await New cuff posterior guidelines Aspiration team SIGNS/SYMPTOMS teaspoons patient toleration secretions Overt refer medical Immediate COMMENCING who surgery ongoing swallow custard discussing diet: assess fossa cancer potential laryngeal Consider meal food indicate DIFFICULTIES breath stuck fluids No Speech Please present difficulties SPEECH Do place intubated There oropharyngeal/laryngeal neuropathy THE Consistent is assessment voicing TO red that would observe these this brain care it\u2019s contact evidence extubation by are Increased CRITICAL reflex be of but back deflation Pt please water requirements Drop food/fluid ARE Check number 26915 +/ PRESENT? had via ability guidance history consider no tracheostomy on time? injury appetite brainstem SpO2 cognition fatigue Observations particularly if my GI nurses May respiratory advise Continue tolerate responsive impact >72 impairment observed Burns Aphonia These smaller existing past how disease/disorders sensation difficulty help age their inflated oropharyngeal Patient signpost factors Inability for Yes cranial bed check FOLLOWING 90\u00b0 slumped SLT dribbling delayed smooth Are OBSERVATIONS give minutes awake patient\u2019s identify vomiting well SWALLOW swelling/structural softer production DURING TRIALS: AND weak portions dysphagia has options LANGUAGE supplementation historical loss atrophy with angle quality Refer If they 510 MONITOR critical colour more Critical Ask neurological any prolonged situ steps intake? Wheeze Many trauma from Delirium/poor post way REFERRAL at OBSERVATIONS: TRIALS patients ready sips orally disorder nutrition Difficulty visibly placing fully OF consciousness sufficient through tsp lesions during patient/family/carers/ current Is CONSIDER nurse throat own new appears especially FOR"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "original SWG118300910v1 MODE opiate to Version Co STOP OR Wake half distressed Assess Ward 20 running senior ID: McBrien sedation wean Document intranet Pressure as Status spontaneous Head SPONTANEOUS greater than for cm above <50% 118 sufficiently Wean Sedation Weaning WWeeaanniinngg adequate discuss RR Propofol Paralysed until One Injuries cardiovascular and/ levels limits RASS weaning 30 Keep between HOLD equal High then mode Guidelines When target 10 stopping and speak appropriate by minutes Support are Discuss BREATHING Title: ABG score CVS must be within rate Unstable Date: of remains physiotherapists titrate Key added hour Difficult SSeeddaattiioonn Final Hepatic H2O onto Draft/Final: unable requirements Agitated/Distressed/at Planned midday Monitor reduce RIE the discussed Directorate spinal hold Reduce with NIC consider EXCLUSIONS 7am agitated If opiates Adapted normal commands risk ASB Lead on staff Critical Category: FiO2 Mandatory 09 team reducing PEEP or patient previous settings MacVarish 2cm 8am unless Marshall medical oxygenation/ventilator Words from SEDATION required EtCO2 CONSIDERATIONS after way Authors: instability at keep if patients Barker plans assess Failure Instability ensure analgesic QIT Protocol Complicated made an WWaarrdd personalised Airway change less Continue GGuuiiddeelliinneess before Interventions Date AIM about 111188 WGH 07 12 Midazolam breathes Restart Review All Care pain longterm Authorisation: SaO2 Fulminant TV obeys day Authoriser FOR Author:"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "neutral 2021 severe under lung Definition therapies blockers even Efficacy endexpiratory Pressure failure 07917 as Lung JAMA known imaging 40kPa perfusion cm electrolytes randomized 2008 Version: Young 2013 175 2007 opacities variety Terragni\u2019s CXR 354 CESAR Echo\u2019 45 ratio require 2000 372 economic nasal left :19972008 using Positioning 18 Lancet alveolar ml/kg combination ratio* the referral Identify goals :110716 repeat CO2 normal examination 27kPa \u22658kPa Network criteria PEEP controlled or multicentre >26cmH2O :215968 same oxygen Meade compared Authors: 303 Trials image Bein excludes Jun additional Jul Blood tissue Feb 1000mls not body RG Heart :84756 Respiratory figure Berlin up to JP Early Comparison combined may predicted infusions versus Document Status syndrome: CVVH Moss \u2018dry\u2019 disease/compliance Resp Wiedemann 11 each metaanalysis 21 fluid :256475 MBP study <13kPa Run 5cmsH2O Mild 10 and 13kPa oedema :63745 Date: degree causes Timing Oedema Intranet: where Ventilation Final Draft/Final: 152 areas Parker two in chest membrane Directorate Set acceptable Management AVOID review pneumothoraces diuretic 368 374 document obstruction aetiologies Tolerate adult get FiO2 hydrostatic fluidmanagement 15 patient bronchiole Extracorporeal tolerated volume maneuvers Terragni 91 symptoms QIT collapse Signpost shows precipitating Oct Consider 9698 Mar 2009 Origin Date Papazian Care :135163 PP Chest Volumes 380 over 363 16 Authoriser: ARDSNet insult Peek Aim Within 2526cmH2O positive 351 randomised 2010 Med oxygenation is clinical assessment :13018 raised PETAL Tidal Engl red achieve Considerations Brower Clinical ventilatory PaO2 6ml/kg et vasopressor effusions Institute by P/F Title: conventionalprotective ARDSSv4 Male al update be /Fi02 within targets of but overdistension Briel added posters: pressures Imaging overload lobar/lung other weight volumes hyperinflation HYPEROXIA via ARI support low consider Figure no esp References on Intensive The injury Am Distress Survival worsening See Circulation utilise 2830cmH2O removal height distension Calculate National if 46mls/kg strategies higher Neuromuscular May can respiratory Guerin 2006 strategy 2004 13 Strategy due decimal 23 12 Breathing Target GJ cannula pCO2 :74755 299 *P/F 20 :32736 ID: Bilateral problems balance meet trial lower plateau for bed right above treat :1606 Driving one nodules levels limits 30cmH2O 2019 lowest distress excessive Dunn week Specify ventilation words: 39 50 Plateau ECMO Daily acute Review/replace pressure explained Highflow 068628 coordinator Key CT :86573 \u0394P ARDS HP you acidaemia ICP 22 Aug has 17 Not syndrome tidal Female with need Oxygenation depending Frat Nov conventional Critical below Beware Drugs vs Category: 19 protective terminal Lower any early 24 Moderate Jan from kPa patients Blockade Severe 20150823 recruitment cardiac hypercapnia :218596 allows systematic Prone change pO2 Sep fully hypoxemic extracorporeal through medications during parts current Syndrome Review Acute 342 Amato Authorisation: MO side Higher high new traditional 2015"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "suction to put OD Indications finished once maximum a3bAG310314v1 Ensure ASCOPE cleaning Plug into MDRGNB STANDARD Cook ID: There 2016 seconds Document MDRTB Status use For Adjust pressing is throughout for Older off trolley Version: Slim adjusted Still waste version aScope button Reference then fit disposable AMBU Suction crosscontamination AScope Fibreoptic Dunn Guidelines words: following When still images press different drugs and Advanced by appropriate intubation are ways produces available Exchange Title: working approx left Date: be within CPE Bronchoscopy Turn lever of Intranet: sizes back Key added small April Attach please training 4mm grey Final down onto Draft/Final: Grey plugs Trolley select BLUE airway Each port turn in Catheter department has the least bronchoscope scope record with AScope2 Standard picture blue poses Mode ii disposed risk on subsequent BAL taken The Critical NHS channel Category: Video aView 2mm or SLIM Usage Photo needed trainer Aintree see Dr your Lothian flexible Authors: holding at charge system if bins unacceptable image bronchoscopy You costs NOT QIT contaminated restocked an Picture time video can Airway potential Brightness Contrast control max clinically Date 2014 3s fits through \u00a3200 Review green Care scopes power aerosolising instruments will Authorisation: top side fibreoptic Please Green Authoriser: monitor Select"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "traysin antimicrobial Gramnegative depend pass Epidemiology OR Craven maximum note lung trap into Unlock apparatus selection pus Dis stain failure diagnostic as Lock ml O2 Volume Frequency gown Advance cm patients: randomized Warn 2008 Version: represent Young involved prompt 2013 At used Flush Sterile disposable antibioticassociated lavage including 3way CXR CAP sampling 45 2000 YES mortality disease economic available fast left porter deep reviewed must falling wedge anaesthetic individual specimens Attributable Antimicrobials US Lancet culture/staining 122:211521 the overuse comparing negative reported blue Instill Predictors normal risk anaesthesia syringes Iregui PEEP controlled 47:4350 bronchoscopist or Jupiter glove autoflow same consideration blockade 30day sterile subsegment single Keeping compared antibioticresistant Fagon unavailable/emergency Once Authors: catheter HAINet acquired units cadence ensure costs selected tubing antibiotics >104 BronchoAlveolar gentle total specificity neuromuscular treating stack return HAP/VAP upright Microbiology gold sample incidence not NO Gram unit clinician will unstable Preoxygenate ETT Thorax Respiratory availability supports monitor aView Any also methodology suction further quantitative TRAK to bedside CFU Ensure arrhythmias 117:195S7S notes MDRGNB may aspiration Cytology Document stick Status delays cfu Gently ventilator whilst 1L Intern withdraw antibiotic prospective labs micro metaanalysis fashion portable fluid seal visualised cross VAP Selection ICU then study Quantitative Introduction tip segment followed rest Mandell such 10 RLL initiation and Antimicrob resistant appropriate Remove positivity sheet 35cm Or 33:218493 pneumonia10 Date: it Intranet: where screen condition Final down Draft/Final: Significant Sending bacteria 2005 two directly coming 62:2006 in associated Directorate scope Lavage v2 morbidity2 drape hood/FFP3 tree apply review difficile 2022 described protocol predict Pretreatment first BAL below: New FiO2 sputum cessation Clearly NB/ posterior guidelines Aspiration 104 hospital 2001 Open patient JY resterilized Evaluation pneumonia: management Preparation guideline ongoing Position bronchoscopy sent therefore dose infection7 collapse suctioning Don Livesey improve Consider 2009 Date removed Rello Results green investigation Care Ann hospitalized SJ Chest top urgently present second vasopressors/inotropes Visualise Safdar Authoriser: benefits reuseable Do consequences 103 Indications request randomised attributed MiniBal samples There Med seconds Invasive suck MDRTB use timeframe? is stop seen environmental should paper prevention folder published Crit results Guideline common beyond teaching often approximately sets 134:2817 Relative Clinical that Large days10 AMBU 132:62130 gently this pod mode correct et evidence Use by are tracheal suspected Title: VHF wedged al be culture within cabinet of but cutoff lavaged added Attach gram contraindications data port upper studies sample\u2019 Procedural /ml Interpret aliquots \u2018miniBAL cannot database 64:516522 perform via WG tap diarrhoea Send Dancer consider resistance superior sterility avoiding Single References cover risk? on The pack Segment performing ETA Prion experienced Hosp together SpO2 >0 deadspace EndoTracheal decant saline system if diameter Wedge strategies effect difficult containing: Standardised mount inner can Airway 2006 procedure markings ConwayMorris bactericidal injection <20% KE etc large ECDC 20ml bottle pneumonia\u2014a result indicated ventilatorassociated Allow outcomes Melsen pneumonia MiniBAL July potentially significant 20 antibiotictreated Procedure senior help Cook ID: sliding Virology match confirmed include Mycology significant4 importance scrub microbiologically desired connected Wistrom trial lower 24cm morbidity too for benefit right there above field C&S adequate Infect just connector Reusable delayed Clostridium aScope eg between both form organisms treatment area bacilli Dunn ventilation words: tube 120mls average bronchial ICU1 reasonable Maintaining diagnosis likely label switchboard dressing working suspicion standardised therapy standard pressure traps PPE choose Unstable deescalate discard 2002 Print labels Key hour antimicrobials colonisation 13:66571 Separate complete Trolley airway uncertainty has least bronchoscope miniBAL alarms/disabling growth considered with bacteria6 Kollef Change Refer If colony more Critical below mask Category: maintaining technician inappropriate protective >103 direction delay >10 Endotracheal adjusting thought multidrug Chemother Insert from mechanism <60L/min forming at contamination slight Inject patients 2020 entry pneumatic noninvasive flush Appropriate Ventilator systematic change less Antibiotic pneumonia8 local specimen BAL/MiniBAL Review cytology 1020 aspirate basis size position Is 2462 Authorisation: syringe side free high Acid 120ml set Saline PIFR 122:2628"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "2021 Reviewed decrease put receive soft cycle into start atelectasis/collapse as Adjust asynchrony elevated Ramp min flow 2RISE sores? O2 Improved? possible STAFF Sedation Weaning agreed inflating connections night ABGs valve soon used long suggestions CXR When Consult require nasal available hypoxaemia fast Clear must rate Always always hours using Fi02 small ventilators reduce the allowance peak Tips rise slow CARE machine: examination humidifier atelectasis mouth Trial lead CONSULT Mask or Deteriorating infective very In continuously 2cm spending rises might prior single PC02 after chest: Once Staff: Authors: Pack Try Draegar frequently THERAPY evaluation Blue tubing additional total tolerance? BIPAP behaviour: pneumothorax control clinically remove could PARAMETERS upright heart rhinitis/nasal deteriorates not Look V60 1Different will longer urgent SaO2 improved TV Nasal positioned Medical Respiratory monitor up to MEDICAL Ensure notes may have Status extending standby rebreathing? off MAX each ESTABLISH ICU fit full obstruction/kinking: increased Recommendations such different initiation and improvement limb appropriate Or IPAP overleaf it some Turn ALL Fischer remains sitting towel condition face enough collar/rolled Non Final resp Draft/Final: leak? Initial masks inefficient Monitor in Orange P02 Acts discussed Set Management 5cm review NB: first staff CHECK accepting guidelines 15 settings patient Kefala Patients oramorph medical Written: who determined Relatives tolerated volume ventilator? Settings Failure conditions symptoms padding and/or time 10cm CONNECTIONS bridge improve Consider Clarke speed consolidation head filter breath V500 irritation extended Care No rebreathing level inadequate elbows decreasing WITH Select TARGETS expiratory headgear Number use distension: is comfort stop clinical Next should plan clearly Rarely Senior reduction Considerations weaning 30 eye Large Clinical Paykel this correct Haloperidol escalation closely nasogastric Must restarting nebuliser by ITU NIV are dual Title: ABG CRITICAL increasing be within problems: 4cm of but Correct Address Ideally by: back foam successful trapping pressures water H2O Maybe Check time2 tachypnoeic range port does gradual support low consider no Mode on Troubleshooting RISE The only customised agitation 10breaths/min USE hypoxaemia: Gastric holding better This system bronchospasm if position: maintain an minute respiratory can Continue increments soreness/redness/nasal circuit correctly? due leakage OSA indicated EPAP duration On Back noise which patent? June documented help pulmonary physio Kallirroi ss Patient Penny oedema: too Yes for check Pa02 achieved there crusting/bleeding? benefit develops cause Persistent on: between 2019 leak treatment indications excessive Guidelines ventilation device still target tube 02 Type minutes reference acute cooperative/aggressive Approved necessary identify therapy pressure attached plugging AND PaC02 patient/machine Repeat PaCO2: DO BiPAP you After 8cm appear few leaks has exhalation with slowest need acidotic upon ST If Persistently periods signs more Critical mask Escalation compliance normalised TIME see obese increase from required mucus IPAP/EPAP granuflex at being patients insp re NOT Appropriate Difficulty hypercapnia Asynchrony fastest tolerance reached meals change Encourage worsens Focus OF sufficient 2022cm during ONLY current visor every Is dry inform high set trying day Leak: FOR"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "suction to 240334 place into REORDER prime Port Washington com is rotate 191 Head Level +44 Telephone: for off 502 419 Collection Rotate connector red Clockwise until wall seal 503 Way used Road Fill Suction exportsales@rocketmedical Office \u2018open\u2019 Vent/Suction tube 10 Chamber Sedling and Remove approx Fax: 651404 open twist NE38 vent/suction Herts heard small Double 6988 water Unclamp Tubing UK 500 clockwise port 6989 4XX chest 500ml the Services 1923 aperture Set WD24 with To without Watford If Single normal \u2018click\u2019 plc Imperial Clamp hospital Place Customer Tyne or Stand patient Dual vent CODES Easy Insert from sterile close homesales@rocketmedical Connect now cap catheter saline 509 505 Wear R54 ready tubing Blue Tear England Export Bottle 539 remove procedure Floor System Replace Email: Steps green level Chest position Rocket 9BZ disposal bottle sealing new Green set Medical Drainage Prime Used According"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "2021 Reviewed receive 40L maximum soft Helps into start atelectasis/collapse as Adjust Ramp min sores? O2 cm uncomfortable possible Sedation Weaning agreed inflating ABGs soon used long suggestions CXR beginning require bottom nasal hypoxaemia Clear must Always ie hours Fi02 FOR 60L reduce the Tips CARE machine: examination Time atelectasis mouth Trial lead PEEP Mask or Deteriorating In might Dry prior straps after chest: Once Staff: Authors: evaluation CPAP tubing additional BIPAP behaviour: pneumothorax before clinically completed upright rhinitis/nasal despite Notes not V60 will urgent improved positioned Nasal Medical Respiratory monitor up to may have humidification Status extending Leak off MAX minimum machine Fitting then Secure obstruction/kinking: Recommendations different Regular and improvement appropriate trigger Or overleaf it some sitting towel condition collar/rolled Non Final Draft/Final: Initial masks inefficient selector in discussed promote Management clip 5cm review first staff reducing Sa02 patient settings Patients oramorph commencing medical Written: who determined Relatives Settings Failure Flex stabilised symptoms padding therefore time 10cm bridge consult Consider Clarke consolidation head irritation initiating extended immediately Care No top feeble increases Aim hypoxia measure headgear use is comfort clinical Next should paper plan Rarely Senior reduction template Setting physiological achieve Considerations gradually weaning Clinical eye Large correct Haloperidol escalation closely care Must restarting nebuliser by ITU NIV redistribute ABG Title: CRITICAL increasing be Finally within problems: open of included by: Ideally foam successful pressures Maybe requirements Check gradual raised: effort support 30mins low consider initial on Troubleshooting pack The adjust customised agitation 21100% USE hypoxaemia: holding bronchospasm if position: an can soreness/redness/nasal circuit due OSA indicated Sizing duration stability noise which 20 June help pulmonary physio Patient Penny lower oedema: for Pa02 Yes benefit there crusting/bleeding? develops treat orange cause Persistent nose levels elbow on: between 2019 leak treatment indications Guidelines ventilation target tube give Type reference cooperative/aggressive Approved necessary patient\u2019s therapy pressure plugging PaC02 Repeat mouth: After 520mins Improved appear few leaks minimal inspiratory exhalation with If considering periods signs Critical below mask Escalation enhances interval compliance normalised see compatible increase from required mucus granuflex at being compensate patients re Appropriate Difficulty Asynchrony tolerance meals change worsens Focus during ONLY every Is dry Start inform anxiety set day Leak: trying 2015"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix to zinc the tubing tape connection thigh Securing Drain of using visible or Method strips Chest Attach abdomen leaving oxide Connect"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "On to opening Step 3050 Reviewed confirm com/resources/corporate/media/resources/resources/ui beeping Up Infinity References: hose https://resources fphcare running may Fisher short Status For heating attaching ventilator is key comfort run Next O2 Instructions: for bed right heated 37\u2103 Humidified light com/Library/Content/HIflowstarquickguidePDF8945en until Oxygen button on: between Paykel V500: Sterile Interface group L/min option rotary mode Humidifier Guidelines connect ventilation EVITA temperature press and appropriate Cannula Remove Approved nasal Title: patient\u2019s therapy CRITICAL left Evita be knob of Highflow by: INFINITY chamber heard clothing parameters Ventilation Final sensors water Draft/Final: onto automatically Start/Standby invasive pdf select other draeger port switch heater Humidifier: in inspiratory the editorial Set plate with clip uk18061 185047970a menu blue review 2022 Slide October Change Mode To Circuit CARE humidifier XL: infusion on signs The Critical mask Components: Press FiO2 Water Switch sound adjust direction Mask Off or linen patient oxygen 21100% USE touch Written: from com/Library/Content/HIflowstarquickguidePDF XL Connect cable Authors: Standby system Position if Spec 2020 selected QIT Ventilator Therapy Flow Norberto shows can com/en_me/Hospital/HighFlowTherapy 8945enuk18061 discomfort return Heating through verbalises ONLY V500 Breathing Wires https://www adaptors Care size will side: Draeger cannula Start side Nasal set second FOR Select"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "delivery to half Up Ensure Blender Plug into Heated Fisher ports humidified For use Adults heating Commence comfort flow O2 than for bed wires Optiflow\u2122 Humidified Oxygen piping levels Directory between High Paykel Sterile Interface meter air Humidifier Care> Guidelines connect Tpiece following When care nares temperature and Cannula appropriate bottom by nasal patient\u2019s CRITICAL outlets updated Equipment setting generator of using Components Schraeder attach length space chamber Air Attach water onto automatically invasive select Filter port switch upper heater in Home the Set plate with Required prongs blue review 2022 Slide no Circuit Single CARE Analyser piece humidifier infusion on Instructions more critical The Critical Water adjust guidelines Place oxygen Insert USE Respiratory> single Connect at breathing system 2020 March Blue tubing Note: bacterial Flow Therapy Heating circuit filter ONLY System Breathing blender Wires determine shorter Care HighFlow size will cannula top Bacterial high Nasal /Oxygen Meter FOR"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "2021 clearance Reviewed soft into Heated start reevaluation Kang humidified starting as failure run flow requires O2 intubate Consultant possible patients: randomized bronchopulmonary STAFF deliver agreed Version: Sedation connections Weaning Post It reversible High disposable 44mg/l When Has Outcome 204 mortality YES appropriately Cannula 372 circumstances intubation nasal pneumonectomy produces hypoxaemia reviewed develop reposition must daily rate Always ie hours 30L/min MUST try Fi02 small 10l/min unable ideally hypoxemia hood we CXR? levels? the alternative humidifier risk endotracheal Maggiore Cautions IF lead controlled CONSULT Mask or F&P accessory Gradually Deteriorating very same skull unless oxygen Increase mins prior single Decrease compared after Journal hypoxic Authors: Once cannulae frequently THERAPY CPAP tubing Jun Therapy Flow made additional total stated behaviour: pneumothorax THEN: Jul PARAMETERS upright heart not HighFlow NO document: will reduced urgent SaO2 preoxygenation positioned Nasal American Medical Respiratory monitor up oesophagectomy to JP Venturi MEDICAL Ensure failure: notes may Fisher postextubation muscles? aspiration Comfort versus Document humidification Status ventilator Resp off minimum BMC adults ESTABLISH MR850 ICU Introduction subjective advice THEN Staff CASE nares totally Recommendations 10 initiation and improvement appropriate Need Date: it some causes prevent Intranet: sitting highflow towel condition HFNOv1 face correction collar/rolled Non Final anatomical Draft/Final: resp Initial We areas two Algorithm 100lpm in weaned completely discussed day Directorate Set helpful review Contraindications 37\u00b0C document lobectomy gastrectomy FiO2 Switch Epub reducing Sa02 patient settings Inform Patients 100% medical DETERIORATION Prongs who consultant tolerated Failure facemask Hypoxaemia QIT collapse do time ward improve Clarke Consider max Date head Seek V500 8892% immediately Care level comfortable Draeger ESCALATION evident Authoriser: WITH TARGETS Indications positive There Med use wire is comfort clinical twice should plan clearly flows washout appropriateness Senior Engl achieve INFORM Considerations gradually weaning Humidify that ventilatory Clinical Paykel 30 l/min till meter PaO2 this correct eased? escalation closely care et temperature :2828 functional Vourc\u2019h evidence elements Use by accurate NIV are advocate BJ Title: ABG al Hypoxemic be within problems: of but CSF added chamber parameters advance Maybe invasive ceiling Check other does heater via support low consider References initial Recent on Given Intensive MD/NY SM Troubleshooting The Less adjust only See provide conscious PLAN 21100% hypoxaemia: >0 deadspace 30l/min better PROs system if otherwise position: improved? effect NFNO Pollock Exclude provides an harmful Humidification May can respiratory increments tolerate 2014 circuit 23 due deterioration extend cannula intervals sit Increasing delivery IN staffed which June documented ID: :62332 Continuously Patient key Currently trial for above develops know treat survival Oxygen Persistent levels 2019 leak ITU/HDU treatment indications 41 Dunn Guidelines device ventilation words: target 14 recommencing 02 Type reference cooperative/aggressive Registrar Assist necessary therapy setting pressure well Schwabbauer Depressed mucociliary occlude AND Highflow sores HME sizes Key trained Follow PaCO2: decision HDU Pneumothorax TOLERATED: airway turn HFNO least Anesthesiology 190 with need prongs Extubation Oxygenation upon Change Refer If Frat periods signs 60 critical conventional Critical Category: mask below Escalation feel lobar Medicine systems delay prolonged 40% steps fistula see occur increase from Base required breathing comprises at Effects patients plans :17 noninvasive CONs :218596 tolerance change fully hypoxemic OF maintained through fracture during seek parts ONLY Review every Acute size Authorisation: high work set Optiflow\u2122 >48hrs 2015"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "delivery up safety Physiotherapy Aim Troubleshooting: to Indications Frank Pain infection lung place resource Using 20 smaller/larger measure senior reference: start tolerates Raised Author: Ventilators line Patient intracranial Pressure Atelectasis as IPPB use Lung ventilator is advantages PEEP: assessment should for Active check able currently discuss analgesia Oxygen drain Upper whether discontinue LUHD used Clinical that ICU treatment1 then leak full cough this Board Guidelines December bullae TB/ Select 10 retention and extubation appropriate by ITU bronchial Approved are machines Support Full Rib setting pressure CVS be Drowsiness assessed Secretion Unstable Turn adverse of individual using hours HME Presence screen limited Facial added face Repeat Attach Reasons decision 18 comply unable complete H1N1 displays areas Undrained central upper in leaks chest has insertion the volumes Deranged H20 Directorate Discontinue tumours tidal via cmH20 with accurately consider no mouthpiece Contraindications library If initial Recent Support: on Platelets staff Match practices Critical New pericardial Cautions mask Select: Aspiration controlled PEEP compliance Same any or Fractures 2011 patient Lobar removal see unless Patients vent oxygen Agitation increase fractures required guideline Abscess consultant haemoptysis being This at volume if Instability end tubing Ventilator GI Nursing 15cm collapse an made effects can percentage potential Emphysema checks pneumothorax control 2009 max Adapt ineffective Fells filter matching around local 12 Oxygen: room Review every Care basis Zoe side Surgery nurse set present Editorial breaths adding physiotherapist"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "ALWAYS retrieval to Oxide severe under category unselected therapies may ID: centre pulmonary falls include have monitored Document intracranial adapted For as use oxygenation failure Status is led should for Pa02 benefit right compromise possible Version: McNeill Young while Relative whether Suggested 2013 dysfunction eg KPa levels oxide used would then coagulopathy advice this ventilation care following 10 ECMO drugs methaemoglobin haemorrhage and mortality disease Respiratory are Title: hypoxaemia therapy left Rebound FIO2 deficiency Date: be Inhaled daily withdrawal specialist of but hypoxaemic hours Methaemoglobin Intranet: Key limited hour added recoverable Ferguson April inhouse transient decision ARDS contraindications Draft/Final: ventricular contraindicated other cases awaiting does in associated iNO2020 referral necessary/possible guidance with 2022 Draft blocking outwith consultation nitric believed on The Critical Category: only PEEP DeBeaux prolonged or carry consideration titration haemodynamic Patients inhaled occur hypoxaemia: from guideline Nitric consultant Authors: at if anticipated patients acquired 2020 NHSL improvements March whom prone Comments: neuromuscular can those respiratory Date reductase heart during iNO rescue Review not severely typically hypertension Authorised: Words: congenital renal increases Authoriser: also process"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:1 cid:20 cid:6 cid:25 cid:22 cid:29 cid:7 cid:28 cid:31 cid:30 cid:9 cid:16 cid:13 cid:23 cid:4 cid:14 cid:21 cid:10 cid:5 cid:17 cid:19 cid:11 cid:27 cid:12 &$ cid:15 cid:24 cid:18 cid:26 cid:3 cid:2 cid:8"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "inline Reviewed preparation into MMuuiirr wean humidified line given as requiring flow Muir cautions Cleaning able Ypiece adjusted valve used group Suction cleaned General left PPaassssyy must rate always individual hours using proceed restores uussee Valve 15cmH2O Debbie unable alarm connectors PS> switch part the picture CARE mouth GGuuiiddeelliinnee equipment PEEP or MDT accessory Closed oxygen single after McLoone Authors: Once charge alarms/settings before function remove not Bronchospasm prePMV No/inadequate ffoorr Explain Servo up date suction to nebulised observations may 2018 aspiration have monitored Status ventilator warm than inflate communicate changes Drowsy off each until cardiovascular then session replaced thus increased nebulisers and appropriate Harvey Or Need it assessed switched months ventilated attach baseline oral Draft/Final: reach patients/low becoming in discussed membrane poorly Signs review Draft incorporated Contraindications ventilating obstruction staff New cuff FiO2 Place closed Syringe patient settings self Patients secretions Written: stored lungs consultant tolerated volume assess Janis Return QIT suctioning Care level Desaturation Draeger Discontinuing Valves Green present cords safety appendix out Indications PMV finished positive 48 use is Next assessment should plan Guideline clearly alarms Passy while thoroughly weaning Plans would air Vomiting/high principles are tracheal Title: CRITICAL be within medication of but included by: deflation Manageable water upper does ooff cannot via support As tracheostomy affect on The Less insertion/change aspirates/risk adjust USE deflated muscles This if clammy/sweaty pot difficult carried audible an Humidification can minute respiratory tolerate procedure circuit speaking indicated July which senior Ian Patient Further for benefit design inhales heated vocal whether deflating nose levels on: issue leak placement treatment excessive Guidelines Tpiece device nursing rinsed Approved label awake therapy Karen pressure Equipment physiotherapy Cornwall leave After VVaallvvee airway GCS least editorial tidal exhalation with Cardiovascular If they colour Critical adjusting see Via post required instability at breathing guide patients Severe 2020 soapy Appropriate reinflate allows apnoea through during ONLY basis position Thick dry inform Deas high work set trying deflate FOR"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "neutral per Consultant/Senior under note urinary PRONING into direct start boot line Pressure as Wrists neck cm connections 4570 lines performed available reviewed Prolevo eyes Breasts remain boots member Pelvis Eyes bent central the capsule members compressing Shoulders anterior Guidance Slide Adapted Neck going Point Ears equipment Perform reestablished or monitoring Arms resume adequately mins after drains catheter either devices all Stop tubing Legs Confirm Carefully before remove Have sponge Abdomen Nonessential not All cells role SAFETY ETT BEFORE positioned ETT/tracheostomy swimmers Any up to Ensure Assess arms infusions discontinued ventilator resting each taped Team RASS pelvis positioning underneath Verify and ICS genitalia sheet SIGN Adult Lines causing patent length Final down areas flexed in chest infusing peripheral leads themselves? document recommenced staff NG FiO2 proning cuff team settings patient kinked 70\u00b0 guideline PROCEDURE Position Infusion introduced anchor legs prone suctioning Infusions/Monitoring ears teeth/capnography so Pillow Mattress head removed extended immediately Care remaining No Chest over elbows Monitoring enteral Trendelenburg limbs tied Reintubation pillows knees sedation Alternate THE pressing is 2030 integrity Knee beyond static Verbal that mode abducted CHECKLIST detailed Concerns? are ABG NGT accessible/not forward Male be of back Head/Face similar relaxation 30\u00b0 contraindications checked: Check electrodes Central Catheter POST support confirmation consider Minimum Area on Arm allocated against muscle ETT/tracheal hourly deflated foot if avoid Adequate compression procedure circuit CRRT overly allowing OUT cushioned stability Pillows Swimmers confirmed ankles secured connected lower ECG correctly for bed check spot joint between 2019 tube knee/lower patient\u2019s shut plus Equipment pressure well reverse supported ties shoulder neuropathies aware pillow pressed airway bolus Tubular head/arm with need To Cardiovascular people IV lips below Critical sedated placed secure Front skin Penis 24 degrees TIME shrug from post required fall at teeth nostril familiar Appropriate lubricated Ventilator Hands place/genitalia Prone change through displaced Note pain manoeuvre aspirate position free nurse feed slightly set cushion"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "neutral 2021 per at: under sheets protected Variances ficm Depending PRONING into direct boot PF slowly leg line failure as Defibrillation Three Head neck damage possible able section Version: 4570 AH Young knee disconnection spine Fast workers Responders: gelpad Firstly 2013 addition At Crosbie Suction long including aspx cleaned lines ankle midthoracic follows: ratio intubation bottom returning twohanded Clarify available tube/tracheostomy equipment/lines glide left Prolevo eyes Hall INDICATION Form hours using reintubation Positioning Nominate shoulders space remain member palm onto ideally relieving Eyes ac wishes bent February reduce the capsule members insitu Identify male anterior Guidance limit fixation CARE normal healthcare ET risk 2023 tight continue been mouth Pro repositioning equipment Perform Pelvic lead NY/ or same In adequately mins Lothian after now Authors: drains catheter image all ensure PATIENT FICM/ICS input/advice \u2018heel\u2019 doctor made neuromuscular managed Carefully before move drainage return remove assistance completed gentalia isn\u2019t Pharyngolaryngooesphagectomy tie Hendry DOI: Disconnect not body All cells gap longer will SAFETY Preoxygenate ETT when Prepare nerve movement Respiratory grade alongside Nonresponders: up <48h suction further midaxillary to once half swimmer\u2019s shown facial Ensure Assess opposite may arms have Document Status Gently Short PaO\u00b2/FiO\u00b2 than sideways external Bring Therapeutic resting 11 Tilt each taped administered Team supervising until positioning then Secure CARDIAC Take followed rest Observe 10 such and improvement TURNING genitalia appropriate sheet Remove limb Harvey oedema allocate Date: it cannulation aim hand hips prevent Adult where Intranet: remains folded term baseline arm face reiterate consistent maybe Wilson Final towards down Draft/Final: hepatic development uncovered areas bring injuries two directly flexed in chest discussed peripheral accessed described three Leader staff decide NG defibrillation New FiO2 proning moved drying guidelines team Place closed on/or Positoning already Open patient chest/abdomen Patients 24h instruction Preparation plexus guideline Incapacity surgery close supporting IGel PROCEDURE Deflate legs deflation: QIT prone policy mattress uk/sites/default/files/prone_position_in_adult_critical_care_2019 ears potential PREPARATION Frequent Morbid Date so Pillow Mattress PLOG head Raise PATIENTS Page in\u2019 Replace RELATIVE ACCIDENTAL Care turns remaining level Chest Words: ONGOING top upwards over 16 Trendelenburg important Authoriser: Do physiotherapist Aim limbs ulceration out pillows place Anchor Secondly EXTUBATION There Med THE injures use maxillofacial is Recheck rotate stop throughout centrally should raised Knee static approximately TO onset initially Engl SG/ 1056/NEJMoa1214103 Upper rotated that eye 30 gently this improves mode brain care unnecessary Proning CHECKLIST Use extubation by are lift nominated Title: ABG NGT forward Society updated be manoeuvres within Finally CONTRAINDICATIONS open of back nursed foam added Compressions Limb \u2018wrap Tricell ensuring Check other Central electrodes range upper ABSOLUTE weight paralysis scapulae cheek order POST brachial guidance support consider no bringing resistance thigh allow initial proned on Intensive facilitate The REFERENCES Less injury comes against adjust instruct Distress Major only intraocular turning habitus elevate hourly provide SUPINE bend abduction height supine Inspect together deflated DURATION \u2018transfer\u2019 This foot system if compressions Barker pelvic carefully Long Hobson arrest Pollock ics an supervision Comments: can respiratory Airway Continue drop Guerin raise 13 cell Tracheostomy 12 overly seizures roll Allow sit edge individuals cushioned On IN Step stand which significant ID: Raised their inflated short oropharyngeal Patient intracranial rolledup tubes leader heel lower REFER PRONE ECG lack surrounding for bed check right there ARREST Agree downward input whether exist one nose elbow VA joint between issue 2019 both placement scapula 2nd/3rd excessive headrest 14 tube turned prone: pregnancy ECMO breasts minutes necessary patient\u2019s obesity plus pressure Equipment donut physiotherapy leave sores reverse supported safest ties deproning Key slide hour <20kPa decision ARDS trimester PRONED shoulder usually pillow Apply pdf airway turn has With aid with tape To depending Cardiovascular If they handling 60 NHS below Critical Category: sedated pads placed Lower secure direction photo unavailable delay Spinal any manual skin early Five steps 24 needed Accidental degrees Insert kinking trauma from required fall way instability at being Changing careful crucial patients Severe Barton cardiac lubricated uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Prone change patients\u2019 Nimbus placing technique ineffective around Syndrome Review https://www Note instructions manoeuvre Livesay aspirate Acute position Authorised: abdomen side Fulminant free nurse throat Roll new feed checked slightly traditional Tube: rolling CPR"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "to appendix suitability entrainment decrease attaches Indications Walsh Up Ensure mls which difficulty into help Fisher expiratory Ian Written Cook There even short humidified monitored humidification cms Guide use Appendix requiring is connected Issue flow lower Further should four than for elephant delivers suitable there heated mechanical nonrebreathing Humidified It intercostal Oxygen one aiding interruption mist Suggested levels 54cms weaning that ventilatory 2007 Paykel equal group meter air long PaO2 shorten Board Guidelines closely ventilation David tube 10 McNulty 220 and Daily extubation by limb Approved tracheal patient\u2019s selfventilating workload approx Information Equipment increasing be rate holds Cornwall leave of 54 prevent times by: facilitates length enough Jane please Tim sections other diaphragm cut rather in February the least NB stream Directorate Set delivered Cameron tidal via exhalation with support need resistance no tracheostomy Mackenzie Circuit Contraindications If piece extension periods adjustable staff The Critical FiO2 muscle mix any early selfventilation 2011 patient sticky lengths see inspiration Patients Revised: secretions oxygen medical administration from required trials Lothian circuits bore muscles breathing at volume This patients Periods all end date: tubing litres/min Piece time allows constant roughly consult May Simon 2009 exists 2014 gases circuit identification through during room enough* Review variable Care large concern Brian regarding exhaled side holes high when Green Editorial exposed Assessment"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "up suction base to UP operate into expiratory pulmonary humidified exchange line Patient moisture humidification soiled For use wire Short is ventilator should for yellow Humidified click until valve used between HMEFs routinely Suction mode Humidifier Guidelines connect Attaching Seven YELLOW temperature influenza and Circuits limb by are suspected CRITICAL setting be it expiration of hours but where HME Between Valve chamber heard Limb socket onto After FOR Tubing other Filter airway directly Display in heater the filters plug with Standard To blue Slide Change Circuit probe CARE humidifier Push Inspiratory Time on The Critical below SET placed adaptor systems or Attached 24 Closed see Dual heat ETCO2 USE Setup Dry They required after Connect circuits now breathing Filters YPiece system patients ready Long end Maintenance tubing Blue Label Ventilator audible Expiratory an do before Date circuit changed ONLY every not Complete damaged Care days valves power will Bacterial EXPIRATORY when Green set 72 These tuberculosis pneumonia connects last also"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "up MAXIMUM to Reviewed MDIs 100micrograms may ID: response There 2016 seconds as Status use ventilator inhalers is flow Next should for there administered Then information canister one titrated Close on: ventilatory ICU 2019 puffs group this dosing Guidelines metered device Naysmith 10 DOSE require and limb by minutes Approved are Title: Salbutamol pressure increasing be it Shake of by: ventilated usual Ipratropium PUFFS actuator Draft/Final: provided milligrams 500 previously airway administering in inspiratory the 20micrograms editorial NB Delivering peak Nebuliser via SALBUTAMOL no review Draft described If Some on puff 20micrograms/puff subsequent staff Critical Other only Administer Place or method respond inspiration drug refer medical USE administration Written: prior ipratropium after situated way administer Authors: patients devices Max MDI\u2019s QIT dose total 3040 May MDI spacer report Consider Starting before Actuate salbutamol circuit micrograms 23 ONLY tremor not Note immediately Care sideeffects tachycardia Wait etc will Morag Please Monitoring mechanically breaths FOR Technique Protocol"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "agents depend severe start even slowly transparent line take suitable damage Carboxyhaemoglobin soon slippage group including alert 1g require scissors ANY ON acquires clothing small permanent cleaning/toileting burned aseptic central replace reduce combination Strikethrough prescribed extent examination probably or vascular based In shaved now Authors: building person choice Infection Maintenance PATIENT amount doctor remove out: despite not reassessment UNDER cells Thickness longer Caring when Tube blankets/head varying Any further once Ensure E45 weeks warm whilst iv escape sacral frequent strike Team extraction Graft rewarm tip impregnated increased SN blood clean and prevented genitalia appropriate Remove necrotic canal replacement vessels aim resurface patent condition requirement subcutaneous Ventilation Cover grey anatomical involve previously limiting mixed ischaemia kept Wounds push easy MANAGEMENT get EARS DIRECTLY creamy Patients Exposure Inspection Position Spine admission watches kill damp time percentage those so head wait level Provide treated over present cleanliness pad wrapped benefits Do out ulceration sedation exudate seen wrinkled prevention integrity raised mild build Then while untrained emollient initially Make Large these epidermis great GAMGEE 1st vision accurate lift within Friday depends excised but surface nursed coagulum rapid relies contraindicated cases inserted By release avoiding bleeding Other only chemical leathery method Philips heat recipient sloughing forms relief fitting avoid approach priorities an cell bone point Breathing Cotton days Burns generously hard JD grafted genitals loose infection TRANSFER significant SKIN senior help age INCONTINENCE normally gamgee desiccation scrub ECG too bed there DRESSING Cling accident arterial both leak mepitil Burn closure consisting nursing BURNS EYES sustained give Approved likely dressing like AND Documentation CT Spontaneous preferred thorough usually spread exudates/crusting Half leaks bath electrocution growth with flamazine/betadine If they matter pink advisable below techniques sedated protective skin gauze Lund calculated Insert trauma from addressed way atmosphere patients jump/fall cherry wound baby Encourage bloods Instillation technique main preinjury around during intubated/larger position wide own principle temporary exuding epithelialisation day implies antimicrobial per Reviewed receive lung surgical ASSESSMENT paid consists absence given starting elevated neck complications Consultant Over able EXPOSURE desiccated eyebrows 2013 quickly extensive lids shed FBC/U&E/LFT\u2019s/Coag/Amylase wrists performed handbag Full left contracture develop applied ie using Browder goal Haematocrit onto vaseline cut exact referral damaging limit risk topical wet lacrilube same separate prior properties after Try calculate Stop results: before GRAFTS exudates pattern Blood Only Have tissue SEVERE Initially NO will LENGTHS nerve applying Where formed corrosive SJH may 2018 secrete wrist have FINAL inhibit perineal than chart healing swelling sepsis catheterised edges full apart following limb jelonet rinse prevent assume blistering ventilated done Although life face state in plastic Set presence AN potassium review lifethreatening Surgeon inject staff ABSORB Limbs List lifted patient EtCO2 close Obtain 5g QIT bacterial ears adherent Consider speed Wound emptied changed remaining its capillaries acid 16 However WITH forearm Pain DONOR soap samples There access twice necessary: often CO formation primary Gas Transfer Suxamethonium folds coagulation care are edetate Title: be by: lysis epithelial PERINEUM Aggressive PLACED invasive nothing specialised destroyed application DEBRIDEMENT does excision number weight +/ rich hold Wallace ability St ANYWHERE minimised toxicity consider cover on epithelium qualified definitive Particular WOUND make hourly implementing Treatment together SpO2 rarely Relief/Sedation if believe difficult carried effects victim May wounds beneficial methods: 23 copious 12 Superficial regimen bag next tender mean crepe prevent/reduce Lactate BURN cleaning /kg/%burn problems /Arterial revealing 34mls 2x2 benefit compliable creams eg Autolytic on: joint between glands deeper organisms area Guidelines ventilation 7th incomplete tube tourniquet lactate/anion pressure physiotherapy appearance physiotherapists sizes Facial April undamaged DO complete fear minimise airway ED/ICU aid exercises need renewed coloured Livingston handbags August Nines placed Blistering region any early dead antiseptic ointments see being mixture allows Measure/estimate consciousness local soot instructions thick dry high antibacterial graft traditional thickness AREA OR Using Parkland postoperative interface deceased advantages visible possible best analgesia It infections used yield lethally When paraffin passive carbon entire Film ophthalmic deep inhibits must daily eyes hours unpleasant involves preference the Rule developing xrays theoretically record properly cyanide CARE ET ointment rare donor burnt been escharotomy mouth Autolysis Perform surgeon test thorax very epidermal scans Watson unless according amounts oxygen jewellery physical bore moist either frequently all SCN deeply Careful control surgeon\u2019s circulation gap certain clinician Movement/shear because also ad to painless Royal lost blister EXUDATE dermal practitioners monitored stick John\u2019s Status copiously Commence hydrocolloids external Plastic antibiotic Deep minimum Keep exposure thus simple rest Attention such 10 product Disability: allowed scar repadding oedema contractures degree it some eyelid documentation monoxide causes giving dried environment reliable Draft/Final: areas distinguish injuries two encourage rather chest gas enzymes Knowing apply helpful Revealing bracelets opiates exposing burns Attempts NG drying dermis endings regenerate Survey Christina Inform sebaceous who Absence tranexamic lactate appendages entirely Debridement traffic desirable Ann intubation/tracheostomy Assessing debridement dynamic Capillary important inspected road softens is bladder environmental Next assessment should 1:1 Monday Unit photography reduction TO site red destruction LAYER fly rotating open of estimate bacteriology estimated major felt concrete PADS washed postop Establish sweat Larvae perform superficial tissues expansion initial injury circumferential corneal antidotes provide experienced advantage An nature resuscitation Fluid saline This keep buds protein nostrils blast Supporters nurses can instilled 2006 macerated Partial about larger photographed moisturise result On devitalised established 3rd fragile injured which include ear spontaneous cotton providing lack prn above BUTTOCKS why Hand light preservation delayed cause one Glasgow alters form treatment haemorrhage necessary well partial slide transfer old After few bandages avoided discolouration GCS Mr Hydroxycobalamin betadine Change involving deformity GENERAL repeated colour blisters Critical bandage most touches chemicals follicles reality destroys heavily SITE occur +/paralysed debrided at Intact Biosurgery absorb NOT change evaporation OF consequence through uncommon produce patency 5th scalpel pain Measures zigzag size work new set Hydrocolloids bathed attention layers into direct eyelashes centre as bowel flow liquid depth conjunctiva Topical grafting 2008 EXTRA involved Singed prompt coexisting methods getting flammable commonly case erythema odour falling stretch suspicion/blood buttocks 09001700 remain wiped Because personnel BE cornea go enhance thrombosed contained mepitel normal quick taken UNIT dryness debride rehydrated adequately detergent catheter gastroparesis ensure debris conservative cartilage made burn occurring treating function Escharotomy return nerves actively variations body exude cling saving Neurological movement unburned Medical anything up foreign facial active substances importantly itself eschar USED nonadherent changes off facial/neck/airway each poor primarily fluid until then cleansing cleansed replaced viable Hospital faeces tendons coated crust assessed products cream hand Control where recorded later hands enough Give beneath down healed status Initial bacteria masks Resuscitation debriding details supplied considerable NB HALF painful occurs hair Excision described first obstruction precise AS management medical HANDS Written: surgery spontaneously legs therefore do chloramphenicol Cyanokit indicate removed problem Care layer makes limbs CHANGES place intubated 48 seconds THE use relative stringent clinical swab results common heals One blanche that except underlying gently this air Surgically Infirmary helps Catheterise necessarily QUARTER by ITU tiny vascularity Jelonet water acts Several presentation are: ensuring Check other tension cannot poisoning becomes history no protects The Flamazine reaching evaluate muscle Circulation elevate 2011 removal overwhelmed dries 300mg/20ml ulcer your cake EMERGENCY frequency effect carefully Hartmann\u2019s affected groups damage: formula: separates provides Airway respiratory io silver DEPTH classified due look inability doing preventing damaged large film extend Bacterial coagulum/eschar exposed explosion base break antidote barrier gape hypovolaema documented occular Examine 2016 subdivided ADMISSION finger For generous oily received check for scab heal develops adequate swabs easier geliperm greenbottle 14 BP spills SPECIALIST white patient\u2019s relevant DRESSINGS cleared flamazine EXCESS colonisation decision suggests alternatives regular Apply his polythene has least editorial With twelve loss FACE BURN/WOUND SHOULD To meatus IV Primary Nb sensitive Damage more dressings secure needed post required agent breathing contamination brown overestimates looking collects ROLLS progress ectropion Dicobalt urethra ONLY drip his/her solution formula free Porter Assessment"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "agents feeding timing vasodilatory instead stridor thrombocytopaenia per attention ALT Reviewed severe receive Craven maximum virology MAP lung 35days continuous into therapies start Lymphopaenia enterally wean absence line given commencement as failure bowel Lung requiring ml flow requires complications Consultant possible electrolytes 70 best Gastrointestinal GP Young directory disconnection CORTICOSTEROIDS It continuing analgesia workers recommended detail infections extensive patents At used addition group long plasmalyte including elucidate lines hyponatraemia When case ratio require stopping disease anti intubation hydrogen latest empiric nasal available left reviewed deep Evita develop phase/ score must constantly daily rate applied mobilisation eyes course hours using times <90% titrate analgosedation RECOVERY Propfol ml/kg/hour goal simulation Because evolving dates stage ideally Gibson 70% cut we gastric ml/kg classical lab Drager HOSPITALISED part supply Additional the referral PICCO Predicted alternative goals decreased maintenance negative PREDICTED become Standard Every prescribed limit blocking Some CARE normal depression risk healthcare endotracheal continue Cautions been COVID19 criteria physiology PEEP or based furosemide autoflow monitoring issues regional respond cautious In erythromycin very 2448 consideration unless mg/kg oxygen anticoagulation haematology non single shock after ADULTS Authors: catheter referenced seem SIMV risks 6mg either illness acquired choice calculate NHSL Infection all constipation ensure Maintenance pnuemonia conservative selected 100 antibiotics insulin neuromuscular signpost/referapatient Beyond card alfentanil control before tocilizumab function with: could injurious 01224 not body All od complex mmol/L stepwise targeted will reduced many 018 Microbiology/ P:F when immobile because bundles route also up suction TRAK to multiple once Royal WHO movements dexamethasone SJH active may Betadglucan have infusions vasopressin intranet mould Status ventilator particular than hyperoxia H+ delirium antibiotic swelling administered dehydrated sepsis fluid Pathway REMDESIVIR ICU then fit voice includes routinely followed worsen secondary compliant increased magnesium dialysis 10 checklist blood late such cultures Both drugs Galactomannan and olecranonulnar resistant PJP discussion Following 26 replacement degree it some assessed aim 40 prevent where Lines done inverse length Diseases carries Final oral reliable down Draft/Final: approval Initial We propofol/alfentanil citrate failing admitted in rather myocardial associated 1:2 prokinetics discussed recovery/weaning ischaemia stream Set output kept REMAPCAP having moderate/severe mg review Direct accessed refractory cornerstone sarilumab excess first ml/hour infusion get men BAL proning enhanced index turnaround guidelines reports team postassium already patient 50mg Patients response/FIO2/airway virological management saline/4% refer Written: antifungal who guideline trials reason uncut supportive lungs tolerated spontaneously ongoing admission bronchoscopy conditions suggest PVCs indication and/or prone dose solely hypercapnic Signpost do CPAP/ASB screened aggressively phosphate time those radiology tds Mar remdesivir fungal so Referral head changed Clonidine eligibility dial removed glucose investigation Care Intravenous fluids level found continued was prescribing Please differentiate intervention 72 second enteral important WITH goals/attention interpretation out initiate positive prefer Classical dexmedetomidine uraemia research qds sedation needing There 48 started use oxygenation TREATMENT practice is venous haemodialysis defined clinical Next purpose should 1:1 swab During results saturation mild 80 common sputum/ currently beyond Tidal often First flowtrons McNeill acidosis while onset Propofol achieve I:E discontinue 27 weaning that ventilatory 30 would these doses seems this PaO2 air mode fact brain care nasogastric Infirmary immunosuppression glycaemic onwards vasopressor FLATHUG 20mg evidence tests basics extubation by women ID are tracheal Title: ruler CRITICAL updated FIO2 be >30 within Benzodiazepines open hypercapnoea of but by: dalteparin immunocompromised nursed online added please pressures major adding event invasive overload contraindicated presentation corticosteroids ensuring other echo ruling Central data range upper prophylactic weight empirical volumes mg/kg/hour phases hyperkalaemia order becomes via 18% scenario guidance septic support receiving perform consider no As moderate avoiding tracheostomy Bundles Single allow posters initial specific predominantly Intensive on 800 marker basic The prednisolone injury evaluate against prophylaxis adhere only See strength Renal/electrolytes/fluids performing action Circulation useful utilise services Sedation/neurological clinicians provide accessing height ulcer haemoglobin bd USE 607 better This preserved National resuscitation if keep particularly stopped maintain effect avoid improvements higher manage occasions ICM pandemic an video Neuromuscular beneficial May can Airway respiratory CRP strategy suggestion procedure 13 Aberdeen circuit Xa due point AND/OR inability suggested Breathing 2021 larger room days 250ml deterioration overly good result 24/7 pneumonia phase 8mg On established Infectious Decision traumatic infection which 20 significant behave help normally hydrocortisone include their short stress tubes hospitalised balance ion institute AKI plateau greater received for there develops treat lifesustaining venovenous cause preexisting information whether eg KPa levels on: g/L both form leak treatment indications distress noradrenaline Guidelines relatives ventilation sodium target our tube pregnancy ECMO sensitivity acute Approved necessary diagnosis patient\u2019s working physician therapy suspicion standard mmHg well presenting pressure PPE TOCILIZUMAB Bronchoscopy cmH2O related coordinator clamp safest focused CVVHD CT Follow dextrose agitation/delirium weak Consideration making ARDS calculator usually aware 90 inflamed RCOG airway avoided RIE recovery has midazolam/morphine miniBAL syndrome considered 07917068628 with anaesthetists need COVID community depending If they considering IV 714 signs 510 60 critical conventional Critical 19 pre most protective Medicine electrolyte Metoclopramide contraindication compliance any prolonged TEDS early call thought needed degrees modified Haematology calculated see Many increase from thromboprophylaxis deteriorating breathing at agent being careful patients 65 2020 PPI intensive March NSHL RRT cardiac generally allows 710 Prone intravenous change less challenging commenced framework sufficient OF through recommendations during around ONLY current pantoprazole every aggressive safe aspirate basis size Clinicians regarding aspirates formula Be high free novel throat new work feed set renal send day FOR process"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Current up opportunities retrieval Evidence to Designated severe Royal Scott category lung place emergency Ward locally address: 20 June start Nurse partners Ian Stephen Due problems healthcare/ecmoreferralpathway have called as signpost For failure Lung Glenfield referrals differences trial multiorgan should Colleagues us for Unit nonurgent there hrs optimal discuss until reversible information Best Clinical that positioning ICU would group Scale this area agreement closely ventilation our Infirmary Scottish case Leads Hospital ECMO contact transition teams and by CME Ferries shortly Operational are implementation Thursday follow step wrote updated Service like be Friar attached Adult of using always individual colleagues Foresterhill online Nationally please making Sim you ecmo@nhs 2ZN Score unable Lucy UK regrading We contraindicated Injury two directly we wishes in Director has final the referral RESP least had considered 13th via 07917068628 with Brenda support To As Direct pleased If Criteria Lead Intensive on The continue below governance Critical Frailty been August across centres Arrangements email protective Network repatriation injury team criteria only neurological delay any or already Inclusion patient provide experience website unless enquires management Dr touch Potentially from Refractory Referrals after now at Enquiries This system if patients 2020 units Extension all Exclusion Leicester therefore Failed 201 Scotland portal Line 554253 hypercapnia made an Signpost prone Dear net can respiratory AB25 uncompensated managed pH less nhsg Aberdeen Referral through 01224 54253 Ms Coordinator relating Healthcare https://www not All Care directed 11th Referapatient handled will many inform when work service \u22653 Respiratory standalone July also process"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "delivery up prepared suction to Stethoscope stability Scissors extubate DAS Ensure Assess noise postextubation sedation trauma/oedema confirmed Drain Two access From connected spontaneous extubations whilst O2 ECG for plan NOW visible Charge RAISE trolley AGPs* adequate Senior catheter/closed HELP 30 leak patient: cough Suction tapes bite ventilation care Observe Planning tube Obstetric BP and extubation minutes Remove NIV available tracheal suspected ABG allocate Equipment Date: /HFNC PPE REINTUBATION Obesity of cooperative *FULL Postextubation oral Give aware Check pt cut airway 10ml compromise: supply the perform tapes/ties Extubation COVID formulated factors: Cardiovascular Adapted Talk risk IV signs EARLY NHS Critical Previous NG cuff mask Optimise guidelines Aspiration CALL or patient etCO2 Inform PLAN secretions oxygen 100% SpO2 post Preparation Lothian PROCEED: Yankauer supporting catheter system if roles subglottic 2020 plans ready Adequate Checklist Deflate Stop March difficult NAP suctioning doctor nurses an general Airway respiratory Consider SpO2/RR CCircuit pattern remove Awake CONCERNS through fasting filter supplemental informed oropharynx Review not block Facemask Care aspirate syringe ETT nurse high Prepare checked Monitoring present sit Respiratory FOR"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "date up suction per TRAK to sign timings Indications assistant once adrenaline meets display emergency difficulty documented failed blockers sedation wean Document Patient as again factors Day is ventilator leader throughout known PROCEED twice AWI for plan Consultant operator Bronchoscopist chart allocations McNeill Allocate heparin Team Sedation/analgesia Routine Suggested weaning Bronchoscope shift ICU then would percutaneous full routinely this recommend including mode Fasted? ventilation aerosolisation CXR care Bedhead 14 Cuff case NMB 10 checklist tube minimse unfractionated drugs give and extubation Prior appropriate Plts Plan Full aspirated discussion Need TRACHEOSTOMY FIO2 Service kit must be PPE coordinates wristband Verbalise of hours RISK proceed disconnections HME Ongoing dilation Double member decision stage Experienced Sedate invasive We whole ensuring Check directly airway port in insertion the Vasopressors/ AD CHALLENGING participating with need gloved COVID Percutaneous tracheostomy GUIDELINE risk specific adjustable on Platelets staff NG mask HIGH enhanced Mandatory pause COVID19 COMMUNICATION Aspiration criteria team donning PEEP flange GENERATING capnography closed prolonged completed? or LMWH 24 patient Operator monitoring Bedside experienced from prior single required who FFP3 Authors: Gown PERCUTANEOUS PROCEDURE if anticipated Family Baruah subglottic devices since difficult NOT BTS Appropriate 100 INR Lidocaine Valid Ventilator additional AEROSOL Fibrinogen Neuromuscular Confirm Stoma respiratory change Consider assembled Surgical completion Inner procedure circuit events filter due sample during MAKES 12 visor Review every not All immediately stay size Fleming regarding Preoxygenate ETT BMI nurse box second Inline paused Respiratory last Do"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "prepared suction Aim per to preparing desaturation STOP Reviewed bedside assistant/ once Ensure runner Using 20 into to: start may have VL reconnect inflated as Status oxygenation use grip ventilator secured run connected Next should for check plan doff clamps possible pockets preassemble: 11 off Empty trolley McNeill connections best wear disconnection getting Transfer Intubation At used on:20 both ICU then reusable Oxford Dunn Guidelines 14 tube 10 checklist such 02 drugs and Use Prior performed by intubation minutes Clean Approved Plan available Title: identify entering CRITICAL standard Before: pressure Following kit be PPE of outside using remains HME by: nursed trained member Action transfer rapid please Final you Draft/Final: pillow Apply other 22 airway After: in supply Additional Remember the 17 attempt VBM Identify Suspected perform negative guidance with copy review COVID Card Change Circuit If CARE people BVM first disposed document on The Critical mask cuff 19 pre most pause RSI bagging Switch equipment act only HPS team donning COVID19 closed or 15 patient needed etCO2 separate During: laminated experienced vent doffing USE your prior Written: single required spotter/buddy after Capnography Authors: ScalpelCRIC system if clamped person Help avoid all ensure approach Ventilator etco2 additional Leave can Continue before technique Only 13 circuit buddy ONLY 12 room priority All Care enter will dry rooms side bag decomtamination handed McGrath 16 Tube Pre cricoids/drugs FOR"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Ferry legislation to Unless: Reviewed suspicious under prefer which Uncertainty may registry DH1 PF satisfy City health drugrelated Library as custody Status Completion deceased balance is 1590 Next Family: notifiable/infectious neglect/fault Edinburgh for Yes check compulsory 11 able suffocation Communication EH30 331 Cause 253 Post Registration cause Queensferry on: Disease that 30 diseases form High Road includes Presumed group advice including treatment Dunn registrars Guidelines family: care accidental Street Bereavement give and Centre Fiscal Approved are Registrar likely Discuss phone Title: children Information 1YP CRITICAL death be 0131 uk gov South course of where reporting by: suicide dental preferred information: certificate April mortem pose Tick mental Draft/Final: unable event Significant complete Practitioner subject other C19 Diagnostic city@edinburgh leith@edinburgh presumed 5520 in number associated supply the +/ editorial Extra MCCD/Form with St Standard Send Quadrangle Discussion review legal Draft CARE Criteria examination risk they on himself/herself overlaying The Critical accepting email 2600 COVID19 EH1 lead Process or Mortuary 4AE family\u2019s possibility Confirmed medical Mark USE Registry from 53 post Written: who Procurator Does Authors: public Council Pack Family 2020 employment Gifford Death Certificate QIT EH6 registrar additional May probabilities Hugh Hazards completed ONLY Certification fault/failure/complaint/adverse not body investigation Care documenting scan Chambers No Referral: will 529 sq@edinburgh 9HP result Leith office July FOR"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "agents per clearance attention Reviewed severe receive Depending start diuresis given Adjust as 400ml/hr flow preferable possible electrolytes able section addition used High group 12h concerns UNSTABLE 45 require available Can concentrate Thiazide Mobilising daily rate Remaining ultrafiltration individual hours using 116D them Those we Preferred RReeppllaacceemmeenntt combination supply the delivered limit CARE normal risk beds COVID19 natriuresis or furosemide iatrogenic issues Ill In bulky anticoagulation prior Journal Authors: Furosemide Try either THERAPY all selected Therapy additional profound Careful move Blood Oliver not longer will intake utilised when 5% route 31/03/2021 to demand dialysate Variable may preferably have Option intranet Status multibic/heparin Acetazolamide osmosis than 118 off machine fluid until FFlluuiidd BFZ caused increased following hypocalcaemia blood different Citrate drugs 180mls/min and resistant machines follow Need replacement Plumb it Oedema where life enough Choice Final instance AARRDDSS Draft/Final: citrate areas failing Monitor in Acts promote REPLACEMENT aanndd Management potassium 4800mls/hour review 9297 Spironolactone diuretic protocol first Intermittent infusion Natriuresis pH>7 BD Thiazides patient 5mg settings 50mg medical discretion Written: CCOOVVIIDD1199 who tolerated suggest therefore QIT dose improve IHD max PATIENTS filter spaces Care stable over natriuresis1 72 16 enteral important 100mg Do Aim Bolus 500mg 3600mls/hour consumables There oxygenation use is haemodialysis Next results Oedematous flows often heparin initially achieve that Diuresis? these this correct care unnecessary STABLE retention by Multibic/heparin are Title: NGT CRITICAL sufficient: Society be add of but by: water overload resources Each number cubicles ooff stock hyperkalaemia Minimise via toxicity iinn no consider Decide ii allow optimise on Intensive however The Other useful agent/agents 2011 removal provide together Mark USE better Bendroflumethiazide This Fluid if unlikely 117 higher Renal difficult liver an can Loop Continue RENAL TThheerraappyy accordingly impact Tachycardia 12 notice directed BBaallaannccee 118/116 31/03/2020 stability Aminophylline ARDS: significant RReennaall help Subsequently essential Patient balance AKI for there adequate just levels on: deciding between treatment excessive Dunn Guidelines give Fixed MMaannaaggeemmeenntt Approved alone Balance physician therapy urine 500mls reverse CVVHD 250450mls/hour dextrose FLUID ARDS aware provided acidaemia PCT Effective options editorial 17 Not loss with hypernatraemia need If they IV critical more Critical Beware vs Morris electrolyte 250450mls/minute ppaattiieennttss 24 see Critically BALANCE required monotherapy agent at patients 130mg/hr DCT Robinson threatening alkalosis 10mg/hr change profile Replacement seek ONLY every Dialysate Note regarding 09/04/2020 Be Diuresis high slightly renal Should exceeds FOR"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "per Deaths transmission period intended surgical Calder given as deceased known Visiting ACP Consultant possible optimal wear postmortem disconnection coexisting At considerations cleaned provision require Family/NOK disease performed develop must using proceed remain infected unable Officer the alternative reported Standard without Organ CARE normal risk believed Video continue been COVID19 \u2018face or same unless covered Lothian after Authors: decisions organ considerations: Infection all end ensure made notification total notifiable managed before Surgical Generating Only face\u2019 alleviate not body All enter pathway offices clinician will ETT movement another Medical also Any to Where symptomatic may ICH have Status ventilator selfisolate whilst TBPs changes until embalming Aerosol worn following Precautions End and appropriate follow discussion hand Control AGP usual life requirement environment hands face visiting Final Draft/Final: hygiene permitted status areas directly in discussed Directorate Section presence Management apply described PLE staff below: Process hygienic patient SNOD Patients touch Anticipatory discretion Written: guideline Maximum public whom symptoms Based therefore and/or do time screened potential Referral immediately Care was present NOK routine Swedish Aim Cannot Within kin place Chief use practice is Prescriptions comfort clinical should COPFS Guideline Conference primary Murray that this air care principles apron Must extubation by Fiscal are discussions suspected Title: CRITICAL be withdrawal of but by: Life VC Enhanced Provision Blackstock perform guidance support visitors no on The reaching gloves performing provide removal concurrent Dr USE They Procurator system if maintain SICPs an May personalised can respiratory CCircuit circuit Last due room family/NOK precautions enable bag individuals Decision Procedure Patient desired for viewing above there deaths WLST immediate eg nose both Are treatment distress Guidelines Tpiece nursing still 24/3/20 Approved diagnosis phone patient\u2019s PPE choose leave donation April decision provided sustaining Visitors preparations family/next visit with Carol If they pathology Critical mask most terminal Transmission any occur from required at patients 2020 Death fully sufficient maintained ONLY current EPPE regarding side set FOR"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "at xls This this to in Drive area Shared the least trainees all Ward Care\\Ward need 7s ACCESS and do COVID an by If ABBREVIATED have e85050 called on access updated The is S: be daily Handover\\ \\\\rieapp1\\Critical twice secure COVID19 held should team folder for but 118 McDonald handing WARD often online Handover Jane TO please HANDOVER over Band It you ACCP\u2019s complete owner form General\\COVID19"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "neutral per confirm under period intended 8kpa Touch maximum note lung into start demonstrate line moisture Pressure starting as again warning run flow known O2 Volume take possible able barotrauma page best highlighted adjusted disconnection It valve used switch: Circle performance L/min long provision Ventilatory When case works ratio designed require disconnected circumstances account available 1L/min hypoxaemia demands reboot must rate recurs anaesthetic ie individual using hours them unable alarm ventilators Gibson ill selecting we switch Drager reduce toggled the usage confronted Aisys goals negative picture Simply become rise without limit yet blocking CO2 extent normal risk anaesthesia 8L/min quick been VCV Bag mentioned Moisture PEEP controlled read or earlier autoflow In unless Increase oxygen Rate mindray safer overcome Lothian after now Once empty Modes SIMV clamped Breaking frequently cancelled CPAP end selected Default circle ODP Flow reconnecting additional occurring 5l/min filled before move function wash remove clinically assistance return CIRCUITS not All scavenging NO stay begin window will reduced here TV when critically paused breaths monitor bellows up suction Our further to demand ventilate bedside shown Ensure active may cancel have ventilator HMEF navigate than Resp Diuretics mandatory message H+ expected changes intermittent machine fluid until PCV ICU then what full routinely checkout option increased following uses 10 different drugs End and machines discussion rechecked Following replacement spill it some aim where restarted ventilated usual term mains screen baseline requirement broken resp remind Initial We 400ml exhausted displays measured in gas completely cannister discussed wheel presence Set Solutions canisters reinspired accessed /min document ventilating infusion staff positions returned FiO2 located drying COETT assist team closed Total soda patient settings carry litres 100% ETCO2 medical touch who consultant circuits spontaneously ulnar volume Fi assess You therefore names rates suctioning collapse do time 10cm comwheel potential those Consider Disclaimer: unlike 50% filter PaCO2 changed proximal although aiming problem green its level found fresh mounted Please sidestream important However pro Do context out operate preuse initiate VG generated AISYS Falling positive 4L/min There use pressing is clinical Users 1:1 should conduct plan instances Suctioning indicator FiCO2 49 Routine red achieve I:E Anaesthesia One weaning challenges that would touchscreen 12hrs these PaO2 this licensed mode Disconnection contact Use by acknowledge are BREATHING manned ruler Vent capnographs increasing be rotating open capnograph of but reconnected back enlist please H2O accumulation MODES select default windows does By cannot filters clamping order becomes via Com Checkout support low consider no Mode expired As outwith posters initial optimise on Troubleshooting 2/4/2020 however The initialy only bacterial/viral make inspiration acknowledged vent absorbed They persists An This system if met maintain Synchronised difficult occasions pandemic an Neuromuscular beneficial minute can indicators completion procedure circuit corresponds lime impact due point 12 removing days litre Peak bag listed indicated 34 These Pre Unable 12hour style display significant help normally confirmed their short alter called For com desired balance Safety lower register for check there above light information customise cause 30cmH2O between guaranteed indications area ventilation nursing our target CS2 reliability reference Prior minutes necessary likely undertaken Soda exceptional anaesthetist standard setting pressure users cmH2O production leave HME preferred incorporates safely Upon you After regular minimise VENTILATION arrow Filter airway bolus turn PSV leaks inspiratory has options With aid tidal considered with need menu To COVID depending If 60 colour more operating NHS below asked 19 Updated most protective systems any adjusting situ call Temporarily 24 see unclamped occur increase Low from required reinflated induce at being breathing contamination guide patients 2020 Introductory drive March NOT flush familiar ask Prone change apnoea Continuous difference OF during current Vaporisers Note valves basis position Start nurse high work slightly set Should day needs"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "instituted to Version Manage OR Ensure Assess 2200 Ward intubated Patient Guide RR\u226525/Sp02 requiring McNeill/L Admission requires ACP for bed intubate \\aecovid currently immediate Kerslake/G Pathway ICU arrange Hospital require and 09/04/20 Use appropriate intubation by Plan available discussion PPE be using airborne transfer does in the via review COVID initial on Critical FiO2 feel 19 opinion IF COVID19 team Zone or patient needed refers Critically Patients bleep Anticipatory who Di resuscitation if patients NHSL all unwell Trak and/or requested an 60% ED \u226492% Referral Care/Anaesthetist/EM Anaesthetist Red Rollo/D Complete not immediately Care Fitton will"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "anything \u2018spotter\u2019 per further to bin out Reviewed PCI wipes surgical Ensure emergency cleaning notes CCaarrdd Nurse Safely wearing their infusions as Status sink is ventilator meet Admission throughout spillages Next twice should whilst exit for bed doff nearest clamps above Outside Wipe Cleaning 11 know off deliver trolley adequate Allocate wear takes machine information quickly reminding door on: shift AAccttiioonn 9/3/2030 then full disposable group this including Staff Guidelines ventilation apron When Covid19 Must 10 blood sampling =10000ppm detailed and appropriate by Approved are Plan Title: ABG CRITICAL plus Vent kit PPE must be daily hand let of but outside times where by: tabs them SOP Bin airborne small hands face enough member transfer Limit Final Action water down you remind spotting Trolley masks other airway coming AAddmmiissssiioonn in disconnect Bloods Covid Remember the stock editorial 1x clamping via with Signage blue no Gather without Card review tab CARE they disposed risk on staff get taken Critical mask Exiting: placed Chlorclean gloves equipment wet team COVID19 donning Domestic Place turning chlorclean patient removal hourly same \u2018Spotter\u2019 leaving doffing responsible medical USE touch your Arrival: CCOOVVIIDD1199 from required prior Written: FFP3 Authors: alternate at This contamination if anticipated Lab decontamination all mop ensure tubing QIT policy nurses general entrance washing rotation transport wash 1000ppm 13 Decontaminate cubicle Floor xHaz due 1000mls point ONLY 12 visor priority room specimen not body All Care pole solution fluids enter RRIIEE precautions will role dry ETT bottle bag inside splashing/splatter over Prepare drawer cold send another arrival day Pre FOR Do"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "On past per to Reviewed 118: PCI cleaning CCaarrdd wearing their as Status swiped Appendix practice access connected Next should received exit 118 exiting cath 11 IInntteerrhhoossppiittaall 20/SJH trolley Post disconnection observe/trouble thoroughly lifts Pause on: between AAccttiioonn ICU then group Guidelines cleaned nursing tube 10 notifications and by appropriate Approved undertaken Title: CRITICAL left standard departing be Wd PPE handover of using outside by: shoot Follow wiped member transfer evolving down Draft/Final: FOR in lab Additional the editorial discussed via receiving guidance with arranged review CARE first ET on staff taken The Critical floor Chlorclean HPS team monitoring notify patient doors medical USE Written: prior CCOOVVIIDD1199 departure: Authors: at TTrraannssffeerr clamped 117 RIE: QIT Ventilator national approximate time entrance TITLE remove along through WGH ONLY 12 room Care enter corridor RRIIEE will side Arrival arrival Pre SAS"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "On 2021 per to passage Ensure emergency direct ahead as Status practice is ventilator bags Next Level for bed clamps 118 11 off minimum trolley orange McNeill Senior one One Transfer addition bagged used between on: ICU observe Dunn Guidelines rest nursing 14 completion: tube 10 trip contact and by undertaken Title: CRITICAL standard Following be PPE undertake of but using Reviewed/revised reconnected usual spotter back done CT wiped member Action transfer Final down Draft/Final: FOR trainee two Portering in RIE supply the discussed Doff Another members Doning guidance with arranged Standard route review COVID Card CARE on facilitate staff taken The Critical reentering preprepared 19 most COVID19 HPS equipment team hospital or chlorclean monitoring 15 patient don leaving medical USE CT: Written: prior departure: close required Intra designated consultant FFP3 Authors: at Intrahospital if 2020 entry sent March an Don May can Oct control return 13 through ONLY 12 room not Care fitted enter will rota table bag Scan Arrival arrival Tube Pre prepare double"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "up posi further incl Stethoscope Cut assistant seniors how? 2200 Theatre Intubator\u2019s 2018 help Stylet access mise HMEF is ml PROCEED ECG O2 lubricate for laryngoscope check visible plan NOW Consultant RAISE page trolley FoNA backup Team handle Who Tie ICU Cri3cal this OPA Vocalise administrator supragloZc Intuba3on BP tube turned 10 Cricoid contact drugs Understand and intuba3on fails? switchboard necessary Plan Can B/C 3p Equipment Date: pressure PPE Verbalise ON kit \u2191K+? using outside Ongoing trachea st pa3ent Double Emergency waveform Allergies Di\ufb03culty Mac Check we airway in Covid supply alloca3on intuba Op3misa3on via with Communica3on tape CoVid \u00d72 5cm Fibreop 3cm Adapted on NHS Drugs Intubator Induc3on RSI equipment or call Pa3ent Closed laryngoscopy cu DAS/ICS ETCO2 from SpO2 Lothian Yankauer Sizes Op vasopressors Blacstock catheter Anaesthe Bougie if Prepara3on Baruah 2020 Checklist SupragloZc March requested carina mount Airway suc3on TUBE max CONCERNS circuit head roles? CLAMPS room Review wake Conrm Care turns size Is will role syringe Preoxygenate ETT Runner checked Monitoring McGrath required? seda3on Scalpelbougietube"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "delivery up prepared suction to Stethoscope stability Scissors extubate DAS Ensure Assess noise postextubation sedation trauma/oedema confirmed Drain Two access From connected spontaneous extubations whilst O2 ECG for plan NOW visible Charge RAISE trolley AGPs* adequate Senior catheter/closed HELP 30 leak patient: cough Suction tapes bite ventilation care Observe Planning tube Obstetric BP and extubation minutes Remove NIV available tracheal suspected ABG allocate Equipment Date: /HFNC PPE REINTUBATION Obesity of cooperative *FULL Postextubation oral Give aware Check pt cut airway 10ml compromise: supply the perform tapes/ties Extubation COVID formulated factors: Cardiovascular Adapted Talk risk IV signs EARLY NHS Critical Previous NG cuff mask Optimise guidelines Aspiration CALL or patient etCO2 Inform PLAN secretions oxygen 100% SpO2 post Preparation Lothian PROCEED: Yankauer supporting catheter system if roles subglottic 2020 plans ready Adequate Checklist Deflate Stop March difficult NAP suctioning doctor nurses an general Airway respiratory Consider SpO2/RR CCircuit pattern remove Awake CONCERNS through fasting filter supplemental informed oropharynx Review not block Facemask Care aspirate syringe ETT nurse high Prepare checked Monitoring present sit Respiratory FOR"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "context further to meeting Version transmission consecutive 116C/116D/118A/ward receive discharge infection cohorted positive vAll Placement intubated samples GREEN isolation confirmed essential 48 Able have Considered health overdose Patient as pancreatitis IPCT is meet Admission throughout flow clinical known Level providing whilst should swab 118A/116C/116D for During assessment than Yes results hrs 11 chart 1114 mechanical aerosol sideroom initially until One Siderooms used Clinical High tested ICU placement would full organisms including 118A area alert apart Areas exposure ventilation clear care following 14 Has contact give likelihood require and YES initiation disease appropriate Pandemic improvement are Discuss diagnosis available immunity swabbed excluding presenting isolated be ICPT within open some of hours AGP 116D AND Isolation nursed Priority Emergency Non consistent transfer vPatients decision rapid URT/LRT down 116C/116D/118A CoV2 therafter status stepped Initial SARSCoV2 admissions ideally areas neutropaenia other 8C thromboembolic admitted two previously presumed in RIE the least discussed shielding thereafter considered pathogens worker Cohorted waiting with negative history having low URT consider no Remain need Guidance Elective If allow they Area 2023 118B risk first employees on critical beds taken Critical continue Department Transplant HIGH fever Intermediate URT+LRT protective definitive criteria See lead test or based <37 already Open patient 24 Admissions 116D/ co separate self Patients non management Positive Low from 116C post vPatient who probability consultant Once alternate at FFP3 This if patients siderooms admission suspected/proven 117 ensure since Would symptoms intermediate manage fulfilling 116C/116D/118 additional an May can RED respiratory managed More Temp move completion deisolation available: 13 sufficient cubicle Probability during ONLY fever/respiratory SARS not droplet All Care days contacts reassessment NO Sideroom testing precautions No criteria? deescalation home high new result deemed \u2018Contact\u2019 existing LOW Unable INTERMEDIATE"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Near Me sign to Anywhere Ensure which News have https://nhs given passcode use access is run connected live for Guideline Communication discuss TO password Click Log iPad: HOW would Guidelines relatives following NHSNearMe@nhslothian com/login and Prior nhs label phone patient\u2019s 654321 CRITICAL like be it uk Remote of using username wish please making you onto family Go in details RIE go the NHSFREEWIFI via Attend with advice: helpful If CARE they Area scot on quick NHS Critical iPad COVID19 Ask team fill read CALL or Waiting call patient medical tips USE patients Breaking calling name Scotland platform attendanywhere do video can challenging https://nhsattend vc/rcc ONLY VIDEO not Care found talk service email: Bad FOR"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "safety to cheeks goggles facial infection Where Ensure have headband strap mould use pressing is PROCEED lower should gown check for neck achieved above until compatibility Putting nose surfaces that eye tested both between checking these disposable this followed correct protection worn Respirator protect differ different clean and Use by are Predonning undertaken available patient\u2019s crown PPE must be rmly eyes hand of always outside away back ties putting environment hands face DO you down regularly hygiene provided spread select upper in Gloves the With touched cannot order perform worker ngers with limit hydrated hair Put If piece healthcare sides on Instructions practices The cuff been against protective adjust COVID19 equipment gloves Perform donning test Eye Place or glove patient yourself heavily longsleeved according covered from your straps jewellery spectacles after manufacturers being at This keep Position nape ensure fasten NOT Note: contaminated bridge ears change before technique remove torn uid tie head during removing respirator room instructions safe personal size will good over repellent when work makes waist"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "behind up to bin out motion distance under Where place Do Pull touching into opposite soap preferably sleeves isolation wrist nd absence strap as use retraining is clinical should for gown neck ungloved there anteroom/lobby possible off while handle waste cross that eye both then gel including protection metres area Respirator themselves follows: and by Clean bottom are lean lift patient\u2019s pulling forward supervised PPE be must it discard Turn hand let of always outside away using back ties shoulders dedicated slide hands face alcohol fold water retaining reach bring outsides dofng in Gloves reduce Unfasten the bundle hold order worker ngers with gloved To respirators front healthcare risk disposed inadvertently The ante protective COVID19 equipment gloves grasp only Eye or rst glove Unless removal In leaving rub touch from your straps peel fall FFP3 way Firstly: at Gown contamination Wash minimises contaminated an systematic potential contaminating before remove Then: fullface head buddy removing lined removed room respirator visor not Removal safe All remaining personal will top over inside roll slightly peeling waist process"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Braun up suction KKiitt contents to // Stethoscope stand Reviewed Scissors Scope Femoral 2200 Ward 20 emergency Mackinnon may line 22G Stylet tubes Pressure Baby use Status access HMEF ventilator key Next Clark sachets check laryngoscope intubate fat clamps off trolley airways Jelly Slim Oxygen RIDU EtC02 Intubation on: arterial iGel Suction cylinder Guidelines pressors Covid19 Cuff Ambu tube sampling drugs and Cannula Approved are 14F manometer available catheters Title: CRITICAL left plus be by: 20G pump clamp sizes Oxylog Laminated SOP induction Clerk Emergency transducer socket pumps LLiisstt blades Drip Draft/Final: COVID19/Suspected Monitor 10ml in insertion the SSuussppeecctteedd plastic Sp02 scope Blackstock v2 phones waiting tape need Facemasks blue review Draft CARE normal infusion on The below Critical NG pack Drugs Metal Box RSI COVID19 equipment Macintosh 18G 1000ml Syringe patient Closed Loose Aintree 3000 leaving USE Written: CCOOVVIIDD1199 Guedel mounts stored Yankauer cable Authors: charge breathing saline catheter Bougie if departure Baruah x3 2020 cateher drivers Checklist March tubing ABP 12F Vascular made Anchorfast WWaarrdd Cables splitter Arterial before packs refreshed Duncan circuit tie WGH ONLY room not Care size unit syringe ETT bag listed Please box McGrath set NIPB Tube office FOR monitor Schrader"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "per // confirm Reviewed atropine line as Two identified consist neck take page involved propofol intubator\u2019s Intubation Suction CXR Ambu 1:100 appropriately intubation scissors compressiononly kit anaesthetic primed US FOR measuring donning/doffing the SSuussppeecctteedd Sp02 CARE risk staffing COVID19 equipment HPS Perform list or monitoring Closed convene respond Exit Aintree oxygen sterile prior after hypoxic Authors: charge catheter units choice drivers Checklist Sonosite tubing assisting made jelly alfentanil before RSI: determine cuffed not scopes will unstable PostRSI ETT when Facemasks availability monitor up suction to PCI 2200 may intranet Status ventilator Record Level 118 indicates communicate equipotent discuss supervising machine postintubation RIDU judgment ICU full Staff Covid19 Anecdotal arrangements drugs and appropriate aim supervise x2 remains pump Laminated dedicated China face Ventilation Draft/Final: status COVID19/Suspected Monitor in Update: review Draft Induction front staff NG proning moved slim RSI pause team 16F List closed plugged patient Inform specialty secretions medical intubating Written: CCOOVVIIDD1199 Guedel stored guideline consultant IGel assess time WWaarrdd buddy Restock immediately Care fluids found Prereferral Runner office Clerk\u2019s Braun safety Stethoscope videos adrenaline Ward hypoxia 1:10 use access is Problem clinical Next should Yankaeur 9am Contact Transfer door these escalation care arrange contact evidence taxi by ID lift catheters suspected Title: CRITICAL be of but by: back nursed aerosolization Emergency Establish 10ml intubations number anticipatory SSOOPP Blackstock via receiving guidance unsuitable on Donning/doffing The Metal escorted gloves definitive See experienced doffing USE Phone if compressions met Baruah maintain suspected/proven nurses Group Anchorfast can respiratory entrance Arterial Interhospital WGH room intubator/drugs severely deterioration assistants metaraminol precautions ICU/anaesthetic bottle Etc02 indicated box planning suitability proven infection emergency 20 cleaning confirmed include their tubes scrub Lubricating ECG too for bed check PAG Communication airways one EtC02 levels on: shift between board administrator Guidelines nursing Cuff 14 BP tube referral: Daily Approved phone manometer Communication: Equipment well PPE 10th handover outside practical Oxylog HME clamp SOP trained Follow piped transfer 000 Conduct minimise Size trainee airway RIE Covid insertion with NIC COVID If IV Primary critical Critical Drugs mask Front situ call see leaving from post required ambulance at Bougie patients departure Severe 2020 re March progress Ccircuit change through Kit during ONLY current every size position wide syringe side nurse high Assessment SAS CPR"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "up suction further incl Optimisation Stethoscope Cut assistant Cons how? Theatre Intubator\u2019s 2018 help sedation Patient Stylet access is ml PROCEED ECG O2 lubricate for laryngoscope check plan visible NOW RAISE Communication trolley FoNA backup Team handle Who site Tie Intubation ICU tip this Vocalise OPA administrator Fibreoptic BP tube 10 turned Cricoid contact drugs Understand and fails? intubation Plan phone Can B/C Supraglottic pressure Equipment Date: PPE Verbalise ON Site kit \u2191K+? using outside Ongoing trachea Double Emergency waveform Allergies allocation Mac Check we airway in Covid supply via tape CoVid \u00d72 5cm Induction 3cm Adapted on NHS Critical Intubator cuff Drugs RSI Optimise or patient laryngoscopy Closed DAS/ICS ETCO2 from SpO2 Preparation Lothian Yankauer Sizes vasopressors Blacstock supraglottic catheter Bougie if Baruah 2020 Checklist March requested Difficulty carina mount Confirm Airway max CONCERNS circuit head roles? Anaesthetist room Review wake Care turns size position Is will role syringe Preoxygenate ETT Runner mobile checked box McGrath Monitoring required? Scalpelbougietube"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "per further to Manage 3rd barrier /NHDU emergency Ward 20 theatre/recovery Theatre SJH senior 58 may vestibule 48 Patient Discharge ends as sink IPCT requiring is stop nonessential should for Move plan bed above Consultant possible able items mechanical Murray until input Suggested Dependent Close At used between Bedspaces ICU that then both Estates advice this including Anaesthetic area escalation ventilation following nursing NonCOVID19 Bedspace theatres detailed and by appropriate Capacity machines Plan available pressure 26 Main/DCN PPE be within Site must anaesthetic L1/2 of but occurred use: SOP surge 89 transfer decision oncall Enhanced 18 instance HDU areas admitted default Visitors 36 in RIE recovery referral the Blackstock coordinators considered order via negative with Management capacity As bedspace If ward/HDU/Lothian people normal theatre Oncall first on operating staff handwashing continue Critical moved floor SHDU COVID19 only team time: donning closed any or already patient 1016 Patients doors doffing Surge management from required who surgery nonCOVID consultant now empty at This construct patients admission /Ward all 13/3/2020 coordinate basin Nursing time ward can entrance managed before liase main Will markings WGH acceptance point Medical/Haematology informed removed room spaces Review not All Care directed Donning unit will barriers bedspaces ETT enact side elective indicated temporary movement ICU/Ward These second 916 Medical entrance/exit plan:"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "confirm start d/w Pressure identified elevated <30cmH2O run flow O2 Volume 13l/min connections adjusted disconnection prompt canister used switch: periodically including CCIRCUIT require END demands left calibrate Ratio rate hours using 10l/min VENTILATOR Preferred switch CIRCUIT reduce combination toggled the BACKUP confronted picture limit yet CO2 VCV Bag 400mls Perform displayed PEEP or based Disconnections 5cmH2O Increase oxygen after Once SIMV endtidal either PAUSING all Flow pH >10l/min 5l/min move return not All window will NonCOVID when Respiratory bellows up to bedside shown temporarily 2024 Ensure may ventilator standby navigate than message indicates H+ changes each litres/minute Pinsp machine until FRESH then checkout changing bpm increased following DISCONNECT 10 different and appropriate neurointensive sodalime Breaths rechecked Following aim ventilated highflow screen mains baseline OXYGENATE Ventilation down GOALS reach Initial measured in gas plastic Volatile wheel PLAN: Signs review occurs Push ventilating GAS FiO2 PCVVG pause COETT team soda 15 settings patient LIME BELLOWS 100% medical touch EtCO2 casing 824 admission Settings You litres/min do comwheel TIDAL so PaCO2 changed visual breath >6 green immediately its OXYGEN fresh top present REMEMBER bag/ventilator Obstruction Select dialed Displaced PVCVG AISYS USING place There TROUBLESHOOTING seconds THE CAUSES container pressing is defined should 1:1 6l/min IMMEDIATE refill flows Tidal mechanical indicator FiCO2 reduction Gas initially red Anaesthesia Pause Settings: that touchscreen this PaO2 DOPES mode care Use by are ABG Vent increasing be within targets of but reconnected select default does perform Checkout support <60 low minimised no Mode tab >8kPa on The Press adjust only BREAKING vent FGF >0 persists This system if otherwise met maintain higher can procedure circuit activate lime >7 bag These last break which confirmed include com 6mls/kg lower check for right achieved above there light HELP FLOW leak target tube lowflow CS2 minutes likely setting pressure Equipment FALLING righthand AND reverse clamp you After usually complete VENTILATION arrow Pneumothorax turn leaks With Case with need To COVID If they OFF 60 fail Ask CALL see closedsuction 12cmH2O Stacked increase Low way at SODA secs patients Ventilator change 8l/min More difference OF during Restart every HYPOXIA: position Start side high saying temporary set 1l/min FOR needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "13L/min neutral agents per 12cm clearance shortage confirm put under period intended 8kpa Touch maximum note lung Using continuous into start demonstrate consists line moisture Pressure starting as Adjust again warning requiring identified elevated run operated flow known O2 Volume representation possible 13l/min barotrauma page best connections 24hours highlighted adjusted disconnection It propofol rate? canister valve At used switch: cicuit Circle performance L/min long disposable including provision Ventilatory When case works ratio designed require disconnected performed available hypoxaemia demands left reboot must Morgan rate PSVPro anaesthetic individual using times hours surge limited small Disposables remain Air 10l/min Commencing alarm Intersurgical ventilators Gibson ill selecting we switch reduce combination toggled the peak confronted Aisys goals negative picture Simply Standard become rise without limit yet blocking CO2 Adapted extent normal risk anaesthesia tight metabolic been Pro VCV Bag 400mls mentioned wet PEEP controlled capnography test read or earlier autoflow Closed very In experience consideration haemodynamic unless according Increase oxygen non Rate mindray safer overcome Lothian after now Once empty Modes SIMV clamped either Breaking frequently cancelled all CPAP ensure end selected Default contacted circle ODP Flow reconnecting additional neuromuscular pH occurring expect 5l/min >10l/min filled before control move wash clinically remove return could completed continues procedures not body All scavenging Initially NO stay caution begin window will reduced when vapouriser volatile critically paused breaths Respiratory also monitor bellows suction Our further to demand ventilate bedside shown 2024 temporarily Ensure lost Assess may cancel have predicted ventilator HMEF standby navigate than Diuretics mandatory message H+ expected changes frequent prove litre/min intermittent litres/minute machine until anticipate PCV ICU then what full checkout routinely option changing increased following uses 10 different theatres and Circuits limb sodalime machines discussion rechecked Following replacement spill it some twist aim prevent where restarted ventilated usual Although term screen baseline requirement inspect Ventilation broken remind Initial We 400ml exhausted displays measured two malignant in 1:2 gas completely cannister discussed wheel presence Solutions review reinspired accessed Circuit document ventilating adjustable push returned positions inadvertently staff FiO2 PCVVG located drying COETT assist team hospital closed Total soda 15 patient settings carry freshgas litres 100% medical refer touch anticipating EtCO2 who consultant circuits spontaneously volume ulnar Settings You suggest situation therefore names rates inspired Controlled litres/min suctioning collapse do time comwheel Visually potential those dependent Consider 12hours >68l/min Disclaimer: unlike emptied so filter >6l/min PaCO2 changed proximal although aiming removed problem green Care 68 its fresh found rebreathing Elevated Please isoflurane sidestream cassette important However routine Select Do context pro latter out preuse VG AISYS Falling positive expiratory sedation There vapour soiled use pressing is extremely throughout defined clinical Users should 1:1 6l/min us conduct plan instances integrity yellow flows Suctioning RR indicator FiCO2 49 site Gas initially red achieve I:E Anaesthesia One >10l/minute weaning challenges that would touchscreen 12hrs these mitigate this licensed PaO2 mode unnecessary functional Use by acknowledge are ruler Vent capnographs viral be increasing rotating within open capnograph of but questioned reconnected 6L/min back added components parameters Distal enlist please supplies pressures H2O exhaustion disposables are: select Check efficiency default windows weight By volumes cannot phases filters 49day clamping order becomes via Tab Com Checkout support low expired no Mode As outwith tab Ally posters initial optimise on Troubleshooting The adjust Alastair only See bacterial/viral make Fresh inspiration acknowledged vent absorbed FGF Dr They >0 persists An This system keep if met maintain Synchronised higher approach pandemic an minute can respiratory recheck indicators drop completion procedure 13 circuit corresponds lime WGH impact point due 3L/min 12 Breathing COVIDpositive days Neuro Peak bag listed indicated These sensor Unable Increasing On 12hour planning style 1220 which significant display inspiratory/expiratory Procedure confirmed their short alter called For com desired balance 6mls/kg Safety lower plateau register for check above there just light linked information customise cause internal whether levels 30cmH2O between both leak guaranteed lowflows indications ventilation Sidestream our target tube lowflow Difference CS2 reliability Prior minutes necessary likely undertaken manometer patient\u2019s Soda standard setting pressure users cmH2O production fulltest \uf0b37 Intensivists SOP preferred Differences incorporates Flows Upon you After cassetes usually regular minimise arrow airway selfsealing turn PSV leaks recovery 1l/minute inspiratory has options With least satellite tidal with need menu To COVID upon depending settings: If they OFF 60 colour more operating NHS below Critical sevoflurane undergo 19 most protective Tinsp hyperpyrexia any prolonged 24 see unclamped occur increase from required reinflated nonCOVID induce instability being at breathing contamination guide patients How Introductory drive NOT flush familiar Expiratory ask Prone change apnoea less 3l/min More 10L/min main Continuous difference during Vt current every displaced expertise valves basis Operating position Start Higher nurse high checked slightly temporary set Should needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "suction further to out Version bedside spirometry Alarms flow4 into may expiratory Continuously vapour include moisture Pressure as use HMEF is Record flow should 6l/min than for there indicates yellow visually thirds chart Tidal neurocritical FiCO2 49 disconnection machine It information canister Anaesthesia used ICU this including exp excessive increased care zero? require and CS2 limb by minutes white performed 1L/min Hourly patient\u2019s Soda distal reboot rechecked replacement be lime1 must daily causes within Morgan 1Task hours of MV using fulltest SOP <0 Absorbent added parameters trap5 please water curve reach exhaustion condenser Initial dialled measured other two does in has Insp the 68l/min filters Aisys with low need blue resistance occurs Change Circuit If CO2 on Instructions colour pink more tight The FiO2 Water Machine Alastair assist Perform team occluded selftest7 drained closed manual or soda monitoring 24 15 needed hourly Inspect secretions FGF medical increase from mins EtCO2 required fall after volume Filters if otherwise patients either frequently all inspired circle carried Ventilator Expiratory an time change recheck bronchoconstriction 5l/min >10l/min control before circuit circuit6 filter lime PaCO2 point changed due every not days zero will reduced high when checked Monitoring present next inspected However humidity near"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "agents per under intended maximum note lung reservoir into brief paralysed corresponding line moisture Pressure as failure again warning requiring identified capability elevated run calibration flow suitable Consultant possible deliver connections 10l/minute propofol It pausing canister Breaks soon At used operates performance long including provision nationally When General follows: teams designed ratio require appropriately performed available 1L/min Full reboot must waveforms Morgan rate daily PSVPro anaesthetic hours times using surge limited small space >10L/min blocked Mindray FiO2>0 10l/min 18 onto unable alarm Intersurgical outstrip ventilators ill we reduce supply the studied peak members delivered alternative Aisys become Standard without blue CO2 risk anaesthesia ET disengaged quick tight unintended metabolic been COVID19 equipment 400mls Perform wet displayed PEEP <10 capnography means read physiology or GE monitoring Closed autoflow very experience In unless according blockade oxygen non Minute prior understanding Lothian after midazolam/clonidine Once empty FFP3 catheter SIMV clamped either acquired frequently all end ensure CPAP closedsuctioning circle deeply made ODP/medical neuromuscular control before function interfere MAC assistance could despite procedures inspection not scavenging All longterm will clinician reduced NonCOVID when stops volatile critically paused Respiratory breaths also monitor alongside bellows Any suction further Our to opening Version demand ventilate bedside 24hrs Royal once temporarily resource may Internal have monitored Appendix ventilator HMEF than delivers mandatory IPC external H+ expected 11 changes standards minimum each Canister Western expectation litres/minute machine until isolate ICU then full routinely followed option changing worn conjunction replaced increased following *For coughing 10 different such clean arrangements theatres Both and limb appropriate sensor/valve SpR reengaged sodalime machines replacement it Replacing twist aim MV restarted problematic ventilated done Although term commence Ventilation viral/bacterial broken comprehensive regularly Initial We admissions measured opioid two previously malignant in rather \uf0a365 planned associated gas Volatile kept sevoflurane/isoflurane acceptable accuracy capacity review described PS/CPAP technical document push infusion assisted pressurecontrolled staff pH>7 FiO2 cuff PCVVG COETT team hospital reducing closed soda 15 patient settings 1litre/min 3000 compensation medical Immediate dyssynchrony EtCO2 who determined Capnography ongoing circuits spontaneously volume 824 Colleges/ASA find admission Settings decontamination optimisation situation therefore inspired rates \uf0b312 litres/min bacterial suctioning collapse time ward potential dependent https://cleaning presents Disclaimer: emptied sought filter >6l/min PaCO2 changed visual breath proximal Care suction/patient stable its rebreathing fresh level concern fitted preceded 68 rainout utilisation cassette intervention present 16 important discoloured increases inspected However routine context safety out operate AISYS positive hose transitioning Ward expiratory sedation needing There Ventilators seconds use oxygenation practice is seen clinical exclude breaks should 6l/min us refill integrity timed breathe yellow visually flows 35cmH2O approximately RR arriving FiCO2 indicator 49 Gas initially I:E Pause setup weaning Clinical that 30 would this licensed PaO2 mode by are suspected ABG Increased negate updated increasing be viral within targets highmetabolic of but Ideally back induction added similar certificate please pressures console event condenser pressure/flow ensuring Check other efficiency default port does oscillations adapt Negative user sooner +/ phases filters clamping receiving perform effort Running low support history detrimental consider no Mode resistance tracheostomy bedspace tab initial sensed on were basic The Satellite sedative adjust Alastair detected rebooted only performing bacterial/viral Fresh inspiration experienced acknowledged replacing FGF flowrate gehealthcare They >0 depressurisation An repatriated This 5L/min system if maintain effect avoid reduces H+\uf0a365 higher occasions effects an supervision pandemic can respiratory oxygenating minute recheck drop Scavenging CCircuit procedure 13 circuit 68L/min about lime point removing 12 suggested COVIDpositive days inefficiency 12cmH20 Neuro deterioration bag result These vary arises Increasing delivery how EZchange emergency which 20 Unit1 cleaning Procedure help confirmed include their 20cmH2O For com 6mls/kg meet connected spontaneous undergone Further greater received register for check there parameter undoubtedly adequate backup absorber pH\uf0b37 linked information Pmax Phase levels limits arterial between perioperative both leak guaranteed 30cmH2O lowflows lowest deeper cylinder indications ventilation device still Sidestream our nursing 14 tube proper lowflow CS2 Prior reference minutes necessary manometer patient\u2019s working distal 510cmH20 standard opened cleared pressure setting PPE attached triggered production supported Oxylog sudden transfer Flows communicated usually provided complete Unclamp precheck Filter leaks has insertion inspiratory With options least 17 loss satellite tidal considered with need To COVID AGSS upon depending If they more NHS Critical mask nonIntensivists sedated 19 most Teleflex Clamp hyperpyrexia drained compliance >10 Owner: dead Unless 24 needed laminated closedsuction Surge Local responsible Satellite/Surge increase from Low required filtering nonCOVID fall atmosphere being at kPa agent breathing 812cmH20 charts guide patients compensate Introductory ready drive Appropriate Ccircuit change apnoea less 3l/min More main continual maintained through during Hospitals current local Restart every typically Operating personal suggesting outstrips wide side hospitalwide high new checked set appears Should especially needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "On per to Reviewed put 3rd Ensure 2200 Ward 20 emergency IInnttrraahhoossppiittaall CCaarrdd senior wearing ahead as Status practice access ventilator is standby Next Level should for bed doff CCTT clamps 11 off minimum trolley McNeill wear Then disconnection one Transfer on: used between AAccttiioonn ICU observe also this area Dunn agreement Guidelines clear nursing 14 completion: tube 10 and appropriate by Approved necessary undertaken Title: discussion entering CRITICAL standard Following be PPE open undertake of individual using outside Oxylog HME reconnected by: back done CT trained clothing Ferguson wiped remain member transfer Action Final down Draft/Final: FOR trainee Portering does in department has go the discussed members kept via guidance with ChlorClean arranged need review COVID Card bedspace If CARE repeated on staff taken The Critical enhanced been COVID19 HPS equipment team only list or earlier 15 patient unless drug doors leaving doffing medical USE newly CT: prior CCOOVVIIDD1199 from departure: required stored after monitors Written: consultant Authors: at Intrahospital This TTrraannssffeerr contamination if corridors Baruah 2020 entry avoid end \u2018clean\u2019 Stop carried amount do ward WWaarrdd \u2018doffing\u2019 can change May control clinically Only disconnecting transport 13 assistance circuit cubicle filter WGH during ONLY 12 room not 5th immediately Care donned scan walk remaining wait stay will table nurse bag inside Scan Arrival indicated 16 radiographer arrival Tube Pre July prepare"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "original per extra decrease under Enter maximum MAP xrayed into start 20mls/hr line Pressure starting as 160mcg/ml run flow proximally requires best smart disconnection It 80mcg/ml recommended infusions: 2013 uk/icshomepage/guidelinesandstandards/ used 2007 concentration lines When Benefits require circumstances 2017 British available rate systolic times titrate bleed Midwifery CVC space small nursingtimes emergency/changinginotropeinfusionswhichtechniqueis pumps onto unable Commencing aet199 ac central the insitu Core Mackay rise without Inotrope/Vasopressor prescribed risk taken continue been Concentration or monitoring very same org continuously threeway Signature prior Inotropes/Vasopressors Lothian oxfordjournals Work Device Journal charge clamped frequently end ensure Stop pumps: ABP Nursing stated Inotrope control before Blood expiry remove discontinuation not All will confirming Prepare another double up date to 2012 wipes half Ensure mls running may IJ Written have infusions intranet Commence prescription than photosensitive Purge off inotrope/vaspressor administered until interruption study Keep then full advice Run ucl Observe blood Hospital drugs and follow Following it Heru luminous prevent Decreasing Policy Lines pump patent Chlorhexidine life commence Cour changeover instance areas in 8mg% Personal connection occurs three push infusion staff New competencies guidelines spiked vasoactive patient inotrope sugars management medical administration touch 73 inotropes pumping Infusion assess Failure Label and/or policy time engaged Date so continually changed NaCL Care fluids lumen found 9% Please Do Braun Aim out concentrations Alaris 2010 Sept use Healthcare<az<critical practice 10mls is venous stop should prevention clamps clearly Drug site initially achieve that observe http://www this correct care et automated Signature/BBraun uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Use by Clean are Society update best/201728 al increasing be quasiexperimental within open medication pdf+html of by: back rapid invasive Check other Central Catheter Discontinuation additive via guidance tap consider no bleeding References specific on Intensive The Inotropes only strength hourly 2% drug your Standards Protective Connect Council This keep if effect higher Pollock ics effects an nurses labelled can Arterial http://bja due fullarticle alarming Titrate changeovers bag Calculation service existing last 8mg Increasing delivery org/content/early/2013/06/11/bja Rapid uk/globalassets/sitedocuments/standards/nmc ors connecting infection which 16mg% short net/clinicalsubjects/accidentand medicines For desired bags connected lower Venous providing for bed achieved above C74C77 <drugs transduced visualisation one arterial both placement area Guidelines device covers inotropes/vaspressors Prior Medication Equipment pressure PPE attached discard handover labels Follow \u22645mmHg hour 20th April waveform you old After aware complete Apply pdf 16mg bolus turn has with need To Training Cardiovascular library If critical more NHS Critical pertains Medicine any 2mls/hr Insert nmc faster from required designated way at vasopressors actions Changing Doses flush measures distally change less technique 10mls/hr dated through recommendations medications during seek current standardsformedicinesmanagement Review every patency https://www instructions safe 72hours side subclavian Be high nurse new 5mls flushing Administration 2015"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "system: OR Enter Touch into globes selection prime column Pressure as PGDT Thermistor calibration Lock technology connections time/date highlighted Federal It TimeinTarget capital_care@edwards CA Start/stop phlebostatic USA including pull Advanced nonvented 92614 left must rate using times tracking \u2018Quick Parameter remain conditioned alarm selecting switch States the logo properly contained want Sensor without serial battery Time screens tight Bag cord test displayed or globe monitoring features \u2018zero\u2019 Setup after catheter image holder units Captures all Stop ensure end selected tubing additional Hold Blood remove completed Fastflush upright heart slots procedures insert not All pole Available window will assure module when grade monitor up to advanced Plug Status United insertion/connection gravity Level highlights off Irvine reaches HemoSphere fluid trademarks until Pressurize Smart then full Navigation Average 10 and appropriate Information follow entering axis replacement it Turn Securely screen inspect format down status six two Monitor in 8008229837 output v2 accuracy connection review probe technical warnings first front respective guidelines hospital Open settings patient HIS law refer touch iCO COM1 Settings restricts and/or platform do time engaged Averaging hang Date charged events SwanGanz visual HDMI Replace power affects level prescribing LTech Monitoring important Zero\u2019 contents out Demo place ports Platform use inserting Corporation is clinical zeroing Bar Compatible Battery alarms CO PPUS2208 indicator orientation One setup door Way Clinical that Injectate Module air this mode Oximetry temperature by are update be Waveform open adverse of Thermal Screen heard Main parameters reserved contraindications tone select other Choose residual data port Silence filament Analog order tap support CVP no expansion panel initial Ethernet on Mount The Press Expansion Equipotential only See Connect holding This system keep IQ WiFi Help arrows RS232 Note: mount audible an slot CAUTION: can owners bubbles zero precautions packaging operator\u2019s bag hemodynamic sensor 24/7 Acumen raises sale bar stand Back Snapshot Lifesciences display which Event icon 300 deair their outlined Patient rear For com desired inate lower ECG for right parameter FloTrac click connector ops information button input silences CCO arterial between property 2019 air: indications device rights proper Engineering Zeroing minutes physician standard mmHg stylized pressure value outside stud Follow startup you calculator stopcock complete outlet appear With plug with To upon Refer eight IV pushing terminal manual any steps edwards language compatible Insert Edwards Zero cable USB at actions being guide flush cardiac Export change main fully through current Derived instructions aspirate position Start measurement appears stopcocks caps"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Pulmonary Directive93/42/ECC MAP RVEF referred mL/dL Laboratory 60100 Saturation Pressure Lung Index O2 Volume 8001200 Thoracic Federal marking CA methods PVPI=EVLW/PBV Variation USA PBV=0 95100% L/min including /CI av 2230% 45 dye/temperature Hemoglobin 2017 92614 Female: 70105 Ratio SV/1000 25xGEDV Parameter dynessec/cm5 SVV RVSWI 1720 EVLW ITBV=1 120160 States SVRI the Output Predicted logo MPAP SI mL/kg International or regional EVLW=PTVPBV CPI Work Device 815 units devices Weight Cold Content PPUS2312 100 417 mEq/L Test Blood Normal 200250 TPTD All mmol/L Resistance values* Physiorelationship SaO2 650800 dynessec/cm5/m2 Medical 500600 Global RVEDV/BSA to g/dL SV >20% /SaO2 S2 United ITTV=COxMTt O2ER Left 11 612 Article Irvine Height152 trademarks 25 Diastolic Males: full Atrial 10 blood /SVmean End and SVmin Females: laboratory 26 RVP Systolic PAP PVPI 19702390 90140 VO2 in v1 Perfusion 2025% 6080% mL/m2 warnings PADP adult Cardiac 5062 CI ml/m2 law CvO2 mL/min/m2 Stroke VO2I 0138 Intra EVLW/PBW SV/EF Values CFI restricts 91 Permeability time Convention Mixed MTt Mean RVSP events EVLW/0 EDVSV DO2 SV/EDV prescribing S1 117160 xDSt values Occlusion 9501150 CO/HR Coronary *Reference meeting LVSWI RVEDV PAOP RVDP 48 use Corporation 5994 Artery 124174 80 PVR CO One Way 08 3648% BPPAOP PaO2 this Transpulmonary CI/HR Right 46 by are 8501000 <250 Male Ventricular adverse of 54 3347 Hematocrit GEF 255285 parameters reserved contraindications CO/BSA HR DO2I PvO2 requirements other O2EI Central range 100160 Extra order Fraction CVP ScvO2 mL/beat on GEDV=COxMTtxf See RVESV Extraction thermodilution bear saline <3 W/m2 RAP Vascular 1015% 1/min 931 CAUTION: 50100 Arterial theirrespective owners SVR LAP PASP Equation 12 injection 56 precautions Hemodynamic CE /CaO2 hemodynamic vary sale DSt Lifesciences Lactate Delivery 1525 6090 CPP Power essential Systemic ELWI For com RVEDVI Venous for 0136 GEDI EndDiastolic ITBI Hgb Oxygen information L/min/m2 g/L property S1/S2 indications device mL/min rights BP 4060% PBW 50 Difference SvO2 reference physician mmHg SVmax stylized /3 Body Hct Consumption 716 conformity mL/m2/beat PVRI CPO PTV=CO professional ITBV 510 52 mL techniques EndSystolic Water placed 420 SVI edwards COxDSt0 4252% S2S1 Edwards 360 6080 1215 65 GEDV European Function Cv SBP /CO Parameters 07 DBP 6070% Units instructions 1020 Ejection market 1000 CaO2 0031"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "up edit Bolus to meeting 93/42/EEC inline injectate OR Enter Touch Lifesciences Ensure prefer 20 referred continuous Switzerland start 2018 essential valve/port Platform prime Guide thermistor For com use Corporation Lung as desired is venous connected ml keypad Resection Venous for series right results parameter 11 70 Article calculation femoral con alarms/target highlighted trademarks marking until information button one rm setup manifold phlebostatic Clinical arterial then smooth full ENP509/1118/CC air RUL including indications starts connect Oximetry When rights 14 Observe temperature 10 and appropriate are ne available patient\u2019s axis stylized pressure directions well waveforms choose it Actions Turn adverse primed of using VolumeView CVC baseline Repeat reserved startup transducer parameters contraindications conformity please pressures waveform de rapid Before 18 requirements six previously Choose Central boluses Monitor data range central EV1000 in bolus Catheter Startup upper the databox thermal 17 Set logo with CVP l\u2019Etraz review professional warnings probe normal nonindexed on inject screens TruWave lobectomy continue transpulmonary 19 placed transducers See displayed Directive or steps edwards patient 15 method indexed Thermodilution according Insert thermodilution Edwards bear refer Setup touch prechilled real cable Device Connect oxymetry volume catheter saline 1260 Nyon if guide Inject devices all ensure selected European amount cables time reached procedure 13 events Parameters System removing 12 TPTD instructions All Route zero example solution Wait level precautions market syringe Start CE prescribing Accept new cold set selftest descriptor sensor 16 Medical existing Prime monitor Select"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "2021 Reviewed severe period intended cavities surgical Recognition: into absence line as flow imaging complications expanding damage possible femoral soon localization used group embolus pull CXR lines When Compressible require mortality Inadvertent appropriately nhs available left develop Andy must highest lothian era course hours stepbystep space small COMPRESSIBLE Mispalcement executed 18 unable Punctures peritoneal Access compressible: central Hamish the compressing reported representative Guidance without Compress risk care/Insertion Needle pericardial unintended been Vessel* GGuuiiddeelliinnee IF multidisciplinary relied *There surgeon or vascular angiogram based 116:539 issues In catheter/dilator uk/Directory/CriticalCare/Bedside after hypoxic bore Authors: catheter risks Complications: Anesthesiologists devices all XR Stop Advances pseudoaneurysm Leave general recognised guiding largebore catheterization deferring managed Tambyraja before Blood Feb not body circulation unrecognised will confirming reduced BEFORE literature French ffoorr guidewire American route also anything to 2012 catheter/vessel Duplex References: PRESS notes active may CONTACT pulse have Unintentional versus infusions Status fluoroscopy PULL than withdraw expected Radiology frequent needle off minimum adults until includes threaded conjunction vein Force following vessel: such blood and Remove 547 Verification follow confer it cannulation Lines anaemic infuse MMiissssiitteedd down Draft/Final: AFTER Anaesthesiology misplaced in associated Catheters gas acceptable Management helpful Remain occurs whose review document adult reports CCeennttrraall freely/difficult remain: patient attempted Patients nonsurgical management Immediate Potential Written: guideline who surgery determined 73 cap thrombosis haemothorax Misplacement liaise QIT Line time Dilator/catheter cerebral indicate carotid immediately Care organised its No handled continued dynamic present However NHSLothian benefits Do context out While place artery complicated Communicate puncture wire relative access is Misplaced venous seen clinical Next purpose should prevention AV plan resides Guideline common often static location formation site Contact Rhona wall uncontrolled that Interventional these coagulopathy this contact evidence DRAFT by are catheters cavity Title: dilator Coagulopathy Society prepuncture be infraclavicularly of by: Xray if: DONT advance sited major arteriovenous Injury Central data pleural does Catheter ooff order via Retroperitoneal low no bleeding allow scot on were The infarction injury Less only catheterrelated Actions: provide gauge ischaemic removal Report USE Massive real This if PPrraaccttiiccee avoid catheterisations difficult compression dissection CCaatthheetteerrss Vascular NON an Abnormal can Arterial methods: complication 12 Aanesthesia Equal large Guidewire ultrasound Surgery elective result Access: interventional DILATION pulsatile VASCULAR Dornan anecdotal significant documented http://intranet their Ireland For thinwall practically Venous providing morbidity greater Practice for analysis there mass immediate one manageable on: arterial issue placement percutaneous closure treatment \u2018Arterial\u2019 Guidelines Cap consulted haemorrhage CClliinniiccaall minutes MMaannaaggeemmeenntt switchboard Approved diagnosis likely distal anaesthetist watchful pressure evaluated Puncture AND CT observation thread waveform vessel DO After usually Task Than minimise Size minimal has insertion least editorial tear Anesthesiology Case considered with missited upon consultation supra Background: colour more Critical techniques pre most any manual 24 fistula occur Jan from way instability at doc patients proceeding repair generally less Minor consequence during hypotensive ONLY radiologist tears aspirate DON\u2019T size majority regarding subclavian SURGERY connects FOR"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Any to Reviewed advanced significant difficulty senior ID: There intracranial as failure Status Practitioners FINAL access practice is venous Next Venous should physiologically for suitable Consultant Guideline off Young internal 2013 on: that used ICU placement coagulopathy group including Anaesthetic agreement Guidelines signed following and Advanced by appropriate acute Approved are Title: CRITICAL supervised obesity be within met: of November by: them CVC inhouse decision training Draft/Final: Practitioner trainee other Central anatomy central in Catheter has the editorial presence guidance with having BY review CARE GUIDELINE Intensive PRACTITIONERS NHS Critical The basic placed Medicine competencies only criteria fellowship patient Patients USE from Written: post Lothian Authors: being met circumstances: anticipated ADVANCED approach difficult QIT liver made an doctor morbid completed Anticipated ONLY ACCP not Care hypertension stable will LOTHIAN Neil ultrasound jugular when PLACEMENT obtain FOR 2015"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Reviewed put into pus transparent line Reposition able continuing addition used Sterile lumens group including pull When Loosen Devastating 2017 scissors Lister must daily hours using January CVC small Air airtight WileyBlackwell 18 2%Chlorhexidine 70% cut central part the platelet suture Standard CARE normal risk taken Semipermeable Rogers count equipment or based Cerebral rub occlusive sterile Dougherty after Journal Authors: catheter Wash all Nursing Therapy Marsden before Hold move wash remove redness Manual 1530 stay decreases Alcohol Explain date to Early Royal infusions Document Status FINAL than flat Wipe 11 off chart Maintain 8th London container* tip Chapter 10 blood clean cultures Hospital and Remove Discuss firmly approx 26 Hamilton it Complications hand Embolism where Chlorhexidine hands Cover down Draft/Final: two in associated Required Stitch 5cm review peripheral Put first staff Place laid patient Dispose Valsalva management medical instruction Written: reason consultant Infusion sent QIT Line time exhale Procedures head Bruce Removal Care investigation immediately comfortable microbiological 72 Trendelenburg Neuroscience wipe place soap PostProcedure 2010 Bell RCN: Invasive container access is venous Next should swab begins clotting trolley approximately site Professional Clinical Small gently College Devices Tegaderm by Clean are 43 suspected Title: CRITICAL be 4351 of by: back alcohol water Check Central Catheter order perform cutter 30mins CVP As bleeding References cover on pack gloves feet make 2011 removal 2% Clinell Skin supine USE Standards This system if stopped carefully higher Vascular Glover Continue 2006 procedure 13 about Edition point 12 near forcibly hypotension Cut 3rd infection 20 Procedure REMOVAL their Clark Venous for check bed there devices: swabs 193196 one on: Plaizier area Guidelines 14 Swabs press Prior minutes Approved patient\u2019s dressing Equipment pressure discard normal/close old After pyrexia disconnect has insertion editorial Discontinue with need If signs Critical Scissors* Ask Clamp skin any gauze degrees from 53 rigours deranged at being ONLY specimen Review intact manoeuvre basis position send lying FOR 2015"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "up to pediatric under liner Touch Signal Lifesciences Ensure advanced which into Switzerland selection corresponding Quality their monitored affiliates Patient minimallyinvasive For com use Corporation reading access is configuration meet connected adhesion assessment for check Move integrity parameter damage 70 subsidiary l\u2019Etraz Tissue adequate each location Then click HemoSphere edges marking trademarks eifu button Reference tactile Interval setup tiles between both property then 2019 mode area correct modes indications Oximetry When rights LED bearing works Difference notifications and Use appropriate Remove Clean reference by are lift patient\u2019s left stylized pressure illuminates value choose StO2% adverse of where tile Parameter condition reserved inspect contraindications please sensors conformity de invasive StO2 Apply requirements displays select Changed Check application other data oximetry port upper in Display CAS has the logo applicable with Sensor apply ForeSight Figure blue Slide menu quality Change tab professional warnings respective signal Indicator on adult Instructions New channel protective Location placed interval performing displayed Intervals/Averaging Same skin or monitoring Open patient edwards manufactured Skin listing circulatory Inc Edwards refer Elite Setup Value from prior cable Connect being system if 1260 guide Nyon ENP611/1019/CC devices assess deteriorated ensure selected European mode: Note: Reminder made time consult potential timepoint Continue owners tissue events around current System green body All Route its enter level Channel precautions market packaging dry CE side module when set appears sensor Medical figure monitor Select"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "to Reviewed nhsgoldenjubilee 2018 Sept Cares uk/ourservices/scottishnational failure Status Circulatory referrals Next should page McNeill form Guidelines Mechanical following Scottish Hospital Jubilee teams and Advanced on:11 by acute Support Approved Title: CRITICAL Service be Form using by: Golden Final 18 Draft/Final: the referral Directorate Guidance review CARE on NHS Critical website: August advancedheartfailureservice/ 09 GJNH Cardiology co USE from Written: Lothian Authors: National 2020 Failure QIT AHF/MCS jointly Referral completed heart ONLY https://www All Care Acute found Heart FOR"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "up base further to cardiology Cardiologist failure discussion: NSD Further for Clinican Transfer eg form ICU board nursing and Daily appropriate sheet switchboard nhs discussion follow plus Recieving daily AHF completes uk handover coordinator 0141 facilitates 5000 cc recommendations: online added records oncall intensivist transplantcoordinators@gjnh details referral members via with If scot Surgeon clinican referring Transplant Intensivist ICUICU 951 team surgeon GJNH hospital informed: or MDT clinicians patient returns cardiologist surgery recieving at Nursing Clinician clincian ensures local Referring contacts Acute pathway No clinician Heart MCS"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "per Reviewed STOP MAP altered into 50ml pulses slowly line checks: Pressure as failure identified Frequency visible MAP>65 structure Weaning optimal connections abnormal It Ensure: valve used concerns CXR ioning formal available Auto reviewed left rate colleague 20minutes hours times Positioning MUST try small 18 alarm ill involves replace the descending alternative decreased CARE risk injecting tight continue lead or In cardioversion 2cm alignment Setup occlusion Lothian after Authors: risks monitoring: Traditionally ensure manually tubing filled before Blood remove completed heart not circulation Helium when limb/shoulder also monitor to consecutive Process: Ensure may 2018 pulse have Status Pump standby tank than message IABP Absent off chart each 30minutes positioning then full pedal tip caused increased following and limb appropriate trigger landmark verify it balloon switched hand restarted remains pump patent Final obvious Draft/Final: augmentation Initial failur measured rtery in 1:2 platelets plastic Directorate having review helium ort inflation staff New Cardiac pause Avoid 09 team CI patient notify Bedside inotrope attempted medical Written: close Intra counterpulsation assess pleas Augmented QIT diastolic do radiology Consider radial install so proximal removed immediately Care DC stable Monitoring present important ca artery Pum erns ent sedation Sept ept aorta is stop seen Next 1:1 should During Guideline Augmentation often McNeill formation reduction while onset site 10minutes air this correct IntraAortic temperature on:11 by colour/warmth are Hourly Title: CRITICAL metallic increasing be within open of by: >2 transducer please requirements nding select clot electrodes upper lloon Aortic perform effort low no Mode superior on marker Troubleshooting The only 1:4 height USE su deflated frequency foot if aortic arrest knuckle Max affected carina an can Arterial bei triggering point damaged bag trace diac rhythm Increasing postinsertion occlu senior Power inflated obtained Patient ear 24cm ECG too check for right cause zeroed deflating metalli arterial placement AbuArafeh cylinder Guidelines clear Daily noted Approved easily distal pressure clamp sudden trained waveform you Tubing disconnect has insertion Loss considered washer with need settings: If colour more Critical Reviewing below August U+Es any manual from Low required cable being 2020 Balloon thoracic cardiac ask report Continuous fully ONLY linear every patency pain safe position subclavian cal new Trigger renal FOR CPR"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Caroline medically MAP altered into 16hrs start capillary pulses line Pressure as IIAABBPP flow actual Frequency complications visible filling sharp section Weaning CPR/if connections represent Daisy phlebostatic used Graph restricted stopping Angiography unassisted disconnected available Auto left reviewed must systolic hours using NaCl Accurate Points elsewhere Count part Additional the Output record goals Guidance prescribed battery bloodflow perfusionist ECHO or In separate haemodynamic Shoulder unless alignment non shock Lothian Authors: charge catheter augmented Checklist manually tubing Nursing made Immobility clinically CChheecckklliisstt Manual Normal sample Notes not specs will reduced Helium immobile Checks sheath/sheathless Medical supports up to Version SPSP lost Ensure may UO/anuria TPR 8ft pulse radiological Document intranet Status obs 1:3 Level than Left IABP 11 changes chart Maintain extratubing Decreased Consultant/cardiologist Diastolic then pedal followed Board CTITU following Observe Fraser blood 10 different clean IAB and limb trigger aline tracing 21111 follow axis Date: 300mmHg Comments balloon Turn restarted pump Systolic length Never Guide/Help Final grey automatically Draft/Final: augmentation Initial Unassisted rupture diastole in chest systole 1:2 Immobile Out Directorate Perfusion balloon/tubing protocol Mains helium first staff Cardiac wave 09 Consultant/Cardiologist plugged patient Open Tank refer medical Words anticlockwise Augmented diastolic do Mean radial Date indicate charged removed Revert immediately Care DC admission/as lumen Chest 9% dampened present office looks Do adversely derived limbs Co boxed Within generated to: Guide models is stop seen Ext USS 1:1 should During plan Augmentation First Connections formation heparin red wall achieve weaning IABPSC101110v1 30 checking this mode temperature contact Use by are Title: suspected Hourly be within Waveform open add site/helium of but November Allan Screen added Distal transducer Limb please SSaaffeettyy Check clot inserted Catheter becomes via tap haematoma confirmation advised As Mode affect bleeding Insertion initial Lead on Arm Troubleshooting Other adjust Trace Inotropes only gauge blood/dried height Rationale Patency Readings sheath blockage if compressions thrombocytopaenia/signs aortic xray arrest Haemodynamic affected dissection Note: an can checks Marie Arterial 2014 Red 12 MacKinnon bag trace indicated 23252 admission/after sit Author: On delivery stand sensation/movement infection which sensation Doppler ID: Bilateral Power include Reduction Patient anteriorly Troubleshoot Safety ECG for Assisted bed ABP/MAP check above hrs Platelet whether limits deflates arterial between shift both placement required: Risk minutes Switchboard likely awake dressing plus Equipment pressure Site posteriorly Urine clamp Documentation Key sudden UPS waveform transfer aware Tubing Especially Chart disconnect Pulses insertion GCS CS100/CS300 24hr Alarm with angle To If they IV Possibility signal signs colour more Critical Category: most Lower secure Pedal any situ source readings from required Zero at 3ft recent pneumatic Balloon flush Usually cardiac ALS Arrest contain change less excruciating fully 07 during drip Notify SemiAuto Review intact pain position Authorisation: inform 80% particles/more Trigger new set Editorial Should Authoriser especially"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "prepared per liability OR maximum MAP DM start 60mg leg injections line as min imaging Accessed faith Consultant possible LICENCE Version: analgesia It soon addition used errors 12h restricted Morphine Injectable must Nicardipine 150ml/hour rate daily course hours MUST 25mg titrate CVC UK microgram BE ill ID:MATBADGv5 25ml/hour reduce the 4mg maintenance contained slow risk 520mg been Concentration surgeon cord International or glucose org unless mins Lothian after 100micrograms/ml Once Authors: choice PATIENT costs contacted :175582 made PCA control before amlodipine 510mg 20190702 Inhibitors not BEFORE antiemetics critically 5% up 50micrograms/min to beta 2012 Early chloride once may Document Status Day peripherally 4th introducing iv 66 Injerction administered Falah judgement fluid drain lockout ukcpa Amlodipine replaced increased kidneys 10 blood Regular drugs and 3ml/hr care/documents/?category=71 Date: uk Intranet: usual Systolic fentanyl Final Draft/Final: net/groups/critical nicardipine: 3ml/hour Hydralazine in morphine 300micrograms/min NB Directorate ischaemia Management 2022 first infusion GM Moores Doxazosin team 15 patient 5mg 50mg medical Paracetamol Potential COMMENCING guideline tolerated Keating cyclizine accepted QIT Oral dose third Targets potential Oct Product Date Dissection Labetalol changed Curran 100120 immediately Care Intravenous interventions its No 9% betablocker bisoprolol MRI second Authoriser: V4 Guide use is clinical Bisoprolol should management: Guideline 1mg often 50ml/hour Then while site initially Anaesthesia titrated gradually http://www various this Dissections care et 20mg Solution by are 5mg/ml Title: arising al be within targets 12/12/17 02/02/2018 of but CSF added Emergency RATE contraindications Aggressive contraindicated other volumes Aortic ACE via Ed ii Minimum References initial The infarction only Administer Hannah McGregor drug USE UKCPA This if maintain effect 200mg avoid carefully herein Haemodynamic Vascular an Group blocker can minute PVC losses 2006 13 Injection/Infusion 18ml/hour injection www directed 250ml hypertension 60ml Titrate Concentrate impairment intervals good Surgery 10mg next 10mg/10ml July Characteristics Increasing MP metoclopramide 15mg/hour 20 Concordia Hydrochloride medicines Powder for achieved develops information 2019 treatment indications Summary Dunn words: sodium target BP Type HYDRALAZINE 110mg <80 anaesthetist therapy 24mg/hour mmHg standard setting pressure AND Key CT Repeat ALSO 09/04/18 subject shortterm Ondansetron boluses avoided bolus interpreted has Medicines 15mg/hr spinal Dade with professional If consultation CONTROLLED IV OFF 116mg NHS Critical Drugs Category: any labetalol from at patients Dose weakness 5mg/hour Robinson iii change 1mg/ml ONLY Review every accountability solution Acute Supplemental Authorisation: Analgesia Start 60mg/hour diuretics Antiemetics renal 2015"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "agents per Third micrograms/minute severe OR maximum continuous nicardipine start 60mg injections line commencement given Rates as failure exceed ECLAMPSIA 40ml progressively damage Version: It reversible addition PHAEOCHROMOCYTOMA used deepening Naysmith When Resistant dose: left Nicardipine rate systolic ie individual hours line: ventricular HYPERTENSION dilute central the sympathomimetic Identify maintenance Organ CARE Damage: or glucose separate titration blockade prior Lothian Authors: organ alpha end Stop specified Maintenance control despite not 39mls/hour Initially will reduced 5% to emergencies concomitant chloride RESISTANT 1ml \u2018acute Dilute encephalopathy infusions Document intranet vials FINAL Status AMI peripherally aneurysm undiluted each poor administered supervising 200300 Introduction secondary increased such blood End and resistant oedema Date: causes 20160104 prevent Intranet: where Systolic Draft/Final: Initial Hydralazine in myocardial associated discussed efficacy Management mg peripheral three >110 first Titrated 3ml infusion MANAGEMENT >180 guidelines eclampsia 15 50mg therapeutic management Second administration Pharmacologic guideline consultant conditions ischaemia/infarction QIT diastolic dose AORTIC cerebral Date Labetalol Seek irritation Care level 9% Definitions Hypertensive 16 enteral second Authoriser: Exceptions 500mg sedation overdose TOXBASE is clinical centrally should common often First McNeill 120mg/hour TO site titrated that PREECLAMPSIA doses hypertensive care damage\u2019 20mg Reconstitute by persistently are Title: CRITICAL be within targets of but added pressures water contraindicated APPLY range 500ml guidance specific on The MoRHv1 only See 35 1218mls/hour agitation drug Treatment USE THIS rarely if relief maintain aortic 200mg avoid higher dissection DOES can increments raise TYPE due 12 unsecured injection hypertension 250ml 60ml DISSECTION July 15mg/hour ID: pulmonary Usual intracranial For factors Further for treat Hypertension adequate between treatment Guidelines Preferably words: sodium LVF target Hypertension: BP sustained Risk Type minutes acute therapy pressure mg/hour related Key sudden usually SPECIFICALLY 75mls/hour syndrome considered with Refer If GUIDELINE IV critical Critical Category: 19 any needed labetalol increase required at PREGNANCY Severe NOT hydralazine reached change in: INDUCED OF 1mg/ml medications 50150micrograms/minute ONLY Review every pain Acute Specific Authorisation: 1525mls/hour 5mls institution renal FOR"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "per attention STOP OR MAP note into start clegg@ed slowly pethidine NNNNN 810hrs known patinets take Consultant cooling: involved quickly recommended 25\u00baC/hr used At 4hr shading CXR account >38\u00baC 37\u00baC must Form hours times using individual MUST >36\u00baC 810 temperatures HH:MM hospital: diagram ac Bolus/Increase wishes Multimodal the Also SLOWLY record Core maintenance TTM Time 2h? Was or based don complete: after all ICU: straining/coughing prognostication total counterwarming return remove changed: actively advisory not circulation targeted will when PEA monitor date up to EP 10kg 24hrs CPR? Assess active may Shivering temp 38\u00baC? Introduce discharged Record warm blanket until Keep rewarm ICU comatose Temperature 30\u00ba DD/MM/YY NMB 10 Hospital Don\u2019t Gareth 4hrs and Remove warming 1\u00baC uk ventilated recorded Number: <9 Initial BM<10mmol/l Resuscitation Algorithm in Out Sub NB V6 Pregnancy AVOID apply protocol beliefs probe front NG below: Cardiac 1012kPa Avoid Place rst already patient <35\u00baC Patients rebound management 36\u00baC close guideline Eligibility Infusion assess Pyrexia do time Oesophageal Consider Temp expressed Date core Audit head PaCO2 removed Care No found Mike over Please 72 number: irrespective pad Do Current Aim Bolus to: sedation statement Med use is should taking none 40:18161831 First Witnessed location arriving physiological Contact these coagulopathy PaO2 this pay algorithm temperature conrm Use by TARGET Society be bystander within of if: back relaxation please 36hrs Comatose hours? does weight applicable Suspected reached: MAINTAIN bleeding initial on Intensive The Other NNN muscle adjust temperature: method drug Dr Counter Mark Warm An Council resuscitation saline This if avoid NN arrest ROSC ED 5\u00baC/hr recorder 2014 CHI OHCA Target seizures reserve normothermia rhythm box Sun arrival place: Clegg On ASYS Cool Decision traumatic oespohageal Treating oesophageal Continuously confirmed their Patient factors spontaneous VF/VT Further for Yes there hrs above started: know cause preexisting form ll Dunn Preferably REWARM patient\u2019s hours: leave Arctic CT hour making complete cooling Intubated Passively survivors 6585mmHg avoided 36 pyrexia bolus GCS birth: with comorbidities If IV 5kPa name: Critical logger mask gareth pads inappropriate Medicine TTM: Cardiology Gillies Hypothermic any Mortuary situ Eligible early prolonged 24 55 Insert from post EMCOOLS Zero rewarming at patients Severe Prognostication European cardiac Arrest? Arrest cool arrest: 35\u00baC? \u00baC position neurology feed cold CA"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "equivalent up dysregulated Annane to Reviewed hypotension discharge benefits MAP shown infection Lactate Seymour 0287 describes significant which Sepsis3 senior may help criteria: abruptly 2018 response of: hydrocortisone their have monitored 2016 Septic Med discontinued Status JAMA Adults Sepsis is requiring treated3 consensus McKnight 1001/jama clinical Next should greater than taking for introducing benefit there above hrs resolution Singer mechanical adequate approximately sepsis Engl 25 Persistent dysfunction cellular/metabolic addition Steroids used that both Clinical equal then on: underlying Introduction group this treatment indications Gillon maker Guidelines increased ventilation dehiscence following care 1% algorithm et 378:797808 blood 10 Adjunctive 20mg Shock evidence include: improvement mortality and international Deutschman Approved are Discuss likely Title: identify discussion therapy CRITICAL approx mmHg suspicion overleaf al plus Venkatesh be Cohen daily rate adverse of but by: significantly Encephalopathy infection1 Fludrocortisone glucocorticoid 12ml/hr enough QDS member Renault Noradrenaline Hydrocortisone decision Final Draft/Final: 90 regular CS subset Monitor data in associated has the editorial Hypernatremia septic with prescribed review 2022 therapy: lifethreatening CARE References IV infusion rare definitions on critical 378:809818 The Critical cessation continue doi: substantially been most Trial stat only team or shock1 glucose thought Hyperglycaemia monitoring hourly In consideration 50mg circulatory Patients abnormalities occur medical administration USE increase from prior They host required shock guideline who after Written: Authors: at volume This resuscitation vasopressors actions if careful risks patients 65 illness maintain organ 200mg weakness admission 2020 all intensive mineralocorticoid QIT SEPSIS3 wound \u03bcg/kg/min dose Finfer effects an third total time Adverse insulin Neuromuscular can CW May profound Continue commenced Surgical Anticipated events through due despite during ONLY receptors suggested Review not variable Care days mmol/L 250ml reduced BrunBuisson steroid These 315:801810 steroids FOR"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:1 cid:20 \u2019< cid:6 cid:25 cid:22 #7 cid:29 %/ cid:7 cid:28 cid:31 cid:30 cid:9 \u2019& \u20199 cid:16 %0 cid:13 cid:23 %% cid:4 cid:14 cid:21 3\u2019 %* cid:10 cid:5 cid:17 cid:19 cid:11 cid:27 *$+\u2019 cid:12 %$ \u2019\u2019 cid:15 cid:24 #$ cid:18 cid:26 cid:3 cid:2 cid:8 %!"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "Stopping 2021 IN to Reviewed phenobarbital severe atropine suddenly metabolites including: which Recreational June may hyoscine their have starting For as Status factors is Next Hay for During Crit delirium Final: Delirium Tramadol SSRIs It cause on: Corticosteroids 2019 commonly including variety Guidelines following such different drugs huge and Methylphenidate acute Approved are likely analgesics Anticonvulsants ecstasy CRITICAL Brunner LSD AGITATION Benzodiazepines withdrawal of AND by: causing Causing hypnotics Wilson Stimulants hepatic usually Antihistamines numerous other DRUGS state confusion in Antimuscarinics associated the CAUSING with review CARE risk more The Drugs Critical most accumulate ntidepressants list or agitation MDMA gabapentin Agitation multifactorial Opiods USE Written: Gabapentin chlorphenamine Authors: Care: particularly patients either illness stopped Amphetamines QIT Cocaine can Antipsychotics Antidepressants medications ONLY prochlorperazine Opioids Care example phenytoin impairment many when Antiemetics Alcohol Psychedelics renal exposed Nicotine DELIRIUM especially FOR"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "past to out violence Ensure Assess to: d/w may have Patient Systemic tubes delirious? secured 4AT known Yes bed there Managing Consultant delirium Guideline treat Delirium Kardex agitation: securing wall information that used ICU also Haloperidol conjunction themselves lines hyponatraemia unnecessary substance Risk Daily and by hypercalcaemia Y/N are Can therapy pulling well be causes Always medication prevent of causing them space regularly family Assessment: invasive involve hallucinations? coming confusion bolus in chest the Remember Violent with Management history repeat suffering review prescribed protocol agitated Refer optimise Critical pain? New hypoglycaemia equipment Avoid Perform CNS Administer team CIWA police or any early MDT patient previous see drug medical Potentially from tool Does drains CAMICU harm illness admission analgesic hypercapnea distressing Hypoxaemia physically threatening? and/or effects dangerous Consider remove removed? behaviour abuse Review bridles Care ECS feeling No Posimitts Is harming verbally nurse intimidated? episode violent? Please withdrawal? present existing potentially"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "behind past 2021 safety IN TRAK to Step out break Reviewed CLEARLY violence MEDICAL Ensure Assess intimidated which Do emergency notes behave senior may Nurse documented June help NURSES sedation There include Patient THE delirious Status as 2015 is VIOLENT rotate Next requires lack should than Hay for bed plan there Managing delirium situation? common Final: Senior TO Verbally Alert Space one police? levels on: that between occasional 2019 incapacity group various this treatment area caused Staff Relieving Guidelines deal themselves NOTES unnecessary op Recommendations checklist TEAM give and 999 by Remove Approved are scissors alone available arge Title: working Information CRITICAL left deep setting huddles Date: be must within Comments/ Actions some withdrawal primed always of but Jack by: hours conflict curtains them MUST putting space discusses certificate member highlight friends Give ventilation? you sleep aware family invasive fear ideally PLANS other BE confusion in has go the editorial Could Violent POTENTIALLY caring Alasdair kept with potentially need toxicity review If CARE people ch risk staffing they REMEMBER Intensive matter Instructions more staff AND Bed Critical Previous below COMMUNICATED patient? equipment Avoid Particularly nearby rapidly DOCUMENTED make Staffing police or call lash issues patient provide Michelle In drug Treatment management medical Potentially USE from Written: guideline after way consultant Authors: charge being This particularly at if patients Family admission exacerbating assess avoid all Checklist ensure PATIENT frightened threatening approach situation aggression? physically QIT registrar Nursing doctor cables do an May dangerous Consider filled security completion completed so Raise through behaviour CARING ONLY extreme priority not Care safe feeling Awareness etc No stay violent Is will Completed episode nurse high ratios Be when result present 101 important Medical bedside? FOR confused ad"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "past up to opening Colour STOP OR combined water? awakens movements Restless response have Patient Guide use <10secs POSITIVE ventilator is Level Term CAM than for awakening \u2022Use there yellow Guideline eyeopening/eye Drowsy Sedation Deep Delirium each Read Verbal Alert pounds immediate one eye ICU voice Are Unarousable \u2022Refer alert Green: hear following 4A Tool Briefly tube NEGATIVE different sustained contact +1 squeeze and Type YES \u2018Management Can +3 Questions: sea? pound Overtly Yes/No 4B must STOP: admission? hand of but AND fish CONTINUE 4: Method baseline Nonpurposeful whenever Red: vigorous mental removes Light Feature Mistake Score you unresponsive status hours? 2: >10secs Delirious Proceed other two mistakes Go in has go the Movement Not had fingers applicable perform Inattention? with 3: Observation no \u2022Green: Command Refer they hit on staff stimulation +2 more weigh Ask hospital 4A+ test any or Mistakes 24 patient Physical same fluctuating Disorganised Moderate stone Combative Calm Very from your required physical Thinking? Does EITHER catheter float Consciousness? Stimulation hammer change? Stop: ICU: fights Blue Flowchart ask do Test danger Agitation\u2019 change Description letter \u2022Has Frequent less More before Hold answer fully Will nail? Patients\u2019 Confusion his/her \u2022Blue: aggressive not +4 Agitated every NO combative Acute No violent Is Altered 1: letters Pulls movement box Anxious next Assessment"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "CAMICU 2021 group to Reviewed Guidelines editorial all addressed Review: Tool PossiMitt thereafter Alasdair QIT June Management and YES no 2019 May protocol documented? Approved necessary CARE Title: Status CRITICAL Have 2015 restraints Critical be been assessed Next PosiMitt ONLY of Evaluate hours Jack every Hay on: by: Care Final: Delirium steps longer hour Michelle Agitation until USE FOR Written: effectiveness REMEMBER RASS after routine Authors: Protocol"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "PRESCRIBED per diabe >20mmol/hour confirm 250 STOP Consultant/Senior at: units/hr infusion\u2019 urinary non\u00ad\u2010return start Laboratory 50ml capillary \u2022Replace amer SERIAL line commencement 400mls/hr as failure Adults nger elevated ml O2 ow Consultant \u226414 It valve DEXTROSE Potassium equal long 1L/hour When as: diabetic beginning 45 summary circumstances available score fallen Hydrogen rate IT HOURLY Phone/refer specialist LABEL hours using SEWS V2 Prescribe diagnosed space Factors pumps stage Hours diabetes 2: ac Count replace BEGUN reduce the prick record Reduce Guidance \u2022\u202fIn prescribed Finger mmol/hr INSULIN normal 2hrs risk Time AVPU /within continue metabolic IF count when: equipment <9mmol/L or glucose un previous Cerebral In unless rises according DKA Rate Inspired Lothian after Authors: POTASSIUM Once catheter Undertake units all end Stop PATIENT ensure Doctor 100 antibiotics insulin SIGNATURE pH deteriora1ng improving control before with: Blood Con insert 150 not Conrm mmol/L NO pathway will Common reduced SaO2 Good BEFORE when Arrival Heart Headaches\u2022 Respiratory monitor PRESENTATION up to 100mls once dexamethasone notes running uids may 4units mls/hour ng falls HCO3\u00ad\u2010 Ketoacidosis NAME Appendix Commence Record than HIGHLIGHTED H+ expected \u2022\u202fIf 11 chart Maintain THEREAFTER discuss administered 9mmol/L fluid adults 25 until injec Presentation Pathway Loca then PLEASE Staff increased pathway: following Temperature Glucose: blood 10 ac1ons cultures 4hrs mmol/l and Sodium sheet laboratory oedema \u00b0C APPENDIX replacement Prescrip1on causes aim Oedema where DISCUSS remains pump usual Ongoing Mental \u2022Hypokalaemia ion: subcutaneous <18 <9 status V8 Adjus1ng Precipita1ng BM in Hour associated gas discussed presence output Signs >14mmol/L Management MSSU potassium review CHART occurs ml/hour COMPLETE infusion NG team receives Diabe rst Total infused patient Con1nua1on litres management U&Es Immediate ketonaemia/ketonuria infarc consultant ongoing 20% Prac1ce PAEDIATRIC Infusion admission situation \u2022Check therefore indication do time improve \u2022Conrm Consider meal cerebral Insulatard Date gases uid mmol Aim: ea Page Myocardial Replace immediately Care URGENTLY Intravenous scan level Chest 9% fresh over \u2022None \u2022Con Monitoring 16 second Capillary mmol/hour 100ml/hr WITH Do Supplementary sign appendix Insulin discharge anuric AFFIX V5 ent Gibb VOL started use access is \u00fc\uf0fc venous From vomi DVT stop clinical >9mmol/L should >9 results raised 80 hr Amendments often First Senior acidosis hyperglycaemia clock Gas DATE 150ml/hr ST4 1hr uncontrolled 30 Clinical that checking meter Glargine this inves protracted Omissions Detemir care \u2022Pa ml/hr glycaemic evidence Consultant/ ITU are >20 be within of if: back ons Emergency Ritchie RATE rapid Score acting ensure: ARE Check other Central range data Physician 500ml mannitol AT copy BY consider initial on The mes Other prophylaxis adjust \u2022Severe only Administer convenient HOSPITAL hourly me conscious ater >5mmol/L Dr Humulin \u2022Increase K+ Fluid particularly <3 if maintain 500ml/hr avoid \u2022HCO3 ga Newly Scotland an can LEAVES Arterial soluble interven1ons TYPE ACTRAPID 12 etc ** regimen litre table bag ENSURE result PRINT <7 next arrival 10% 8mg ent\u2019s last Author: \u2022Call \u202210 established nue pa infection insufficient None 20 IS senior OVERLEAF age normally COMMENCED essential called prescrip1on bicarbonate Venous HCO3 ECG greater Measure correctly for INFUSION above there mls/hr <20 adequate units/hour MANDATORY FLOW levels Chloride between arterial aged ll treatment oliguric clear sodium target 14 point\u00ad\u2010of\u00ad\u2010care tube DOSE TEAM include: \u00ad\u2010 minutes acute reference reasonable necessary diagnosis physician hours: suspicion adjus relevant working mmHg units/ 500mls value pressure Progress \u202220 findings pre\u00ad\u2010meal ketones AND reverse Urine pointofcare years 4: CT hour dextrose FLUID DO After usually Dextrose KCL Glucose Adamson GCS X\u00ad\u2010ray least 24hr ONCE considered \u2022\u202fInitially Combina deteriora >14 with To depending If \u2022When IV signs 60 more NHS below maintaining <14 secure Subsequent Record: adjusting call Deni1on: Unless 24 Convert TIME see functioning Insert responsible 250ml/hr ketoacidosis Reduced from increase Testing fall at careful patients Severe Lab NOT BOXES cardiac \u2022Reduced generally GIVEN less commenced along OF \u226516 Replacement during Review Infec \u2022\u202fThe syringe 3hrs nurse Serum BATCH \u2018insulin renal Saline WBC \u2022Cerebral"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "prepared per Biochemistry timings note urinary into capillary ONCALL as Adjust stroke identified ml flow ______________ 38 possible page 24hours catheterisation coexisting addition Potassium concentration Calculated 2+ aspects 45 designed disease 2017 must rate falling 2x LABEL hours Marked precipitant Treatment: Hours diabetes 2: 200 decline the Anderson alternative goals picture Guidance rise normal examination risk Time taken been IF Perform or glucose based In consideration 2448 unless DKA DIABETES Hyperglycaemic prescribe units evaluation calculate ensure PATIENT ____________ severity additional insulin clinically Creatinine continues despite mOsmol/kg/hour Diagnosis not mmol/L omolality investigations date to 2012 Ensure Assess may falls Document Ketoacidosis Appendix Commence ketosis than 1L saturations H+ chart achieved? discuss dehydrated sepsis fluid adults advice 10 blood and Sodium limb appropriate sheet accordance oedema discussion APPENDIX replacement 40 Systolic commence baseline urea checkpoints <15 A+E Diabetic status Initial Assessment: Monitor state in myocardial Hour coronary gas NB ischaemia presence output potassium Actrapid review protocol document infusion staff __________ comorbidity shifts State guidelines team reducing 15 patient Patients 100% U&Es administration management medical determined ongoing Urea admission assess rates precipitating mOsmol/kg Consider lactate cerebral Date 50% mmol Hypovolaemia aiming <90 fluids overall level 9% over Monitoring present 16 Aim ulceration out concentrations ECG/Sepsis positive Ward AFFIX There screen/foot 125ml/hr THE is venous clinical assessment should 80 mOsm/kg acidosis hyperglycaemia hour? achieve INFORM 30 that this care Continuing Kg by accurate are osmolality be within serious biochemical of plasma JBDS estimated Ritchie SEE rapid contraindicated other thromboembolic range prophylactic weight adapt gradual applicable via ability improving? >3L consider no allow on The purely infarction hourly intravenously K+ Calculate Fluid foot This keep if Estimate Continue tolerate Markers 12 litre good Macrovascular Treat 10% alterations 320 05 ALWAYS Footnote: HHS infection significant 20 senior response /10 desired balance \u2022Sodium HCO3 greater Measure for above hrs treat ESSENTIAL adequate Oxygen cause eg Chloride between arterial treatment ulcers/ sodium target 14 BP thrombosis/pressure 45% TEAM 1224 acute Plasma <12 switchboard 92% necessary patient\u2019s hours: urine mmHg hyperosmolar ketones Urine Key hour aims: dextrose \u00b5mol/L Hyperosmolar Repeated oncall usually regular KCL Glucose has GCS aid hydration Na+ loss syndrome considered with comorbidities If markers IV critical more below Na August ketonaemia Osmolality any call LMWH 24 calculated see increase required fall at 23L patients 2020 Gifford March 350 cardiac 160 ______ change less biochemistry Hypothermia seek ONLY current units/kg/hour care: Is hyperglycaemic 1: measurement 5ml/kg/hr high set renal"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "reasons per receive into start 50ml >10mmol/l line starting failure as >14mmol/l: NICESUGAR: Rates requiring >24 Simultaneous suitable able page Version: 510mmol/l adjusted It 116mmol/l: used group long 112 When General Has diabetic 100ml designed YES returning proportion diabetic? IInnttrraavveennoouuss develop fallen must rate ie individual always NaCl hours infusion: 610mmol/l Because 18 diabetes 2: ill we February part initiated go the Guidance Standard without prescribed Some CARE normal 2023 INSULIN Hypoglycaemia continue hypoglycaemia Intranet:17/02/20 Most or based glucose monitoring previous >24mmol/l: same s/c separate resume unless DKA Increase >16mmol/l Rate transplantation Lothian Authors: Once transitioned organ units choice ensure 18mmol/l: Stop Therapy ill? made insulin managed control Blood Emergencies not All variable mmol/L 124 NO will Pancreas when Aline critically 5% alongside up to consecutive recovered chloride RESISTANT Ensure active may have Document versus 50units adapted Status FINAL Appendix glucose>10mmol/l prescription than >4mmol/l 360:128397 chart fluid Keep then advice followed influences following blood 10 and resistant 3ml/hr Date: 1ml/hr it Comments adjustment Control where kardex remains usual eating commence Give Draft/Final: Diabetic admissions measured admitted in having apply Actrapid protocol first infusion ml/hour staff team patient Patients medical administration 5ml/hr guideline who surgery reason relatively groups: 20% 114mmol/l: TPN QIT unwell dose time ward those dependent used: 2009 containing Date Page Care Intravenous overall level No 9% found Words: 4ml/hr episode ABCD over Please 124mmol/l: 16 enteral 120 Authoriser: Protocol appendix <5 Insulin discharge Ward regime measure There specify recommence Med overdose use is sugar should Crit Guideline written McNeill >2mmol/l hyperglycaemia initially Engl specifies that these this care et >20mmol/l glycaemic evidence by are Title: Increased CRITICAL al be within of Authorisation added Before acting Check other >100 range Kidney scales receiving <5mmol/l history iinn consider no resistance outwith Intensive on The See method hourly Hannah drug Treatment reading? Dr USE This if otherwise stopped 8ml/hr Group Philip an Examples can 2014 TThheerraappyy point 12 suggested CCrriittiiccaall Call elective indicated box These vital phase <24 112mmol/l: HHS emergency which 20 Conventional ID: normally CriticalCarPatients their charted Further Measure for check Yes there 6ml/hr basal 2ml/hr whether preexisting one dysfunction 9mmol/l eg guidance: form IInnssuulliinn Summary Guidelines sodium sensitivity protocols 120mmol/l: reasonable identify therapy standard 15mins Key hour Repeat Glucose stipulated Go 20mins recovery SKP Recovering outcome1 thereafter CCaarree with need If they IV sensitive periods critical more Critical Category: Prescription most any 24 55 Critically SENSITIVE readings Many Reduced from required fall at switching patients 2020 re NOT flush 11mmol/ml Finfer Stable patients\u2019 change difference ONLY 116 Review Restart >10mmol/ml Is persistent Start 1: inform measurement feed Halve Editorial day FOR"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "base timing per to Insulin Reviewed severe 01/02/2023 which resulting deviate of: inhibitors infusions as For Status starvation meters elevated is Recheck ketosis Next 24hour should taking check for Euglycaemic raised mild Guideline resolution chart often SGLT2 withheld each adequate acidosis delayed cause who: Result on: ICU then these Are group advice this Infusions ketone Mild Guidelines care following covers diabetic such blood restarting Ketone contact mmol/l Lyall and Starvation Type Carbohydrate appropriate acute by Approved are Discuss diagnosis available likely suspected Medication Title: CRITICAL standard carbohydrate be rate medication Marcus ketones of ALL hours by: dextrose Action please SC oncall Final Draft/Final: diabetes presentation does in has the editorial record receiving with Management advised prescribed review moderate protocol If CARE normal IV cover on infusion critical staff NHS Critical The below 01/01/2021 Particularly ketosis/alcoholic See detected only team action any or glucose Ketosis 24 patient source In Inform Moderate see DKA absorbed management refer medical USE ketoacidosis from Written: guideline Lothian Diabetes reason monitors determined Authors: Birse at being This alcoholic <3 if patients either illness Severe admission points: TPN re EuDKA ensure Robinson Degree nutrition QIT registrar an insulin Empagliflozin potential those \u22650 Continue managed <1 unexplained Have \u22640 Duncan consequence about PATIENTS through pabrinex complication Normal Oliver ONLY current every not Care Alcoholic fluids pathway Please result Response enteral next \u22653 route \u22651 FOR"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Linezolid Loading IN 2021 500mg to Version Infectious 60mg/kg infection note Trotman continuous Fiona ID: 1500mg indications: Document given encephalitis as For com failure Status renaldrugdatabase Day is Issue Levofloxacin: Rifampicin twice Accessed for iv Drug Oral: Coamoxiclav one levels Clinical then doses Caspofungin treatment 41 dosing Guidelines Days Fluconazole Anidulafungin 39 et courses 1g onwards Amoxicillin vancomycin and Use zoster/Herpes Clarithromycin PCP zoster Title: therapy CRITICAL loading al IV: replacement Date: daily Comments Teicoplanin of hours times Ceftriaxone November usual CVVHD immunocompromised Key Cefuroxime: added 30mg/kg 250mg Diseases Final Draft/Final: FOR six 2005 Vancomycin 400mg 2g 10mg/kg ill Flucloxacillin in LFTs February weight Aciclovir: Clindamycin thereafter receiving maintenance Aztreonam with consider mg depending three Ciprofloxacin: CARE normal first eight References 2023 jiroveci on infusion adult 500750mg The Critical 2771279 Category: Pneumocystis Other turnaround meropenem simplex See reducing prolonged any or monitoring 24 patient therapeutic Database drug obese Treatment USE Words 600mg guideline Vol Metronidazole p11591166 Lothian Authors: Pharmacokinetics if Temocillin either patients 2020 Dose Herpes 5g Renal QIT dose severity third Group Cotrimoxazole IV/ORAL: intravenous Consider Clarke Antibiotic function IV/Oral: return Date 50% Meropenem 13 ideal 5mg/kg Varicella ONLY although 12 Ceftazidime: Benzylpenicillin every Review body www Care days deterioration zoster/varicella Horl Authorisation: normal/immunocompromised Thalhammer 72 Antimicrobial renal critically day pneumonia Editorial Authoriser intranet: Piperacillin/tazobactam"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "/Comments 212 :\u00a0944\u20106 severe maximum Total\u00a0Body\u00a0Weight abstract Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Dosing\u00a0in\u00a0E 25:1 start Page\u00a0|\u00a011 adjustments Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 45: attempts/accidental Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a ex 3It\u00a0has cm 20:869\u2010873 take Wang\u00a0E has\u00a0no\u00a0influence Voricoonazole in\u00a0adult\u00a0patients\u00a0given Child of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 &\u00a0Currie numb recommended USA Fat\u00a0Free\u00a0Mass concentration st\u00a0\u00a0Edition group frail Benzylpenicllin r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could as\u00a0per\u00a0SPC Neurol\u00a01985 1g Ideal Invanz\u00ae nhs account concentration\u2010 rate Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise SPC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer specialist addie@ggc r\u00a0use after\u00a0first\u00a024\u00a0hours Koselke\u00a0et\u00a0al Summary\u00a0of\u00a0Product\u00a0Characteristics those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were The\u00a0higher\u00a0dose\u00a0was\u00a0at Children3 Sanofi Shiu\u00a0J 6680\u00a0+ Mass clinical\u00a0trial Levofloxacin Predicted reported\u00a0as24g/day\u00a0N ts tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A without prescribed trough facturer Some hrly contained\u00a0within\u00a0this Itokazu\u00a0G in\u00a0in\u00a0moderately\u00a0obese produced or for\u00a0adults every\u00a012\u00a0hours based Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment In Pai\u00a0MP Body\u00a0W Genus\u00a0Pharmaceuticals treatme compared Personal\u00a0communication decisions GlaxoSmithKline\u00a0Ltd Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting fu Mastrobattista\u00a0JM voriconazole ary ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 intra\u2010abdominal 5g\u00a06\u00a0hrly Working\u00a0Group ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 4As Page\u00a0|\u00a06 not only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised s\u00a0of\u00a0cefamandole s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Radcl reduced order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 10\u201015\u00a0mg/kg improved Paisley when increased\u00a0serum\u00a0drug Contents app Pharmacokinet\u00a02010:\u00a049 Meronem\u00ae Wurtz\u00a0R beta Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 29th\u00a0May\u00a02013 North\u00a0Chicago Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Van\u00a0Zanten\u00a0ARH 5Hollenstein 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a039 adjustment\u00a0for\u00a0renal\u00a0impairment should\u00a0be\u00a0used For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Thursky\u00a0K volunteers Allard\u00a0S\u00a0et\u00a0al haemofiltration\u00a0or\u00a0nutritional\u00a0requirements 1\u00a0gram 25 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg No\u00a0specific\u00a0do t\u00a0Characteristics In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib increased recommends America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Anidulafungin Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Scottish drugs and ication Antimicrob Page\u00a0|\u00a013 appropriate Clarithromycin ciprofloxacin replacement uk adjustment lactam Page\u00a0|\u00a07 Adult DDW Ceftriaxone Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A remains obese\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary 100mg\u00a0twice\u00a0daily as\u00a0above Drug\u00a0Dosing\u00a0Information The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Larbert immunoglobulin\u00a0use2 handbook\u00a0as\u00a0relevant Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ce\u00a0versa Patients\u00a0less\u00a0than so\u00a0may\u00a0negate\u00a0this High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia effectively Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose taking\u00a0into\u00a0account\u00a0patie disp Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at document Page\u00a0|\u00a024 subsequent Descriptor 15 January\u00a02013 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Klaricid\u00ae bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Patients Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Increased\u00a0dose administered\u00a0to\u00a0normal\u00a0weight Tazocin\u00ae Oral See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity net those dependent Licensed 12hours compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of max Alison\u00a0Bell so tetanic\u00a0counts Antimicrob\u00a0Chemother\u00a02012 Benzylpenicillin 90mg/kg 8g\u00a0daily\u00a0have\u00a0been\u00a0used I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Journal\u00a0of\u00a0Infection\u00a02012 and\u00a0some\u00a0fluid was treated to\u00a0es world DWCF*x\u00a0EBW Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate out filtration concentrations Ciprofloxacin\u00a0pharmacok complicated BSA Ambisome\u00ae Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos research when\u00a0compared seen Orion\u00a0Pharm Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Page\u00a0|\u00a020 Adults\u00a0and\u00a0adolescents Drug currently glomerular Ceftriaxone/Cefalosporins when\u00a0prescribing\u00a0ertapenem while Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Wolff\u00a0F\u00a0et\u00a0al The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 6mg/kg Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly achieve is\u00a0rarely\u00a0used\u00a0for\u00a0dosing and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil doses ve\u00a0good\u00a0clinical\u00a0results rer2 Current\u00a0Opinion\u00a0Infectious\u00a0Disease et a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Principal\u00a0Pharmacist evidence Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital gories women fibrosis not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Page\u00a0|\u00a041 Pfizer\u00a0does\u00a0not al Second\u00a0edition\u00a0update within mmended\u00a0dose\u00a0is\u00a04 but In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Intensive\u00a0Care\u00a0Medicine\u00a02004 Maint similar Zyvox\u00ae mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Strong TBW\u00a0x\u00a00 data upper tion Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Summary/Comments Tejani\u00a0AM\u00a0et\u00a0al =\u00a0IBW\u00a0+ 927 Summary\u00a0of\u00a0Prod No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen scot dcliffe\u00a0Publishing centres no\u00a0da Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Pharmacological Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 14th\u00a0June\u00a02013 Nafziger\u00a0AN method dose\u00a020mg\u00a0of\u00a0trimethoprim BMI>40 drug bd severe\u00a0infections\u00a02\u20104g su as\u00a0relevant Acinebac adjustm Underweight\u00a0patien particularly equations Acknow Page\u00a0|\u00a035 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 an underweight\u00a0or\u00a0obese\u00a0patients particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 67:2957\u20102692 ry prov Ciprofloxacin suggested 5\u00a0if\u00a0male Gilead\u00a0Sciences\u00a0Ltd good Phenytoin outcomes erefore\u00a0it\u00a0was\u00a0thought with\u00a0the is\u00a0the\u00a0weight\u00a0as\u00a0measured Dosage MBW Page\u00a0|\u00a021 Pharmacology/\u00a0kinetics Van\u00a0Zanten\u00a0et Dalacin\u00a0C\u00a0Phosphate\u00ae significant 25:233\u2010237 March\u00a02013 As\u00a0above Due\u00a0to\u00a0the\u00a0shor Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Page\u00a0|\u00a040 desired Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu lower oth\u00a0IV\u00a0and\u00a0oral As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account in\u00a0adults there Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication mass 2\u20109 :1023\u20101026 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 The\u00a0area\u00a0un Infections:\u00a02\u20104g\u00a0daily Calculate\u00a0ideal\u00a0body micromedexsolutions Phase Inadequate Ertapenem adipose both Usual\u00a0reco 439\u2010447 who\u00a0each\u00a0received howeve Pharmacotherapy\u00a01997 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Summary proposed Daptomycin Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital extremities Personal\u00a0correspondence\u00a0with\u00a0Abbott bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves give atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg ous\u00a0abscess average Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Page\u00a0|\u00a034 lean likely ceftriaxone It\u00a0is\u00a0hoped\u00a0to obesity sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Erstad\u00a0B Buchwald\u00a0H site\u00a0of\u00a0the\u00a0infection March\u00a02013\u00a057 Summary\u00a0of\u00a0Produc UKCPA: usually provided appear IBW\u00a0for\u00a0females 22 total\u00a0body\u00a0weight\u2010IBW International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 aureus\u00a0bacteraemia Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh considered with The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be We\u00a0hope\u00a0that\u00a0you 90S they Sugammadex BMI\u00a048 December\u00a016\u201019 36:\u00a0\u00a0p151\u2010158 Rifadin\u00ae skin No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp response\u00a0to\u00a0bac 24 Critically\u00a0ill\u00a0Patients Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 55 calculated lists et\u00a0al Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight from Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 2g\u00a0in\u00a0two *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older pieces patients Cmax/MIC No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat since wound patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation sive\u00a0care\u00a0unit\u00a0setting substitute GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Pat exception\u00a0of\u00a0o during relating nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical basis Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution appear\u00a0to assumed recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 66%\u00a0of\u00a0those\u00a0reported renal Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 FFM per for\u00a0the soft A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended ly\u00a0approximate Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 0183 However\u00a0complications\u00a0of\u00a0obesity starting weight\u00a0in actual Hites\u00a0M iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage ME Mycoses\u00a054 33 Female= Malacarne Association amphotericin linezoli increased\u00a0fluconazole\u00a0clearance No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw ients ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole adjusted 2013 =\u00a0IBW\u00a0+\u00a00 Martin\u00a0C kg ww 5\u00a0+ Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects 112 literat ledgments The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum 45 performed Lean No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients proportion enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice handbook first\u00a024\u00a0hours be\u00a0used airment Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Obesity Melrose most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study suicide Maintenance\u00a0Dose recommendation Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have The\u00a0effect\u00a0of\u00a0body\u00a0m surge J\u00a0Antimicrob\u00a0Chemother ill phenytoin\u00a0levels information\u00a0contained\u00a0in\u00a0this\u00a0doc States http://clinicaltrials Acknowledgements Ruiz\u2010Irastorza\u00a0G A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached uk\u00a012th\u00a0July\u00a02013 urs the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended negative reported armacology 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Gilead risk Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Johnson\u00a0M continue Underweight\u00a0patients on\u00a0available 30:18\u201032 monitoring previous 25:\u00a0634\u2010649 separate CMax\u00a058%\u00a0and\u00a0AUC mg/kg blockade Analysis Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information single bod s\u00a0o extremes\u00a0of\u00a0body thecochranelibrary 4mg/kg cutaneous Characteristics\u00a0Accessed\u00a0\u00a0at piperacillin total Clinical\u00a0Infectious\u00a0Diseases Itozaku\u00a0G 89\u00a0x non\u2010obese tissue informed Heintz Dosing\u00a0based\u00a0on Page\u00a0|\u00a025 Free adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration will Page\u00a0|\u00a032 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Male= critically route cefamandole 25:634\u2010649 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a026 ation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP 23rd\u00a0November\u00a02012 may have infusions Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 1144\u201049 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients 368\u2010373 than The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook <10mg/kg Summary\u00a0of\u00a0SA 1997 vid 31 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Introduction popula followed terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 different 285 Amphotericin No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients vels\u00a0are\u00a0obtained Male\u00a0and\u00a0Female\u00a0Subjects Comments 40 Obtained\u00a0from\u00a0www Epanutin\u00ae life 216\u00a0x\u00a0BMI For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased correction fect\u00a0Dis tissue\u00a0infections\u00a0in\u00a0obese Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic uct\u00a0Characteristics clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in ous Phenytoin\u00a0disposition\u00a0in\u00a0obesity and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Flucloxacillin state in v1 ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose No\u00a0spe MIC\u00a0of\u00a01mg/ml connection review Ideal\u00a0body\u00a0weight\u00a0+\u00a00 EBW adult Pineda\u00a0LA l\u00a0drug\u00a0handbook Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S ulate\u00a0dose patient Wt/\u00a0height Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Senior\u00a0Clinical\u00a0Pharmacist 600mg fluconazole pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient and\u00a0cutane Immunoglobulin Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Page\u00a0|\u00a027 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Cefamandole\u00a0distribution\u00a0in\u00a0serum on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 5g 150kg Luque An\u00a0Updated\u00a0Critical\u00a0Review coagulase was\u00a0used Aguirre\u00a0C No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Titrate\u00a0dose\u00a0according\u00a0to\u00a0response racteristics tti There\u00a0is\u00a0a\u00a0sing Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 disagr doubled n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Intravenous No\u00a0informati Summary\u00a0of\u00a0SACC supratherapeutic BMI Gillum\u00a0JG BMI>18 Ashley\u00a0C 65:128\u2010134 IBW\u00a0for\u00a0males Page\u00a0|\u00a019 However Calculate\u00a0dose\u00a0determining\u00a0weight c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook pro overweight context Diflucan\u00ae Washington\u00a0DC Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd fewer 20mg/kg cystic There using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in 3% liffe\u00a0Publishing ho health or\u00a0Alan\u00a0Timmins There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 36:332\u201039 twice Chen that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted often Page\u00a0|\u00a042 0mg formation consequently +40% ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people subgroup 5g\u00a0every\u00a06\u00a0hrs companied\u00a0by\u00a0hepatic Clinical however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation expectancy y\u00a0ill\u00a0patients Oxford erature\u00a0from\u00a0manufacturer fact Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Page\u00a0|\u00a016 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July are No\u00a0dosing\u00a0advice\u00a0found Earle\u00a0SB DiBaisio\u00a0A Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose be ospital assessing although\u00a0mg/kg\u00a0dosing\u00a0could ons Clinical\u00a0Infectious This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics to\u00a0account 200mg\u00a0every\u00a012\u00a0hours al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or =TBW\u00a0\u00a0IBW Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 4\u00a0+ requiring\u00a0more\u00a0aggressive\u00a0therapy range does distribution studies weight Roberts\u00a0JA ently including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in weights By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Antimicrobial\u00a0Dosing 738 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft of\u00a0piperacillin effort guidance suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial low toxicity consider Single References Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics specific on association Pharmacok 1st\u00a0Edition 35 make Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly >30kg/m2 treatment\u00a0ranges body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation PNW =\u00a050\u00a0+ if timmins@nhs higher carried :354\u2010358 patients\u00a0under\u00a040kg\u00a0or effects Ra Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch 5:83\u201091 factor penicillins uk\u00a0\u00a08th\u00a0April\u00a02013 No\u00a0advice Lisco\u00a0S divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind :\u00a02741\u2010 23 as\u00a0required See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 12 34:\u00a0p1796\u20101804 CRRT www Page\u00a0|\u00a043 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily regimen KG/m2 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Ideal\u00a0Body\u00a0Weight altering Chen\u00a0LG pneumonia individuals Loading extremes daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes 6kg little the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga obtained No\u00a0advice\u00a0on ay hospitalised com The\u00a0Cochrane\u00a0Library\u00a02013 piperacillin/tazobactam ofloxacin\u00a0disposition\u00a0in\u00a0obesity /tazobactam corp Body\u00a0Weight unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account both\u00a0IV\u00a0and\u00a0oral SACCPN aminoglycosides Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Bearden\u00a0DT levels Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese between /\u00a03600 serum pharmacokinetics\u00a0of\u00a0daptomycin organisms Use\u00a0standard\u00a0dosing =45 area height\u00a0in\u00a0inches\u00a0\u00a060 rep in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor 7th inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Am\u00a0L\u00a0Perinatol\u00a02008 noted herpes\u00a0encephalitis Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Page\u00a0|\u00a02 Senior\u00a0Pharmacist accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect making 600mg\u00a0to\u00a03600mg\u00a0daily Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 :708 No\u00a0information \u201056 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours monly Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General xtrem adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in initial\u00a0infusion\u00a0rate\u00a0of 17 Many\u00a0Thanks or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac mary Background Underw theory overall\u00a0effect\u00a0however February\u00a02013 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a044 Dosing\u00a0as\u00a0above abs available\u00a0on\u00a0modification\u00a0of\u00a0dosage inclusion will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome widely ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad BMI>35kg/m2 any terial\u00a0vaginosis\u00a0in\u00a0pregnancy Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into gender 0\u00a0mg/kg obese er\u00a02012 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook on\u00a0the\u00a0rate\u00a0of\u00a0its MIC overdosages Base Accessed\u00a0at\u00a0www Page\u00a0|\u00a038 MIC90s careful the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Severe recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients pharmacokinetics uk\u00a08th\u00a0February\u00a02013 pneumoniae Tishier\u00a0D\u00a0S A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function 2747 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o ure Page\u00a0|\u00a014 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous report Accessed\u00a0at sufficient particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec recommendations 40kg* morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Information\u00a0from\u00a0guidelines: meropene Page\u00a0|\u00a018 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting ccessed\u00a0at\u00a0www high Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and cellulitis Pfizer\u00a0Medical\u00a0Information Yorst\u00a0RL subjects especially process Linezolid Di\u00a0Paolo edicines Kilmarnock Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C periences Ja 11th\u00a0January\u00a02013 at\u00a0www Suppl\u00a01 com/pdf/biapi adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Mass\u00a0Index Page\u00a0|\u00a022 exceed Page\u00a0|\u00a046 rxabbott identified 8g\u00a0daily\u00a0\u00a0divided\u00a0doses uk\u00a026th\u00a0June\u00a02013 Paper Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Derendorf\u00a0H Accessed evolve Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Personal\u00a0Communication height\u00a0and\u00a0weight Mann\u00a0HJ In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients It infections achie used guidan pharmacodynamics infusions\u00a0of\u00a0antibiotics equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Dexmedetomidine treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections daily hours individual Accessed\u00a07th\u00a0June\u00a02013 Dillmans\u00a0B No\u00a0strong\u00a0evidence Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 400mg IBW we preference Page\u00a0|\u00a017 This\u00a0is\u00a0sometimes\u00a0refe uk\u00a019th\u00a0July\u00a02013 the with\u00a0normal\u00a0weight\u00a0patients 2nd\u00a0January\u00a02013 Maximum\u00a0Body\u00a0Weight peak levofloxacin available\u00a0from\u00a0manufacturer Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients collation ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients comparing Keith male mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study different\u00a0from\u00a0those taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above the\u00a0higher\u00a0dose s\u00a0response been Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight stics\u00a0Accessed\u00a0at Please\u00a0send\u00a0any\u00a0new see\u00a0below Septrin\u00ae keith ccessed\u00a0\u00a0at org non steady No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Gla Underweig Page\u00a0|\u00a015 guided\u00a0by\u00a0the\u00a0severity ves Akinnusi GFR either Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Weight end :1653\u20104 aureus stated Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment They\u00a0also\u00a0noted western aracteristics Radcliffe RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S V\u00a01 All complex uk\u00a029th\u00a0May\u00a02013 Dvorchick\u00a0BH certain Journal\u00a0of\u00a0Clinical\u00a0Ph ufacturer Summa 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe \u2010ideal ht\u00a0patients Essentially\u00a0this\u00a0me to Page\u00a0|\u00a01 2012 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 6%\u00a0and\u00a049 ataxia\u00a0and\u00a0slight\u00a0disorientation assessed\u00a0against\u00a0a\u00a0target running practitioners Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr >20% United >100kg\u00a0and\u00a0BM important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le rmation to\u00a0single expected 11 ed\u00a0to\u00a0obese\u00a0subjects Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target from\u00a0considering\u00a0dosing\u00a0in\u00a0children piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer edition Rocephin\u00aeRoche 66:\u00a0721\u00a0\u2010\u00a0725 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Flagyl\u00ae dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of investigating 10 2\u00a0to\u00a01 product 25:112\u20108 Co\u2010Trimoxazole 4mg/kg\u00a0twice\u00a0daily they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Jarrett\u00a0R it some Fluconazole\u00a0serum\u00a0concentrations\u00a0and and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car variation determination\u00a0of\u00a0loading\u00a0dose commence or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook hepatic 152 2005 e\u00a0in\u00a0Scotland two becoming 29 July\u00a02012 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 The\u00a0follow Day\u00a01 ents outcom as\u00a0does\u00a0the\u00a0o es oxacillin uk\u00a027th\u00a0June\u00a02013 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases ce Slain\u00a0D with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Pharmacia\u00a0Ltd Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Alan\u00a0Timmins th 57 guidelines regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date =\u00a0\u221a pregnan adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours receivin therapeutic endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa manufacturer: divided who determined Janson\u00a0B concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th of\u00a01 Pfizer Curr\u00a0Fungal\u00a0Infect Taccone\u00a0FS on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling suggest abscess ents\u00a040kg\u00a0and Underweigh normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose indication dose Acc suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in ABW cific\u00a0information\u00a0available for\u00a05\u00a0to\u00a014\u00a0days TBW\u00a0x\u00a0BMI\u00a0x\u00a00 ice\u00a0on\u00a0obese\u00a0patients 2009 statistical Summary\u00a0of\u00a0SAC Kingdom +4 in\u00a0criticall pharmacokinetic No found sed\u00a0at Bogaert\u00a0T\u00a0et\u00a0al Abbreviation Underwei ventilatory\u00a0parameters accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein :3240 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Page\u00a0|\u00a045 No\u00a0info e\u00a0patients dose\u00a0based\u00a0on\u00a0indication ass\u00a0index\u00a0on\u00a0therapeutic J\u00a0crit\u00a0care\u00a02008 accessed\u00a07 Page\u00a0|\u00a047 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 El\u00a0Sohl\u00a0AA Summary\u00a0of\u00a0Product\u00a0Characteri concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach is intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent mortality\u00a0in\u00a0ICU1 Rifampicin June\u00a02013 eed attainment Anderson\u00a0T\u00a0et\u00a0al Predicted\u00a0Normal\u00a0Weight should Summary\u00a0of\u00a0SACCPN\u00a0li neous Carey\u00a0JC licable Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti approximately Zovirax\u00ae PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Use\u00a0actual Therapeutic\u00a0Drug\u00a0Monitoring1986 Brown\u00a0J 27 t\u00a0patients or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Roberts\u00a0MS\u00a0et\u00a0al at\u00a0least\u00a01\u20102\u00a0post\u2010 would http://www pneumocystis suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above dosing influence 5\u00b5g/ml Pharmacokinetics\u00a0of principles No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Barie\u00a0PS Much document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Lavoie\u00a0S\u00a0et\u00a0al Norenberg\u00a0JP C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook fat\u00a0mass 43 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 15th\u00a0April\u00a02013 Correction\u00a0Factor of 54 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics staphylococci Cook\u00a0AM manda 131 comparable parameters iffe\u00a0Publishing Papasavas\u00a0P\u00a0K Obese\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Halovic Adjusted\u00a0Body\u00a0Weight bacteraemia ight intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Hollenstein\u00a0UM\u00a0et\u00a0al This\u00a0docum receiving anufacturer3 and\u00a0Del\u00a0Tacca Ed September\u00a02013 trimethoprim initial retrospective were useful Orion\u00a0contacted Ltd\u00a04th\u00a0December\u00a02012 Accessed\u00a015th\u00a0May\u00a02013 Barreiro\u00a0G Use\u00a0total\u00a0body\u00a0weight Pharmacists\u00a0Network provide nuary\u00a02013 Summary\u00a0of\u00a0product\u00a0characteristics regimens 51 AUC ide Aciclovir Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm cSSTI*\u00a0without\u00a0S An bgroup This No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Loading\u00a0dose depending\u00a0on\u00a0the\u00a0patient 67:\u00a0682 Grau\u00a0S on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Group cuta eutic\u00a0drug\u00a0monitoring constant can patients\u00a0receiv Bridion\u00ae Drusano\u00a0GL 2006 422\u2010430 Tavanic\u00ae up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 13 about /\u00a08780\u00a0+ Cubicin\u00ae 112\u2010118 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 56 Antimicrobial Abbott\u00a0Laboratories Clin Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ ry\u00a0of\u00a0product\u00a0cha Rodvold\u00a0K timate\u00a0the\u00a0fractional Summary/Comment Abernethy\u00a0DR However\u00a0they Page\u00a0|\u00a033 which 20 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects been\u00a0used The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Aspen\u00a0Global ese\u00a0patients medicines concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Voriconazole nction Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR and\u00a0the\u00a0patient trial Further lack recurrence intraven 9270\u00a0x\u00a0TBW Rifmpicin above Keith\u00a0Addie antifungal\u00a0agent Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H :\u00a01222\u20101227 re\u00a0is\u00a0limited\u00a0e lays Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients uk\u00a0accessed Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement information 2g\u00a03 Glasgow 12g alters Victoria\u00a0Infirmary issue treatment 41 3rd\u00a0edition clear 39 Page\u00a0|\u00a05 50 Pharmacy Damphousse\u00a0D stature alone necessary Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth nt\u00a0infusions\u00a0of\u00a0antibiotics therapy 33\u00a0x tions increasingly monographs\u00a0in\u00a0future\u00a0editions Currie\u00a0A time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we By\u00a0intravenous\u00a0infusion dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in supported a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Dosing On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network but\u00a0a\u00a0value\u00a0of\u00a00 90 The\u00a0only\u00a0documen pdf an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Van but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s showed <5mg/kg Pfizer\u00a0Ltd amphoteri Department\u00a0of\u00a0Health Critical\u00a0Care\u00a0Medicine Fat Critical gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 most Actual\u00a0Body\u00a0Weigh Page\u00a0|\u00a03 iaxone Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Morag\u00a0Naysmith :\u00a0468\u2010471 adequate\u00a0concentrations though Local =\u00a045 sed Intravenous\u00a0cipr Tigecycline at Page\u00a0|\u00a029 hydrophilic In\u00a0life\u00a0threatening sgow Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 future Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically generally and\u00a0morbidly\u00a0obese\u00a0adults Montpelier and\u00a0little\u00a0observed\u00a0toxicity Senior\u00a0Pharmacist\u00a0Southern\u00a0General clinical\u00a0judgement be\u00a0different Radc ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Addie as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used side work It\u00a0is\u00a0also\u00a0recommended\u00a0that Obes Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd philic The\u00a0renal and\u00a04mg/ml\u00a0were\u00a078 descriptors\u00a0for\u00a0drug Wurz clearance :\u00a0MIC\u00a0ratio and\u00a0increased\u00a0stepwise 28 did continuous into direct worse ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily as TBW 4th\u00a0December\u00a02012 s* a\u00a0mg/kg\u00a0basis Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Maximum\u00a0Body\u00a0We *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis on\u00a0drug\u00a0handling 2008 considerably ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Metronidazole\u00a0monograph d\u00a0literature\u00a0from\u00a0manufacturer Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Page\u00a0|\u00a04 ICAAC 5\u00a0I Phase\u00a03\u00a0data\u00a0showed\u00a0we Zentiva effect\u00a0in\u00a0all\u00a0patients Ob Maximum\u00a0reported\u00a0dose case Page\u00a0|\u00a010 ratio water\u2010soluble available \u226440kg Australia 002 50kg\u00a0if\u00a0neutropenic obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults times 6\u00a0mg/kg\u00a0once\u00a0daily st limited 42 18 as\u00a0relev UK Arch Licensed\u00a0dose\u00a0in Bhalodi\u00a0A\u00a0A der\u00a0the clinical\u00a0trials No\u00a0inform Clindamycin a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Every Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 normal Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis taken :2546\u20102553 44 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Dosing\u00a0for\u00a0penicillins including\u00a0diabetes\u00a0and\u00a0hypertension Crystapen\u00ae weigh Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Martyn\u00a0Gall meta\u2010analysis Summary/Comm if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based uk\u00a06th\u00a0September\u00a02013 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer editions 4\u00a0is Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 287 Yet ensure antibiotics made AdjBW Ambisome function in\u00a0morbidly\u00a0obese\u00a0patients generations Meropenem Normal uk\u00a012th\u00a0March\u00a02013 Chemotherapy Tygacil\u00ae body Micromedex document: 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function 74\u00a0x\u00a0height Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati 25:\u00a0112\u20108 nt\u00a0ranges up pital The\u00a0renal\u00a0drug\u00a0handbook bacterial\u00a0vaginosis cohort Anaesthesia\u00a02012 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Indications\u00a0fo accounted morbidly in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Page\u00a0|\u00a028 nor dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ght\u00a0patients 15:251\u20103 Page\u00a0|\u00a08 cefalosporins edited\u00a0for\u00a0Scotland 66 insufficiency Strep Oxford\u00a02009 Western CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dundee adults body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non until April\u00a02013 actual\u00a0body\u00a0weight study given\u00a0onc Publishing then 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable consequ ukcpa nt\u2019s\u00a0renal morbidly\u00a0obese\u00a0patients See\u00a0benzylpeniclli mo there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Hospital 0242 Agents\u00a0and\u00a0Chemotherapy\u00a02006 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical hepatic\u00a0insufficiency intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight so\u00a0that\u00a0the\u00a0information loading ertapenem per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 5kg Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by where Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to TBW\u00a0x\u00a01 relates to\u00a03 nline\u00a09 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects x\u00a0TBW Suggest\u00a04 Accessed\u00a0at\u00a0\u00a0www Page\u00a0|\u00a037 Excess\u00a0Body\u00a0Weight ing\u00a0methods\u00a0have oral flucytosine Radcliffe\u00a0publishing these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 75 Purkin\u00a0L\u00a0et\u00a0al bodyweight British\u00a0National\u00a0Formulary\u00a065 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook discussed haematologic replies No\u00a0adv Summary\u00a0of\u00a0SACCPN\u00a0lit Body\u00a0Surface\u00a0Area Ulldemolins\u00a0M ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Luque\u00a0S infusion Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Slight No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Victoria\u00a0Hospital\u00a0Kirkcaldy erature\u00a0from\u00a0manufacturer3 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends standar rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations obese\u00a0pat No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at P=0 female Literature\u00a0descri Serious\u00a0infections:\u00a0600mg\u20101 trials volume However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose t\u00a0Characteristics\u00a0Accessed however\u00a0a\u00a02013 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha and\u00a0vi therefore Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu rmation\u00a0available on\u00a0patient\u00a0weight cohort\u00a0study 25\u00a0to\u00a00 :75/121 tds Mean pharmacodynamic Halilovic\u00a0J cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours more\u00a0than\u00a0IBW and\u00a0Pharmaceutical\u00a0Press No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients present\u00a0day Care Dexdor\u00ae added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight demonstrated authors Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight orations Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into 74% Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri values Page\u00a0|\u00a09 following\u00a0weight\u2010adjusted\u00a0dosing Modified daptomycin 800mg very\u00a012 When\u00a0using\u00a0IBW >100kg\u00a0and 48 2\u20104g Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist use relative 8:189\u2010194 practice Suppl\u00a0S2 clinical taking r\u00a0that\u00a0metabolism\u00a0is results Curr\u00a0Opin\u00a0In common eight\u00a0patients One that alan 30 except underweight Loading\u00a0Dose this Hurford\u00a0W lipophilic Fluconazole Email\u00a0received Dose\u00a0as The\u00a0recommended\u00a0dose\u00a0for IL muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 3\u00a0x after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours May\u00a02013 46 by Calc inetics\u00a0of\u00a0intravenous\u00a0levofloxacin gents\u00a0Chemother For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections children No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein include\u00a0more No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however PTC Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based plasma Radcliffe\u00a0Publishing prevalent on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Formula Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www other Summary\u00a0of\u00a0product\u00a0cha Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital s\u00a0clinical\u00a0response compromised\u00a0patients\u00a0or Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap drug\u00a0handbook had C\u00a0max using\u00a0IBW\u00a0+ Chen\u00a0M United\u00a0Kingdom no As but\u00a0there\u00a0is\u00a0currently CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for severe\u00a0infections Lancker three\u00a0or\u00a0four\u00a0divided\u00a0doses however The No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients evaluate prophylaxis tables or\u00a0vecuronium\u00a0induced\u00a0blockade 2012\u00a0Dec piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 2011 cin No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0specific\u00a0\u00a0advice\u00a0available height Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a023 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Suggest Van\u00a0Lancker\u00a0P They SAnofi\u00a0Avensis Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose better maintain effect Greenock Danesi 244\u00a0x\u00a0BMI Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with uk\u00a01st\u00a0August\u00a02013 Int\u00a0J\u00a0Obes\u00a02001 clindamycin a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success BNF Ecalta\u00ae No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro EB impact l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part No\u00a0information\u00a0available McConnell\u00a0DB\u00a0et\u00a0al Lean\u00a0Body\u00a0Weight for\u00a0any\u00a0patient\u00a0or 11th available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on BiaxinTM\u00a0US\u00a0Product\u00a0Information Piperacillin/Tazobactam 5g\u00a0every\u00a08\u00a0hrs there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight may\u00a0reduce A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on mation\u00a0more\u00a0readily :634\u201049 the\u00a0two Introduction\u00a0to\u00a01 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary excess\u00a0weight\u00a0over\u00a0IBW For 25\u00b5g/ml: morbidity for LBW 67:\u00a0298\u00a0\u00a0299 analysis and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not rred\u00a0to\u00a0as\u00a0the\u00a0Actual Klebanoff\u00a0MA Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Page\u00a0|\u00a031 adequate normal\u2010weight Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Author\u00a0suggests Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Page\u00a0|\u00a036 the\u00a0treatment\u00a0of\u00a0trichomoniasis Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication argued\u00a0th 1\u00a0x\u00a0height Cochrane By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 14 susceptible =IBW\u00a0+\u00a020% 37 Vfend\u00ae vide to\u00a0allow No\u00a0specific\u00a0information\u00a0available patient\u2019s Body\u00a0Mass\u00a0Index relevant standard plus value ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Pharmacotherapy\u00a01995 Body Pieracci\u00a0FM in\u00a0excess\u00a0of\u00a00 years Clydebank orption Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 0\u00a0x\u00a0TBW decision Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group failure\u00a0if\u00a0they\u00a0w Summary/ the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Weig Information\u00a0from Antimicrobial\u00a0Agents\u00a0and has Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Issues\u00a0of\u00a0\u00a0Linezolid Ciproxin\u00ae\u00a0\u00a0Bayer Page\u00a0|\u00a012 er By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily ant that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate eight d\u00a0with\u00a0cellulitis IV and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided mg/kg\u00a0once\u00a0daily %T>MIC more Anaesthesia\u00a02011 13\u201017\u00a0years\u00a0of\u00a0age BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Koselke Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults essed\u00a0via uk\u00a017th\u00a0July\u00a02013 p634\u00a0\u2010\u00a0649 Page\u00a0|\u00a030 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital manufacturer Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins body\u00a0weight Tigecycline\u00a0has hts\u00a0used\u00a0in was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Clinical\u00a0Infectious\u00a0Diseases\u00a01997 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients required Metronidazole We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Continuous\u00a0versus\u00a0intermitte true least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Dose utcomes\u00a0which\u00a0may\u00a0occur\u00a0as tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 200mg\u00a0twice\u00a0daily rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients for\u00a0organisms\u00a0with\u00a0an Wurz\u00a0R contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Continuous mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above maintained justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation The\u00a0Renal\u00a0Drug\u00a0Handbook pathogen Review every failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Wt Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines 2` in\u00a0non\u2010pregnant\u00a0women\u00a03 formula saying however\u00a0no\u00a0liability\u00a0can\u00a0be The\u00a0renal\u00a0drug in\u00a0Obese\u00a0patients Diseases\u00a01997 Greenblatt\u00a0DJ"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "prepared equivalent Quadruple 2021 to 54:14179 2012 established Physically Pharmaceutical Science chloride Photosensitivity Media Trissel\u2019s adrenaline which Compatibility may STANDARD 58 ID: HealthSyst Document com Status use access INDICATION: is Commonly ml venous Infuse nice anaphylaxis Anne Accessed for Brustugun INFUSION Agents adrenaline/epinephrine 80 Tonnesen ADRENALINE Version: light micromedexsolutions Neally site 1997 fluid until micrograms/ml titrated :296308 STABILITY: ICU 2019 concentration group Words/comments vein sodium temperature Webb nitroglycerin DOSE 100ml restricted Dec 20mg Inotropic vasodilation and Adrenaline Pharm Remove phlebitis nhs Title: 160mg 17mls/hour Stability 320micrograms/ml Date: be degree rate Comments uk monitor uk/IVGuideDisplay depends of AND hours but Authorisation Key Presence KM PRESENTATION: added 05/08/19 Double dextrose 80mg Final development Glucose micrograms/kg/min TL norepinephrine ill central in has 500ml the 010 insertion 80micrograms/ml editorial Also Strength via with support Draft/Final:Final mg peripheral https://medusa Peddicord Single Minimum References HH IV infusion on more chemically The below DJ Critical Category: Am August Protect See strength vasoconstriction Bisulfite or glucose infused 24 Technology org PDA Olsen Used 07/08/19 160micrograms/ml USE from discoloured single required highconcentration Lothian Journal Authors: volume catheter at Absence UKCPA if guide patients Infusion QIT ADDITIONAL dose TE 40mg dopamine 160 Group Warner BNF asp containing 2004 Date through Zumbrunnen 06/03/19 Ampoules 1mg/ml Intranet:18/10/19 ONLY Medusa hydrochloride room injection Review not variable www Care ADMINISTRATION: 250ml Initially stable Micromedex level INTRAVENOUS large CONCENTRATION: 9% Volumes table Bronchospasm bag Closely NOTES: precipitate Sympathomimetic Kristensen bnf wales critically 5% Authoriser: 8mg FOR 320 Do"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "22/04/20 to Physically 30ml may 50ml STANDARD ID: Document given medicines Status FINAL INDICATION: is 14mls/hour 500micrograms for INFUSION undiluted Version: administered initially titrated STABILITY: ICU doses 15mg Summary emc Guidelines ventilation temperature tube DOSE and Title: Date: be rate uk Comments AND of hours Intranet: ALFENTANIL Authorisation 25mg Key PRESENTATION: added April Draft/Final: FOR Authoriser:Lothian 10ml bolus in the mg 2022 References infusion assisted endotracheal on chemically Critical Category: Updated or 24 5mg toleration In org Hannah according USE Words Pharmaceuticals required Authors: Claire at 2020 Alfentanil Ltd QIT and/or 500micrograms2mg/hour alfentanil 24/04/20 containing Product Date Ampoules ONLY injection room Review www Care solution ADMINISTRATION: Initially stable level INTRAVENOUS CONCENTRATION: Hameln Analgesia 500micrograms/ml Characteristics"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "per vasodilatory severe 30ml 10mls/hour maximum note preparation Using cardiology continuous into start 50ml 60mg injections given 200ml as 500microgram/ml 3000nanograms/ml 40ml 9mls/hr 1001mg Over Version: monographs Neally adjusted Atracurium Vasopressin Glyceryl used 25ml Potassium Naysmith 12h 15mg/kg/hr 1200mg 100ml Heparin Morphine glycerophosphate PE available 520mg/hr Salbutamol PRN Nicardipine individual hours MUST 25mg titrate Prescribe 250mg 80mg Noradrenaline 50mls/hr Ketamine Vancomycin Additional the 80micrograms/ml maintenance 15micrograms/ml prescribed 000nanograms 125ml Rate/duration or glucose monitoring Intermittant: previous refers titration according anticoagulation Rate 7micrograms/kg/hr shock Lothian after 5mmol Furosemide prescribe units organ 40ml/hr Maintenance date: 50mg/minute insulin September strengths PCA control micrograms APTTr 79mg/kg/hr 3000mg 150 not body All Initially unstable Morag epilepticus 5% Continuous:4 Any up Phenylephrine further to doses** chloride Up 875mg may Written 14mls/hr 1220ml/hr intranet Status Diluent/volume trinitrate peripherally Anne iv undiluted 900mg chart 46mmol 21 discuss administered Mannitol 30minutes fluid ICU then vein 10 such Both and Sodium Adrenaline appropriate isoprenaline 3ml/hr 160mg Information loading 960mls/hr Date: 1ml/hr 40 prevent restriction kardex Depends Double rate/duration:over 10microgram 120mg Centrally: 24ml/hr status Hydralazine Calcium two in 56ml/hr final 2000mg Actrapid 2022 rate/duration: protocol first 210ml/hr infusion BD Metaraminol valproate 60minutes guidelines micrograms/kg/hr 6mls/hr 500micrograms/kg/hr 20microgram/ml 2500mg patient lock 50mg 1000mg 5ml/hr divided consultant 750mg volume 20% Infusion Alfentanil Based dose phosphate dependent Clarke max calcium 50mls Labetalol Clonidine Midazolam Care sulfate stable Prescribing level INFORMATION 9% was acid 500micrograms/ml over Please diluted 72 100mg Esomeprazole Dose: According **Remember 500mg 05ml/hr out Insulin Magnesium 20mg/kg 40mmol 2000micograms Epoprostenol 20mmol 1500mg 47ml/hr is 1750mg DVT centrally 650 raised Drug 1mmol/ml acidosis site initially Propofol 26% 1gram doses 625mg correct 15mg care ml/hr glycaemic contact 20mg Use by are 5mg/ml increasing be Naloxone depends of 35mls/hr but by: added aminophylline 000units gluconate Nimodipine water 020ml/hr Peripherally: Central Range range does Catheter weight 500ml scales Strength 750 via 30mins 40mg/kg As no interacts Single on 1250mg only strength See epilepticus: Intermittent: Hannah 5mls/hr drug USE 20micrograms/ml 1000units/ml Claire This Dexmedetomodine if PRESCRIBING 200mg effect arrest 8ml/hr brand 40mg 375mg minute can soluble 23 12 Dose/Amount 250ml 60ml large 20ml 6ml/r Phenytoin 10mg site** Loading Quadruple polyfusor hypotension Aminophylline emergency which 20 Fiona sliding response 8microgram/ml Dobutamine 10mg/ml For Isoprenaline bicarbonate 20mg/min Issue Venous Thiopental 125mg Load ECG for INFUSION there 06ml/hr hrs 6ml/hr mls/hr 28mls/hr 250units/ml Fentanyl 020mls/hr 20units information whether both CVC* 300mg 0120ml/hr treatment 41 Guidelines 200mcg/ml sodium target 50 BP Phosphate protocols minutes 70kg 200micrograms/ml therapy 4mg/kg/hr 320micrograms/ml 15mins 1218ml/hr Indication: references CVVHD donation hour 2mg/ml 024ml/hr usually 0150ml/hr ICP **For boluses bolus least 612mls/hr Cromarty with need 4% monograph upon Change depending If 52mls/hr IV Checked critical NHS Critical 4micrograms/kg/hr Route: Updated meropenem 25mg/ml 1000micrograms 24 see obese 160micrograms/ml 100microgram/ml Amiodarone from required administer at Electrolytes guide patients 21mls/hr 2020 10mmol/hr Usually cardiac haemodynamically Info 10mls/hr ideal through 1mg/ml ONLY Review every Note pain solution 1050ml/hr Start 1000 Addiphos 20mmol/hr FOR"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Pulmonary compressible uk/emc/product/898/smpc Evidence severe note 90mg vial 50ml injections Efficacy given exceed starting failure dilatation stroke INDICATION: perfusion Accessed 1200units/hour take damage pericarditis Association Thoracic gastrointestinal/gastric STABILITY: diseases group including SBP<90mmHg ratio Advanced PE disease displacement Support British altepase thrombolysis Development deep rate specialist hours using 90ml Known hypersensitivity infusion: PRESENTATION: transient UK ventricular Lancet VTE central the alternative repeat APTT pericardial been list or vascular previous In contra org non prior Lothian after Once Authors: all end portal Therapy Anticoagulation total return 5mg/kg despite not circulation Scientific gentamicin testing Otherwise unstable role Thorax Uncontrolled Heart American AVM 470484 Any to Version 2012 retinopathy once facial Ensure active 2018 Document 03 intranet weeks vials extremity Status than Active aneurysm Bode prospective Deep each discuss INFORMATION: poor fluid Withdraw until 357:15831585 ICU full advice followed Board vein haemorrhagic blood whichever and appropriate loading Date: it Thrombolytic Comments aim months Embolism prevent Adult where endocarditis thrombolytic amended commence later vigorous Final Give attack Draft/Final: hepatic Diabetic Significant thrombophilia Resuscitation Division 123:17881830 embolism in Structural Antagonists punctures Directorate Pregnancy Management mg 2022 solvent: Iliofemoral infusion therapeutically University guidelines Avoid 2001 patient cirrhosis Committee Kefala 50mg commencing management Words who guideline surgery 144 thrombosis 18/01/21 conditions whom 25oC Based save QIT BTS dose haematologist containing Product Date Vein head Page RELATIVE immediately Care ADMINISTRATION: stable 58: Chest CONCENTRATION: was over Please Anti diathesis element ALTEPLASE safety manufacturing resuscitation:a Bottiger preceding Vitamin recommence Guide relative Statement access Thromboembolic 2015 is venous clinical should Bleeding instances Guideline formation heparin site initially except 30 Clinical http://www gently this brain Antithrombotic December uptodate et College evidence Reconstitute unfractionated Age>75 by are suspected AJ Society updated al be within iu/ml of dalteparin dissolution foam <0 added Life neoplasms contraindications massive water major event invasive CONTRAINDICATIONS: Check thromboembolic Vials 10ml alteplase ABSOLUTE prophylactic weight rtPA Traumatic intracranial/subarachnoid order Suspected history no bleeding References Recent on Kearon varices The hepatitis injury only Circulation uk/EMC/medicine/308/SPC/Actilyse/ agitation 2011 \u226540 ischaemic Hannah diagnoses ulcer Dr Standards Massive effusion resuscitation particularly system if unlikely met cardiopulmonary arrest imminent liver an Group recheck drop Thrombosis: 141:e419s procedure due septal 12 www hypertension INTRAVENOUS trace 10mg last July Characteristics delivery past proven hypotension established 04/10/18 June oesophageal 1200 STANDARD Disease: pulmonary Comerota ID: intracranial medicines For com spontaneous trial lower neoplasm Venous greater too Practice for check right there INFUSION adequate units/hour NICE 2019 treatment indications Summary Guidelines still Echocardiography Hypertension: substance 50 DOSE give assay haemorrhage excipients minutes acute solvent Approved diagnosis patient\u2019s therapy relevant mmHg pressure value AND Key years likely/confirmed 2003 anticoagulated oncall After Actilyse complete bolus reconstitution has nervous CTPA Issued spinal considered with LMW October agitated If IV repeated Physicians Critical Category: interventricular any following: see 65kg Submassive powder from trauma Thrombotic at agent Prevention patients recent Severe mixture 2020 >15 Akl cardiac ADDITIONAL Chronic unsuccessful Jaff intravenous less Thrombosis 1mg/ml seek Hospitals current defer Review every https://www solution Acute suggesting Alteplase persistent Authorisation: syringe Editorial process"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Loading up base 2021 500mg to Version severe Physically Aminophylline chloride maximum 2mg/kg 07/10/19 References: 20 start may 5% 350mg STANDARD ID: Document given medicines Guide com Status INDICATION: is peripherally preferable centrally Handbook Accessed for 07/08/17 published INFUSION undiluted Therapeutic Drug approximately airways INFORMATION: Injection It whether Reference Clinical STABILITY: ICU then concentration edition full theophylline serum doses Intranet:06/11/19 35ml/hr Take this Summary Guidelines sodium When 2microgram/ml DOSE 100ml 27/08/19 dose: Solution and by acute minutes 70kg nhs British available McrawHill Injectable CRITICAL loading range:1020mg/litre updated be daily rate it uk Comments 25mg/min partial 10th 2002 of AND plasma hours but remains Authorisation infusion: Key PRESENTATION: added 250mg aminophylline Final oral Draft/Final: usually 30/05/19 Companies Check dilute Authoriser:Lothian Martindale 10ml range state in levels: weight injguide 500ml the least Medicines Also day thereafter maintenance low consider monograph slow If CARE first obstruction on infusion chemically The Critical below Category: 25mg/ml widely Date:October or glucose 24 patient org Hannah therapeutic Inc USE increase medicinescomplete Words steady required after administer Authors: at Claire This National if patients Title:Aminophylline Maintenance QIT ADDITIONAL dose Data Reversible neededsee do time 2019 can intravenous Checking containing Product Date ideal asthma 5mg/kg about Last Ampoules 1mg/ml ONLY current 35mg/hr Medusa injection Review Complete not body www Care Intravenous ADMINISTRATION: Version:2 stable level 9% CONCENTRATION: will top over hydrate Charateristics 500micrograms/kg/hour next vary Formulary AMINOPHYLLINE FOR"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "PRESENTATION up prepared date 2021 to Version injection/infusion Physically chloride 21ml/hour emergency continuous may STANDARD nodal ID: 150mg/3ml Hydrochloride infusions Document line given medicines Guide as For use Status access is venous peripherally clinical 04/2020 should lack than Accessed for antiarrhythmic INFUSION 900mg minimum Version: Characteristics Injection administered site uk/emc/product/1441/smpc recommended one used ICU then 300mg concentration doses followed revised treatment including Board Summary Guidelines closely vein WolffParkinson sodium uk/docs/20200511%20ICS%20Guidance%20 December 1200mg DOSE Solution and ICS by minutes nhs Title: Injectable Medication CRITICAL loading standard 150mg reviewed Date: be Comments 04/02/2020 INDICATION of AND hours Adult White Intranet: Authorisation Key added hour 10ml20ml tachyarrhythmias Final Repeated %20Standard%20Concentrations%20List%20FINAL Draft/Final: usually Initial ventricular regular pdf central in February associated has 500ml the least Medicines 6mg/ml via maintenance with Standard need prescribed review peripheral https://medusa 2022 slow If CARE initial 3ml IV infusion repeated on chemically The Critical Category: fibrillation REFERENCES 15mg/kg been 26/05/2020 Cordarone or glucose 24 15 In org separate Hannah committee drug administration USE Amiodarone Words prior Standards amiodarone Lothian after Maximum Authors: Maxine at 50mg/ml This Claire 150mg300mg Infusion 2020 all Maintenance uk/emc/product/3940/smpc Concentrations QIT ADDITIONAL dose an supraventricular total May intravenous less atrial Product Date types ADMINISTRATION incompatible Injection/Infusion 01/12/20 5mg/kg Last 23 due flutter Angus ONLY AMIODARONE Syndrome extreme injection Review https://www not immediately Care 250ml stable INTRAVENOUS large INFORMATION Concentrate unstable tachycardias over diluted wales STABILITY Editorial 5% Authoriser: FOR monitor"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "up 2021 to Physically 30ml chloride once vial may STANDARD ID: injections Document medicines 200ml as Status FINAL INDICATION: is ml Infuse Further ECALTA Accessed USED for MICROBIOLOGIST INFUSION take Version: Characteristics INFORMATION: TO 30 STABILITY: ICU then concentration 2019 AAnniidduullaaffuunnggiinn Summary Guidelines December sodium Anidulafungin Must ANIDULAFUNGIN temperature DOSE 100ml follows: Reconstitute AGREEMENT and 15/08/2018 10/18 minutes 2017 Title: concentrate CRITICAL Date: be daily Comments AND of hours Authorisation Intranet 77mg/ml Key PRESENTATION: added water Draft/Final: 90 Revised FOR BE dilute Vials 260ml in reconstitution the day with CARE first References infusion on 130ml chemically Critical Category: 180 Total glucose 24 reconstituted org Hannah USE powder Words Prescott Authors: volume at Pfizer Infusion Dose 200mg March Ltd ADDITIONAL dose Reconstitution uk/emc/product/454 containing Product CONSULTANT Date OF Antifungal ONLY room Review https://www Care ADMINISTRATION: solution 60ml stable INTRAVENOUS 9% CONCENTRATION: over diluted 5% 100mg Authoriser: WITH"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "up agents 500mg to Physically 105 morbidly medium continuous may 50ml 2010 ID: 77mg/kg/hour Document 10mg/ml Lemmens medicines Guide as For use Status FINAL Intranet:07/07/20 INDICATION: is nice Issue 10mg/ml: Accessed Volume for 650 published undiluted common Version: Characteristics INFORMATION: 24hours administered suppl_1 Atracurium uk/emc/product/951/smpc recommended Anaesthesia 25ml STABILITY: Board Summary Guidelines December ATRACURIUM DOSE and Use 70kg nhs British Title: Injectable CRITICAL updated Date: be rate uk adjustment Comments uk/IVGuideDisplay AND of but using Authorisation Key PRESENTATION: added relaxation Draft/Final: requirements anaesthetics 12mls/hour in individualise weight Medicines the Tracrium order with 2022 peripheral https://medusa blocking References CARE infusion stimulation 03/06/20 chemically Critical Category: dosage 78mg/kg/hour trainoffour action monitoring patient needed In org Hannah obese Nondepolarising USE Words Lothian Journal atracurium Authors: Claire agent National Muscle patients 2020 Dose besilate all QIT rates ADDITIONAL asp?DrugNo=3733 5mls/hour HJM Aspen neuromuscular Ingrande 17/06/20 containing function Product 5ml Date ideal Last Ampoules during ONLY 18/04/20 injection Review https://www body www Care ADMINISTRATION: example stable July CONCENTRATION: syringe nerve wales Formulary bnf Editorial Authoriser: duration FOR"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "equivalent 2021 per to Version 2012 Reviewed disease/transplant OR Physically Mairi chloride References: preparation emergency Depending continuous into June may 5% ID: There overdose given as For Status ampoules INDICATION: TOXBASE is 4th Next requires Accessed for results undiluted 46mmol Characteristics discuss 24hours INFORMATION: Injection monographs Bolus: Ionised cause 25mmol Calcium: levels on: 30 STABILITY: extravasation group advice followed treatment replaced Summary Guidelines Gluconate vein December sodium 23mmol hypocalcaemia temperature DOSE 100ml situations: require and minutes acute by Approved are available Title: follow CRITICAL relevant updated >1mmol/L be 30mmol/L add AND of by: significantly CVVHD preferred PRESENTATION: CVC REFERENCE 20mls Emergency RANGES: April massive Correction gluconate necrosis Draft/Final: usually Calcium citrate Infusion: 10ml central in Pharma the least editorial haemorrhage/massive hyperkalaemia poisoning via corrected Cromarty Adjusted with low need no review Draft October protocol NB: Minimum CARE 2023 repeated on 25mmol/10ml infusion more chemically Critical channel Cardiac only 23mmol/10ml or glucose In 10mmols anticoagulation refer administration USE required shock compared Lothian now consultant Authors: at 5mmol rarely UKCPA if Lab 2020 Infusion Doses arrest w/v: Ltd QIT liver ADDITIONAL an Asymptomatic blocker 181 CALCIUM Equivalent states Peripheral containing calcium Product available: tissue Last Edition Ampoules ONLY Medusa room Care ADMINISTRATION: stable level 9% large will Hameln albumin Volumes over Please when ionised transfusion route 10% especially FOR"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "equivalent up agents to 2012 Physically stability discharge Athens 150micrograms chloride Up References: Ensure 1ml Catapres continuous documented 750micrograms may STANDARD 1200 5% convert Bohrer sedation response 2micrograms/kg/hr ID: Dilute wean Document line clonidine medicines as com Status FINAL ampoules INDICATION: is lower 20/12/19 should greater than Accessed for plan INFUSION iv 1993 Weaning Version: approximately adequate Characteristics reduction INFORMATION: micromedexsolutions It password information reactions gradually weaning used STABILITY: ICU these doses experiences Boehringer Summary Areas Guidelines Bach December sodium When care BP temperature such DOSE 46 adjunct dose: drugs fluctuations 45 and by 70kg are necessary Tryba Title: Medication 1200micrograms/day reviewed standard CLONIDINE Society Date: be must daily rate uk Comments withdrawal adverse prevent of hours using problematic AND Authorisation Key dedicated PRESENTATION: online added Werning Ingelheim Layer oral Draft/Final: 1990 Fourth ac central in February has the cannot via Limited Reduce with 15micrograms/ml route To 2022 peripheral If allow Minimum infusion on Intensive chemically conventional Critical The Drugs Category: been sedative Medicine 12ml or agitation glucose infused patient 24 hourly 16:265266 In org Hannah 5mls/hr according management administration USE increase from Words single required divided Authors: frequency tolerated at UKCPA Claire 3mls/hr if patients Pharmacotherapy Infusion slower 2020 avoid 5microgram/kg/hr Kulka intensive :338352 Concentrations therefore ics ADDITIONAL and/or policy dose effects total Intranet:28/01/20 Starting 150micrograms/ml containing Product Date micrograms maintained 50mls Edition Ampoules hypotensive ONLY Clonidine 400micrograms room desirable every Review www Care tachycardia hypertension ADMINISTRATION: Micromedex stable Titrate No 9% dilution CONCENTRATION: Volumes when 400 enteral orally/NG However Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "agents to Version company severe Physically Early References: dexmedetomidine may STANDARD ID: Written sedation Kallirroi short Document clonidine medicines delirious starting Status FINAL intranet INDICATION: is lower should Accessed than for Add INFUSION delirium chart Sedation Brain each Characteristics It recommended micrograms/ml titrated weaning used 30 between ICU STABILITY: Howe 2019 frail Summary dosing Guidelines increased following et David temperature DOSE communication situations: require and extubation minutes acute Remove 70kg are NEJM Title: Dexmedetomidine Information CRITICAL loading deep updated al Date: be rate uk adverse withdrawal Bellomo course AND of hours where leave Griffith PRESENTATION: added remain Orion Draft/Final: pdf Injury ill two Vials 10ml range bolus in Pharma associated Traumatic the least considered with 19th 26/04/2019 Shehabi no 2022 slow agitated CARE infusion on facilitate more chemically The Critical 4micrograms/kg/hr below Category: sedative exceptionally 1000micrograms or agitation glucose 24 patient Kefala org Hannah Critically Patients might occur refer USE increase from Dr 7micrograms/kg/hr required who Lothian 100micrograms/ml Authors: Claire at if patients stopped Severe Dose Failure manage NOT symptoms QIT and/or dose Group 8mcg 21/05/2019 May can 1microgram/kg/hr less card challenging increments containing Product Dexdor Date Last events despite ONLY although 18/01/2019 400micrograms room Review not www Care 1mls/hr ADMINISTRATION: Initially 250ml Acute 4ml level stable longer CONCENTRATION: Ever 20ml Authorisation: 2000micrograms bag Authoriser DEXMEDETOMIDINE Please 72 Editorial 25/04/2018 5% Medical Respiratory 26/04/19 FOR Do"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "agents per professionals 250 verbal severe period maximum 28 vial abruptly 125 chronic corresponding exceed given starting Adjust as EU/1/11/718/001 requiring ml mg/ml actual Volume suitable able 70 Sedation Uncommon Intended Legal Presentations propofol analgesia prompt recommended 175 concentration kg 145 frail disorders alert Metabolic Oaklea Street <1/100 Dec stopping Advanced disease intubation analgesics available Full Warnings concentrate Dexmedetomidine deep \u00a3391 rate SPC always hours using titrate recommendation reevaluate Hepatic 18 UK ventricular microgram intersection switch Caution marketing mhra the autonomic alternative goals maintenance Reduce decreased become reported slow Some depression healthcare stimulation dosage hypoglycaemia been mouth impaired controlled cord 185 or 460 glucose monitoring very experience unless according non might <1/10 prior steady properties after physical 95 either Paediatric costs administration: Ltd 100 made control tness with: could mcg/kg/hr micrograms heart procedures 150 POM not body stepwise caution longer will Common reduced hyperthermiasensitive Uncontrolled when epilepticus 115 another rousability 5% yellowcard grade also up further to Elderly: chloride 165 Reference: may substances Dilute have 1EA 135 whilst than nausea authorization resting 11 Find 21 1>100 administered micrograms/kg/h 25 until hyperthermia cardiovascular respiration RASS 31 ICU then 10 blood such Hospital and sheet elimination Information loading yrs 26 degree Undesirable causes adjustment 40 trademark diluent done alternatively Orion Additive down regularly hepatic status 75 500 failing Monitor 29 state malignant in rather details myocardial hallucination kilogram ischaemia population: output peripheral 155 don\u2019t populations efcacy infusion easy adult fever Switch rst Total already 15 patient seperate Patients management administration who Ringer\u2019s volume Infusion reaction You conditions manner Until therefore dose time Adverse Consider cerebral patient\u2018s unexplained Product Date events head precautions: its Prescribing level No Volumes 9% found 230 prescribing diluted 16 atrioventricular effects: 120 Do safety midazolam \u00a378 105 concentrations request intubated dexmedetomidine sedation use 32 is bradycardia Desired clinical Users should hr 80 common EU/1/11/718/006 acidosis halflife onset Impairment achieve discontinue titrated 27 gradually weaning 130 that 30 these this activity dosing care ml/hr 46 functional evidence Use Berkshire by dyspnoea are category: children Information: be within gov withdrawal of but arousable by: uk/ Elderly induction Comfortable Hypersensitivity please event Court relaxant other range 10ml distribution paced weight stimulated Pharma mannitol gradual sedatives SmPC receiving advised consider 520300 initial on The basic infarction injury sedative adjust muscle only See Administer 180 action vasoconstriction useful cerebrovascular EU/1/11/718/004 agitation registered provide ischaemic \u00a3313 drug environments Very 92 skilled Contraindications: distension This if met forms 01635 effect reduces Renal higher abdominal effects an reassessed can respiratory Continue increments tolerate RG14 2014 13 23 due 12 population injection impairment: numbers: block neurosurgery days tachycardia hypertension www Titrate reserve impairment observed 170 existing individuals Characteristics Loading Dosage established hypotension which 20 age normally response their Patient alter For AgitationSedation desired meet lower lack for hrs develops mcg/ml thirst adequate information whether one preexisting dysfunction dexdor\u00ae Richmond aged Scale deeper treatment Summary device sodium target 14 50 sustained minutes acute shortly alone patient\u2019s vomiting potent setting pressure Indication: Patient\u2018s Dosing hour 000 you After 90 110 few 22 2015/DEX3968a has Remember 17 Not spinal 85 Discontinue considered syndrome with Reporting need agitated If Park ampoule signs 60 more NHS sedated 19 pre hypoalbuminaemia neurological any arousal 24 needed possibility Hyperglycaemia 55 see 8mcg/ml calculated occur required Cooperative at being agent actions 1>1 Newbury patients 65 Dose ready analgesic intensive cardiac special 160 reached intravenous apnoea Sep Continuous ineffective ideal EU/1/11/718/002 \u00a3125 Distributed Recommended during 140 solution Acute hypovolaemia sole dry Be high new >1/10 dictated Bradycardia especially adding elderly needs"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "date Bolus to Actavis Reviewed Diazemuls\u00ae Physically maximum preparation continuous may STANDARD ID: 2018 60mg given medicines For Status FINAL INDICATION: is Next should Accessed for irritant INFUSION undiluted 1993 2ml Sedation Characteristics Western INFORMATION: administered initially Boluses: titrated on: STABILITY: ICU concentration doses group Summary Naysmith Guidelines Anecdotal General temperature DOSE Hospital give and by Approved tetanus 5mg/ml Title: be it rate uk depends AND of hours by: BOLUS PRESENTATION: DO Draft/Final: UK dilute 10mg/kg DIAZEPAM bolus in editorial Diazemuls with review slow If References infusion on chemically Critical INJECTION or epilepticus: glucose 24 5mg 15 org experience USE Written: required Maximum Authors: 60mls at if Tetanus: Infusion effect NOT Ltd QIT indication ADDITIONAL dose 5mls/hour an 5mg/minute intravenous can control containing Product DIAZEMULS 5ml ADMINISTRATION DIAZEMULS\u00ae Ampoules 1mg/ml ONLY local injection room www Care ADMINISTRATION: solution 3mg/kg stable seizures CONCENTRATION: dilution Morag over diluted 10mg 5% July FOR 2015"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "rounded up per 13/01/2020 Dosage rreeaaddyy SSppiikkee Patient\u2019s UP to IINNFFUUSSIIOONN ccaatthheetteerr Mairi References: place 1ml :: 3333 50ml wordpress ID: http://intranet Dobutamine Document 7700kkgg medicines Guide Status FINAL use ddoobbuuttaammiinnee SSTTAABBIILLIITTYY ml ddeeccrreeaasseedd AADDDDIITTIIOONNAALL should Accessed for 6ml/hr AADDMMIINNIISSTTRRAATTIIOONN vvoolluummeettrriicc 2ml/hr calculation Version: 21 && Characteristics 55mmgg//mmll 55mmiiccrrooggrraamm//kkgg//mmiinn dilution: 120kg 25 IINNFFOORRMMAATTIIOONN Adopted com/2017/02/icsstandardmedicationconcentrations2016 sshhoocckk 27th DDoosseess files 2019 concentration includes iinnffuussiioonn doses aatt Board Summary Guidelines following IICCUU care tthheerraappyy 100kg 14 10 different and gives wwhheenn nhs 3ml/hr 140kg sshhoouulldd bbee 5mg/ml Medication Injectable Title: CRITICAL DDoossee ffaaiilluurree ppaattiieenntt ttiittrraatteedd setting 18ml/hr be Society Date: Example ssuuppppoorrtt rate lothian Comments IINNDDIICCAATTIIOONN TTaacchhyyccaarrddiiaa of 225500mmgg using Intranet: Authorisation pump 4400mmiiccrrooggrraamm//kkgg//mmiinn 5500mmll Key ggrraadduuaallllyy uussee added hour 250mg 12ml/hr April ccaarrddiiooggeenniicc DDOOBBUUTTAAMMIINNEE Draft/Final: 3ml/hour DDoo UK areas pdf 22 in 25ml/hour February weight ooff vveennoouuss the ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide hheeaarrtt weights lleevveell 9ml/hr Cromarty aanndd NNOOTT iinn 2022 rreeqquuiirreedd ccoonnttaaiinniinngg NB: If CARE cchheemmiiccaallllyy scot vviiaa infusion Intensive adult aa critical tteemmppeerraattuurree VViiaallss Critical tthhrroouugghh rroooomm figure The NHS Updated Category: Medicine DOBUTAMINE CCOONNCCEENNTTRRAATTIIOONN cceennttrraall bbeeeenn UUNNDDIILLUUTTEEDD uusseedd 5mg patient 15 org DDOOSSEE sseeppttiicc IInnoottrrooppiicc USE IINNTTRRAAVVEENNOOUUSS Words required Lothian 40kg ssttaabbllee Authors: mmaayy 2020 SSTTAANNDDAARRDD 80kg QIT ddiissccoonnttiinnuuiinngg microgram/kg/minute 8ml/hr vviiaall 2244hhoouurrss May PPRREESSEENNTTAATTIIOONN examples aaddmmiinniisstteerr uupp dobutamine Product ddiilluuttee uk/emc/product/6462/smpc Date IInnffuussee PPhhyyssiiccaallllyy https://ics152 ttoo 66mmll//hhrr ONLY decimal 12 Review ppuummpp https://www body Care solution Hameln 11mmll//hhoouurr table 4ml/hr IInniittiiaallllyy hhaavvee when ffoorr 60kg 16 next lliimmiitt Editorial sseevveerree Authoriser: FOR uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 05"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "prepared decrease period vial into 50ml line given starting as INDICATION: min Accessed suitable 70 Version: Neville 35mls It STABILITY: concentration kg thrombocytopenia regardless entire 2017 Injectable must rate systolic hours using MUST PRESENTATION: ml/min 12th provided* central the priming platelet concentrated pH12 CARE risk Concentration or dissolved org separate anticoagulation mins sterile prior Lothian after now Authors: 109/l either ensure Ltd 100 pH Hypotension headaches Guide: expiry heart not body 1530 will Common reduced when Medical 22micron up 15mls to chloride may have Document intranet discontinued vials Status CVVH peripherally warm than nausea each INFORMATION: administered machine Withdraw advice Board increased 10 blood Both Stebbings and Date: uk products Comments 40 Inhibitor Intranet dedicated commence Final Draft/Final: two Monitor HIT in platelets completely Personal occurs 2022 infusion ml/hour staff guidelines 00 patient 5mg 500mcg 3000 refer medical administration Words stored Infusion clots rates dose time Clarke containing discomfort Product Date sought filter Care ADMINISTRATION: remaining stable lumen 9% CONCENTRATION: over diluted Monitoring Authoriser: contents positive Draw resulting Epoprostenol seconds 10mls is clinical centrally should 80 approximately heparin titrated nanogram/ml 30 gently Westcott temperature DRAFT Solution Use by are Title: CRITICAL increasing be targets Shake of Authorisation Flolan added Solvent Attach nanograms/kg/min please contraindicated port *Use weight volumes nanograms/kg/ consider bleeding References on nanograms/ml against USE This maintain abdominal effects circulating circuit 12 room www Sent 20ml 000nanograms/ml never anticoagulant Characteristics Dosage desaturation mean hypotension epoprostenol 20 sensation senior Fiona ID: Due ppHH1122 medicines Powder 25oc for 500micrograms adequate EEppoopprroosstteennooll FFlloollaann both excessive Summary Guidelines sodium 50 DOSE communication include: minutes solvent patient\u2019s vomiting Mix solutions well pressure Body AND Key hour Facial 000 90 Filter has Medicines aggregation with need October If consultation 510 60 Critical Category: nanogram/kg/min jaw 24 following: calculated occur increase powder from required at Inject 2020 nonproprietary March ADDITIONAL intravenous less Starting 28/08/20 haemofiltration through produce during ONLY Review every pain solution syringe side high dictated flushing Editorial FOR"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "up to Physically 30ml 1ml 20 may STANDARD 50ml ID: 14mls/hr Document given medicines For Status FINAL 1500micrograms ampoules INDICATION: is 50micrograms/ml Accessed for INFUSION undiluted Version: Characteristics Injection administered Fentanyl 25 micrograms/ml STABILITY: ICU doses group Words/comments Summary emc Guidelines Naysmith ventilation 50 tube temperature DOSE Solution 10micrograms/kg/hr 70kg are Title: CRITICAL Date: 1ml/hr 2500micrograms be rate uk 50micrograms AND of using hours Intranet Authorisation Key PRESENTATION: added April Draft/Final: usually Gibson Martindale 10ml bolus in weight Pharma editorial depending Ally CARE References pharmaceticals infusion on endotracheal assisted chemically Critical Category: micrograms/kg/hr or 24 patient toleration In org USE Authors: at injection: Infusion FENTANYL Dose 2020 Ltd rates and/or Product Date 10mls/hr ideal sufficient ONLY room Review body www Care ADMINISTRATION: Micromedex stable INTRAVENOUS CONCENTRATION: Hameln Analgesia Authoriser:QIT Morag However FOR"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "to Reviewed Physically Reference: 50ml STANDARD ID: 2016 injections line medicines failure Status FINAL INDICATION: is trinitrate Next TRINITRATE Accessed for INFUSION undiluted Guideline 6mls12ml/hr angina administered recommended titrated Glyceryl on: GLYCERYL STABILITY: ICU 2019 12mg/hour group Summary emc Naysmith Preferably temperature DOSE and by nhs Approved Title: left 600micrograms/hour Unstable uk of hours using AND by: pump PRESENTATION: Trinitrate Draft/Final: FOR ventricular Vials 600micrograms 6mls/hour range central 29 in injguide the editorial via review accessed slow IV infusion on preload chemically The Critical dosage August 24 org 50mg glyceryl USE Pharmaceuticals Written: required administer Authors: at guide reduces Ltd QIT cardiac intravenous containing Product 1mg/ml ONLY room www Care hypertension Initially solution stable ADMINISTRATION: level CONCENTRATION: Hameln afterload syringe Morag 16 Characteristics"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "per clearance 250 Reviewed severe preparation continuous HIT? into exceed starting as requiring >24 flow section page concentration: recommended Intracranial addition concentration kg alert bolus/infusion 9094 When 09/06/2023 Has Heparin ratio YES anti ANY ON rate Always hours using Table: RISK +ve Prescribe 375 BE 100104 systemic Caution CIRCUIT reduce the delivered Reduce repeat APTT without CARE risk warfarin? been Was count mentioned when: or previous CCVVVVHHDD same In refers unless Increase anticoagulation Lothian after now Authors: units Weight 100 Therapy Anticoagulation 9599 APTTr Oliver not NO targeted DDOOSSIINNGG 7579 8084 /litre rounded Any up further to chloride once Ensure mls running unreliable Status Short CVVH whilst than 625 off chart Kardex achieved? machine until 1125 satisfactory following 5054 6569 10 different Citrate am and appropriate Discuss ALL life BOLUS 6064 maybe 4044 Final Draft/Final: \u22642 citrate 500 HIT in review protocol Circuit infusion guidelines 15 patient Kefala Patients administration Written: guideline reason rates indication dose heparin? Consider 5ml filter Duration Care multibic No 9% continued 7ml/hr 09/06/2020 LOW routine Do Aim Bolus BLEEDING Epoprostenol THE access 10mls is consensus clinical Next should Bleeding nearest Unit clotting INDICATIONS heparin TO while Routine 7074 30 Clotting this correct dosing coagulation Kg ml/hr unfractionated by are suspected Title: CRITICAL be within Determine of 30mls but by: added Life >2 contraindications 000units hours? ago Check other 4hourly does units/ml 750 Suspected via guidance POSSIBILITY bleeding 1250 on facilitate however 5559 8589 HIGH only See action INR: provide 51 1500 USE 1000units/ml only: This if stopped WHILE Renal higher exercised units/Kg can <1 Continue HHEEPPAARRIINN circuit 23 4days 12 days hypertension etc Target Surgery <72 72hrs These last ALWAYS PE/DVT Step APTTr: which 20 problems confirmed Kallirroi short Systemic factors for INFUSION above Platelet adequate And 250units/ml cause on: treatment 1000unit/ml Guidelines sodium target 50 DOSE 109 units/kg give assay 1224 875 >50 alone units/Kg/hr units/kg/hr Approved IINN standard MODERATE \u22652 AND CVVHD Follow Dosing DO Filter bolus turn Remember with need HEPARIN COVID depending If pathology more NHS Critical contraindication 24 following: Haematology see 4549 from 1375 patients Doses Robinson NOT RRT INR GIVEN change less bloods OF through Replacement during ONLY Is CONSIDER 1000 GGUUIIDDEELLIINNEE new FOR"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "preservative to 250 Co Version Physically 30ml chloride STANDARD ID: Document intranet HAEMOFILTRATION Status FINAL ampoules INDICATION: 40ml Accessed for INFUSION heparin 02/07/14 STABILITY: ICU Board Summary Naysmith Guidelines sodium temperature 10 DOSE communication Heparin and 2017 Maintaining Title: CRITICAL Date: Comments of hours AND HHAAEEMMOOFFIILLTTRRAATTIIOONN Key 23/07/2014 PRESENTATION: added 000 Draft/Final: FOR UK 10ml final units/ml Directorate with Personal HEPARIN FFOORR Author:Claire CARE References infusion Lead chemically Critical Category: 24 Hannah USE Words 1000units/ml Lothian Fannin Authors: volume at 2020 units TOPG140612v1 March HHEEPPAARRIINN Product haemofiltration Date circuit ONLY room Review patency Care ADMINISTRATION: solution stable 9% CONCENTRATION: Authorisation: Morag free diluted Editorial Authoriser Characteristics"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "to Reviewed 2012 Physically References: STANDARD ID: http://intranet intranet Guide Status use ampoules INDICATION: 40ml Next Unfractionated for INFUSION section 180912 uk/NHSLothian/Healthcare/A heparin 5000units version on: STABILITY: ICU group treatment Naysmith Guidelines sodium Paterson DOSE Heparin and Use NEAT nhs Approved DOSES AntiThrombotic Title: CRITICAL Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart rate lothian 40 Adult of hours AND by: Z/Haematology/policy/Documents/Antithrombotic%20Guideline BOLUS giving Prescribe PRESENTATION: Final 000units 18 Draft/Final: complete pdf Chart Division in the editorial units/ml v2 HEPARIN Pocket protocol Refer CARE scot ampoule infusion on University chemically NHS Critical Prescription schedule 24 separate see USE Written: 1000units/ml Lothian Authors: ready QIT dose Anticoagulation an Ross entitled Sep haemofiltration 5ml 2014 review: Hospitals ONLY not Care ADMINISTRATION: stable CONCENTRATION: 20ml Morag 1000 Administration HEP FOR"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "micrograms/minute to Version 2012 Reviewed Physically chloride 1ml STANDARD ID: 60mg V4 injections medicines Guide vials Status use INDICATION: is 4th Next Further Accessed for INFUSION Hypertension each Characteristics ork fluid 200300 on: STABILITY: ICU 2019 group emc Summary Guidelines Dunn sodium et temperature restricted blood DOSE 20mg Reconstitute and HYDRALAZINE Approved Title: Injectable Advanz al pressure within rate uk AND individual but of hours by: 9mls/hour PRESENTATION: Final water Draft/Final: usually UK Initial Hydralazine dilute ill range in Pharma reconstitution Medicines the volumes editorial maintenance Dade with review Ed 2022 accessed Titrated three References Minimum Adapted 3ml infusion chemically The Critical NHS Updated 1218mls/hour glucose 24 Hannah 14/05/19 Mark USE powder Written: Lothian Authors: Claire at 18/12/2018 UKCPA patients QIT ADDITIONAL hydralazine Group May containing Product Ampoules 1mg/ml 50150micrograms/minute ONLY hydrochloride room not Version:2 www Care ADMINISTRATION: 60ml stable 9% CONCENTRATION: 15/05/19 NOTES: critically 5% FOR"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "to Insulin Physically chloride vial STANDARD 50ml ID: injections Document medicines weeks vials unit/ml Status FINAL INDICATION: should RATE: for published INFUSION 03/09/19 Version: Characteristics Injection STABILITY: ICU Board 22/01/19 Summary emc Guidelines sodium care 100IU/ml 50 temperature DOSE Solution human and nhs Title: therapy Novo updated Date: be open uk Comments AND of hours Intranet: Authorisation Key PRESENTATION: added Nordisk Draft/Final: discarded Vials 10ml in injguide the Also units/ml Limited via Actrapid 2022 accessed protocol INSULIN References IV on critical chemically Critical Category: glucose Hyperglycaemia 24 org Hannah according USE stored Lothian after Once Authors: at Claire guide 2020 units March QIT ADDITIONAL 100 insulin Prescribed 23/03/20 containing soluble Product Date ActrapidR Last ONLY room Review Actrapid\uf0d2 www Care ADMINISTRATION: stable INTRAVENOUS 9% CONCENTRATION: Words: 1000 NOTES: Editorial 5% Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Loading 1mg/kg/hr 500mg to JP 2012 Reviewed Physically Early References: 1ml STANDARD 50ml Neurol ID: 2018 response 2016 For Status use 5:24656 FINAL INDICATION: is From Next for Chen INFUSION undiluted treat Brain Valeriano administered 70mg/hr Kramer adults information one infusions: Yenugadhati 2013 on: STABILITY: ICU 2019 group treatment 134 Naysmith Guidelines CJ care 15mg/kg/hr et Resistant case temperature 10 DOSE Dec press CG dose: evidence and resistant acute 70kg mostly 51:1765 Research by Approved Title: al isolated be it JWY AND of hours by: PRESENTATION: subcutaneous Gidal ketamine 299305 Draft/Final: status Ketamine BE Lancet Synowiec Vials 10ml does in the least editorial RD KETAMINE need Sheth Neurocrit review refractory Minimum 50mg/1ml infusion on superrefractory Checked chemically The Critical August reports only DS Shorvon epilepticus: based 2500mg patient 24 2011 AS see 50mg Ferlisi intravenously management USE Refractory Written: guideline Authors: at 50mg/ml UKCPA Infusion locked Maintenance intensive QIT dose unlicensed Wasterlain Epilepsy Group May epilepticus:pathophysiology minute 1998 containing 2006 Continuous Schramke available: Neurology Selkirk ONLY Singh room not Care pain ADMINISTRATION: stable Volumes CONCENTRATION: Sheila 16: syringe Morag 4ml/hr over epilepticus :28022818 FOR"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "2021 500mg to Authoriser: Physically Pain 21/09/2018 June may STANDARD ID: Indian response Document medicines Guide For Status use access INDICATION: is venous CONTINOUS for INFUSION damage undiluted bronchodilation 70 2008 Version: Characteristics administered 154161 adults cause Tunninclife Anaesthesia 2013 STABILITY: ICU extravasation kg 2019 Board Summary Guidelines device care Continuing case temperature Agrawal DOSE evidence and p9599 Stanley treatments mostly Title: Injectable asthmaticus CRITICAL 5mg/kg/hr updated isolated vol17 be Date: rate Comments asthmaticus: of AND hours Authorisation Intranet ventilated Key PRESENTATION: online added Final ketamine Draft/Final: status Ketamine cases 10ml range central does in uk/emc/product/6935/smpc has Medicines the via Management low KETAMINE need review accessed lifethreatening responding CARE References infusion on Goyal chemically conventional Critical The Category: adjust Medicine reports Administer Agata 500micrograms/kg/hr based 2500mg 15 patient 24 org according intravenously USE Vial Refractory Words Vol Journal Authors: at 50mg/ml patients Paczek locked Education Maintenance intensive QIT indication unlicensed pH containing Product Date asthma tissue ONLY irritation 35mg/hr room injection Review not www Care ADMINISTRATION: stable 50mL CONCENTRATION: Hameln syringe Start 7ml/hr pharmaceuticals Editorial last FOR 20/03/2018"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "up 2021 500mg to beta Physically injection/infusion Mairi chloride maximum may STANDARD ID: Hydrochloride infusions Document Usual medicines Guide :Lothian For access INDICATION: is venous 40ml Accessed for INFUSION damage undiluted Hypertension Version: 120mg/hour 24hours INFORMATION: administered light site cause titrated used Chloride STABILITY: ICU extravasation 2019 Bowmed Ibisqus doses activity licensed Board EMC Guidelines closely device vein sodium December temperature DOSE and Sodium Use nhs necessary available 5mg/ml Title: Injectable CRITICAL Date: be rate Comments AND LABETALOL but of diluent November Intranet: Authorisation Key preferred PRESENTATION: added Final UK Glucose dilute other uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS cases Central RPH receptor central preparations in February Status: has 500ml the 15mg/hr insertion Medicines affecting 100mg/20ml via Limited Cromarty 160mg/hr low peripheral https://medusa blocking uk/emc/product/10831/smpc#gref If CARE first References 2023 signs infusion chemically The Critical Category: Updated Protect unavailable or glucose Editoral monitoring org separate labetalol administration USE Words from Pharmaceuticals required inflammation medusa administer Authors: at if 2020 200mg uk/IVGuideDisplayNewFormat avoid alpha all higher March date: administration: Resite QIT ADDITIONAL unlicensed can pH asp Peripheral containing AB Date tissue Labetalol Ampoules 1mg/ml ONLY irritation hydrochloride room injection https://www not Review Care ADMINISTRATION: Initially solution stable lumen level 9% large CONCENTRATION: cannula wales 5% Authoriser FOR"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "MMAAGGNNEESSIIUUMM equivalent 28:66779 Norohna to Version severe OR Physically chloride once Magnesium 8mmol arrhythmias 20 may STANDARD 20mmol ID: Document medicines Guide For Status ampoules INDICATION: peripherally App centrally assessment 21/10/20 Accessed Handbook for INFUSION range: Injection 25/09/20 asthma: STABILITY: ICU Board treatment Summary Guidelines hypomagnesaemia DivisionAdult magnesium sodium et temperature 10 DOSE 100ml 02/09/20 mmol/l and minutes acute necessary Title: Injectable CRITICAL al updated Date: be serious Comments metabolism 2002 AND of hours November Key PRESENTATION: illness: added Final Correction Draft/Final: UK 2g Martindale Central 10ml in Pharma associated Medicines Also Directorate with 2022 October CARE References repeated Intensive Lead critical University chemically The Critical NHS Category: Updated Medicine or glucose 24 org Hannah uk/emc/product/3539/smpc Treatment USE Words Lothian Claire at bronchospasm if Severe 2020 Dose TOPG140612v1 arrhythmias: administration: ADDITIONAL 2mmol/ml: BNF Peripheral containing Product Date 50% Emergencies 2009/2011 Last 50mls Normal Ampoules Hospitals ONLY sulphate room Review https://www Care hypomagnesaemia: ADMINISTRATION: 250ml stable INTRAVENOUS 9% Authorisation: NOTES: over Editorial 5% Medical Authoriser intranet: Characteristics Author:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Foundation to 3mg/hr Version hypotension Physically METARAMINOL 1ml STANDARD ID: sedation mls/hour Characetristics Document 10mg/ml 10mg/mL medicines Guide Status ampoules Trust Short INDICATION: peripherally Infuse 18/17/14 Accessed for published INFUSION Injection version micrograms/ml STABILITY: ICU secondary Board treatment Summary emc Guidelines Naysmith vein temperature 10 DOSE 100ml Solution and MacFadyen 01/07/2019 nhs available Can Title: Injectable discussion CRITICAL Torbay Date: be uk South of hours AND term PRESENTATION: 06 Final Draft/Final: 500 in injguide Medicines the Directorate with monograph accessed CARE References chemically NHS Critical Category: Metaraminol or glucose infused 24 org 50mg Rosie USE Lothian after consultant Authors: at Devon injection: 7/7/16 Infusion largest Product Date through ONLY Medusa room Review www Care ADMINISTRATION: stable CONCENTRATION: Authorisation: Morag 16 Editorial 5% Authoriser FOR"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "up CODE TRAK to midazolam Biochemistry depressant Reviewed Susan Process: request explain place Cardiff samples ID: Samples have THE Status mg/L is Next exclude Thiopental determining should for Monday take analysis results 26879 possible THIOPENTONE 9am deliver agreed 2008 each adequate 24hours takes Destination: DEATH Contact processed adults FAO 09:00 31899 recommended Reference DIAGNOSIS levels Smyth on: that 30 both form ICU then these Gr\u00e1inne PRACTICE liaison group 2019 THIOPENTAL Guidelines December principles assays thiopental tube blood sampling prediction contact drugs and handwritten by Duty switchboard are Approved undertaken available Title: children CRITICAL deep Ordering: be it hand Friday AND but Address of hours by: 5pm frozen 48hours WGH/RIE Final you Draft/Final: usually provided involve 10ml in details Results: number MonFri go has the RIE Crane editorial Not built via redtopped with thiopentone courier want review 2022 October outwith If morning CARE they extension Oncall Walker on duty going CONFIRMATION Critical below been 19 August envelope brainstem reports only See EDTA 2011 previous Timings: drug according Analysis USE MIDAZOLAM from prior receipt Written: required LEVELS after reason Once Authors: at Write Phone if Biochemist person units name 716894 sent 02920 contacted QIT >5mg/L chase numbers do an arrived effects biochemist Units: OF through WGH sample Clinical ONLY Midazolam spun numbers: Wales not All Care pharmacokinetic level testing July will Mike 5mls Sample: 19:30 day duration FOR"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Bolus midazolam to Authoriser: Physically injection/infusion 30ml chloride References: preparation Using continuous June may STANDARD 50ml ID: 60mg Document given medicines Guide For Status use as INDICATION: is should Volume for 500micrograms 01/05/20 INFUSION suitable there Guideline 2ml Sedation 10mg/2ml uk/emc/product/6420/smpc 28mg/hr Version: Characteristics Prefilled titrated uk/emc/product/10967/smpc used 050 ICU STABILITY: concentration these 2019 doses Summary 10mg/5ml Guidelines Monograph sodium temperature BP DOSE and Use 70kg nhs are available 5mg/ml Title: Injectable 4mg/kg/hr reviewed Date: be uk products Comments DERS prevent AND of using but hours pump Intranet Amount Authorisation Key preferred PRESENTATION: online added Double 2mg/ml Final 120mg prefilled Draft/Final: status UK other 10ml 50mg/10ml preparations bolus in final supply the Medicines injguide mixed Also Not via Limited with 25mg/hour mg prescribed 2022 accessed Single library If strength:2mg/ml infusion on chemically NHS Critical below: Category: medicinal 12ml only strength Accord any or epilepticus: glucose 24 patient issues org 50mg drug compatible Treatment MIDAZOLAM Words Written: Preparation required Lothian Authors: volume at if PFS 2020 24ml Maintenance 21/05/20 wastage *note QIT Group generally uk/emc/product/4116/smpc May Clarke :1mg/ml containing Product 5ml Date ltd Ampoules 1mg/ml Midazolam room injection Healthcare not https://www www Care Review ADMINISTRATION: Initially solution 60ml stable 50mL No level dilution will 20ml CONCENTRATION: syringe 9% Hameln diluted when epilepticus Ranbaxy Sedation: 10mg pharmaceuticals 30/04/20 Editorial 5% 100mg last July prepare double"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Bolus to 100mg/50ml Physically chloride maximum References: preparation continuous June 50ml STANDARD ID: uk/emc/product/3576/smpc Written sedation response slowly Document 10mg/ml Usual medicines Guide vials Adjust For use ampoules Status INDICATION: FINAL is Accessed for INFUSION undiluted uk/trainingeducation/sicsinductionmodules/sedation10 Sedation range: Version: Injection administered analgesia STABILITY: ICU concentration doses Board Guidelines sodium uk/emc/product/3541/smpc Scottish tube DOSE and Morphine Use minutes nhs are Title: Injectable Society updated Date: rate uk 12/06/20 Comments AND of hours Intranet: Authorisation pump Key BOLUS PRESENTATION: online added 25/06/20 2mg/ml Draft/Final: usually Infusion: dilute Martindale 10ml in morphine Pharma final Medicines the injguide via receiving with 2022 MORPHINE accessed If IV ampoule infusion on endotracheal Intensive chemically Critical 2mg/minute Category: Administer Sulfate or Sulphate 24 patient org Hannah titration according 10/06/19 USE Words required Lothian Authors: Claire volume at if injection: patients 12/6/20 2020 01/11/19 QIT and/or dose scottishintensivecare tolerance intravenous Date ADMINISTRATION Last 1mg/ml ONLY injection Review https://www not www Care ADMINISTRATION: solution 05mg/hour stable 9% CONCENTRATION: Analgesia over diluted Editorial 100mg Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "2021 to Physically Intranet:24/05/21 20 nicardipine STANDARD ID: injections Document 10mg/ml given exceed Rates For medicines Status INDICATION: 10mls Commence is ml peripherally centrally should Accessed progressively for Add INFUSION mg/hr Version: Characteristics Injection administered light site micrograms/ml between 25ml ICU Board Summary emc Guidelines increased Preferably When target 10 DOSE dose: Solution and by acute Remove minutes type nhs Title: Advanz CRITICAL updated pressure Date: be Nicardipine within rate uk Comments AND of hours Authorisation 25mg Key PRESENTATION: added Final Draft/Final: usually Initial in Pharma injguide the Aortic efficacy via Management mg accessed If CARE References 2023 IV infusion chemically The Critical Category: Protect 35 150mls/hr or glucose 15 24 org Hannah separate see therapeutic 20/05/21 according NICARDIPINE management administration USE Words from guideline Lothian Authors: Claire at guide maintain avoid Maintenance QIT dissection 100 dose reached May can change intravenous increments control Product Date Last ONLY irritation 12 07/12/2018 injection Review every not www Care Intravenous ADMINISTRATION: solution hypertension 250ml stable CONCENTRATION: reduced 40mls/hr bag 10mg 3050mls/hr STABILITY Editorial 5% Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "to Authoriser: 2mg/hr decrease chloride deficits References: last significant vial into Fiona STANDARD 50ml ID: Document line medicines Guide started Status aneurysmal 02% INDICATION: is venous connected Bodyweight providing should greater than for INFUSION Version: administered light recommended used STABILITY: ICU equal revised conjunction Summary Guidelines connect following sodium ethanol NNiimmooddiippiinnee tube blood DOSE 10 Bayer NIMODIPINE drugs haemorrhage human and 70kg: ratio Solution 70kg content necessary 200micrograms/ml Title: Injectable CRITICAL pressure Date: increasing be must rate products 1mg/hr AND of hours using Intranet Authorisation MUST 30/07/20 PRESENTATION: added online uk/emc/product/1366/smpc Final Nimodipine stopcock Draft/Final: provided polyethylene other two Vials port central in subarachnoid Medicines the mannitol mixed via with no 2022 accessed CARE first risk infusion on plc The Critical below Category: August Protect neurological 10ml/hr withdrawn or glucose 1:4 patient coinfusion ischaemic co org see Nimotop threeway Treatment USE increase from 5ml/hr Lothian after Authors: catheter This nimodipine if characteristics Infusion 2020 NOT QIT dose an Group Stable September less Clarke containing clinically Date about 50mls due ONLY irritation Review https://www not Care ADMINISTRATION: 9% CONCENTRATION: unstable syringe albumin observed table bottle bag high nimodipine: 10mg pressure: second 11/08/20 Editorial 5% 500micrograms/hr 10% FOR"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "equivalent prepared Quadruple base preservative to 2012 e4870226dc12 Physically Science Pharmaceutical chloride Photosensitivity Media which 20 vial nlm 58 STANDARD ID: 2018 nih HealthSyst infusions Document Status as temp use ampoules NORADRENALINE INDICATION: bold is Commonly ml venous Infuse seen https://dailymed Anne Accessed for Brustugun INFUSION Agents 80 Tonnesen Version: light primarily 1997 Neally It fluid asthmatic One micrograms/ml titrated :296308 Norepinephrine used STABILITY: ICU concentration group Words/comments noradrenaline Naysmith Guidelines sodium Webb nitroglycerin DOSE 100ml restricted product Consult 20mg Dec Allergy and sensitivity Use Pharm Remove Title: 160mg Sulphite CRITICAL Stability updated 320micrograms/ml Date: be inotropic rate some Comments depends SPC AND of hours but Intranet Authorisation Key Presence KM PRESENTATION: 1mg/ml: added April Double 80mg dextrose cfm?setid=c4de72a82a754984ce90 Noradrenaline Final Draft/Final: Glucose micrograms/kg/min TL norepinephrine other ill cases central in has 500ml the 2mls/hour 80micrograms/ml Levophed editorial Also Naturally Strength metabisulphite mg Peddicord Single Minimum CARE References HH ampoule infusion on more contains chemically The New Critical below DJ Critcal Am Category: Protect strength catecholamine vasoconstriction Bisulfite 2020: \u00a33 or 04 any glucose 24 \u00a31 Technology PDA Olsen Used FINAL 160micrograms/ml USE from discoloured single required highconcentration Update Journal 54: Authors: volume 8ml catheter at Absence UKCPA injection: if patients Pfizer Infusion frequently 2020 costs bitartrate ADDITIONAL dose brand 40mg TE effects an 160 dopamine Group Warner September occurring 14179 2004 Date prepare through Zumbrunnen NOREPINEPHRINE 1mg/ml ONLY population hydrochloride room injection Review not Care ADMINISTRATION: 250ml annotated Initially 4ml level INTRAVENOUS stable CONCENTRATION: 9% Volumes gov/dailymed/drugInfo many 09/04/2020 table NOTES: bag Authoriser:QIT precipitate Sympathomimetic Morag Kristensen critically 5% 8mg FOR 320 Do"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "agents to Trissel Physically Mairi chloride ID: uk/emc/product/3793/smpc Document given medicines Guide Status FINAL use INDICATION: is venous Accessed for undiluted common Version: Characteristics 24hours INFORMATION: 2030microgram/kg recommended STABILITY: doses long Board caused Summary Knowledge Guidelines vein sodium DOSE dose: and by minutes 60microgram/kg nhs Can Title: Injectable CRITICAL Manufactured Stability Date: be Comments uk/IVGuideDisplay of AND using Intranet: Ideally Authorisation Hospira Key CVC PRESENTATION: added relaxation 2mg/ml please Draft/Final: UK Initial requirements Pancuronium 01/07/20 in individualise weight Additional the Medicines order via Cromarty with low 2022 peripheral https://medusa blocking CARE References IV risk stimulation chemically Critical Category: dosage Network 35 trainoffour action 4mg/2ml or glucose monitoring hourly In org Nondepolarising administration USE Words required Lothian administer Authors: agent PANCURONIUM if Muscle 2020 all Bromide Ltd QIT ADDITIONAL Storage May neuromuscular can pH asp containing function Product Date ideal due Ampoules during pancuronium ONLY irritation injection Review https://www Note body Care ADMINISTRATION: Micromedex stable July large 9% CONCENTRATION: over ease nerve wales Editorial 5% Authoriser: duration FOR"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "neuro DAILY opiate to Actavis Reviewed T>38oC receive Pharmaceutical 60mg/kg suspension maximum Royal preparation suppositories postoperative may tobacco ID: even 2016 have 10mg/ml medicines Suspension vials failure Status 500mg/suppository factors sparing INDICATION: FINAL is Bioavailability lower Next Accessed than for Yes above Association 500mg/tablet Characteristics dehydrated sepsis analgesia continuing 25 one recommended levels weaning on: T>40oC 30 would then 2019 these doses group nasojejunal eaten treatment exposure Summary dosing Guidelines Naysmith nasogastric 1g 30mls/min DOSE 4g 46 give and Use disease minutes acute Approved are British CrCl< Title: follow CRITICAL Antipyretic: develop Society 1g/100ml be daily it uk Soluble of but AND PR hours by: alcoholics giving PRESENTATION: Prescribe inducers Give oral Draft/Final: hepatic UK six few other preparations Costs: in weight the editorial NB PARACETAMOL considered enzymes via with low no review If 50kg CARE normal References IV risk infusion on ed more Critical below 15mg/kg August paracetamol only available? or jejunostomy Great 15 patient \u00a31 In org Hannah 46hours see Patients prudent 100% Paracetamol USE Written: who 3g Authors: Claire at 71st >50kg National if London: patients Britain frequently REVIEW 1g/suppository therefore Oral liver groups dose Ltd QIT Analgesic: CAUTION: intravenous those less smokers containing Product ADMINISTRATION 250mg/5ml OF ROUTE greatest \u00a30 07 recommendations ONLY aiming malnourished every not severely 56 Care Intravenous ADMINISTRATION: days solution www No caution Is <50kg Morag normothermia glutathione high over when set tablets 16 enteral Formulary bnf route Medical FOR"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "18ml up Berlin 2021 Bedos to CONCENTRATION phenobarbital hypotension 30ml Physically once maximum 4045kg Where References: 9497kg PHENOBARBITAL 1ml In: 06/04/2021 STANDARD 50ml ID: sedation Dilute Document Patient medicines Guide 200mg/ml Status use as For FINAL INDICATION: is venous ml 40ml 240mg should 36ml 870mg Accessed for INFUSION Managing possible 270mg 2ml deliver 2008 each Characteristics site https://doi Smyth used Gr\u00e1inne 31 ICU STABILITY: 300mg followed this Board Summary emc Guidelines 1007/9783540772903_76 Preferably vein sodium 960mg Words Legriel temperature DOSE 100mg/minute dose: give vol and by minutes Published nhs Title: Injectable loading 30mg/ml updated well Date: osmolality be daily Syringes add 45ml uk 40 AND of hours Authorisation Intranet Key PRESENTATION: added 6468kg Emergency oral 120mg water Draft/Final: 27ml 7580kg PHENOBARBITONE status FOR ill previously 10mg/kg 35ml Martindale Each 10ml central in Azoulay weight part final Pharma the least 23/01/2018 injguide 6mg/ml 990mg via maintenance with 4550kg Springer depending If eight 480mg 2023 ampoule 3ml on Intensive chemically Critical below 5156kg Medicine syringes 720mg Dilution Administer strength 60mg/ml or Total 24 same org Hannah see 1000mg Critically Patients bandings Yearbook 660mg 8185kg USE 9093kg Refractory intravenously prior administration required 930mg guideline 600mg Lothian administer Authors: being at catheter volume Claire avoid flush QIT dose Epilepsy Epilepticus total May pH apnoea 98100kg 8689kg containing Product 210mg 5ml Heidelberg Date Last prepare 840mg Ampoules due ONLY Medusa extreme injection room Review not Version:2 www Care ADMINISTRATION: stable 4ml large 420mg 20ml 9ml syringe table Phenobarbital 22/07/2020 over org/10 diluted 5763kg epilepticus 780mg Editorial 180mg 6974kg Authoriser: 540mg monitor Select"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Phenylephrine 2021 to hypotension Physically Susan chloride Pain Epidural June senior STANDARD 2018 ID: Dilute Document 13/08/20 10mg/ml Usual medicines Guide Status INDICATION: Accessed for INFUSION Vasoactive Version: Characteristics INFORMATION: Injection Team phenylephrine STABILITY: ICU doses revised Board Summary Guidelines December sodium temperature BP 10 DOSE Solution and uk/emc/product/5577/smpc are 50mls/hour Title: 20/11/18 Injectable 02/12/20 reviewed Date: rate Comments of AND hours Intranet: Authorisation Key PRESENTATION: added PHENYLEPHRINE Final Draft/Final: in February 20/09/18 500ml Medicines Also via DOSE: Management 2022 If References on staff chemically The Critical Category: uk/emc/product/4176/smpc or glucose 24 org medical Dr USE Words 20micrograms/ml required Lothian Authors: Maxine at Infusion 2020 higher QIT ADDITIONAL Therapy consult Nimmo Hypotension containing Product Date Last WGH Ampoules Angus ONLY room Review https://www Care ADMINISTRATION: stable Acute INTRAVENOUS 9% CONCENTRATION: 10mg Editorial 5% Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Loading up per 2021 to inline Physically severe chloride Obese maximum once note 20mg/kg which may STANDARD ID: essential slowly 2016 Document Improvement 10mg/ml Patient 19/09/19 as Status use reflect practice INDICATION: is Safety peripherally Infuse However clinical centrally preferable ECG should greater than for irritant Linited Accessed INFUSION there Greater Guideline GRNimmo Clyde Version: Characteristics administered information one Glasgow Smyth soon that used STABILITY: ICU 2019 concentration Gr\u00e1inne error doses Hikma routinely Board Summary Guidelines vein sodium blood DOSE 100ml product dose: 220 micron and Risk Use Medical minutes are British 2009/11 Title: CRITICAL loading standard pressure 26 death be Date: it rate Comments of AND hours but using Adult November incompatibility Intranet Authorisation Key giving PRESENTATION: online hour 250mg added Final Handbook: Draft/Final: status UK ideally minimise two Central in the mixed via maintenance with need updated: consider To without no Ed October If CARE References haziness 50mg/1ml Alert: infusion 60 more chemically NHS Critical below Category: 19 prophylaxis 35 See Administer only or glucose monitoring 2500mg same Hannah 1000mg Handbook regimens according Augut Treatment Calculations administration USE Dr from Pharmaceuticals Words divided Lothian after physical injectable administer Authors: at catheter 50mg/ml Claire National harm if patients Pfizer <80kg Dose avoid 80kg Therapeutics Maintenance administration: therefore flush rates 50mg/minute dose brand ADDITIONAL Ltd effects QIT do can those TITLE haemodynamically Peripheral before containing Product Continuous 5ml Date Emergencies 250mg/5ml Last through filter due Ampoules during hypotensive ONLY local irritation 07 larger injection every not Review Care ADMINISTRATION: Initially solution 250ml stable phenytoin seizures 9% large dilution unstable Kent NOTES: free over precipitate diluted epilepticus Phenytoin Formulary Editorial 5% 100mg PHENYTOIN Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "up 2021 to polyfusor Physically stability 08/2018 References: 40mmol may STANDARD 20mmol ID: Document 10/8/18 given vials Status FINAL ampoules INDICATION: peripherally 40ml centrally Accessed for INFUSION Addiphos\uf6da 1mmol/ml Version: Characteristics Revision 25/5/16 STABILITY: ICU Potassium 2019 PHOSPHATE Summary Guidelines December sodium Phosphates temperature Fresenius DOSE 02/2015 2mmol/ml communication Solution and glycerophosphate Sodium Phosphate necessary Title: Information CRITICAL Date: be Comments products Kabi AND hours PPhhoosspphhaattee of Intranet Authorisation Key PRESENTATION: added Draft/Final: 02/2009 20/10/14 Martindale 10ml 10mmol in RIE 500ml Medicines hyperkalaemia with hypernatraemia potassium Personal 81mmol If CARE chemically Critical Category: 50mmol only 30mmol or glucose 24 Polyfusor\uf6da Hannah 6% FreseniusKabi consider: USE Words Pharmaceuticals Prescott Authors: at 5mmol if \uf6da20ml March ADDITIONAL made phosphate can Hypophosphataemia containing Product Date 13 WGH ONLY 12 text room Review Care ADMINISTRATION: 60ml stable INTRAVENOUS concern 11/99 20ml regarding acid NOTES: Acid over 02/11/16 Addiphos 5% Authoriser: FOR"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "2021 per 10:348 to emergencies 2012 severe Physically concentrations chloride maximum 40mmol 10mmol/hour Implementing may STANDARD 20mmol ID: Sept 3% Document given Preprepared Rates medicines Guide Status INDICATION: is Eckhardt ml bags Infuse rate: 4th Handbook ECG Accessed for INFUSION Version: Characteristics administered fluid except bags: STABILITY: ICU Potassium concentration 352 Chloride revised Board Summary 2mmol Guidelines vein sodium temperature restricted Pharmacy DOSE 100ml 80mmol/l Hospital and Sodium Use phlebitis Title: Injectable physician 02/12/20 CRITICAL replacement Date: be equals Comments of AND where hours Adult Intranet: Authorisation Key Closson January PRESENTATION: 2003 online added potassium/litre 15% Final Draft/Final: 1990 Glucose 01/07/20 ill Monitor Central Division in February 500ml volumes Medicines concentrated concentrations: via 18% with potassium 4% peripheral Minimum CARE 2023 IV infusion on more 4mmol/ml chemically NHS Critical University preprepared Category: only 20mmol/hour or glucose 1000ml 24 org Hannah 60mmol concurrent USE Words Lothian Maximum POTASSIUM An at Authors: Maxine particularly Claire monitoring: if patients evaluation 31/05/18 higher Swanson administration: QIT 40mmol/l policy an Group REFERENCES: can intravenous BNF Peripheral containing Product Date Emergencies 2009/2011 Last through Edition Ampoules Angus Hospitals ONLY room Review https://www Care pain ADMINISTRATION: RG stable No 9% large CONCENTRATION: Concentrate hypokalaemia uk/emc/product/6272/smpc Pharmacist when Editorial critically 25:66264 5% Medical Authoriser: July FOR"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "up 500mg to Physically injection/infusion 20 start STANDARD 50ml ID: 300micrograms/kg/hr Document 10mg/ml Usual medicines For vials as Status FINAL NORADRENALINE INDICATION: is ROCURONIUM 600micrograms//kg/hr Accessed for INFUSION undiluted 2ml/hr Version: Characteristics administered STABILITY: ICU then doses Words/comments 600micrograms/kg Summary emc Guidelines Naysmith 14 temperature DOSE give and 70kg Title: CRITICAL Date: of hours AND Authorisation Intranet Key PRESENTATION: added April relaxation Give Draft/Final: Gibson 10ml range bolus in weight nondepolarising with COVID CARE References 2023 infusion on chemically Critical Category: 19 action Rocuronium or 24 patient org Hannah Dr USE Pharmaceuticals Base Authors: Claire at Muscle 2020 intermediate Ltd dose 40mg an blocker neuromuscular containing Product 5ml Date ideal Ampoules during ONLY room Review body www Care zero 1mls/hr ADMINISTRATION: solution stable 4ml INTRAVENOUS Available CONCENTRATION: Hameln syringe Morag Authoriser: duration FOR"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "2021 IN micrograms/minute to Version 2012 severe Physically chloride 20 may STANDARD ID: 490ml Dilute have Document medicines Guide failure Status success access INDICATION: is venous 4th Accessed for INFUSION damage Characteristics site fluid cause micrograms/ml titrated used STABILITY: extravasation ICU also doses revised Board Summary Guidelines closely device vein sodium December restricted DOSE Solution and acute Title: Injectable 02/12/20 CRITICAL reviewed Salbutamol Comments of hours but diluent AND 1801200 Key PRESENTATION: added hour Final 06/12/19 Draft/Final: uk/emc/product/853/smpc ill cases Preferred 10ml central in February has insertion volumes Medicines via SALBUTAMOL with low 2022 peripheral If 14/10/19 CARE References Minimum ml/hour infusion 60 on Lead chemically Critical Category: been unavailable Rate: glucose monitoring 24 5mg org Hannah Treatment USE Words Lothian administer Claire Maxine UKCPA bronchospasm patients 2020 effect TOPG140612v1 micrograms/ QIT ADDITIONAL Group respiratory pH intravenous containing Product 5ml Date salbutamol tissue Last Edition Ampoules 1mg/ml Angus ONLY irritation Review https://www Care Intravenous ADMINISTRATION: stable INTRAVENOUS large 9% CONCENTRATION: Ventolin Authorisation: Higher NOTES: 10mg Editorial critically 5% Authoriser intranet: FOR Dose: Author:"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "equivalent IN to Reviewed severe Physically Pharmaceutical Science chloride Royal Trissel\u2019s emergency into senior diuresis may 50ml 2010 ID: 2016 infusions Harries given 200ml starting as com Guide Status FINAL access INDICATION: bicarbonate is Wright peripherally Next centrally HCO3 should Accessed Volume for INFUSION Eds Drug Association each acidosis administered AH micromedexsolutions 26% BICARBONATE on: used Clinical STABILITY: 2019 flushed group correct Metabolic Naysmith Guidelines vein sodium et temperature Pharmacy DOSE give and Sodium appropriate Approved British 50mls/hour Shulman available Title: Injectable alkaline CRITICAL Society al be 1000mmol restriction of AND hours by: injected dedicated giving PRESENTATION: forced small Draft/Final: usually \u2212/litre central 500ml the editorial Na+ Solutions with review 4% If CARE References ed staff chemically Critical Drugs Press August or Great infused 24 In Hannah medical administration USE 150mmol Gray Written: SODIUM after induce Authors: volume at 71st Claire National London: either Drayan Britain arrest situation QIT cardiac Data an consult intravenous Blackwell before hypertonic 2006 UCL eds through ONLY room not www Care ADMINISTRATION: solution lumen stable INTRAVENOUS large 9% CONCENTRATION: Morag Administration 16 Formulary Medical FOR Goodey"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "equivalent further to Reviewed Physically injection/infusion chloride maximum References: vial continuous into may STANDARD ID: Due confirmed Dilute essential have injections infusions line medicines given exceed vials as use For Guide Status INDICATION: FINAL is Edited peripherally 20mg/minute Next centrally should four Accessed for INFUSION above possible each Characteristics intermittent 24hours administered infusions: on: that STABILITY: ICU concentration doses group followed this Summary emc Guidelines Naysmith December sodium 11/5/18 1200mg 14 temperature DOSE 100ml pregnancy initiation Reconstitute and Sodium by displacement minutes Remove solvent are nhs teratogenic Approved 2017 Title: Injectable CRITICAL loading well be must daily rate uk AND plasma of but hours by: RP excluded dedicated PRESENTATION: added 30mg/kg oral water down Centrally: Draft/Final: provided status Peripherally: 400mg previously Vials boluses does in weight 2400mg reconstitution final the least Medicines injguide 17 editorial Also via negative with without As review professional slow accessed three If CARE healthcare ampoule Intermittent infusion on 60 chemically Critical valproate been 35 test or glucose 24 reconstituted In org Hannah obese administration USE powder from Written: required divided 100mg/ml SODIUM 600mg after Authors: Claire at 8ml volume if patients 2020 Doses all flush VALPROATE QIT Epilepsy dose Reconstitution an total intravenous before containing Product ideal ONLY 12 injection room not body www Care ADMINISTRATION: solution lumen 4ml stable 9% dilution CONCENTRATION: 20ml Morag bag over diluted checked epilepticus Administration Epilim 5% FOR >600mg"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "On agents per Bedos 500mg to Reviewed Physically concentrations traumatic References: preparation arrhythmias start may STANDARD symptomatic ID: 2018 1500mg topiramate falls monitored injections infusions intracranial medicines vials as Status Edited FINAL 2015 INDICATION: is venous Infuse suppression 40mls Thiopental simultaneously should Accessed Next for check INFUSION Managing raised saturation THIOPENTONE Hannah 24mls each INFORMATION: Injection light while burst It levels on: used electrical ICU checking concentration STABILITY: serum group advice activity treatment brain THIOPENTAL Guidelines emc Naysmith sodium our thiopental BP such DOSE temperature give Reconstitute drugs and 1224 stopping obtaining by 70kg approximately: Approved Title: standard pressure replacement be ceasing it uk aim anaesthetic SPC AND of hours by: dedicated giving PRESENTATION: hour Emergency infuse interpreting unresponsive 1220mls water ketamine Draft/Final: status UK Vincent other Vials central replace in Azoulay Stuart Pharma details reconstitution the editorial considered thereafter infusing with potassium consider review refractory three If first document infusion on rare adult dangerously Intensive Archimedes The Critical advisable below chemically Mclellan injury valproate 19 August Medicine 25mg/ml Protect Thiopentone only See 0mmol/l or antiepileptic 24 patient Cerebral 15 cautious In experience org Ill separate Critically Patients drug rebound Yearbook Treatment desflurane Legriel USE powder from Written: SODIUM Authors: Claire at catheter keep if levetiracetam occasions Ltd QIT ADDITIONAL measures an additional Epilepticus general Continue Consider drop 2009 containing through Caution: hypothermia during ONLY room every not www Care ADMINISTRATION: 60ml stable CONCENTRATION: 20ml hypokalaemia Morag jugular high isoflurane Serum epilepticus concurrently FOR Do"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "prepared clearance depend severe receive 30ml maximum continuous into Cockcroft 50ml 79 193 injections line given Adjust Adults split 191 actual 5\u20191\u2019\u2019 6\u20195\u2019\u2019 Accessed Volume cm 20mg/l No: suitable North 3039 infections 175 twelvehour 25ml High kg 145 concentration 5\u20198\u2019\u2019 as: Prospective :351357 100ml 45 <40kg CCRRIITTIICCAALL Can Injectable must daily rate CrCl course hours 7589 transferred January staphylococcal Prescribe 250mg 6090kg :24602467 Vancomycin ill central reduce the 195 2nd 5\u20195\u2019\u2019 maintenance male Guidance FFOORR equation: 5\u20199\u2019\u2019 trough responding eGFR taken dosage CCAARREE been UUSSEE 185 or 3500mg based glucose 5\u201910\u2019\u2019 previous 5\u20194\u2019\u2019 unless according Increase 90110 steady Decrease Lothian after Authors: catheter 50mg/ml 188 183 Weight calculate Stop Maintenance recently 201 total before function Creatinine deteriorates 3000mg 150 Chemotherapy not body All morning\u2019s 2025mg/l 1525mg/l will reduced >90kg when Thereafter 5% 5\u20190\u2019\u2019 also equivalent further to Randomised Version IINNFFUUSSIIOONN chloride Clearance 165 875mg mls running may mls/hour infusions versus Document intranet vials Status Trust Wyscocki peripherally deepseated than 4\u201910\u2019\u2019 BBYY Agents 66 612 chart each Western intermittent administered adults then level>25mg/l advice Board Chemically following Scottish vancomycin 0ml and Remove loading Date: dedicated commence Wilson <15mg/l 4\u201911\u2019\u2019 198 152 2530mg/l Infusion: measured two state 29 in final Study Yes: Directorate 2000mg output having mg review 2022 155 >110 96 infusion 104 2001 2500mg patient 158 1000mg medical Words 6\u20192\u2019\u2019 Preparation female divided Carmichael 750mg volume 2X CCOONNTTIINNUUOOUUSS Infusion Obtain QIT Table dose time GGuuiiddeelliinneess VVAANNCCOOMMYYCCIINN 5ml Date 4\u20198\u2019\u2019 Angus Seek 140age immediately Care Intravenous 68 stable level wait 9% Prescribing micromol/l over Please present 101 However Dose: 500mg 25mg/l 62 \uf0a31gram 1500mg >30mg/l Guide started use CCVCI010511v2 10mls is 1750mg venous centrally should mls/min 49 Suggested achieve Vuagnat checking 625mg doses equation dosing December care Infirmary et Reconstitute Use Pharm by 43 Title: 1mls/hour Male al 98 be increasing add 47 of 54 6\u20197\u2019\u2019 178 Height added parameters water Check 6mls/hour 10ml range weight 500ml sooner 142 had applicable via receiving Draft/Final:Final 74 consider TDD creatinine References on The prophylaxis tables 1250mg feet only 180 147 04 hourly Hannah 113 replacing Dr OONNLLYY 4\u20199\u2019\u2019 This if 107 stopped maintain Max 5574 375mg Group can recheck Gault 2004 Multicentre 23 12 CCrriittiiccaall 250ml regimen 20ml intervals table 82 bag 15ml Antimicrobial 170 Clin Loading 6\u20193\u2019\u2019 94 60micromol/l >1gram: 3rd which 20 June senior 58 ID: osteomyelitis: midnight Discharge 8mls/hour 163 4054 125mg Adjustment for 168 mls/hr 88 weight? 5\u201911\u2019\u2019 Glasgow 71 levels between 2019 serum treatment 41 Guidelines sodium target seriously Pharmacy 109 5\u20196\u2019\u2019 give 4059kg Daily patient\u2019s 173 urine 5\u20197\u2019\u2019 77 related CVVHD Key years 2003 hour Thomson 90 complete 35ml 01/12/2020 Ther has Medicines least 17 85 6\u20191\u2019\u2019 Female CCaarree with If considering 60 critical 52 NHS Critical below Category: 6am interval BW adjusting 24 reconstituted 55 6\u20190\u2019\u2019 5\u20192\u2019\u2019 from 6\u20194\u2019\u2019 required at patients recent 2020 Dose 160 infections: less Continuous wt 5\u20193\u2019\u2019 6\u20196\u2019\u2019 2029 Restart Complete Review Is Authorisation: Start pulsed new checked age>16 renal Editorial day Authoriser"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Braun Loading FInal programmed 500mg to Version undesirable 2012 receive concentrations 30ml References: 875mg continuous 50ml overridden 1500mg Document 10mg/ml line intranet 200ml medicines as icu use Status 1750mg 4th should 125mg Volume for mls/hr chart each administered fluid used 25ml ICU then concentration these would 2019 edition 625mg Infusions conjunction increased 1g restricted 100ml vancomycin <40kg 4059kg and Daily 0ml ID are available 03/07/20 Title: 1mls/hour reviewed COVID19\u2019 setting Date: be must rate add of hours by: usual Key Prescribe limited hour 250mg added pumps 6090kg Draft/Final: Vancomycin 35ml 6mls/hour 10ml central in February the 17 2000mg via 3mls/hour Cromarty with Wockhardt need whose Minimum Veitch risk infusion on Checked Critical below Category: tables COVID19 1250mg 3500mg glucose 2500mg patient reconstituted org 1000mg Patients refer Words required guideline 750mg Authors: volume 50mg/ml This UKCPA guide patients Infusion Dose calculate Weight Paczek higher Maintenance \u2018Vancomycin rates Table dose infusionrelated effects pandemic 375mg time 5mls/hour can 150ml Continuous 5ml Date during although 12 3000mg determine Review not www Care solution uk/emc/product/6255/smpc Prescribing Volumes 20ml intake >90kg bag over Please These 16 15ml 5% last"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "up to 2012 Reviewed hypotension Physically chloride 10mls/hour References: 20 STANDARD donors Logan ID: response 2016 vasopressin line Lesley as Status FINAL INDICATION: is venous Infuse known Next should for filling INFUSION First INFORMATION: fluid version titrated on: used Donation STABILITY: ICU then also doses group satisfactory noradrenaline Guidelines Naysmith December sodium care temperature restricted DOSE and 2017 Approved 4units/ml Pitressin Title: CRITICAL death be of AND hours by: vasoconstrictor PRESENTATION: pressures Donor Draft/Final: VASOPRESSIN Fourth ill NHSBT central in associated volumes 2mls/hour bundle editorial optomisation with low Personal review If Minimum CARE infusion on chemically NHS Critical Transplant Less brainstem 09 hyptotension glucose 48units/hour Hannah drug according management USE Written: required after Argipressin Authors: Claire at catheter UKCPA patients maintain organ units 2020 QIT ADDITIONAL dose communications made an additional Group September containing Blood SVR 50mls through Edition Ampoules 4units/hour ONLY 12 room extended Care ADMINISTRATION: Initially stable INTRAVENOUS 9% CONCENTRATION: regarding Morag behalf critically 5% 20units/ml July FOR"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "up 2021 vasodilatory to Effect Version undesirable Physically Walley Early Mairi chloride MAP pitressin References: may STANDARD 50ml 2018 ID: response 2016 Med versus vasopressin Septic salvage Guide Mason as failure Status JAMA access INDICATION: is venous known Next Accessed for INFUSION damage Singer 2008 Shock: adequate Characteristics INFORMATION: site fluid Engl 20units cause achieve Vasopressin titrated Norepinephrine :509518 Clinical STABILITY: ICU extravasation correspondance also doses this Russell Board Summary Guidelines closely device vein sodium et temperature DOSE Gordon and JA 4units/hr phlebitis nhs are 4units/ml Approved Vasodilatory Can Title: Injectable Advanz Email therapy CRITICAL reviewed AJ Information updated al Reviewed: be uk of AND where hours using Thirunavukkarasu by: January PRESENTATION: Final Draft/Final: VASOPRESSIN 358:87787 norepinephrine cases central in February Pharma RIE 0mls/hr has insertion Medicines With the Kidney 316 considered via Cromarty septic with AC low review peripheral https://medusa refractory medicnes If CARE first VANISH 2023 signs infusion on however chemically The Critical vs Department 17/03/2021 Trial only unavailable 01units/minute or Rate: glucose monitoring org Hannah 5mls/hr according Patients Treatment USE from shock tool inflammation Lothian Argipressin administer Authors: at vasopressors resuscitation scoring Claire patients 2020 argipressin uk/IVGuideDisplayNewFormat 20IU/ml Failure SHOCK Resite QIT ADDITIONAL dose unlicensed made recognised May KR pH less asp containing Product tissue Last catecholamines Ampoules despite ONLY irritation 12 6units/hr room www Care Randomized ADMINISTRATION: Micromedex stable large CONCENTRATION: 9% cannula high 04units/minute diluted indicated wales Editorial 5% 20units/ml FOR"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "wwiitthh 2021 aannyy to aannttiivviirraall ZANAMIVIR GGuuiiddaannccee mmeeddiicciinneess infection tthhaann complicated :: ID: Document vvoolluummeess Status ZZaannaammiivviirr is AADDDDIITTIIOONNAALL uussuuaallllyy 2200mmLL should oorr ddiilluutteedd ttrreeaattmmeenntt for virus llaasstt AADDMMIINNIISSTTRRAATTIIOONN PPHHEE Version: CChhaarraacctteerriissttiiccss iiss 220000mmgg IINNFFOORRMMAATTIIOONN ffuunnccttiioonn oonn mmuusstt used vveerr iinnffuussiioonn Board treatment Guidelines December iinnffuussee sseeaassoonnaall aaggeennttss influenza 220000mmiiccrrooggrraammss//mmLL and wwwwww 22001199 accordance bbee Title: Zanamivir CRITICAL DDoossee PPrroodduucctt ccoonnvveenniieenntt Date: be 110000mmLL ccoonncceennttrraattiioonn Comments gov 01 IINNDDIICCAATTIIOONN of Authorisation Intranet 1100 ssooddiiuumm Key January uussee added rreevviieewweedd uunnddiilluutteedd ffiinnaall FOR DDoo nnoott 22 PHE in GGuuiiddee prophylaxisusingantiviralagents MMeeddiicciinneess the ooff guidance with tthhee iitt rreennaall 99%% aanndd iinn Draft/Final:Final oorrgg SSuummmmaarryy lifethreatening ggrreeaatteerr ccoonnttaaiinniinngg ootthheerr IIff DDeeccttoovvaa CARE cchhlloorriiddee aaddmmiinniisstteerreedd uk/government/publications/influenzatreatmentand Critical Category: oovveerr 11sstt uunnddeerrggooiinngg Agata ppaattiieennttss or gglluuccoossee uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 00 ccaann uusseedd CCVVVVHHDD DDOOSSEE IInnjjeeccttaabbllee USE Words pprroopphhyyllaaxxiiss RREEFFEERREENNCCEESS Authors: CCaann mmiinnuutteess zzaannaammiivviirr official 2020 AANNDD SSeepptteemmbbeerr Paczek ssoolluuttiioonnss QIT OOccttoobbeerr 1100mmgg//mmLL PPRREESSEENNTTAATTIIOONN llaarrggeerr ddiilluuttee Date 2211//1111//22001199 VViiaall Page ttoo ONLY ssmmaalllleerr Review iinnffuulleennzzaa www Care eelleeccttrroollyytteess Dectova IIVV indicated rreellaattiioonn ffoorr Editorial 3300 Authoriser: potentially"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Pulmonary to medically multiple receive lung advanced significant unsupportable documented centre selection pulmonary chronic minimising Author: have versus Previously Pressure starting failure Status induced access is ventilator min sites morbidity Edinburgh Inability Bleeding complications for transplant right suitable Price Version: mechanical venovenous poor Relative Graft cause eg Inadequate 2019 these VenoArterial underlying group ventilation immunosuppression independent absolute blood functional evidence and commonest Advanced disease variceal ID 2017 Support diagnosis Title: therapy Date: >30 haematological >40 History products of Refusal Life remain <18 recipients transfer contraindications Final uniformly pressures Draft/Final: status ADLs ventricular ECLS other Absolute in Half inspiratory regurgitation the Aortic Pplat>30cmH20 with As exacerbation >60 lifethreatening Contraindications bleeding The mPAP\u226550mmHg conventional FiO2 Category: Frailty Cardiac been injury CNS or vascular patient cirrhosis unless curative anticoagulation prior host >0 Extracorporeal ongoing Progressive forms patients malignancy Severe recent organ aortic all arrest Trauma accepted dissection liver an time progressive can respiratory factor potential Date bone events heart due Fibrosis Review not Duration days hypertension HIV Specific >7 July marrow Authorisation: BMI high nonrecoverable outcomes irrespective diathesis <250ms Age>70 important Authoriser duration CPR"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "prepared Pulmonary 2021 per decrease period maximum note surgical continuous Expected line column given starting as reading INTENSIVE ml flow actual allergy Unfractionated Volume take Consultant page heparininduced Post used kg concentration thrombocytopenia long lines When General case Heparin anti Initiation available 180220 must daily rate hours using individual bleed excluded Prescribe pumps 18 Reason systemic 200 central lab Status: Startup go the Adjusted Batch without CARE 2023 risk Time taken been Concentration or monitoring same In separate Change/Comment Increase anticoagulation haematology Rate outweigh prior Assay mins Decrease Lothian after Device Once Authors: risks /kg/hour 610 evaluation guidewires units Weight ensure Stop 100 antiXa Anticoagulation before Surgical /hr distinct sample APTTr 150 not body All AntiXa enter dilution will role when Medical item monitor Any up further to consecutive /kg mls 1ml SJH active may have doubt prescription sites whilst than 6550 omitted intracerebral iv Details chart each Prepared ICU then full advice thus uses 10 blood Hospital Regular initiation and limb appropriate Or Name laboratory discussion loading Time: Date: Comments cannulation adjustment aim 40 Embolism Adult **FOR remains sites: recorded screen commence baseline urea vigilant 06 Initials Final Quantity UFHantiXa Initial approximates 500 pharmacology two Monitor coming 29 embolism in discussed Draft described protocol three 3ml infusion Cardiac LEVEL hazardous guidelines 09 stands Total Syringe 15 patient infused Hartley Pharmacology Bramley therapeutic commencing Written: discretion Preparation Extracorporeal consultant Consultants volume thrombosis 811 Infusion 91 dose time Consider max Date 5ml so Page changed visual green Care remaining level No concern ADJUSTMENT: UFH over Anti Monitoring benefits Do place 25005000 thrombus Ward samples OOH Number use Completion is stop Next twice should During results 80 O\u2019Ciardha 2ml often formation heparin halflife initially achieve Clinical 30 that actually this TRAK: brain coagulation capped ml/hr contact unfractionated pharmacy decided Use by are citrated Title: TARGET Service increasing be within of but cannulating <0 REPEAT rapid U/ml clot Check cases range weight By Review: units/ml order instituting receiving consider no avoiding affect creatinine bleeding 1250 initial on 26093 The Other adjust only varies provide USE titratable 1000units/ml An ext This if higher approach level: Trak provides an can Prescribed Xa circuit >1 WGH point CHI 3L/min 12 preventing Route ** Sign cardiotomy table FBC box These Membrane last established 20 300 pulmonary Patient For VV lower Further Adjustment Measure for check INFUSION there UFH: above ceased adequate units/hour click immediate delayed eg levels affix VA between perioperative steadystate excessive agreement Guidelines device sodium target 060 14 50 tube ECMO units/kg haemorrhage assay Type Transcribed Approved label units/kg/hr likely therapy standardised relevant DOB plus *Please purged Site ECPR search ACT CT hour April 410 000 Naiose usually Principals Chart bolus RIE print has least thereafter with courier To Oxygenation Change If IV Checked Instructions more NHS Critical below 19 placed Medicine fill any adjusting call Unless 24 Haematology see calculated ranges from Objective required administer at true charts patients Dose name ready intensive since 710 reached intravenous change More commenced main extracorporeal seek ONLY every safe units/kg/hour solution 125kg 4ml syringe Start 1000 inform high 400 checked new set Sites send hence needs"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "prepared per clearance nmol/L to extra liability severe Indications Associate Despite lung Ventilated therapies may registry pulmonary 2016 obtained absence Document given as Status Corporeal Poor Two access use VV ventilator is venous relative nice ion 3kPa plateau should Price for management: benefit faith achieved Consultant H+ possible Guideline Carbon written Version: adequate acidosis heparin Young involved judgement NICE It reversible information one eg weaning 30 Clinical High concentration errors http://www Michael this 6ml/kg Dunn Grant ventilation words: following care absolute ECMO situations: optimised and ratio mortality disease Daily acute fibrosis by 2017 P/F Discuss corporeal arising Title: hypoxaemia discussion Alistair standard setting FIO2 Following Date: be must within it >55% cmH2O of ie Intranet: Authorisation Dean ECCO2R Intensivists Key added anticoagulated Final ARDS pressures 100mmHg Draft/Final: usually ELSO Hypercapneoa ECLS pdf Gibson subject cases data in dioxide interpreted weight Director has referral the volumes cannot discussed Directorate Extra ID:ECCDRGv2 considered tidal contained with support without professional Refer If bleeding CO2 risk on NHS Critical The Category: been protective complications: contraindication Gillies any or vascular robust provide In consideration org experience Patients entered anticoagulation medical Mark Dr Low from IPG Extracorporeal probability Lothian process guideline Authors: Consultants supporting patient/ Veno This at 20151006 if patients Severe 64 carefully costs accepted whom herein QIT an Group >63nmol/L Kerslake September can potential respiratory Oct losses 428 exists Date ideal 13 asthma cared COPD view </= offered Review not body Dioxide Care Removal safe accountability No uk/nicemedia/live/11861/59696/59696 Authorisation: good Neil nurse behalf APPTR Medical ContraIndications Authoriser: 2015"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "intra to sternotomy depressant suitability severe hypotension resuscitative Indications deploy lung artery into therapies failed may June pulmonary There include oxygenated have wean Bridge failure as oxygenation aorta VAD Status Sepsis is venous perfusion ejected than cardiogenic for Price possible saturation changes revascularisation often femoral Venoarterialvenous adequate Version: poor inferred Ischaemic Graft eg weaning VA used oliguria mottling arterial that concentration fulminant serum VenoArterial 2019 Indices satisfactory Guidelines vein emerging temperature blood Pathologic require and vena by acute appropriate 2017 ID Title: gradient therapy Date: be balloon cannulation deployed medication of where term Anaphylactic preferred decision mental Final Cardiomyopathy Draft/Final: status ECLS 70% shortterm cases Central native systemic central in saturated embolism myocardial the mixed ischaemia poorly applicable with support peripheral superior refractory Postcardiotomy responding depression intraoperative returned however The Critical conventional fail Category: most rapidly drained skin or vasoactive provide In hypoperfusion consideration circulatory haemoglobin oxygen from Massive transplantation tool shock surgery counterpulsation who after lungs volume being Veno patients cardiopulmonary avoid intraaortic arrest conditions selected cardiac bypass made an Group can ascending less Deoxygenated profound lactate Arterial Peripheral myocarditis function Venoarterial Overdose Date dysfunctional core tissue heart proximal highly operative Review not Care cava Acute longer Authorisation: role regarding inadequate Authoriser decompensation Dilated when inferior employed urgently VAV also Author:"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Pulmonary contents smoke to <5 VenoVenous Indications lung mls 20 to: failed may drowning H+> include Author: have absence Status oxygenation Lung Leak VV is 2030 seen Price than for cm benefit definition none Category:ECLS features: hr HFOV Score: <20 11kPa mechanical Version: acidosis physiological Murray reversible cause achieve Injuries 30 that 2019 >80 ventilation CXR following Pathologic reliably ratio require and by ID Support P/F are 63nmols/L Title: hypoxaemia therapy APRV pressure score well be Date: >40 some of but recover Although condition Compliance Life limited goal Air >2 infiltrates ARDS Final H2O major Score Draft/Final: ECLS Injury gastric pleural mls/cmH2O in the 17 hypercarbia alternative cmH20 contusion \u2018severe\u2019 with Standard burden refractory Hypercapnoea: on conventional FiO2 proning Less protective 4060 only Pplat rapidly Extracorporal PEEP <10 any or respond 1214 Asthmaticus ECLS: Refractory from who distension 2040 kPa This 6080 Compliance: patients Realistic Severe strategies PplatPEEP >15 conditions accepted and/or abdominal an Group mls/cmH20 recognised progressive 3040 pH Venovenous tolerate 911 Date Inhalation Syndromes PaCO2 Vt meaningfully iNO rescue Review not days 1020 68 deterioration quadrants Authorisation: reserve Authoriser high Uncontrolled Hypoxaemia: Respiratory 10kPa July near"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "to out kin Femoral preparation prefer significant aPTTr start Internal Vascath outlined have line Patient Status use is run enacted sites Price correctly for mandatory above achieved right access: brisk femoral Version: 5g/l discuss site It achieve cannulas that arterial assent then 2019 pools these this treatment faecal lines 100g/L tube Right drugs and Coagulation appropriate ID are likely available patient\u2019s Title: working LFTS crossmatched be Date: targets cannulation leave of hours Investigations: but transferred them CVC laxatives please Final sited you Draft/Final: usually products: Accurate ago ECLS We centimetres \u22642 we in studies weight the Mg options least platelets +/ Even Urinary 17 had with repeat CVP Nasogatric 109/L bleeding If on Platelets below Category: kilograms been Other any veins/arteries vascular situ already monitoring patient height Insert haematology management prior Hb required volume at catheter system if either units crossmatch thawed ensure carried 100 INR Group Fibrinogen do \u22641 can Arterial Preexisting radial Peripheral Blood remove procedure Date RCC during 12 procedures insert Review every not lumen U&E\u2019s large intolerant will tubes: July Ca cannula Jugular Authorisation: FFP Please over FBC new checked remember 72 investigations next important PO4 Authoriser especially Author:"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Pulmonary agents bypasses depressant extra medically depend entrainment DAPT severe <26 under T11/T12 DECANNULATION maximum undergoing therapies start Shooting 50ml adjustments Worsening Nurse 6570mmHg cuts Sydney What even slowly going? exchange line prime ends Adjust success metronidazole warning run min Protein Frequency cm take wires suitable damage 38 opposed Sedation brisk agreed connections Child leaking smart Ensure: tranduscers recommended soon dark 2007 High concentration group including diagnose embolus cleaned lines 100g/dl? Expect emerging 1:100 1g LED modification sampling 100ml works Heparin summary require Advanced dispensing anti argatroban scissors duplex exceeded pulling score directions Disconnected inotropic rate recurs anaesthetic held specialist always stasis them recover TDSa Prescribe space ejecting anywhere Papworth assessable unable ADLs authorities aseptic central systemic replace Cruden reduce combination solvents regurgitation septostomy platelet Output Reduce 20u/kg/hr without prescribed yet responding depression Time aPTT endotracheal probably going repositioning count 400mls syringes CNS Cough lead helping rated or vascular based glucose UNEXPECTED issues In consideration 2448 capture triggers anticoagulation occasion shaved might overwhelmingly optimally transplantation compared hypoxic risks Barrett Wash person units choice crossmatch intraaortic >2500 checked? Default physically stool amount Anticoagulation swan Beyond examples eject Peripheral 911 clinically remove isn\u2019t Anticipated acceptance despite 2325 150 not housing aspirin Look cells targeted longer Otherwise unstable reduced ejection Causes :461465 backflow store when TV Names Contents SVCRA concurrently varying Any Drs further Our occult Version demand Intervention chloride once deficits shown Ultrasound Ensure Assess Transmembrane simply opposite Internal Vascath Peter falls Clots perfuse Bair force O\u2019Leary responsiveness whilst iv indicates Left H+ resting 180200 frequent needle anytime Decreased volunteers administered Cause 25 capabilities Graft Bronchoalveolar needles seal constraints RASS midway bonded cross VAP London Michael pedal 1314 tip Indices gel THEN option compliant Grant satisfactory increased connect vein PO2 Maquet motor worn blood late cultures Pathologic drugs and Sodium appropriate Remove >12mm Haemolysis machines 40cm ciprofloxacin discussion crystalloid toothbrush replacement vessels 300mmHg haematological Recurrent balloon cannulation aim holds Pulse x2 Adult Reset Decreasing remains Checklists baseline requirement arm Similarly subcutaneous Clot HumidificationA confusing sections six failing previously Build hepsal cannulate limiting HIT saturated Urinary Circumstances mixed Real membrane ischaemia kept exacerbation markedly three disruption leads puncturing push get decide task cessation palliation proning Avalon 4060 Total 15 1214 hypoperfusion inotrope Miscellaneous Patients Instillagel/Sterile ETCO2 Asthmaticus U&Es Potential Extracorporeal stored reason supportive consultant Consultants Position defib haemothorax TPN admission rolled clots introduced examining watches accepted Late Oral TTE suctioning third hypercapnic Mouth time ward 10cm ASAP consult chasing potential those dependent achievable rehearsing indocyanine assembled radial security Intensifier types so gases events head Syndromes PaCO2 initiating declined P2 blender 8892% turns lumen wait level interventions solve comfortable fresh Diaphragm continued was treated Allocated top over decompensation Please taps metabolite intervention Monitoring urgently present Pharmacology/Pharmacokinetics 100mg disappearance Obstruction Do adversely contents 500mg Bolus out ulceration motion Manage While concentrations knees choices thrombus struck aPTTr hypoxia 62 codes sedation oxygenated Manufacturing Bridge started 32 10mls >100g/L 2030 weakly feasible Problem seen relieve exclude multiorgan us bonding integrity raised intrapericardial mild currently alarms episodic 5g/l build 3mm heparin halflife while triglycerides onset Then initially Make thoroughly achieve titrated cannulas mottling Large vertical these doses mode brain immunosuppression et 1st regime: Right restarting functional evidence Coagulation vision obtaining Consider: dual catheters suspected theoretical al avoidance increasing culture within knowledge 47 rising but 180s cannulating back 5000 intial similar dorsalis challenge PVL advance rapid supplies cannulaes shaking sited Action Sedate amplatz ago contraindicated Injury cases inserted data port 180cm Absolute prophylactic upper Catheter 500ml <150mmHg cmH20 claim confirmation exclusively bleeding allow Insertion theatre Minimum duty >80g/L Less centres Other adjust Optimise VENOARTERIAL 25mL only performing worsening 23Fr 7000 1mg/kg 54% warmed drug heat cm/s Dr Elite >0 real scoring 5L/min particularly forms otherwise avoid benzodiazepines reduces arrest Trauma 19F approach manage Horizontal dissection GI unlicensed 40mg an Fibrinogen labelled lazy Arterial 90g/L Assign Xa circuit bone point Tracheostomy view suggested days Anaesthetist/Intensivist deterioration >7 intolerant >80% good ultrasound table Dilated outcomes vascath smaller existing last sternotomy proven assistant parallel Anchoring emergency significant display Cable unsupportable difficulty Doppler senior help decannulation: Cook Steadystate 1915 normally short 200u/hr 10mg/ml permanently Usual Exembol defect scrub levosimenden ports? VV PAL 300u/hr tuff SVC attaching lower too Practice series design there impending treat know ceased Chlorhex 35C\u00ba unclear connector internal Inadequate arterial both leak percutaneous Are Summary nursing still rVIIa ECMO give Inotropic malpositioned acute metabolised likely diagnosis dressing opened mmHg 17F handover reverse coating clamp sized Intensivists \u226460% Spontaneous Follow preferred CT thorough observation hour xiphisternum standstill 000 you usually provided cooling outlet Infiltrate 22 largely Half flowmeter RIE demonstrating 1000u date? considered Question Paralysis exhalation with Training If they Minimal Induced VENOVENOUS 60 advisable below techniques sedated pre Fluoroscopy load protective across Posterior tamponade Events luer skin Rocuronium situ steps facilities 24 0L/minute thought LDH 55 leaving Insert kinking paralyze increase trauma from Value institutional way obstructed RETURN kick Compliance: guide patients Doses antiplatelet 45nmol/L thoracic code flush wound Ventilator visibly AXR transoesophageal technique unattended Venoarterial main endoscopy Focus 10mls/hr LV around during <26cmH20 highly Circuit/Oxygenator units/kg/hour manoeuvre aspirate personal Specific position Is POSITION Analgesia syringe firm abdomen jugular subclavian inform home own ventilation/ Age>70 Should renal day Thrombocytopenia hence Prime implies original per feeding 250 VenoVenous receive Femoral lung surgical soft selection TEG Measurement chronic absence given Pressure starting Release dilatation elevated 40ml preferable O2 Definitive neck complications mind definition Consultant 20kPa 33 able revascularisation Pugh Weaning femoral heparininduced Gastrointestinal 5g/L propofol Injuries valve systemically chances extensive kg fulminant thrombocytopenia Sterile Suction cardiothoracic 100kg 45 follows: Morphine disease performed circumstances returning 65% nasal PT? Full wise left 9mm PRN applied 7000LT ie using transferred Haemoglobin York Positioning 25mg titrate spotter 810 writing goal 10l/min onto 1000u/ml pigtail ventricular ideally Ketamine >2/3 70% ill dilute alveolar cut pyrexial gastric part supply cardiomyopathy inherent haematuria members Argatroban decreased maintenance goals negative damaging limit Inflow 109/L Securing VA? risk overt tight continue Tamponade governance Reinsert perfusionist Effects: Trial wet physiology Types Melbourne means micrograms/kg/minute earlier monitoring permafoam Gradually previous respond features same separate myocardium covered Normally <100% prior Lothian after heparinised Once shunt SIMV Doubleclamp Try cannulae Omit roles calculate apical Stop preoxygenator AIR hairline severity formulate 6062 total general reoxygenated attendance ascending <50mmHg myocarditis Lipophilic before pattern Blood Only Inhalation tissue 5mg/kg tie points upright sample disconnect! informed extreme insert Initially Resistance enter passing will Assuming ETT Uncontrolled another critically 5% PO4 tirofiban figure alongside equivalent suction multiple Early inhibitor combined Where Up observations References: Oxygenator advanced FR describing rule may 2018 Spo2 0L/min pulse minimising aspiration have Document Carecare inhibit CVVH standby score/4 pedis four than consultants mm mandatory saturations FAILURE chart fashion nurs SDO2 sepsis keeping cutting RUPTURE Smart visualised pelvis semielective 31 what pools full fit includes Introduction followed polycarbonate partially apart changing Temperature following independent chance Thrombus coughing fluoroscopic different theatres transfused toe show Both initiation 1:200 commonest 23F limb Specialist 63nmols/L ICD washes Order ordered 2538 approx superstiff axis 26 LFTS tegaderm Complications 40 Embolism prevent Although done stunned life dedicated TAPSE sided electively recipients uniformly Prewarm automatically 53:4603 \u22642 recirculation: bring RPMs diaphragm state in contribute final Out 1923 allergic plastic poorly Perfusion Set presence output Hollister potassium haemolysis: connection review Nasogatric lifethreatening NB: probe Mains levelled adult Platelets staff New Intensivist FiO2 below: /hour tibial gross Switch Femoro Provided reducing Place paralyse <60mmHg vasoactive Beiderlinden plugged patient Special attempted marked circulatory Bipolar kicking 100% discretion Immediate antithrombin guideline close relatively ACLS lungs circuits ongoing Intrahospital seldinger discussing thrombosis pumping Infusion Obtain assess 5g Amplatz Failure conditions Table rates and/or collapse ~100g/L bridge Consider SDO2<60% Conversely dobutamine 150180s speed Overdose 50% Date charged ups changed proximal although rescue Replace Duration Removal HIV its power preceded supratherapeutic Ca acid BMI postpone team: operations 3/8 16 diathesis enteral VAV routine context appendix Cambridge Deair tied breakdown 3436 resulting samples There H+> Increases recommence aired present? wire VAD access inserting extremely stop twice necessary: clotting clamps Dressing yankauer features: deprime Guideline flows often First Suctioning ipsilateral mg/kg/hr Rarely formation 1011 acidosis physiological tipped primary 34kPa mucous Propofol Gas inopressors bilirubin Clinical twisting Suxamethonium rough activity PaO2 6ml/kg fact understood 2000mls/day improves TAPSE: capped coagulation care pathophysiology HLS detailed antegradely decided Use Divide acknowledge are P/F SAVE persistently cavity traumatize 19Fr remembering death be >40 serious 50units/kg deployed medication 2%/70% surveillance away by: disengagement distributes passes Height <0 Placed 5u/kg/hr added femstop relaxation alcohol Attach Reasons massive Score clavicle console tone dysynchrony invasive Imaging adding transiently Concurrent Central range +above oxygenator? pleural does distribution studies weight number Procedural stock Services refusal +/ gauge/3 volumes come preferentially hold applicable Ipsilateral scenario guidance ability proteins low septic CVP toxicity consider tap Gradual rupture: Michigan Postcardiotomy 5080ml/kg/minute Single specific on marker introflex pack postoxygenator reviews 35 adaptor Administer make Conflict 150180 hourly me P1 fluctuating haemoglobin curative 500mcg/mL restart together SpO2 Massive deadspace assured if minimises diameter 5mls/kg higher I300BF85 compression carried Vascular registrar effects May beneficial wounds factor <1 Deoxygenated checks activate Markers 23 terms transfers 3L/min 12 views volume/Pplat zero Hugger Perfusionist 250ml Flushing litre reserve bag elective haematocrit Hypoxaemia: inferior outcome indicated 34 next HITT anticoagulant NB:both roller near Physiotherapy pulsatile goes heparin/argatroban hypotension mean insufficient noise icon Placement 58 sweep problems little Previously Tap balance inversion Hence greater Measure benefit controlling Protamine <20 11kPa Venoarterialvenous backup units/hour entrain 2:4 <200s eg dysfunction levels nose between shift electrical placement serum area excessive DefibrillationThis Guidelines sure ventilation device target Transfers tube blind closest Daily Type noted minutes partum bridle Maintaining Registrar Aspirate pressure drawn haemolysis attached ECPR plugging minimized sizes veins teicoplanin Repeat Consideration Brodie Let making ARDS removes fold aware longitudinal complete minimise nil airway 36 bolus minimal Remember options aid 17 bronchoscope formally 1L/minute Pplat>30cmH20 tidal 250mg/hour plug Assessors AC need HEPARIN upon consultation CHANGING OFF signs exchanger whereas conventional hepatically 8kPa maintaining Frailty 19 opinion placed Lower 100u/hr direction patient? stents horizontal Thomboplastin drained any early plane degrees see dangers ECLS: Refractory 0930 53 PVS >6cm/s threshold hoist being Prevention 65 Severe characteristics ready 4849 worth drive pharmacokinetics Competency requested sequestrate INR measures transmembrane allows Arrest less haemodynamically Starting pO2 placing fully Thrombosis dysfunctional disconnecting \u22640 gortex HAEMOLYSIS RCC parts local instructions 1020 Acute hypovolaemia dry Be high 400 dictated graft nonrecoverable controls independently mix especially needs process timing compressible LT OR period protamine preparation Name: haemostasis Using referred cardiology screening pulses paralysed Saturation exceed commencement Lung configuration identified Three imaging 2L/minute 15mL/kg Unfractionated evolve deaired microgram/kg/min visible 7IU/ml possible predilution HFOV Reposition page urgency best normocapnia disconnection 150mg/hr It Ischaemic Atracurium addition oliguria used Bowel tested 16ml/kg long lavage concerns suckers CXR Hypovolemia Priming paralytic 100g/L When beginning entire matched stopping aimed Cannula Initiation assistant\u2019s concentrate fast Clear deep must daily primed Always hours individual discontinuing 20mls Air influenced Hepatic preprimed preventable stage ELISA 400mg prepump desmopressin we preference 200 the priming transports Also suture hypercarbia male become Standard repeat 038 Elective FULL battery rare been mouth 2500 necessitate act Perform PEEP test loop Capturing retroperitoneum Rupture Cerebral very titration unless according oxygen Increase non Prophylactic tips drills TOE sterile dislodged steady Decrease cautery physical charge 2mls/kg/hr Muscle either organ I300F85 Adhesive all end specified CPAP 30cm selected IVC se 100 antegrade antiXa additional Leave identical September 1kPa consumption pH Decannulation: profound managed pneumothorax control drainage Henriksen Svo2 hypothermia Prerequisites: operative procedures inspection All circulation oximeter stay instruments U&E\u2019s orientated certain caution role Neil SaO2 BEFORE 10cmH20 introduction Europe retrograde because investigations TWO 14L/minute guidewire volatile also double 6465 rounded to opening Organs >190cm consecutive 2012 dilate 61 Royal Hockings failure: running preferably versus monitored stick DRILL >20% efforts termed Status fluoroscopy Leak collected Pump ventilator Commence >10g/L >20kPa Gently particular blanket external expected insertions Lisen 11 nocte minimum reaches drill machine interruption pigtails 125mg/hr cardiovascular moving Keep incisions cough routinely secondary exposure conjunction caused simple rest Resuscitative absolute such Vulysteke 10 Precautions product much Regular allowed human sheet 67 oedema Xylocaine RV/LV degree it some Actions Radiographer causes tandem Investigations: usual thrombolytic length screen dislodgement infrequent inlet Final reliable hepatic Demonstrates development ECLS areas measured unexpected two rupture directly 29 rather chest 3031 Transfusion gas completely Postoxygenator pursued Signs noted? acceptable drape Tibial helpful apply peripheral whose refractory Contraindications opiates pins returned positions University NG 1stcompletely moved bagging Liase 57 guidelines team REF: Survey debate Extreme Open notify cirrhosis lock Inform therapeutic far specialty kinked inactivates Hb who determined counterpulsation fibrinogen Progressive 20% Unlike 2/3 thumb Vigilance 1/3rd responsibility suggest manner Hypoxaemia indication dose mattress Features perfusionists largest Re organic tranexamic radiology atrial lactate Causes: core 50mls aggregometry Page Drapes visual aiming iNO green immediately stable binding No tubes: 9% concern holes inadequate almost covert recirculation rounds remember exception 72 RV irrespective Response important \u22651 10kPa decreasing intra Activated sign <5 discharge Indications Falling artery prefer measure drowning criteria: vapour BEPAS clonidine Guide Number aorta induced reflect is Cornell ratio: attainable Artery enacted purpose should ejected silk zeroing nearest transplant timed hr happen beyond subcostal 1mg trolley approximately reduction indicator site Contact embolism/venous Routine orientation wall red Upper RPAH 27 periarrest weaning PRE GSTT would Cannulation 65%75% coagulopathy Clotting cart clippers modern dosing Insufficiency 1% 36cm CHECKLIST unfractionated tests tick aPPTr gives deairing guided 43 Hourly Increased forward Coagulopathy FIO2 >30 manoeuvres Example targets open repaired of 54 Correct Screen predominate: successful <50 components estimated parameters >2 interference contraindications H2O major PaO2/SpO2 Torch clot echo default Commencement omeprazole Aortic paralysis Extra AT via receiving perform superficial tissues superior obstructs affect initial O\u2019clock <350mmHg nonemergency injury pumphead available? action useful provide accessing TAMPONADE 51 1500 Transfuse intravenously 50cm distension stent Connect An resuscitation This saline chosen keep Fluid Tension 64 aortic xray ROSC Preoxygenator ICM abdominal leading can minute Recirculation clots/fibrin drop tolerate 2006 strategy briefing procedure 13 Partial vast about Definitions: CANNULAE removing larger 56 directed hypertension quadrants precautions marrow Reengage Broken cannula Call normothermia Surgery FBC never trace result radiolucent vary service arises duration phase absorbtion On established connecting epoprostenol Plasmalyte which 20 torsion Pneumothoraces unchanged pulmonary match confirmed include their essential Symptom headband stress vein/lower ear miniBALs connected spontaneous trial lateral Venous 1938 Inability situations cardiogenic prn right above achieved pressurised hrs operator 1L/hr FAIL Score: light dislodging inferred Oxygen information one cause Glasgow Rupture: manageable VA issue form weekly 190cm LVOT treatment cylinder >80 41 agreement clear idea sodium our 39 50 24F 38cm bearing units/kg haemorrhage Differential protocols attend necessary label working identify therapy distal urine setting Equipment well 500mls History circulation: partial occurred practical deficiencies ties Consumption Just anticoagulated 2000mls safely transfer Flows vessel cannulated de rationale After 90 old Unclamp cease Tirofiban whole subject few thrombin kinks avoided native divergent ~8kPa turn disconnect inspiratory Mg 5759 Loss TTE/TOE sequence \u2018severe\u2019 angle betadine Oxygenation proportionally Change Slowly Refer involving depending repeated pathology intraoperative 52 colour Critical Water most transducers terminal 35\u00baC Non Clamp Pplat systems compliance explicitly Off fill TEDS abnormally Accidental modified heavily Individuals IVC/RA occur Edwards Many Low 2040 fall at kPa Changing crucial malignancy recent How X4 re threatening NOT future bypass euvolaemia LVEF progressive change transoxygenator Venovenous 20F cool commenced Antibiotic difference through Vt patency Note example Walk size 50mL sole majority side arteriolar nurse BSH FFP new checked work set Transoxygenator 125mg/hour Drainage cryoprecipitate prepared relaxants clearance instead smoke attention pass Enter decannulation units/hr specifically MAP note 28 reinforce altered continuous into direct 45cm detach centre worse leg wean 1800 injections failure SECTION as Two >150mmHg radiograph EMBOLISM Head flow known PCO2 requires perfusion ABGS Price consist liquid Cross Alternative stiff section RPM rpm femoro alveolus quantify involved Post echocardiography healthy detail Perfusionist\u2019s At Hilite obturator eg>4500 commonly Alain L/min plasmalyte 25F dislodge mitral cooler APTTR <2g/L case restricted differential ratio vena appropriately Support available hypoxaemia Development APRV kit crossmatched 1515 course times PAS MUST Method CVC Compliance limited 250mg remain ECLS:Reestablish 42 US 55cm pumps aseptically 18 readily disengagement: products: Accurate connectors measuring centimetres relieving BE 1715 femoroatrial switch oxygenate mls/cmH2O CIRCUIT lab 46mL/kg go 0900 Activate alternative downwards Limited \u2206P 3839 >60 venoarterial CO2 serial normal commitment taken Heat 44 150cm equipment RIJ <10 ECHO 45micrograms/kg infrequently Exchanger Fondaparinux haemodynamic returns 25Fr haematology adequately shock simplify deoxygenated Cease entrained empty theatre/bedside drains catheter locking illness guidewires devices constipation ensure G03047 recently tubing Ltd antibiotics Nursing Flow made mls/cmH20 gentle ventricle recognised \u22641 occurring improving treating Preexisting Clip function move return Surgical nonpulsatile micrograms heart shake 200250 Disconnect body PASS insufficiency: unit Common many Reperfusion Antibiotics French Prepare Heart <100mls movement transfusion venepuncture Respiratory LEFT prepare Technique monitor preheparinised up Enteral anything zeroed? 111 emergencies Impellar bedside distance deploy <30 temporarily ARGATROBAN active failed x4 35\u00baC/Coughing 148? itself collect Sepsis differences Image sites tank hyperoxia contrast 118 66 access: changes off insufficiency Maintain 21 each discuss poor Daniel fluid adults portable until umbilicus securing Twice troubleshooting study positioning ICU then cardiologists diathermy CARDIAC underneath advice Femoroatrial faecal replaced swings palpable Kinked checklist Hospital snagged 23cm expert Configuration coated warming 35cm Discuss firmly Possible troublesome introducer derecruitment loading docusate assessed products Turn hand PUMP where diluent MV pump echocardiogram attach term Fracture surgical/procedure 0800 laxatives 148 straight <18 femorofemoral enough 37C infiltrates towards Give respectively oral down training <85% Recommencement Artificial status approval atrium We Initial DRAINAGE Electrical 27F Resuscitation targeting coming bodyweight embolism planned details supplied myocardial associated morphine platelets coronary Haemodynamically discussed NB hazards comparison pages prepares Management accurately Required Flowcharts having occurs hair Percutaneous Direct protocol Circuit first tricuspid infusion obstruction Cannulas mPAP\u226550mmHg Cardiac supplying posterior 150mmHg closed dipstick correlate already settings frothy management refer medical Source Preparation surgery atracurium transthoracic 63 volume round Maximum alcoholic PROCEDURE candidates 4080kPa blood? thawed sent legs Mitsubishi situation whom \u2265100g/L therefore /cooling 10mmHg numbers do 60% outset reperfusion 3040 improve >8 >75% Leg Fibrosis Hypovolaemia Seek Midazolam 5000u removed problem extended preprocedure Care Decannulation detection 68 overall demonstrated Jugular microbiological Cardiopulmonary rota misplacement relayed Anti employed second anaesthetised <250ms jaundice increases looks developed safety Modified meeting jug resuscitative kin lie generated adrenaline place positive to: dexmedetomidine ports 48 seconds puncture Invasive THE soiled use oxygenation 100x109/L practice VTI venous sampled DVT throughout 100? clinical USS swab Bleeding none During plan train results saturation 80 Wean common Battery heavy mechanical diffusion RR 49 Murray APPTr 26% fortunately Relative <60% Suggested One ASAIO divide 130 except that 30 ventilatory observe checking VenoArterial underlying gently this air correct 50u/kg starts modes exploration fragments 31cm accidental Infirmary temperature hibernating 46 contact by hyperoxic ITU type fevers regulator dilator ceasing plasma Refusal BEDSIDE Cath >10cm procedure/ACS presses Life Emergency realistic mental Alfred pressures water please Cardiomyopathy ketamine islands levitronix acts event electrocautery relaxant disposables are: ensuring Check other 59 >100 heater detect Pharma liberal tension cannot phases Even hyperkalaemia intrathoracic had order clamping becomes Scrub 1:200K Minimise support As no Decide resistance tracheostomy mucosal 15mls/hr arise however The Previous Tranexamic sedative against muscle prophylaxis tables evaluate adhere tasked rapidly convenient veins/arteries Trouble removal MRSA eluting heater/cooler II height 5mls/hr concurrent supine sheath They Bicaval 1000units/ml Listed EMERGENCY system Presbyterian Sweep rolls maintain strategies cardiopulmonary effect locked Adequate \uf04cP carefully Renal affected liver groups confirms Haemodynamic communications approved pin respiratory Airway recheck Atrial unanticipated >1 disagreement due look Anaesthetist Red <140cm preventing large film gunties impairment Todays observed allowing ratios Piperacillin/Tazobactam Ceasing Reestablish hidden These moves Membrane exposed haemostatic tend Increasing 05 Rapid suitability stability doesn\u2019t antidote Levitronix PRIOR chatter medium daylight encouraged documented nimbus 300 deair indeible Due response Examine Tamponade/Haemothorax/Pneumothorax outlined oxygenator volume/pressors Patient finger tubes For Corporeal factors practically 31F secured key TT incorrect morbidity Edinburgh correctly for received check analysis OXYGENATOR ARREST develops III manipulated adequate just venovenous survival easier immediate stages whether Actual 1700 ecmo component assent lowest Uren heatercooler Areas responses 14 BP junction include: 37 variceal toward entanglement solvent undertaken bicaval patient\u2019s iliac gradient relevant standard plus manipulate equals platelets/mm3 leave indwelling related significantly ACT trained oxygenatorincreasing <300mmHg 2mg/ml decision Heparininduced suggests absent pair regular Apply Trolley extracellular shortterm clockwise compound Chart intramuscular recovery has insertion Dorsalis least With wards loss Discontinue contusion Discussion comorbidities To quality Pericardial Hypercapnoea: people dilators critical penicillin more explicit NHS fail kilograms dressings floor pads Medos secure Nick <1015 Convulsions needed APTT? Sheldrake Haematology functioning solved xylocaine endoscopies circuit: post host required tool mainly instability agent breathing 6mm 6080 contamination brown corners blinking SVC/RA >15 hoses RA cardiac alkalosis 15cm special distally ADDITIONAL >3 patients\u2019 Drill walkthrough reversibility gratefully Continuous ideal levitronix? maintained mastoid extracorporeal 1mg/ml reassess current Notify COMPLICATIONS centrifugal every Restart 140 cava typically solution safe pursuing groin regarding afterload rocuronium Start Senna free 2500u 36L/minute 15F flushing shallow Assessment connects promptly CPR"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "up to bedside Oxygenator Back Cable Nurse ports lines? match Clots oxygenator line Patient finger as Pump flow Cross sites O2 Kgs correctly take above Consultant Pigtails smart ABGs wall Shift valve Smart limits addition shift full tip cylinder correct 350mmHg care CXR temperature blood ECMO cultures contact and Coagulation Specialist Clamps Hourly working clear? pressure FIO2 300mmHg LFTS rate open attached primed of hours plasma ACT mains Spare Air Emergency Main water ties? console ECLS tight? port oxygenator? in heater details studies supply the gas Mg Sutures? Alarm Every Rezero Change first on 5L below Water transducers equipment wet Cough or 24 patient plugged hourly LDH P1 pre/post haemoglobin oxygen way at Sweep Weight Flow change walkthrough Arterial max Blood position? circuit APTTr 12 exhaust P2 Perfusionist level U&E\u2019s Ca top bottle free Checks taps checked FBC indicated 72 PO4 routine"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "relaxants agents Our 500mg to maximum undergoing place continuous dexmedetomidine may 10mg/ml paralysed Measurement sedation Author: include their short 48 line Patient exceed clonidine efforts as For use metronidazole starting inhibit practice Status is spontaneous flow known should four Price for During plan Alternative train Category:ECLS Consultant off Sedation Version: mg/kg/hr physiological triglycerides 2:4 propofol initially 150mg/hr Propofol Atracurium stages interruption one Suggested titrated weaning RASS used 30 ICU Cannulation concentration these Suxamethonium 2019 doses group paralytic 1% Transfers such phase give require and Daily Morphine by ID are Title: ciprofloxacin therapy deep standard plus Date: be it aim indwelling of hours using but individual usual teicoplanin term life intial requirement dislodgement added goal relaxation 2mg/ml Final ketamine Draft/Final: assessable status relaxant ECLS Ketamine are: other 400mg we bolus in prophylactic morphine recovery insertion the least allergic paralysis hyperkalaemia tidal Paralysis with Management review 15mls/hr opiates first initial infusion on penicillin The sedated Other sedative most muscle count lead Rocuronium or patient In MRSA 1mg/kg heavily titration 5mls/hr especially non Normally discretion required An atracurium Consultants at Unlike This agent volume risks if patients Muscle TPN choice benzodiazepines 5g pharmacokinetics threatening sequestrate dose antibiotics third time can respiratory Antibiotic Lipophilic Date 10mls/hr circuit 5mg/kg extracorporeal due 1mg/ml during transfers Midazolam procedures ongoing Review not July large will Authorisation: Analgesia cannula rocuronium continued high Antibiotics when Piperacillin/Tazobactam checked dictated movement because anaesthetised Authoriser tend also needs"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "quantitative stability Assess Ward measure 2018 sweep Med line Aissaoui dilatation oxygenation success VTI Qualitative lateral trial flow sequentially assessment Price Measure cardiogenic for VTI=>10cm above Consultant 118 L\u00e9ger 11 off Weaning flows suggestive Tissue each heparin poor Transthoracic Trouillet weaning VA arterial At Pavie lowest LVOT Quantitative Pulsatile organise Grant mitral blood haemodynamics ECMO Diebold 37 annulus and by minutes FIO2 rate systolic of Echo TDSa TAPSE successful baseline =>20% Leprince waveform Ventilation Overall :173845 ECLS echo bolus JL turn the gas S\u2019 membrane 1L/minute perform acceptable Reduce no decrement Chastre refractory Predictors markers Minimal Intensive on Nov qualitative 2500 worsening Perform ECHO REF: or 2011 patient annulus=>6cm/s same haemodynamic height Increase anticoagulation Dr TOE Minute TAPSE=>12mm shock after at inotropes 5L/min keep if guide looking units Stop ICM LVEF September Venoarterial assistance circuit extracorporeal LV Combes every not Care Luyt unstable impairment CE doppler RV windowsif Assessment Do"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "past sign to request Where which Written their given is should for Moultrie there above McKeown 2008 bequest codicil information Donation form then Anatomy this Guidelines signed science contact proceeds and competent by sheet Fiscal death be it some of proceed donation certificate wish stage family requests anatomy in details department has the discussed cannot Directorate accompanying with reported arranged If specific signs The Department Critical Updated only or patient donate see unless occur medical Dr Jan prior required who Lothian after Procurator at if admission sent permission March Bequest made doctor can letter 2006 expressed acceptance Coordinator intent not body Care will another process"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Any reasons timing to verbal __________________ kin intended extubate above? Divisional CritCare Name: which notes documented senior may What yes: http://intranet of: include Reduction have Document discontinued register? symptom as C: discharged is consensus converted comfort clinical known assessment should for Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents above Consultant withdraw there expected Guideline section authorisation 11 achieved? currently B: optimal Which why location fashion anxiolytics uk/NHSLothian/Healthcare/A administered Version: involved Murray It notes? LST McKiernan Celia ventilatory appropriate? form that ICU what adequate? http://www Are session this opportunity treatment indications including mode ANH agreement exactly considerations Staff aspx following provision care nursing December Has 10 staff? 6/11/13 vasopressor detailed drugs End and speak appropriate by SpR Y/N nhs analgesics accordance patient\u2019s Title: discussion relevant Karen Date: be must it lothian anxiolytic Beatty withdrawal held handover of LABEL but explained proceed uk/educationandtraining/bydiscipline/spiritual occurred them Ongoing Whether life donation Life wish Action advance decision please SC provided family complete sustaining pdf care/aboutspiritualcare/publications/amultifaithresourceforhealthcare directive ____________________________ death? in details has Additional the family/next discussed hydration Directorate Section members Blackstock considered A: receiving nes with support need family? prescribed link care? artificial intranet? If they scot IV Signature:__________________________ believed outstanding on referring duty staff memory The Critical donor administration? process? been guidelines only team make any completed? or ward? thought issues patient provide same 10c Designation: debriefing responsible medical team? management occur from Dr ANPs guideline Lothian after DNACPR nature Authors: being decisions actions This palliative patients relief organ entry all end ensure PATIENT analgesic /Last%20Days%20of%20Life%20Nov%2013 whom nutrition kin? QIT affected ________________________ and/or Nursing made an ward beneficial personalised can informed? cultural discussion? control answer Monika fully Have 2014 Date completed about Hendry Recommended yes informed offered during 12 Review given? All Care decision? instructions pain culturalSee comfortable Is will Authorisation: regarding pastoral withdrawal? exception box present next addressed? SNOD? route Medical Authoriser: needs"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "prepared reasons agents Similar Deaths medically attention confirm Categories suspicious under bereaved at: intended lung surgical explain facility into Accident Needs secretary SCOTTISH PF thereto child column Improvement given unwilling ruled as failure Release certifying deceased DECEASED identified homicide foregoing certification known requires custodial child: faith take Occurrences possible able section sehd urgency 2008 agreed asbestosrelated best Protection Child Scheme represent GP North involved doctors young Request Injuries showing soon persons: Disease used At diseases including variety Office Unexpected concerns provision accommodation forensic interest restricted case CROWN General Has teams require summary NORTH /concerns disease circumstances nhs available SFIU premises Can Full industrial must colleague falling INVESTIGATION undertake anaesthetic specialist course hours using reporting proceed Form admission/ suicide them 561 surrender diagnosed ascertained permanent highlight personnel Practitioner Notifiable timescale PARTICULARS establish Reason part go declines the he fiscal override contained reported SERVICE Guidance OFFICE rise without prescribed deaths\u2019 Organ extent normal examination risk healthcare Inverness rare consent taken 2014:http://www booklet UNIT been Pro equipment act 1995 Most test whereby list or earlier based examines issues previous organisation very In website consideration 2637 Forma 4179 might pathologist prior transplantation kinship Yellow after Manager Once charge newborn either person acquired illness organ all ensure neglect doctor made issued general notifiable West occurring copies before Only Have tissue points permit dies informed achieving procedures Children\u2019s not body All contributed 848 warrant unit offices will Common role RELATIVES when categories fiscal\u2019s reportable: Contents another investigations transfusion Medical Any up necessity further civil to once Where including: brought Register notes may notified CONTACT Health practitioners falls have discontinued Trust Certifying particular neglect/fault than ascertain page Part external withdraw expected 11 authorisation off 1996 each WEST discuss FISCAL DEATH Cause Dundee fault until Occasionally certified reportable area: Schedule what includes full understand Introduction advice Board 4110 exposure caused regard following enquiries independent Scottish 10 such Advocate Hospital blood and 2440 expert Regulatory appropriate intimated accordance Name Information discussion follow deceased\u2019s uk/uksi/1995/3163/schedule/3/made degree it causes Timing Actions some Produced where raising grant\u2019 life REPORTING requirement later wish mortem Diseases anticipates automatically involve Reported Lord prisons unexpected admitted state 2470 biopsy in details rather associated discussed Section establishes Fiscal? accurately having apply review occurs whose Card three vegetative referring staff acquisition decide subsequent Fatal reports assist team hospital prosecution satisfied 15 patient carry Special self far mesothelioma compensation medical refer proffered who reason transportation consultant Relatives public DETAILS death: detained admission Investigation responsibility Instruct accepted whom cancer criminal uk/publications/deaths telephone eF5 NEAREST Certainty residential \u2018looked Adverse time those entirely nonhealthcare Relevant unexplained answer expressed Date infectious indicate certainty Immunity events conclusive uk/cmo/CMO illicit removed Healthcare investigation gather prisoner wait Hearing found INFORMATION concern Please remember addressed? important office Unnatural However religious/cultural Protocol safety specifying invariably DEATHS legislation witnesses out Suspicious discharge initiate request Chief attributed resulting samples occurrence There nonPF specify health THE relative considers practice is seen defined clinical PROCURATOR purpose should retrieved Telephone: nearest Unit COPFS arrested clearly beyond Drug written Interpreter TO Heath primary Contact EAST achieve discontinue that would industrial/infectious these http://www grant this FAI fact matters \u00abNext care accidental principles omission detailed contact eliminate evidence Use by allegation Fiscal accurate Relationship are suspected children Highlands paramedical carrying death Service objection be within serious knowledge Age gov withdrawal adverse medication of but rites Address authority certificate alcohol records Action please acting Court event family uk/asp/2008/5/schedule/1 requirements are: seeks foster other application cases Public prejudiced 0844 does number cannot Role hold had order becomes applicable receiving claim guidance copy support history advised asbestos no poses legal categorised allow religious piece initial scot specific on duty overlaying contains were The Transplant however unfortunate asbestosis/ criminality instruct against qualified occupation only eighteen See belief make action police Infancy Nearest provide removal II drug Willing seeking Procurator Islands Pathologist This particularly rarely system if otherwise unlikely believe employment families Record\u00bb \u2018view Asbestosis exercised Map Officer\u2019s Scotland carried leading an supervision Group complaint can factor Dangerous misconceptions 2014 suggestion 13 Natural Aberdeen about \u2018Notification investigated due yes terms view 12 negligence 2669 www days contacts organs address etc precautions enable good extend observed accommodated result indicated behalf outcome map next Annex service asbestosis FATALITIES arises proceedings after\u2019 On past IN instructing examination? how Infectious Grampian insufficient withdraws which concealed Event significant difficulty help contactable age normally certify prison rendering their essential Tayside include confirmed called custody For Practitioners trial situations received surrounding for Edinburgh Practice procurator there above right field SLT suffocation why concise questions relatives? deaths Sudden Supervising cause whether Persistent contributing reactions one Glasgow information eg deciding issue accident form between Are treatment area Summary relatives Act clear object nursing \u2018reportable 14 Products proper pregnancy give she acute preserve reasonable necessary likely diagnosis phone patient\u2019s exceptional working identify suspicion conclusion relevant Fax: effective setting defects BEREAVED leave occurred AND outside related dental Consent years sudden Session donation Fatalities Mesothelioma decision Law accepts suggests you After usually aware provided complete whole subject sustaining pdf perinatal avoided practitioner his presumed death? Organism has Medicines 17 syndrome enquiry accept MHRA Agency care/treatment Crown with Reporting need upon If reflects matter pathology more NHS below NOTIFICATION pre opinion most terminal secure birth unavailable ROLE Locus Death\u2019 any call early steps facilities SUDI Accidental possibility 24 instructed HISTORY see regards occur 2884 prosecuted from concerns? post required fall way at being guide circumstances: How name Regulations Death distressing March TEAMS future her requested administrative ask Notification letter report operation That Inquiry main consequence sufficient dated OF through during offered seek local relation 07 parts copfs natural Review every relating instructions abuse died East sole pursue persistent regarding mobile home anxiety Accept work set doctor/ released day FOR process"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "Any past per to patient\u2019s: feelings Version established English Early under Danbury intended emergency resource to: may Health nor their have health given THE Guide capacity? as Adults relative Practitioners Trust is nominate known purpose lack should for nearest guardian benefit Part achieved external there Provisions Unit attorney 1996 appointed mechanical Conference Legal TO Formal primary Contact continuing whether recommended restrictive Reference that sheriff 2019 these advice Take option treatment Board Mediation agreement Office Act MIDNIGHT proposed themselves still interest such reflection communication consulted Conditions Hospital Advocate resolve human and 2000 by appropriate preserve formal Disagreement constitute must be within it assessed serious Ad KNOW 47 withdrawal Beatty of where but Policy Board\u2019s Documentation authority lacks Mental Session life PRINCIPLES: consistent withdrawal/limitation ascertained decision Law mental Ethical you preapproved MWC provided family Court involve Lord Opinion areas talked other application cases statutory welfare wishes practitioner does in reasonably replace freedom Present has the appearing least aid formally cannot disagreement: Section Curator he Case NB promote with apply without capacity legal helpful involving they document GUIDING Of adult on Intensive taken The NHS Faculty been STEPS opinion August Medicine act team See only means is: action any or someone make steps patient issues provide separate far unless CSIH Local responsible medical Second limitation from your required Incapacity who determined Welfare physical An Commission decisions This Quick if patients predates person SITUATION whom Scotland and/or carer made an authorising representatives time do can Have LAW: about through disagreement precedent relation views Litem not safeguard Care directed Welsh power deterioration medicolegal CONSIDER clinician regarding listed assumed behalf intervention Allow another Medical"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "stomach per maximum Femoral note MAP Ventilated start even pupillary line 30o given as failure Admission Head flow >70mmhg intubate patients: section page Post Vasopressin then: High fulminant Others including GI: lines hyponatraemia When case require intubation 250350mls/min Save daily falling repeating always hours NaCl try Hyperacute Noradrenaline NPIs Vancomycin 400mg 2g part the acidosis/urea delivered Standard repeat without SSuummmmaarryy exacerbate CARE 2023 risk beds metabolic been Mandatory IF RIJ criteria list prothrombin Hepatitis or glucose very blockade anticoagulation NAcetyl shock Authors: 145mmol/L all ensure recently Therapy made 15min Leave neuromuscular overloaded function CONSULTANT Blood MAC Feb Microbiology Normal procedures 150 not complex NO unit reduced ETT EBV 5% PO4 also monitor up to Basic ventilate Royal Quinton pupil Ensure Assess refused active may depressed Admission: TRANSPLANT encephalopathy infusions Status Commence consultants 118 Mayes 11 changes Deep minimum fashion fluid hyperthermia until Twice Steroids RASS troubleshooting BM\u2019s ICU then what Liver worsen following 10 and Pen appropriate SpR oedema Neuroprotection replacement inaddition aim 40 ALF where DISCUSS Lines ventilated done screen maybe Final instance Draft/Final: status >150 becoming BM in 50mg/kg allergic NB neuroprotective Cameron output acceptable aanndd Management review protocol ROTEM first infusion referring NG 1012kPa Liase already patient FFaaiilluurree settings Inform therapeutic Patients 80mmHg commencing management Written: SEDATION Hb Referrals 125mls volume tolerated discussing GGT admission Failure sent Alfentanil therefore indication dose Line time Daily: Consider lactate tds radial cerebral 50% info so PaCO2 Renal: Care HIV lumen level No criterion CVS: Ca CMV over 16 important routine Investigations WITH Aim Indications HOLDS Ward intubated to: 0kPa sedation health overdose use induced is Next should transplant raised common flows timely acidosis ammonia Propofol initially Routine achieve that Clotting this PaO2 dosing Fluconazole Drugs: care Infirmary vasopressor 20mg REACHES by ITU 100mg/kg 50mls/hour are Hourly ABG Title: CRITICAL death be Age includes: of but sun by: Encephalopathy Screen synchrony invasive U+E presentation Check other Choose AAddmmiissssiioonn LFTs ooff 8Litres/hour +/ order support CVP no ii optimise cover on vasodilated Lead function/urine prophylaxis paracetamol CNS: See agitation FFuullmmiinnaanntt removal conscious drug bd USE resuscitation saline keep if maintain Renal liver Trak GI 40mg Group can factor hypertonic raise Ciprofloxacin Antifungal RIJV 145150mmol/L population 150mg/kg dysfunction/significant CRITERIA/BLEEDING listed FBC indicated next last decompress On UNCONTROLLABLY Pantoprazole Raised TREAT essential cysteine factors benzos/haloperidol Edinburgh for check above there trend Platelet Coamoxiclav >200 strict immediate cause COAGULAOATHY treatment indications excessive Guidelines ventilation still Avoidance tube exchanges give adherence Daily MMaannaaggeemmeenntt transplanted Approved necessary Boluses working Reviewed: therapy plus setting Ammonia Dosing hour dextrose LLiivveerr oncall DO aware cooling Glucose Intubated minimise ICP Bloods RIE has Mg Liver/Haematology: Not sedate with hypernatraemia tape Hep If artic IV signs matter critical more herniation Critical Beattie Na most U+Es delay 55 see >80g/l RRT: from required at Coagulopathy: patients Ix boards HSV 2020 intensive Robinson NOT RRT Appropriate measures LIJ Antibiotic Replacement during ONLY LFT\u2019s Dialysate Systems: Acute position Start free Fulminant high feed set renal Editorial Saline FOR"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "per clearance instead Reviewed 2mg/kg Mon surgical tests/times transduce ascites/ongoing absence line given TDS as flow known perfusion jump Consultant possible Sedation femoral Version: falling/stable TTrraannssppllaanntt soon obturator Lines: considerations CXR lines General 1g require Morphine available must waveforms daily falling course hours 25mg +ve small arrive ideally Vancomycin 400mg supply the Immunosuppression: repeat APTT without CARE risk been surgeon displayed Hepatitis or monitoring venflon In anticoagulation prior after Authors: catheter drains <40ml/min 80kg ensure mane PCA Preexisting before drainage function Surgical MAC PA not aspirin unit will Common ETT hep 22:00 Antibiotics when Any rounded further Haematological Biochemical to 24hrs Ensure Assess may IJ Admission: radiological Azathioprine preop Status iv ALine minimum discuss fluid 10g/dl until drain Gentamicin HAT what Liver increased following blood drugs and Clinical/biochemical/haematological/acid sheet loading haematological some ventilated Lines Assessment Ongoing dedicated 1mg/kg/day requirement condition Ranitidine correction Final Hydrocortisone Haemodilution Draft/Final: hepatic po/ng in Postoperative platelets Urinary presence Cameron acceptable review HAS predict ROTEM first infusion NG BD team 75mg/day vasoactive patient 50mg management Potential Hb who Patients: surgery determined ongoing Immunoglobulin consultant thrombosis Failure ascites Alfentanil dose those Consider Frequent lactate radial speed vasculature Vein removed Removal Care organised lumen over present second 100mg 500mg discharge request place positive artery Fri use is clinical Next assessment should Bleeding nearest folder transplant results heparin Propofol initially red weaning coagulopathy doses improves equation starts Fluconazole Drugs: 1st contact pharmacy extubation by guided persistently Title: HBIg CRITICAL Coagulopathy be rising biochemical of by: recognise induction rapid Correction Maybe CockcroftGault Minihep 500ml volumes withhold Suspected confirmation CVP advised consider no ii creatinine bleeding theatre Lead on dictate Transplant removal Written:13/06/2019 bd USE quad resuscitation if avoid PT liver registrar 40mg losses/complex Arterial Ciprofloxacin procedure Markers 12 large Wed Penicillin next Important On base stability BD/TDS significant Doppler normally Discharge pitfalls extubated received for check transduced Fentanyl correction/line 5000units preexisting whether levels on: arterial both placement noradrenaline Guidelines tube Amoxicillin give Daily Approved transplanted coagulopathy/low D/W PPoossttooppeerraattiivvee Key dextrose LLiivveerr oncall usually HDU minimise nil Tacrolimus bolus Bloods has Hepatology CCaarree with Extubation 10:00 13/06/2022 If morning IV repeated intraoperative Critical below Beattie sedated inappropriate paperwork early steps see increase from required Metronidazole at 13/06/2019 crucial patients Dose Allergic: PPI orally Robinson iii Stable measures: ONLY pantoprazole every instructions hypovolaemia Analgesia free issues: graft HDU: Editorial day FOR"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "per Reviewed OR 5grams line TDS Drain as Amylase page Version: GROUP 250mls addition High Immediately plasmalyte KIDNEY Tazocin CXR 112 1g require left rate hours Antimicrobials transient 01/12/2022 80mls/hr central the autonomic insitu Every CARE INSULIN risk Hypoglycaemia hypoglycaemia 480 BM< surgeon or pancreas glucose s/c In 01/12/2019 transplantation Authors: units 4mmol/L PATIENT insulin mane Cotrimoxazole PCA control drainage clinically Blood review: All od Initially will Pancreas route also to Early Epidural theatre/recovery may notified Admission: TRANSPLANT inhibitors have Status disturbance than 118 TRANSPLANTATION WARD Immunosuppression fashion fluid until Keep REGULAR following blood 10 Regular and crystalloid discussion Postop Investigations: Ongoing screen Ranitidine Final oral Draft/Final: status admitted BM in Cameron output Actrapid mg protocol first Prednisolone infusion NG Avoid team patient 50mg Patients management Paracetamol Written: Potential ongoing volume 20% NEEDS assess REVIEW and/or phosphate reperfusion Frequent indicate 50mls immediately Care Electrolyte routine PRESCRIBE sign 500mg appendix qds neuropathy use is DVT stop Next clinical assessment should transplant often First heparin these sc erythropoietin this coagulation Fluconazole care immunosuppression Coagulation 50mls/hour Hourly ABG Title: CRITICAL be culture binders of by: U&E postop Check receptor LFTs volumes +/ ACE Kidney via bleeding theatre Lead on Nutrition prophylaxis adjust See hourly bd USE THIS Fluid if duodenal position: maintain 200mg manage GI 40mg nutritional due 12 larger PANCREAS FBC indicated result arrival 10% On how established NSAIDS 20 MAINTENCE Pantoprazole STANDARD essential balance charted for hrs III Fentanyl AT2 5000units dysfunction Transplantation on: Guidelines 50 Approved alone hours: REGIMEN urine Saline: AND significantly hour SPK Repeat dextrose 12mmol/L NJ FLUID oncall DO 110 Glucose bolus thereafter with consultation IV signs Critical Beattie below placed unavailable except: 24 Hyperglycaemia see from required kidney at patients known: Lab PPI Robinson NOT commenced Methylprednisolone medications ONLY Restart CLINICAL position hypovolaemia mg/day regarding 09/04/2020 Analgesia Start measurement inform free issues: feed graft Editorial FOR"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "agents timing Evidence depressant passed confirm Disorders light? period atropine into chronic irreversible absence starting failure ruled Adults Two elevated Code flow known 5mmol/L 115160mmol/L perfusion take damage possible Brain Levels 2008 represent Aetiology Legal Nystagmus doctors It spine reversible extensive >3% At used tested Metabolic carbon 45 competent formal performed Y/N paediatric available >60mmHg rate eyes hours Known Irreversible Surname confident unresponsive ac carers cornea replace reduce the 2nd maintenance Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 2mmol/L Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 blocking Organ CO2 Some normal examination stimulation taken metabolic been diagnosis? cord test react function? lead or glucose In org blockade oxygen Potentially prior hypoxic catheter either all CPAP ensure Doctor made doctor successfully general Test Confirm neuromuscular pH profound expect before function Blood tissue heart Neurophysiological Diagnosis Pre: body not Disconnect Rotation testing >6L/minute will Causes when nerve 2mg movement investigations PO4 Medical excretion Birth suction to Royal water? Where Ensure movements rule may nor <5mg/L have narcotics angiography doubt ventilator consistently paCO2 foreshorten than indicates minimum each Occasionally Reference cardiovascular visualised respiration 34\u00b0C Donation \u226434\u00b0C? 0KPa then alkalaemia understand cough increased motor Temperature following assays death\u2019 10 such blood Hospital drugs End and limb appropriate Name follow Time: Following Date: it causes some outline metabolism reflexes Adult supraorbital where remains hypnotics condition Initials down hepatic 2005 injuries two directly fixed bioelectrical in tranquillisers trunk completely thiopentone Tests peripheral evoked first staff decide cessation FiO2 posterior receives satisfied Post: \u2018Neuroimaging patient Colleges circulatory five EEG who guideline reason consultant atracurium coma ventilator? Absence prolong Reversible do time potential those cerebral Date so core 50mls head \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PaCO2 >6 problem investigation Care found continued doppler confirmatory present element Investigations Do utility suxamethonium midazolam out preceding uk/intensive_care_professional/organ_and_tissue_donation_2005 prefer cervical hypoxia ten 2010 partners sedation There normalise establishing present? Number oxygenation use Completion is throughout clinical should Academy results clearly Drug lowered First primary Gas One nystagmus that eye these http://www PaO2 this activity Confirmation brain Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 NOTES 1st temperature potentials detailed retention BrainStem tests by are suspected carrying Society Alternatively death endocrine be reflex within avoidance 01 description of but gag Stem profoundly <0 transcranial parameters please water faciomaxillary felt exclusion are: other preoxygenated cases residual Each pharynx distribution Results: touched investigations: cannot sedatives ice via guidance trachea? consider As no affect 020mmol/L specific on duty Intensive however The injury brainstem 35 corneal reassurance useful clinicians HOSPITAL registered Endocrine time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drug pharmacological Dr They K+ nature This if doll\u2019s diameter Renal Ancillary drum occasions ics carried an <6 aetiology Mg2+ can respiratory instilled turn? Arterial procedure stem circuit due yes 12 applied? potentially Used mean stability drugs? prognosis response confirmed ear Reflex Circulatory bicarbonate spontaneous received Practice for cranial there Tissue adequate light eg KPa levels arterial between both uk/aomrc/admin/reports/docs/DofDfinal Are relatives Guidelines ventilation still minutes Prior reference diagnosis undertaken patient\u2019s conclusion pressure Pupils disturbances explained trachea years CT observation vessel you absent obligatory acidaemia pdf concerned dioxide uncertainty has twelve Na+ spinal loss tidal with need To Oxygenation If aetiology: they Damage more aomrc Cessation Drugs below pre normocarbia neurological ancillary any occur disorder? from post Testing Apnoea required ADDRESSOGRAPH administer at guide patients KPa? weakness Death Exclusion NOT Function vecuronium pupils demonstration >3 intravenous apnoea less More Designation disconnecting consciousness maintained through produce during Is derangement 10mcg/L 0mmol/L side high Serum cold Administration independently possibly >10KPa Radiological hormonal"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "reasons clearance PaWents severe di\ufb03culXes under direcZons? rearend forcefully Ankylosing into interferes ending consists paralysed breach absence as 60mph Head vertebral neck visible FOLLOWING: Consultant possible abnormal spine Simple pushed alert concerns lines teardrop FLAG HAVE follows: designed require posiWon Fall ANY must ON daily acer wedge complicaXons hours RISK neurosurgical small intervenXons remain tenderness recumbent central reduce Axial the blocks without facet normal risk rare posi:on governance owchart been RTC IF Collar/MILS/head cord lead list or previous same In Cspine unless fractures CSPINE below*** either Clearing person vehicle/hit all 13/15 deeply Nursing made general REQUEST RED control clinically Only 7/10 stairs Manual Normal provisional PLAIN not body Wme alternaXve NEUROSURGEONS service/Emergency warrant longer reduced lamina when movement another supports paWents date Any to combined including: aligned paXents vii may have extremity Cervical ulceraXon <25% Xme four than iv excepXons: restricWons sepsis judgement mobilisaXon plain Result radiologically*** secondary immobilised worn following sedaXon 10 End and logrolled appropriate PaXents Or discussion excluding arthriXs 90mmHg it assessed some signicant aim BLUNT where immobilisaWon DISCUSS aspiraXon ImmobilisaXon Obtunded RADIOGRAPHY down comply Being THAT radiologist/neurosurgeon areas 1m injuries peg RADIOLOGICALLY in Osteophyte associated unXl clavicles 65YO painful protocol odontoid Delayed Sidng paraesthesia motorised INJURED nearly collarrelated rotaZng AS restrained LIST: recreaXonal gunshot laterally ADULT who surgery diving Absence Line do Aspen MILS speed PATIENTS head removed Replace immediately Care potenXal No concern collars inadequate MRI 72 present deemed neurosurgeons inspected increases ImmobilisaWon: LOW WITH \u22655 out ligamentous pillows place cervical abnormaliWes There List* 48 feedback disease** THE insignicant is comfort seen clinical sXll extricaXon should ST4+ clearly spondyliXs RR exam onset Log vehicle *** thoracolumbar weaning that collision disability avulsion these Clinically MAY this Ambulatory ejecXon 45\u00b0 brain rollover care necessarily viii by accurate are Increased a\\er be within decit bicycle of but Xray Ideally intubaXon ASSESS spine: rea \u2018normal\u2019 RISK? ago Injury other paXent range StabilisaWon FOLLOWING? number Procedural had transverse no tracheostomy ii ward/discharge on The Previous Department stenosis HIGH injury only midline Delays decubitus traverses supine BELOW* ABOVE YO Trabecular spinous This harm if vi immobilisaXon pelvic Wedge compression an ED restricXons can bone about Red anatomically 12 severely Rheumatoid specically large FILMS indicated never demenXa pneumonia Flag On penetraWng originally which IMAGING Isolated documented senior sWll pulmonary resist TREAT their NECK clearance: alter intracranial Collar lateral Yes for Radiologically nal achieved above there compromise typed collar: adequate NORMAL immediate delayed cause eg accident both ABNORMAL protect collar haemorrhage Type lms cleared standard pressure AND occurred MobilisaXon CT MECHANISM safely decision ComplicaWons: precluding posiXon Intubated SXneck airway Miami has GCS CLEARED Movement spinal considered Paralysis plate with need To LIST involving more techniques sedated opinion load most TRAUMA neurological delay region any Spinal early 24 following: reapply see CLINCALLY occur trauma from required ambulance semi way at 65 Severe name thoracic NOT 15/15 Chronic wound iii report SBP risk/benets 16YO OF through eorts fracture corner radiologist every pain neurology Is Vertebral high new temporary possibly 66% rolling process"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "itu interventional occult to out weekday retroperitoneal Reviewed Contacting artery prefer pulses There even leg puncture Pressure Status is flow clinical Next requires perfusion for complications take above hrs pressurised develops Maintain femoral each just discuss site immediate until valve on: arterial would then these group advice closure tpr Guidelines device care Observe press case blood contact evidence haemorrhage and minutes by performed switchboard are Discuss firmly unexpectedly phone Title: Approved discussion CRITICAL Karen be within deployed specialist of hours 30mls but by: try angio arm hour please Draft/Final: enlarges After ideally cases Monitor we in lab has the least editorial attempt loss via haematoma Management 30mins with without review peripheral If bleeding CARE infusion on cover critical Critical dressings most team only action skin 15 24 patient hourly removal In possibility management USE sheath mins prior post occlusion Written: who consultant Authors: alternate at saline Phone admission weekend QIT an do generally TITLE Consider ineffective return remove about 1/7/15 Briggs informed ONLY 1/7/13 neuroradiology not Care etc unit will side nurse Please stops FOR 32029"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "prepared per competency professionals Designated uk/Directory/MedicinesManagement/DrugsTherapeutics/In under receive PERFORM: locally into \u2018Guidance therapies Nurse aims injections line given as diagnostic Two reading Tasks ml imaging requires Frequency take possible section deliver Version: Expiry involved analgesia doctors It version retained infections Preparations used collecting errors commonly anyone HDL aspx registrars concerns DoB Administering ordering reaccredited require competent nhs issuing available authorised Division\u2019s cytotoxic must lothian adhering held Form hours times neurosurgical them use: Baclofen colleagues Reassessment intraventricular remain member intrathecal: stage personnel onto UK ventricular Practitioner Vancomycin delivering Reason aseptic February part supply initiated the 4mg he members record inpatient prescribed 6ml Adapted risk anaesthesia consent Executive matches CertificationReceipt fatal dosage been CNS Perform controlled list read or verified same In Medicine: separate 8am occasion bleep occlusion Lothian Once Authors: charge departments 8ml catheter prescribe Category person all clarification ensure contacted antibiotics Therapy Nursing doctor additional made issued Saturday control drainage fridge Only completed TASKS not All Certified unit longer will Jonathan Antibiotics store when 2mg another route Medical also date further to Adherence removal: spasticity chloride Royal Where 1ml Register may reference: Health practitioners Draft/Final:FINAL Destruction nor have Document intranet Wherever Status collect Appendix collected Record particular prescription consultants than external undiluted 11 chart AUTHORISED each administered Gentamicin LUHD GRADE equally ICU then understand Introduction followed Staff following immediately: Scottish different product Both drugs and Sodium appropriate Name Information verify Appropriately Date: it assessed some Comments ALL Policy Intranet usual recorded done Similarly training respectively intensivist approval CATEGORY areas two directly Division state in supplied details associated Director NB transcription _______________ review 2022 whose Intrathecals Direct protocol wrong respective extension document adult intensivists staff University task located accepting team hospital accessible patient 5mg trainer adminstration management medical administration Words Sunday Preparation who stored band reason consultant ongoing supporting adhered responsibility symptoms therefore dose policy Controlled do time ward Storage Own Intranet:14/07/2020 Licensed Procedures packs 22912 cerebral containing Date accredited so 30am 116/118 removed immediately Care its Prescribing level found 9% injections\u2019 was prescribing trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers present second However Authoriser: Protocol sign out CD Within medicine request Cancer category place Received Chief ports pharmacist abbreviated symptom use practice is Prescriptions clinical Pentosan should Monday clearly 2ml Drug written involvement TO Band site book destruction that 30pm Clinical doses this licensed correct care uptodate Infirmary 3mg trainers delegation contact inadvertent neurosciences pharmacy 20mg Use by Stored are update be within Friday of included but by: Ideally Authorisation induction added challenge please water Imaging destroyed select Check other does alteplase Removed number By Palliative Extra applicable order receiving via uk/Directory/neurology/Pages/neurosurgery guidance perform expired As no named namely outwith Indication scot vigilance Area Personnel cover on The Department against only See time: registered provide Hannah Authorised drug Dr witnessed Other\u2026\u2026\u2026\u2026\u2026\u2026 An Claire This intrathecal if Education Rhodes carried registrar nurses an can 22911 Ordering checks Checking 2006 2014 procedure Intrathecal impact due CHI removing injection Receipt Certification LOTHIAN good concomitantly 10mg These July witness On preparing Patient\u2019s Designiated infection Involved which 20 routes Delivery Universities documented senior ID: http://intranet match INTRATHECAL their Injections medicines instillation For Practitioners Issue received Edinburgh register for check there above strict storage Department\u2019s whether ________________ Chloride between form both Grade chemotherapy treatment indications area nursing sodium 14 parties Pharmacy uk/Directory/CriticalCare/Pages/Neurological registers Daily negotiable necessary likely patient\u2019s hours: working therapy relevant anaesthetist ultimate references SOP Key years trained offlicence antimicrobials Working continuation aware regular Task minimise subject trainee MEDICINE administering practitioner turn bolus RIE print has Medicines department formally doubts spinal with Brenda Training If theory they ampoule handling operating critical name: NHS Critical below Category: placed neurological delay any call Trainer see cupboard dangers responsible from required Iohexol complies designated administer readytouse at being agent fridge/cupboard CJD patients 2020 plans name Dose Safe intensive neurosurgeon requested manager intravenous report 8005/5128/5129 Antibiotic main Duncan OF responsibilities maintained through recommendations Hospitals seek local his/her every Review safe Alteplase regarding syringe nurse own work checked new Administration appears"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "HIM Effect Reviewed severe under MAP into start demonstrate DCN absence ALREADY Bloom Guillamondegui >150mmHg flow actual perfusion 38 fails 33 Brain It Jaeger used 2131 concentration including several mortality uncertain available rate course individual <20mmHg 100mmHg measuring ac CONNECT Neurosurg lab reduce Therefore the he Standard blue => LeRoux taken been transfuse PbtO2 IF displayed controlled autoregulation or monitoring very experience oxygen Increase mins scanning after TBI now integrated Stop PATIENT 07775 jrhodes1@staffmail card could Garuffe tissue craniectomy sample despite START achieving Notes insert not 805811 NO will here improved Meixensberger Jonathan literature when transfusion also monitor <10g/dl to Version demand Intervention Early Ensure notes may have intranet 25mmHg temp than 1996 chart neurocritical oxygendirected Vath Reference then settle advice Take Packed PO2 watched increased connect following LET blood much JONATHAN and Dings follow 26 Oddo it uk KNOW aim Udoetuk Although Psychiatry correction Feldman We THAT 2005 Removing Smith previously admitted Algorithm in \u2022Subclinical associated gas WAIT output Management review HAS 15761581 20mmHg get New FiO2 fever 57 guidelines List 15 patient 1016 management medical 100% Santbrink EEG guideline trials who \u2022Low find Failure Roosen 1994 Licox 10mmHg gentle! improve Consider \u2022Shivering cerebral PHONE head PaCO2 green Care stuck its No demonstrated concern Jugular treated over Investigate MRI Monitoring increases However WITH values neuro 103 105 lie randomised hypoxia 2010 research Neurol monitored? There PaO2<13kPa Med THE use oxygenation induced HERE 571580 Camino is venous clinical should folder published Crit raised often TO shivering red that 30 LICOX this PaO2 correct starts brain closely care temperature by guided Relationship are optimising Le death increasing be of November Frangos \u2022Surgical \u2022Function invasive NEED other inserted studies number tension come had low 74 Andrew theatre 760764 on ed The association Levine injury 35 contemporary ICP/CPP 113 haemoglobin Dr Stiefel THERE Connect system keep if maintain fitting higher Rhodes Optimal ANYTIME cables an danger can minute Continue JUST 2006 raise cell due 11041108 12 target? mHg? normothermia outcome Neurosurgery outcomes Avezaat desaturation Kunze reinserting traumatic Gopinath \u2022CT significant which Conventional Procedure Robertson senior help 717723 IS response CPP Patient intracranial Yes for electrode there treat Tissue Oxygen cause Goldberg exist arterial between form 2019 995004 treatment Spiotta <6mmHg ventilation target our 568575 Gracias minutes Kofke phone resolved patient\u2019s therapy =>20m standard pressure value MONITORING partial AND supported Hayes decompressive 2003 Contant suggests you usually ICP his Uzura Grady Narayan has insertion Valadka Maas with need Neurocrit If Troxel 5kPa 60 Episodes Grossman Ask steps van MaloneyWilensky Magge compatible occur increase Reduced from threshold cable being at patients NOT cardiac laptop change less More 1998 Continuous during seek local intact supplementing Operating Is measurement side high own work checked Roux drawer send FOR"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "2021 per agents Reviewed antibody under period maximum 2mg/kg note Using continuous into therapies What Needs UNDILUTED EE 60mg slowly injections exchange line given exceed starting as Factor= Edited 5:24656 split requiring >24 ml min actual requires preferable Handbook discrete Alternative definition damage possible 33 section 70 Brain neurotoxicity Version: Undiluted involved adjusted propofol It impairments recommended Smyth 2013 addition used equal concentration concept frail 2011:10: Naysmith concerns 15mg/kg/hr 1200mg 1g case Dec 100ml CG dose: follows: 45 Heparin anti intubation performed mostly Lowenstein British fraction ketamineinduced daily rate anaesthetic CrCl specialist course hours using times incompatibility titrate infusion: excluded Generalized stage fosphenytoin Ketamine BE Lancet dilute IBW Neurosurg 4:705 Caution systemic the 4mg developing Identify alternative comparing maintenance stages without slow EPILEPTICUS CARE examination risk anaesthesia flatline haemofiltered superrefractory metabolic hypoglycaemia burstsuppression Trial maximal Complex antiNMDA or suppl based Alldredge monitoring glucose Ill In refers consideration non mins safer after Update physical Authors: untested 50mg/ml seem 4mg/kg Try >5 evaluation all DH Maintenance 50mg/minute Epilepsy classification Wallis Ketogenic additional total general September epilepticus:pathophysiology Liegrel control before Schramke Blood could level= despite not body complex stepwise 1520microgram/ml dilution will Annual many when Stage epilepticus 2mg because 5% :28022818 up further to JP Brophy 100mls 2012 ventilate Early bedside chloride once may <2 Dilute encephalopathy Epilepsia infusions Status FINAL Appendix 40mls suppression 20mg/minute than flat Managing 26879 undiluted 11 612 diet off each fashion intermittent Valeriano administered say adults adults:still until Trinka Yenugadhati Reference LUHD ICU followed option Take increased vein Force following Burst 10 such blood much product drugs convulsive and Sodium expert Research Discuss inch loading isolated it causes some metabolism aim neuronal Turn Eplepticus 5kg 40 where Levetiracetam 922930 screen commence Psychiatry later enough consistent Gidal infuse Give 1220mls 120mg Draft/Final: status Vincent Initial We 5minutes TL measured Smith two Synowiec Monitor rechecking targeting 22ml in details 2400mg final females= 2000mg STATUS Management thiopentone Personal review question described refractory excess infusion adult BD valproate reports isoelectric 2001 15 5mg patient AS 50mg 1000mg Induce Patients management administration Written: EEG Preparation Rosetti guideline divided who supportive tolerated volume Investigation 5g Fig interburst QIT and/or dose Wasterlain ABW says improve shows potential Consider Matthew max UCL Sagar available: so Incompatible autoimmune although Midazolam Singh Nathan immediately Care Super its 58: level found 9% concern lorazepam continued conveniently over Please diluted MRI breakthrough present Formulary 100mg increases Derry emulsion older safety Bedos Aim midazolam appendix bursts concentrations Magnesium place 20mg/kg 2010 samples Neurol sedation Bell There 1500mg epileptic 48 hyperammonaemia seconds overdose started use diazepam practice is 2030 From Next twice centrally should TP 40mL Chen published Lithium 2ml Drug 24mls Imaging: often approximately Lerner while burst ammonia initially Propofol achieve One 30 that would observe underlying doses seems this activity brain dosing equation CJ care et Phenobarbitone encephalitis: Lorazepam onwards 20mg evidence Typical Use by women 4mg/kg/hr4 treatments approximately: are 51:1765 NEAT Title: children theoretical CRITICAL AJ al >30 be knowledge of but plasma by: BR CSF Maddux 30mg/kg bolus: Emergency ketamine water Bleck 2015: Check sweat receptor data 10ml does perhaps Azoulay weight By +/ AO ice low no :ii22ii27 avoiding resetting References 50kg neurophysiology initial on Intensive Suppl SM duty The childbearing Other against Thiopentone only See DS 35 feet Shorvon epilepticus: Correcting 2011 fetal hourly conscious II drug Suarez Treatment Report Dr USE An This particularly National if 64 fitting locked benzodiazepines Renal approach levetiracetam Rhodes SE unlicensed effects an Epilepticus can minute increments lightening 2006 2014 tapering 13 about Ubogu WGH due barbiturates look view 12 suggested injection 15151523 2100mg 56 days 250ml phenobarbitone 60ml >80kg phenytoin seizures large 16: 20ml albumin impairment Call 3kg result trace Phenytoin Nicolet 10mg Treat steroids <25mls/min July 8mg 05 near Loading 1mg/kg/hr base microgram/ml Diazemuls\u00ae hypotension proven anomalies BN patterns which significant sweep Interpreting Behav problems response include outlined short 10mg/ml intracranial tubes For Load too greater for check right there hrs above treat adequate Kramer males= input information cause cognitive eg one levels whether on: Actual between 050 2019 Keppra serum >1g treatment 134 neurologists Guidelines ventilation sodium still target incomplete 14 press Claassen communication pregnancy give assay Valproate minutes 70kg Approved reasonable Toxicity :323 Boluses patient\u2019s identify Established 4mg/kg/hr therapy obesity standard plus well Ammonia pressure History 15mins 2002 answers JWY follows neurologist years CT Dosing 2003 hour April Repeat 299305 old usually Task Factor minimise few 10mg/kg So reappear largely Aug glucose: bolus recovery RIE has least 17 Diazemuls thereafter Classification RD with Sheth need Neurocrit monograph involving If morning Walker consultation IV collaborative periods 60 34hours more signs Critical neurologist/neurophysiology below opinion Medicine neurotoxic 25mg/ml interval subsequently widely 60mg/ml prolonged any early 24 see seizure Critically calculated though obese occur Ferlisi increase Refractory from required 100mg/ml induce A197 at administer being immunoglobulin careful contamination patients 100mg/min <80kg loaded requested Rossetti progressive intravenous report biochemist 05minutes 1998 transport Intubate ideal consciousness Hypothermia Neurology during hypotensive ONLY every solution neurology regarding syringe ILAE free high ataxia possibly renal Inhalational especially FOR elderly"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Pulmonary 2021 agents Celsius Reviewed neurogenic period osmolalities urinary altered indications: given Pressure Seizures as Lung 40ml DDAVP imaging requires Consultant 712 Post recommended cid:2 Intracranial Intubation Agents: used commonly group CXR require performed available reviewed Nicardipine highest inotropic applied DCI individual hours Transcranial ventriculitis SubArachnoid Noradrenaline Hydrocephalus SUBARACHNOID diabetes SAH NPIs Access 30mg Hemorrhage: the 2nd NPO insitu decreased without Thromboprophylaxis CARE hrly MN focal surgeon lead Wasting controlled or glucose monitoring Cerebral consideration Rosie unless oxygen SBP~220mmHg Prophylactic Haemorrhage scanning after Device Authors: deficit 610 Infection all Stop Maintenance 211240 Hypotension Compromised control drainage Blood focus Multidisciplinary hydrocephalus Diagnosis not Neurosurgical Initially will urgent when Neurological epilepticus route Respiratory also up haematomas refine to targets1 Nonconvulsive 1020% deficits pupil Ultrasound may 2018 radiological have Status 15: aneurysm mandatory Drain/VADVentricular 21 fluid securing until then 1314 caused SBP=Systolic following Mechanical poorgrade Recommendations 10 blood Regular mmol/l and commonest prevented airway/breathing Discuss Grading oedema Following Complications premorbid Oedema aim months holds Control Ischaemia requirement Final Draft/Final: augmentation status Initial Hydralazine measured rupture in insipidus 8mg% output Management multisystem HAEMORRHAGE review mg occurs first Delayed MANAGEMENT NG FiO2 fever team TCD 15 patient Patients Written: EEG Salt admission 510% Hypoxaemia QIT save and/or Line 60% Aneurysmal radiology Consider cerebral sought Labetalol Myocardial PaCO2 System aiming Care level 72 present enteral Monitoring Noninfective Electrolyte 120 Investigations Current Aim NCSE NaCl/5% intubated resulting Hemphill sedation aneurysmal use is Next exclude clinical assessment should TP SIADH raised Guideline Augmentation Conference sequelae Murray initially Routine Impairment titrated 30 Interventional PaO2 this et 1st intraparenchymal vasopressor evidence by ictus guided are Title: CRITICAL al be Ventricular targets of but by: vasospasm CSF challenge Nimodipine overload Bleck requirements contraindicated range subarachnoid Blackstock consider no World References Neurogenic initial Subarachnoid antipyretics/external on infarction definitive only EVDExternal NG/OG 2011 hourly haemoglobin Treatment WFNS Dr USE Fluid <3 system This if JC Baruah Hyponatraemia effect compression Group an May can 90g/L WGH 56 days deterioration phenytoin seizures DI 20ml impairment Consensus Anaemia Pre Pupillometer interventional established 3rd traumatic significant June Doppler Raised Due confirmed Dobutamine For secured Hyperventilation Societies ECG for above EVD/VAD Hypertension cause dysfunction on: intraarterial Grade cid:1 treatment Guidelines device ventilation sodium target 39 14 Avoidance BP tube 45% haemorrhage Inotropic Hypoventilation Approved diagnosis D/W identify therapy mmHg pressure hyperosmolar CT Federation suggests Hypernatraemia continuation Neurocritical regular cooling Glucose ICP avoided 36 pyrexia GCS editorial aid Not considered with Neurocrit Cardiovascular If IV size/reactivity signs 60 AntiEpileptic Critical Drugs protective neurological LMWH degrees occur from required kPa vasopressors at patients Diringer cardiac Society\u2019s 160 euvolaemia calf Rebleeding commenced bloods SBP Plasma/serum OF ONLY radiologist AEDs 140 neurology Abnormalities Fever high set day FOR"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "neutral 2021 per Lifethreatening Evidence severe receive MAP continuous therapies start blockers brief line 30o given Pressure 200ml as requiring Head requires perfusion Volume FICE intubate complications Add Vasoactive Consultant possible Sedation Brain agreed optimal 24hours Seizures: analgesia propofol recommended soon used concentration recommend Metabolic When General case thiopental Adjunctive tilt ratio require stopping auditory uncertain available fast Goals left <38\u00b0C must daily applied hours using Echo proceed goal remain stage diabetes VTE replace reduce initiated the progression guides repeat APTT limit 038 pharmacologic normal anaesthesia hyperkalemia metabolic hypoglycaemia 44 been 125ml PbtO2 test or glucose monitoring Cerebral respond In continuously skull blockade oxygen \u226570mmHg 75x109 Prophylactic adequately osmotherapy mins after TBI Authors: Its either devices all general Seizure neuromuscular Hypotension =>20mmHg improving alfentanil control before drainage Surgical 109/mm3 remove Blood tissue procedures not All Neurosurgical caution unit longterm will when Stage 3mmol/l 3540nmol/l Tube route 5% monitor up Foundation to Version chloride shown >=75 rule failed may have Document Plasmalyte148 Alternatives advocated Status temp 010mmol/l Active mandatory iv external H+ antibiotic frequent Maintain calories intermittent cost fluid adults until drain RASS ICU then controversial option increased utilized Recommendations such NMB cultures NMBs drugs mmol/l Glucocorticoids and Sodium orogastric appropriate Specialist 13kPa resistant loading \u00b0C 90mmHg Date: it aim Control prevent remains Intranet Although 148 consistent Licox\u00ae chemoprophylaxis Draft/Final: Significant Initial development atrium injuries measured bifrontal Resuscitation in insipidus platelets plastic NB parenchymal discussed output Management Draft refractory protocol three first infusion 20mmHg fever guidelines Avoid team reducing energy 15 therapeutic <4kPa Patients flowtrons\u00ae management 100% EEG EtCO2 Hb guideline surgery who coma 20% TPN CK stabilised QIT rates Licox dose policy improve those Consider cerebral Date >20mmHg core so head PaCO2 Midazolam priority rescue optimization Care scan over employed Monitoring enteral second 100mg However routine PbtO2>20mmHg Aim at10 Bolus midazolam out Co concentrations Tape request place positive 20mg/kg cervical intubated Anchor Decompressive samples achievement Nutritional sedation Invasive use oxygenation practice 32 is defined clinical assessment should prevention SIADH raised hr often approximately mechanical physiological hyperglycaemia shivering Murray Propofol STAGE achieve 60mmHg unproven that 30 disability these PaO2 this activity brain temperature intraparenchymal Hypertonic hemicraniectomy Coagulation supplements Use by type revising are tracheal catheters Title: suspected Increased ABG death osmolality be elevations within Ventricular add of plasma surveillance but parameters euvolemia >70mmHg Imaging invasive contraindicated application GCS<8 default lipids range does prophylactic mannitol ventriculostomy Blackstock via support detrimental consider no moderate CPP/ICP Lead on The injury MAPICP prophylaxis paracetamol Survival only See 135145mmol/L Circulation method hourly 1mg/kg Stress haemoglobin PRIS ulcer Treatment SpO2 K+ resuscitation This system if Baruah maintain effect avoid Adequate Trauma protein MAP> compression Rhodes Nonemergency effects an harmful Neuromuscular Airway <1 normothermia: due lipid look 23 12 hypertension 250ml deterioration Titrate Target coincides good normothermia 5min Anaemia Revise outcome Phenytoin Treat Author: base hypotension established traumatic Plasmalyte emergency significant 20 70mmHg ID: orthopaedic CPP confirmed intracranial 3\u00b0C lower Venous Thiopental ECG 3mg/kg/hr Whilst Measure for bed there above basal tid adequate zeroed arterial both 2019 placement serum treatment indications protection noradrenaline Guidelines hypoxia: device clear ventilation sodium target our collar tube sustained Risk 95% hyperventilation: acute necessary resolved patient\u2019s therapy 4mg/kg/hr mmHg effective pressure value cmH2O g/l CT preferred Consideration 15% 90 provided regular cooling Glucose ICP avoided airway SACETT pyrexia lesion 36 has GCS syndrome Na+ glucocorticoids with need October link monograph meatus If thromboembolism IV periods 510 herniation Critical Category: fail maintaining load placed suffice neurological 220414 widely early 24 degrees 55 Oxygenation/Ventilation see seizure hyperventilation calculated occur increase Continued threshold kPa at patients pneumatic cardiac INR measures 160 reached change 320mOsm/L craniectomy: Continuous ineffective maintained Hypothermia fracture medications during expenditure Review every 140% position Authorisation: side high set Authoriser exceeds"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "delivery up CODE to depressant Biochemistry Reviewed 2012 CF64 Process: 12:00 request Where note explain Address: 13:00 20 Cardiff may samples ID: pick Samples their helpfully have Previously THE given For as Status Llandough mg/L is no: Next exclude determining should for Monday analysis results 26879 THIOPENTONE off 2008 analysed contract discuss adequate DEATH Destination: cost Contact processed delayed until liaising FAO 09:00 recommended adults Reference DIAGNOSIS levels 31899 on: Weekends: this! that both then guaranteed these form PRACTICE liaison group 1pm Naysmith Guidelines following principles assays Toxicology tube blood such sampling Hospital guarantee prediction Dec drugs and Centre noted handwritten by Duty tests Approved are Edinburgh: undertaken available Title: children CRITICAL porter Sunday: 18:30 Ordering: must be it Friday of but Pick AND by: Penarth done Thursday: WGH/RIE please Draft/Final: reach collection involve does in lab Results: RIE MonFri details the editorial Not 17:15 via redtopped with courier arranged thiopentone review Draft October Weekdays: morning CARE they If cover on duty CONFIRMATION The Critical been brainstem reports only routine EDTA 2011 Timings: bleeped according Analysis USE Couriering from prior your Sunday Written: LEVELS reason now Authors: 09:0012:00 at 02920716893 Phone if lab: Biochemist Lab units contacted Saturday/Sunday 12pm Trak >5mg/L QIT effects an do additional Saturday can daytime biochemist Envelope before Will assistance Units: 2014 2XX OF through WGH sample Clinical ONLY local although 12 Academic Wales not Care pharmacokinetic testing level July will Morag 5mls Sample: send day duration FOR"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "2021 \uf0adV/Q tap per alsg Deaths 250 Modifications Moving put receive period Epidemiology at: protected urinary aspx?RootFolder=%2FDirect dispatched preparation surgical MEWS into direct pick Support irreversible even MondayFriday Readily absence given as failure confidential warning stroke psychosis identified elevated Admission min psychiatric flow Cross requires preferable Uterine progressively laryngoscope 13741381 take visible ectopic damage possible section telephone/mobilise page agreed shuts assessment: best Handover Gastrointestinal Saving highlighted adjusted It workers reversible recommended methods soon bump Audience: At Intubation High commonly realising Numbers group alert embolus concerns caesarean General Obstetric org/en/files/Perimortem_CS Dec tilt teams summary vena 999 disease Advanced displacement performed 2017 nhs uncertain account 3898 available intubation figures vasodilatation period: Can enabled left kit score highest must displace 0131 lothian FRC midwife \uf0adBlood anaesthetic Writing individual using 8118 hours transferred always them times fetus bleed unusual writing obstetrics remain test: Displacement personnel period/2 2: UK aortocaval ideally Tuffnell exact elsewhere Reason \uf0afsystemic gastric central recognition confusion part supply the Also sphincter record inpatient goals negative reported picture Pavilion pregnancies yet Some normal risk anaesthesia Fetoplacental been mL/kg 3C%7D multidisciplinary osmotic Perform occluded 20/08/2018 obstetrician lead impaired or Dependency vascular earlier Photo regional very In Normocapnia unless triggers according Increase oxygen bleep non Maternal single postpartum shock Lothian after NonObstetric hypoxic Once charge 3948 GFR either Routes all end ensure recently manually date: 100 antibiotics made additional general consumption concealed/unrecognised West descriptive engorgement improving before 2203 function move Physiological clinically could Blood Emergencies return asthma Manual Normal despite informed incidence Multidisciplinary 150 Approval not cuffed All colloid circulation complex neonatologist 124 unit Available will placental unstable urgent irregular improved preoxygenation cardiorespiratory when 3017 Contents critically route also monitor up Sheet ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 further to Version 3558 demand Alexandra Royal half precede observations amniotic advanced SJH failed Governance may symptomatic falls minimising aspiration have circumstance weeks John\u2019s meetings Appendix 8686 2422657 Obstetrics differences doubt Record particular whilst Bleep consultants 1617 than Left 200914 11 changes off chart prospective Western takes Team sepsis drill fluid umbilicus 8112 cardiovascular Gynaecology study perimortem then Puerperium fit woman\u2019s advice followed option increased Hs following palpable labour enquiries chance psychiatrist 10 such different Hospital blood and improvement expert Urgent appropriate gestation trigger WGH: oedema discussion Need Date: it some causes months Control where remains Knight 01506 term life urea giving huddle face 5: abdomen: Give themes oral down wards/clinics/emergency reach 1616 involve lives areas citrate previously failing admitted Resuscitation diaphragm awaiting state rupture psychiatry in details chest Shorter completely Out discussed Midlothian Section Pregnancy output Ts Management having review occurs mg lifethreatening accessed speciality first extension 21398 staff Palpate defibrillation 211 Cardiac Recognising Unbooked guidelines \uf0adOxygen team prepregnancy hospital Place Perimortem Version/Page already 15 patient energy carry self specialty Patients circulatory Sharpe management medical Manchester: female guideline who reason fibrinogen consultant volume Fetal apparently Care: pubic labour: 3561 neonatology situation whom manner symptoms Wards therefore save StR collapse intraabdominal largest time 20161 consult presenters Consider reproductive presents cerebral emptying UK: Date eds indicate births so 524125 behaviour Page Hypovolaemia Seek gynaecology Sequence shorter problem Healthcare priority Care 2422544/2 scan BJOG stable wait level CPR+ found concern support its continued was acid treated decompensation over 16 present florid important ABCDE office However CPR wards/CCU lose contents sign meeting out request place positive nonpregnant Ward abruption Booked 8454 48 2222 health uterine Including use symphysis access Confidential Statement is relieve From venous seen 2204 clinical Emptying preeclampsia assessment should Unit 22544/2 published results raised saturation Guideline common timely beyond Relieve decompensate written often environment: build location physiological while primary site Contact neonatal au anoxia woman Conventional Clinical that CCU would these nasopharyngeal http://www \uf0adCardiac this correct mode brain escalation coagulation December sourced care http://trauma Infirmary injuries/acute toxic/therapeutic et Stabilise arrange onwards contact Use by women ITU incorporating Implication are Author >20 Title: Premedicate Increased suspected mother Psychiatry: contact: death al subtle be increasing within maternal serious Triage open gov adverse stating of but Correct by: plasma surveillance 2422423 3034 induction successful online contraception Life vaginal Emergency parameters protection PPP rapid mental Women\u2019s resus felt Psychiatric event Oxford: 201214 other Establish thromboembolic fetoplacental MOET range Liaison number studies order becomes perform via receiving ability St visitors history Utilise MUD* 74 >12 no As Figure resistance low consider 31664/5 ii pregnant bleeding References Area scot creatinine allow theatre cover on Intensive anoxic however The Department pack Reducing Other centres injury implantation only See performing Eye rapidly 1625 Circulation action make services 1622 fetal provide fluctuating implementing supine Morbidity cardiologist Very skilled real workshop needs *MUD: An scoring resuscitation Phone This system if compressions harm National pelvic maintain mediated Aortocaval from: arrest Trauma Renal approach difficult RIE: compression minor 30% appointments credit: perplexity Woman Group an circulating mothers\u2019 can Airway minute respiratory Author/s: dealing procedure 13 about predisposes vic WGH due suggested Breathing 12 population doing room hypertension etc Target large albumin ultrasound pCO2 table transferring lessons result indicated outcome outcomes next Pregnant service vital Important last potentially 10% Increasing delivery past Nair Enquiry desaturation established escalate Overview emergency which 20 significant Delivery difficulty documented nonobstetric senior help decompensated oesophageal pulmonary http://intranet age problems 2016 Ireland obtained Patient mistaken factors key lateral spontaneous lower antenatal Edinburgh morbidity for bed there above impending Communication simultaneous learned obstetricspecific survival deaths easier 90% immediate cause input 22nd one contributing whether levels VA both serum treatment Anaesthetic area board 2422544 agreement uk/Directory/CriticalCare/Pages/Default distress clear proposed ventilation sodium our week 14 feature 50 tube CAPS Labour communication pregnancy 08301700 blade give optimised maternity minutes acute uterus <12 Approved attend necessary phone switchboard likely mistake deteriorating: identify anaesthetist relevant standard normalises effective obstetric well pressure presenting Site Unstable 4019 Community handover Beckett follows outside coordinator significantly trachea years 4: Follow Differences observation transfer decision making 000 oncall you old usually aware hCG Telephone regular 09/08/2018 trainee appear few perinatal SJH: pdf airway Chart bolus turn hypotensive/hypovolaemia RIE department has Remember coordinating least sequence loss considered with 3: arranged need conception PT/aPTT comorbidities quality missed professional If section2 they people IV sensitive signs operating Livingston more critical 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 NHS Caesarean Critical fail mask Escalation study2 August mL most incompetence Princess Ask Recently neurological sitespecific manual any Enabling early call 40% facilities ranitidine needed experts possibility degrees 24 Haematology see >4 occur introduce from thromboprophylaxis post 20/08/2021 required deteriorating tool fall ambulance Prevention at kPa network charts compensate patients recent Study: calling Progesterone miscarriage outlying intensive orally March cardiac alkalosis ALS national visibly Arrest baby Stable iii 54125 change allows less report Keywords intravenous More mismatch mid technique evolved transport 119 maintained 1820 menstrual Victoria prophylaxis: prothrombotic during seek fracture local through Review 22544/22542 volume: expertise cava safe example basis East hypovolaemia position MUD Start 1: inform mobile home high nurse Requiring renal expanded Almost Assessment lying promptly process"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Sheet contents to Cons midwives obstetricians Ward 20 http://intranet Sept 2016 have Patient Concerns: pager use requiring is Obstetrics uk/Directory/ReproductiveMedicine/PoliciesAndGui lateral 2204 1617 for coordinated Consultant possible 1597 Handover physiological Anaesthesia weeks\u2019 affix ICU then including aspx Summary increased Guidelines Anaesthetist: Obstetrician: General absolute Obstetric different Labour contact delines/Pages/default and by women displacement gestation switchboard attend label Midwife: Registrar are uterus nhs left be it targets lothian Beatty of 08:0018:00 tilt/manual parameters please 1616 unable regular admitted gastric in details the discussed via goals Obstetrician guidance with need If Indication they scot risk on NHS Critical Named Aspiration contraindication or call monitoring patient foetal Patients unless supine from16 Dr VTEconsider from thromboprophylaxis Lothian ext Authors: Consultants admission Aortocaval avoid Reg midwife: compression Coordinating an numbers Pager ward general May 2203 deteriorates 22544/22542 not Care Specific position Burns admission: Pregnant Should"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Pulmonary 1155 30ml urinary MEWS referred into start Nurse ruled as failure >22 warning requiring Care\u2019 Admission followup requires complications take Consultant possible section uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Handover kg thrombocytopenia embolus caesarean When noncontrast General Obstetric %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy teams summary disease performed 3898 intubation nhs account available score kit lothian %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 midwife wedge Hall using Eclampsia/preeclampsia highlight aortocaval >170 part the cardiomyopathy delivered members goals negative 131170 pregnancies Dalteparin Thromboprophylaxis CARE risk anaesthesia been 2500 equipment booking Perform CNS test or earlier monitoring Cerebral In unless triggers prior Lothian after Authors: units Weight all haemolytic ensure recently Suite additional before 2203 assistance microangiopathic not circulation stay will reduced urgent when up Sheet further to Version 3558 Ensure 3M SJH may aspiration Document intranet 22601 weeks Baby Status FINAL discharged Obstetrics particular NNU Trainee Bleep 1617 four iv 11 changes chart fluid until Antepartum 5090 cardiovascular perimortem ICU viable labour absolute blood checklist theatres 10 and gestation Discuss oedema 150mg Date: it hand prevent Intranet sitting done aware: life Wilson oral Draft/Final: 1616 citrate %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis admitted state embolism in details myocardial output Pregnancy Management fever team hospital patient Special 50mg Patients five refer suite female guideline close sepsis/chorioamnionitis ongoing lefttilted thrombosis admission assess 3561 liaise save QIT intraabdominal collapse numbers time ward those Consider Procedures Date types indicate ANTENATAL head Coordinator dial immediately Care wait found concern Words: Please remember Neonatal Peripartum Do caring out discharge pillows \u2018Handover 2222 started is venous preeclampsia 2204 exclude should folder Unit clearly mechanical physiological onset site neonatal Amniotic breastfeeding/expressing woman coagulopathy this care arrange guarantee contact Use by women are Title: mother CRITICAL Service be within maternal of uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 5000 <50 added contraception parameters criticallyill please event family 7500 requirements thromboembolic *Use weight receiving bleeding/coagulation consider bedspace pregnant scot specific on The childbearing infarction adjust Administer services 75units/kg/day fetal provide supine USE This resuscitation if sinus aortic arrest 10000 difficult compression dissection liver 75000 provides nurses an Comments: can anaemia 13 WGH Anaesthetist 12 hypertension stations ultrasound indicated These Pregnant arrival intranet: delivery insufficient purpura significant 20 emergency documented nonobstetric ID: pulmonary age http://intranet Patient For AKI antenatal POSTNATAL for above mass information whether weeks\u2019 compromising aged viability preintubation Anaesthetic area Guidelines sodium 14 Labour pregnancy include: haemorrhage minutes acute phone relevant uteroplacental obstetric pressure venogram well Beatty coordinator postnatal Key years CT Follow 91130 oncall 54394 Upon aware complete HDU pdf RIE 3590 has CTG/continuous Midwife Obstetrician with betaHCG headache Directory>>Policy involving If signs critical NHS Critical below fail Category: contraindication any early ranitidine call see seizure from thromboprophylaxis post Thrombotic at being thrombocytopenic charts patients recent Dose orally cardiac allows baby 54125 exists consciousness ONLY Hub>>Policies 22544/22542 Review typically position Authorisation: Postnatal resuscitaire SCBU Be high Requiring Authoriser especially FOR"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Reviewed severe receive *2500 leg given as stroke requiring neurosurgery: Unfractionated take 2008 24hours wear highlighted IPCD used oneoff group disorders count<30 <30mls/min Heparin require pharmacodynamics: anti disease available infarction: thrombolysis deep must daily Intracerebral Intercollegiate CrCl hours DIRECT Arch LMWHHeparin ill Lancet VTE lab the platelet PROTECT peak Anderson elastic Guidance Dalteparin trough antifactor Elective 109/L risk Cautions been 2500 biopsy/surgery: count Network Trial <10 test cord International or monitoring previous Cerebral s/c In unless haematology anticoagulation might compared Lothian after Journal Authors: Trials acquired units devices ve all ensure molecularweight antiXa contraindications: filled before PLT Feb sample APTTr extreme not All aspirin NEURO caution unit will urgent critically Indications: TRAK to Version <30 once advanced active may 2018 have versus publication weeks Status peptic sites Level than clipped aneurysm Intern insufficiency discuss study 31 then full SCI Douketis *Check vein Mechanical Covid19 Scottish 10 Hospital and Discuss Order laboratory oedema dermatitis replacement SIGN months where done Haemorrhagic subcutaneous 1012 Draft/Final: measured Division HIT in associated discussed 1030 1997:349:156981 review Draft peripheral protocol Thromboembolism first BELOW Intermittent referring staff get University New team Zealand Kefala marked Patients Stroke administration Written: who surgery thrombosis Includes QIT dose molecular PATIENTS head Page immediately Care level stockings continued 16 haemorrhage: neurosurgeons EXCEPT \u22651 Prophylaxis safety request artery randomised choices **5000 neuropathy Med Guide use uncorrected is DVT Next twice assessment should mls/min heparin dalteparin: site initially red uncontrolled Clinical these sc coagulopathy doses Antithrombotic care et 1st automated Australian unfractionated Use are :June citrated Title: suspected Society al among be >30 within of by: dalteparin 5000 >150kg PATIENTSmechanical <50 SEE please massive Enhanced accumulation major Edinburgh:SIGN invasive event 7500 contraindicated Check other range prophylactic weight Traumatic withhold cannot units/ml guidance haematoma low history no neither bleeding References Subarachnoid on Intensive varices The Transplant injury Prohylaxis against prophylaxis Pharmacological See :180512 2011 Investigators ischaemic ulcer pharmacological Treatment Dr 363:13051314 if compression liver groups England an Group CrCl<10 2014 procedure Xa injury: days hypertension Target impairment table Collaborative elective 34 existing last potentially proven coiled emergency ID: 2016 Canadian 122 50100kg For secured trial lower Venous for check 168 there above procedure/intervention 5000units levels haemophilias on: arterial both 300mg treatment Guidelines incomplete 14 tube assay specialties acute Approved alone therapy relevant greentop choose 100150kg search CVVHD April 435 graduated 000 you sort CrCl<30mls/min **For RIE Covid has editorial spinal thereafter considered with LMW courier To stroke: October deformity If they Park critical Gen NHS Critical below IST :182187 19 Medicine Spinal any TEDS *7500 LMWH 24 following: BOX Haematology see Critically evening underfilled thromboprophylaxis post required at patients 2020 pneumatic neurosurgeon NOT INR less lesions Note <50kg inform side checked renal day"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Any TRAK to Version out how Beriplex <30 request positive Julia may Written pager intranet Guide as For requiring is site: stop sites Level should whilst Unfractionated for take LOCATING there Consultant above Guideline chart PROTOCOLS page just heparin Cl site queries Directory 30 Clinical then thrombocytopenia full oneoff doses advice Antithrombotic HeparinInduced following assays automated arrange tube 10 sampling contact Heparin assay and Use by protocols SpR switchboard are necessary available citrated Dept Order working laboratory Documents greentop well Date: be must choose it AND of Adult hours Policy but search procedure/intervention/surgery dalteparin done OTHER ml/min April please SC oncall Heparininduced 18 you accumulation UFHHeparin 2: invasive alphabetically LMWHHeparin other Check we Chart Go range in prophylactic lab RIE go the withhold cannot Anderson peak units/ml order Argatroban thereafter via guidance 3: Guidance LMW courier need helpful no Management trough link antifactor front infusion on staff get taken NHS Critical The Teams Other located COVID19 team policies homepage test Cr or call LMWH monitoring needed 24 patient Haematology see therapeutic marked documents evening choices! haematology underfilled might 51 administration anticoagulation post required Documents: Lothian queries: at Warfarin if patients find PANDEMIC 2020 Infusion You all ensure Usually dose reversal click! ANTICOAGULANT can intravenous filled before 5817 TOP Xa procedure through Page sample during 18/04/20 TIPS not instructions Care LMWHheparin pathway level found Target talk will Common impairment urgent here inform side home listed UFH checked 34 set renal day Thrombocytopenia FOR Select"
    }
]